,Start Date,Start Price,End Date,End Price,Weekly Returns,Bin Label,News,Basics
0,2023-01-08,265.9811706542969,2023-01-15,262.62738037109375,-0.012609126709808072,D2,[],"{""assetTurnoverTTM"": 0.4257, ""bookValue"": 3661, ""cashRatio"": 0.48632625741059476, ""currentRatio"": 1.4143, ""ebitPerShare"": 4.145, ""eps"": 3.0037, ""ev"": 171455, ""fcfMargin"": 0.3376, ""fcfPerShareTTM"": 16.4513, ""grossMargin"": 0.7446, ""inventoryTurnoverTTM"": 1.421, ""longtermDebtTotalAsset"": 0.5736, ""longtermDebtTotalCapital"": 0.8767, ""longtermDebtTotalEquity"": 10.2032, ""netDebtToTotalCapital"": 0.735, ""netDebtToTotalEquity"": 8.5539, ""netMargin"": 0.2363, ""operatingMargin"": 0.3261, ""payoutRatioTTM"": 0.6404, ""pb"": 38.2789, ""peTTM"": 21.3887, ""pfcfTTM"": 15.9521, ""pretaxMargin"": 0.2556, ""psTTM"": 5.3238, ""quickRatio"": 1.1, ""receivablesTurnoverTTM"": 5.034, ""roaTTM"": 0.106, ""roeTTM"": 2.4611, ""roicTTM"": 0.1621, ""rotcTTM"": 0.2386, ""salesPerShare"": 12.7119, ""sgaToSale"": 0.2554, ""totalDebtToEquity"": 10.6378, ""totalDebtToTotalAsset"": 0.598, ""totalDebtToTotalCapital"": 0.9141, ""totalRatio"": 1.0596, ""period"": ""2022-12-31""}"
1,2023-01-15,262.62738037109375,2023-01-22,254.42176818847656,-0.03124431341097267,D4,[],"{""assetTurnoverTTM"": 0.4257, ""bookValue"": 3661, ""cashRatio"": 0.48632625741059476, ""currentRatio"": 1.4143, ""ebitPerShare"": 4.145, ""eps"": 3.0037, ""ev"": 171455, ""fcfMargin"": 0.3376, ""fcfPerShareTTM"": 16.4513, ""grossMargin"": 0.7446, ""inventoryTurnoverTTM"": 1.421, ""longtermDebtTotalAsset"": 0.5736, ""longtermDebtTotalCapital"": 0.8767, ""longtermDebtTotalEquity"": 10.2032, ""netDebtToTotalCapital"": 0.735, ""netDebtToTotalEquity"": 8.5539, ""netMargin"": 0.2363, ""operatingMargin"": 0.3261, ""payoutRatioTTM"": 0.6404, ""pb"": 38.2789, ""peTTM"": 21.3887, ""pfcfTTM"": 15.9521, ""pretaxMargin"": 0.2556, ""psTTM"": 5.3238, ""quickRatio"": 1.1, ""receivablesTurnoverTTM"": 5.034, ""roaTTM"": 0.106, ""roeTTM"": 2.4611, ""roicTTM"": 0.1621, ""rotcTTM"": 0.2386, ""salesPerShare"": 12.7119, ""sgaToSale"": 0.2554, ""totalDebtToEquity"": 10.6378, ""totalDebtToTotalAsset"": 0.598, ""totalDebtToTotalCapital"": 0.9141, ""totalRatio"": 1.0596, ""period"": ""2022-12-31""}"
2,2023-01-22,254.42176818847656,2023-01-29,245.15306091308594,-0.03643048054176057,D4,"[{""date"": ""20230124155348"", ""headline"": ""Dogs of the Dow 2023: 5 Dividend Stocks for Income Investors"", ""summary"": ""The start of the year is a good time to add to your existing portfolio or start new positions. An excellent source to look for ideas is among the Dogs of the Dow. These stocks are the highest-yielding ones in the Dow Jones Industrial Average (DJIA) at the end of the preceding year. The strategy assumes the stocks are temporarily mispriced, and thus the yields are high. Additionally, the Dogs of the Dow are blue-chip stocks with sustainable growth and excellent reputations. Hence, they make good""}, {""date"": ""20230125081451"", ""headline"": ""Why Viridian Therapeutics Is One Of My 2023 Top Picks"", ""summary"": ""Viridian was one of my top picks in 2022 and it made the 2023 list again. Click here to see our take on VRDN stock.""}, {""date"": ""20230125085901"", ""headline"": ""Amgen (AMGN) to Report Q4 Earnings: What's in the Cards?"", ""summary"": ""Volume growth from Amgen's (AMGN) key drugs like Prolia, Otezla, Repatha and others is expected to have been partially offset by biosimilar/generic competition for mature drugs.""}, {""date"": ""20230125100003"", ""headline"": ""Earnings Preview: GSK (GSK) Q4 Earnings Expected to Decline"", ""summary"": ""Glaxo (GSK) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.""}, {""date"": ""20230126082300"", ""headline"": ""2 Top Biotech Stocks to Buy for the Long Haul"", ""summary"": ""Equity markets are entirely unpredictable in the short run.  The biotech industry is a great place to look for stocks that can survive down markets and be successful over long periods since the drugs these companies develop are so critical to their customers' lives.  Let's look at two biotech stocks to buy today and hold on to for a while: Amgen (NASDAQ: AMGN) and Moderna (NASDAQ: MRNA).""}, {""date"": ""20230126090011"", ""headline"": ""Is Amgen Inc. (NASDAQ:AMGN) Trading At A 29% Discount?"", ""summary"": ""In this article we are going to estimate the intrinsic value of Amgen Inc. ( NASDAQ:AMGN ) by estimating the company's...""}, {""date"": ""20230126120738"", ""headline"": ""Warren tells FTC she is \""particularly concerned\"" about Amgen and Indivior deals"", ""summary"": ""Sen. Elizabeth Warren, an outspoken critic of corporate consolidation, wrote to the U.S. Federal Trade Commission to express concern about two pending pharmaceutical deals.  In a letter dated Wednesday, Warren said that she was focused on Amgen's plan to buy Horizon Therapeutics , and addiction specialist Indivior's plan to buy Opiant for $145 million, which was announced in mid-November.  \""Given these companies' records of anti-competitive business practices, these acquisitions could cause further price increases on lifesaving drugs and prevent affordable alternatives from entering the market,\"" she wrote in the letter to FTC Chair Lina Khan as well as Commissioners Rebecca Slaughter and Alvaro Bedoya, all of whom are Democrats.""}, {""date"": ""20230126154351"", ""headline"": ""UPDATE 2-U.S. Senator Warren 'particularly concerned' about Amgen, Indivior deals"", ""summary"": ""Sen. Elizabeth Warren, an outspoken critic of corporate consolidation, wrote to the U.S. Federal Trade Commission to express concern about two pending pharmaceutical deals.  In a letter dated Wednesday, Warren said that she was focused on Amgen's plan to buy Horizon Therapeutics , and addiction specialist Indivior's plan to buy Opiant for $145 million, which was announced in mid-November.  \""Given these companies' records of anti-competitive business practices, these acquisitions could cause further price increases on lifesaving drugs and prevent affordable alternatives from entering the market,\"" she wrote in the letter to FTC Chair Lina Khan as well as Commissioners Rebecca Slaughter and Alvaro Bedoya, all of whom are Democrats.""}, {""date"": ""20230126160000"", ""headline"": ""AMGEN ANNOUNCES WEBCAST OF 2022 FOURTH QUARTER AND FULL YEAR FINANCIAL RESULTS"", ""summary"": ""Amgen (NASDAQ:AMGN) today announced that it will report its fourth quarter and full year 2022 financial results on Tuesday, Jan. 31, 2023, after the close of the U.S. financial markets. The announcement will be followed by a conference call with the investment community at 4:30 p.m. ET. Participating in the call from Amgen will be Robert A. Bradway, chairman and chief executive officer, and other members of Amgen's senior management team.""}, {""date"": ""20230126174317"", ""headline"": ""U.S. Senator Warren 'particularly concerned' about Amgen, Indivior deals"", ""summary"": ""Sen. Elizabeth Warren, an outspoken critic of corporate consolidation, wrote to the U.S. Federal Trade Commission to express concern about two pending pharmaceutical deals.""}, {""date"": ""20230126174510"", ""headline"": ""Amgen (AMGN) Stock Sinks As Market Gains: What You Should Know"", ""summary"": ""Amgen (AMGN) closed the most recent trading day at $254.88, moving -0.65% from the previous trading session.""}, {""date"": ""20230127023400"", ""headline"": ""Bristol Myers Gets CHMP Backing for Sotyktu, Reblozyl >BMY"", ""summary"": ""By Colin Kellaher Bristol Myers Squibb Co. on Friday said the European Medicines Agency's Committee for Medicinal Products for Human Use has recommended...""}]",{}
3,2023-01-29,245.15306091308594,2023-02-05,236.9571075439453,-0.033431984649158974,D4,"[{""date"": ""20230130075258"", ""headline"": ""Amgen lays off 300 employees "", ""summary"": ""Amgen Inc said on Monday that it had let go about 300 employees based in the United States, mainly in its commercial team, citing recent organizational changes to better manage the company against \""industry headwinds\"". (Reporting by Bhanvi Satija in Bengaluru; Editing by...""}, {""date"": ""20230130083000"", ""headline"": ""SCHG Adds Growth In A 2-ETF Package That Beat The S&P 500 Over 10 Years"", ""summary"": ""For this article, I decided to take a look at SCHG, an ETF I hadn't previously reviewed. Click here to read what happened after combining this ETF with SCHD.""}, {""date"": ""20230131080700"", ""headline"": ""First Humira Biosimilar Price Highlights Cost-Saving Challenges"", ""summary"": ""Hopes that competition would bring immediate cost savings was tamped down when Amgen announced a pricing scheme for its generic-style competitor to AbbVie's...""}, {""date"": ""20230131102542"", ""headline"": ""Amgen launches biosimilar version of AbbVie's Humira"", ""summary"": ""Amgen Inc said on Tuesday it launched a biosimilar version of AbbVie Inc's big selling arthritis treatment, the first such competition for Humira in the United States.""}, {""date"": ""20230131112100"", ""headline"": ""Amgen 4Q Profit Declines, Revenue Ticks Down Slightly"", ""summary"": ""By Denny Jacob Amgen Inc. on Tuesday reported lower profit and revenue that dipped in the latest quarter. The biotechnology company reported net income of...""}, {""date"": ""20230131114300"", ""headline"": ""Amgen's Q4 tops views, but 2023 guidance falls on lower end of expectations"", ""summary"": ""Amgen Inc. topped Wall Street expectations for its fourth quarter, but the drug maker's shares fell after hours as its 2023 guidance fell on the lower end of...""}, {""date"": ""20230131121328"", ""headline"": ""Barron's And Bloomberg 2023 Ideal Dividend Stocks Of The Year"", ""summary"": ""Two Barron\u00e2\u0080\u0099s Annual Roundtable, plus one Bloomberg Intelligence, articles published late-January listed 99 intriguing stocks for 2023. Read our analysis.""}, {""date"": ""20230131163855"", ""headline"": ""UPDATE 1-Amgen revenue falls slightly as Lilly COVID deal contributes less"", ""summary"": ""Amgen Inc on Tuesday said its fourth-quarter revenue fell slightly as a 4% increase in sales of its own drugs was offset by lower revenue from its deal to manufacture COVID-19 antibody treatments for Eli Lilly and Co.  Amgen reported revenue of $6.84 billion for the quarter, down from $6.85 billion a year ago, but ahead of analysts' estimates of $6.77 billion, according to Refinitiv data.  Amgen partnered with Lilly in 2020 to increase the supply of its COVID-19 antibody treatments.""}, {""date"": ""20230131163858"", ""headline"": ""Amgen revenue falls slightly as Lilly COVID deal contributes less"", ""summary"": ""Amgen Inc on Tuesday said its fourth-quarter revenue fell slightly as a 4% increase in sales of its own drugs was offset by lower revenue from its deal to manufacture COVID-19 antibody treatments for Eli Lilly and Co.""}, {""date"": ""20230131164400"", ""headline"": ""Amgen\u2019s Q4 tops views, but 2023 guidance falls on lower end of expectations"", ""summary"": ""Amgen Inc. topped Wall Street expectations for its fourth quarter, but the drug maker's shares fell after hours as its 2023 guidance fell on the lower end of Wall Street's expectations.""}, {""date"": ""20230131165923"", ""headline"": ""Stocks moving in after hours: AMD, Snap, Match Group, Electronic Arts, Amgen"", ""summary"": ""Yahoo Finance Live co-host Seana Smith discusses stocks moving in after-hours trading.""}, {""date"": ""20230131172510"", ""headline"": ""Amgen (AMGN) Surpasses Q4 Earnings and Revenue Estimates"", ""summary"": ""Amgen (AMGN) delivered earnings and revenue surprises of 1.24% and 1.49%, respectively, for the quarter ended December 2022. Do the numbers hold clues to what lies ahead for the stock?""}, {""date"": ""20230131183905"", ""headline"": ""Amgen Inc. (AMGN) Q4 2022 Earnings Call Transcript"", ""summary"": ""Call Start: 16:30 January 1, 0000 6:00 PM ETAmgen Inc.""}, {""date"": ""20230201004900"", ""headline"": ""Nasdaq jumps 2% to end at highest since September after Fed raises rate by a quarter-point, Powell signals few more hikes to go"", ""summary"": ""U.S. stocks finish higher on Wednesday, reversing earlier losses after the Federal Reserve raised its policy interest rate by 25 basis points, as widely...""}, {""date"": ""20230201042409"", ""headline"": ""Compared to Estimates, Amgen (AMGN) Q4 Earnings: A Look at Key Metrics"", ""summary"": ""While the top- and bottom-line numbers for Amgen (AMGN) give a sense of how the business performed in the quarter ended December 2022, it could be worth looking at how some of its key metrics compare to Wall Street estimates and year-ago values.""}, {""date"": ""20230201050000"", ""headline"": ""Amgen, Travelers share losses lead Dow's 185-point fall"", ""summary"": ""The Dow Jones Industrial Average is down Wednesday morning with shares of Amgen and Travelers delivering the stiffest headwinds for the blue-chip average....""}, {""date"": ""20230201060100"", ""headline"": ""Amgen, Travelers share losses lead Dow's 336-point fall"", ""summary"": ""Dragged down by losses for shares of Amgen and Travelers, the Dow Jones Industrial Average is trading down Wednesday morning. The Dow was most recently...""}, {""date"": ""20230201074241"", ""headline"": ""Amgen Records Slight Fall In Quarterly Earnings; Lower COVID-19 Manufacturing Pacts Impact Bottomline"", ""summary"": ""Amgen Inc's (NASDAQ: AMGN) fourth-quarter revenues were $6.84 billion, beating the consensus of $6.76 billion, largely unchanged from Q4 2021, and benefited from a 4% increase in product sales, offset by lower COVID-19 manufacturing collaboration revenues. Product sales growth was driven by 10% volume growth, partially offset by a 3% lower net selling price and a 2% negative impact from foreign exchange. Excluding the 2% negative impact of foreign exchange on product sales, total revenues increa""}, {""date"": ""20230201075835"", ""headline"": ""US STOCKS-Futures dip on jitters ahead of ADP report, Fed decision"", ""summary"": ""U.S. stock index futures slipped on Wednesday as investors cautiously waited for the Federal Reserve's decision on interest rates later in the day and a reading on private job additions last month.  The Fed is widely seen as raising its target interest rate by a quarter of a percentage point in its first policy meeting of the year, after the rapid increases in 2022 to tame decades-high inflation.  Investors will also likely parse Chair Jerome Powell news conference for clues on the trajectory of future rate hikes.""}, {""date"": ""20230201080000"", ""headline"": ""Amgen Shares Slip 4.1% Following Decline in 4Q Profit, Revenue"", ""summary"": ""By Denny Jacob Amgen Inc. shares slipped 4.1% to $242.17 following lower profit and a dip in revenue in its latest quarter. The biotechnology company on...""}, {""date"": ""20230201083109"", ""headline"": ""Amgen (NASDAQ:AMGN) Is Increasing Its Dividend To $2.13"", ""summary"": ""Amgen Inc. ( NASDAQ:AMGN ) will increase its dividend from last year's comparable payment on the 8th of March to $2.13...""}, {""date"": ""20230201090401"", ""headline"": ""US STOCKS-Wall St set to open lower ahead of Fed decision; AMD rises on outlook"", ""summary"": ""U.S. stock indexes were set to open lower on Wednesday as investors cautiously awaited the Federal Reserve's decision on interest rates later in the day, while chipmaker Advanced Micro Devices climbed on an upbeat outlook.  The Fed is widely seen as raising its target interest rate by a quarter of a percentage point in its first policy meeting of the year, after the rapid increases in 2022 to tame decades-high inflation.  \""Consensus is that the Fed is going to talk very hawkish today even though it's only doing 25 basis points,\"" said Thomas Hayes, chairman at investment firm Great Hill Capital.""}, {""date"": ""20230201090900"", ""headline"": ""Dow's 235-point drop led by losses in Amgen, Travelers shares"", ""summary"": ""Shares of Amgen and Travelers are trading lower Wednesday afternoon, sending the Dow Jones Industrial Average into negative territory. The Dow was most...""}, {""date"": ""20230201103103"", ""headline"": ""Amgen (AMGN) Beats on Q4 Earnings, 2023 Sales View Disappoints"", ""summary"": ""Amgen (AMGN) beats Q4 estimates for earnings and sales. It launches Amjevita in the United States, which is the first biosimilar of Humira to be launched in the country.""}, {""date"": ""20230201105718"", ""headline"": ""US STOCKS-Wall St dips as Fed decision looms; AMD boosts chipmakers"", ""summary"": ""U.S. stock indexes fell on Wednesday ahead of the Federal Reserve's decision on interest rates later in the day, while an upbeat outlook from Advanced Micro Devices lifted chipmakers.  The Fed is widely seen as raising its target interest rate by a quarter of a percentage point in its first policy meeting of the year, after the rapid increases in 2022 to tame decades-high inflation.""}, {""date"": ""20230201113600"", ""headline"": ""Amgen Inc. stock underperforms Wednesday when compared to competitors"", ""summary"": ""Shares of Amgen Inc. slipped 2.37% to $246.41 Wednesday, on what proved to be an all-around great trading session for the stock market, with the S&P 500...""}, {""date"": ""20230201120323"", ""headline"": ""My 26 Stock ~$384k Portfolio Sports Double-Digit Returns To Start The New Year"", ""summary"": ""My portfolio, built specifically for my retirement, features growth, dividend, and risk stocks for a happy retirement. Click here to see my strategy.""}, {""date"": ""20230201131334"", ""headline"": ""US STOCKS-Wall St falls as Fed decision looms; AMD boosts chipmakers"", ""summary"": ""U.S. stock indexes fell on Wednesday ahead of the Federal Reserve's decision on interest rates later in the day, while an upbeat outlook from Advanced Micro Devices lifted chipmakers.  The Fed is widely seen as raising its target interest rate by a quarter of a percentage point in its first policy meeting of the year, after rapid increases in 2022 to tame decades-high inflation.""}, {""date"": ""20230201133218"", ""headline"": ""FOCUS-AbbVie's Humira gets a U.S. rival, but costs could stay high"", ""summary"": ""U.S. patients will finally get access to cheaper versions of AbbVie Inc\u2019s blockbuster arthritis drug Humira this year, but the cost savings are expected to be limited.  Rival drugmaker Amgen Inc on Tuesday launched Amjevita, the first biosimilar version of AbbVie\u2019s 20-year-old drug, with two tiers of pricing.  One sets a 5% discount to Humira\u2019s monthly price of $6,922.""}, {""date"": ""20230201160311"", ""headline"": ""There's A Key Element Missing From Amgen's 2023 Outlook, Making Comparisons 'Messy'"", ""summary"": ""Amgen issued an outlook that discounts its looming acquisition of Horizon Therapeutics. In response, Amgen stock skidded Wednesday morning.""}, {""date"": ""20230201170619"", ""headline"": ""Why Amgen Stock Wilted on Wednesday"", ""summary"": ""The stock of veteran biotech Amgen (NASDAQ: AMGN) was looking a little tired on Wednesday.  The company's shares fell more than 2% in price, \""thanks\"" to fourth-quarter results that didn't put smiles on investors' faces.  In contrast to gloomy Amgen, the S&P 500 index ticked up by slightly more than 1%.""}, {""date"": ""20230202000400"", ""headline"": ""S&P 500 surges to end at over five-month high, Nasdaq closes up 3.3% as Meta leads rally in tech sector stocks"", ""summary"": ""U.S. stocks ended mostly higher on Thursday after the Nasdaq Composite and the S&P 500 index surged to their highest levels in about five months, buoyed by...""}, {""date"": ""20230202090000"", ""headline"": ""TEZSPIRE\u00ae APPROVED FOR SELF-ADMINISTRATION IN THE U.S. WITH A NEW PRE-FILLED PEN"", ""summary"": ""Amgen (NASDAQ:AMGN) and AstraZeneca today announced the U.S. Food and Drug Administration (FDA) has approved TEZSPIRE\u00ae (tezepelumab-ekko) for self-administration in a pre-filled, single-use pen for patients aged 12 years and older with severe asthma.1 First approved by the FDA in December 2021, TEZSPIRE is the only biologic approved for severe asthma with no phenotype (e.g., eosinophilic or allergic) or biomarker limitation within its approved label.2-9""}, {""date"": ""20230202113600"", ""headline"": ""Amgen Inc. stock rises Thursday, still underperforms market"", ""summary"": ""Shares of Amgen Inc. inched 0.05% higher to $246.53 Thursday, on what proved to be an all-around mixed trading session for the stock market, with the S&P 500...""}, {""date"": ""20230202143534"", ""headline"": ""The 7 Most Undervalued Dow Stocks to Buy in February 2023"", ""summary"": ""While investing in the new normal seemingly focused on meme trades and other high-risk ventures, targeting the companies of the Dow Jones is always relevant, particularly if they\u2019re among the most undervalued Dow stocks to buy. Granted, this venerable list doesn\u2019t bring much excitement. However, these stalwarts command well-established businesses, meaning they likely won\u2019t steer you wrong. Before we begin, though, we need to establish some ground rules. First, none of the most undervalued Dow st""}, {""date"": ""20230202174700"", ""headline"": ""What\u2019s Ailing the Dow This Year? UnitedHealth, Chevron, J&J, Amgen."", ""summary"": ""The Dow industrials fell 39 points, or 0.1%, to 34,054, while the  gained 1.5% to 4,179 and the  was up 3.3%.  Several influential stocks in the index are in the red this year, led by  UnitedHealth  Group (ticker: UNH), which is the worst percentage loser, with an 11.1% drop to $470.83.  Other losers in the Dow include  Amgen  (AMGN),  Merck  (MRK),  Johnson & Johnson  (JNJ),  Procter & Gamble  (PG), and  Chevron  (CVX)\u2014which all are down about 6%, Bloomberg data show.""}, {""date"": ""20230203113600"", ""headline"": ""Amgen Inc. stock falls Friday, still outperforms market"", ""summary"": ""Shares of Amgen Inc. slumped 0.55% to $245.17 Friday, on what proved to be an all-around dismal trading session for the stock market, with the S&P 500 Index...""}, {""date"": ""20230205022900"", ""headline"": ""Top 3 Corporate Events To Look For In 2023 (That Aren't Earnings Dates)"", ""summary"": ""We\u00e2\u0080\u0099re in the midst of the fourth quarter earnings season and already we\u00e2\u0080\u0099re seeing a cautionary setup for 2023 as corporations find ways to cut back.""}, {""date"": ""20230205120000"", ""headline"": ""AbbVie: The Dreaded Humira Cliff Is Here: Time To Sell?"", ""summary"": ""The day has arrived: Biosimilars for AbbVie's blockbuster drug Humira are now being sold in the US. See whether it's not time to sell ABBV?""}]",{}
4,2023-02-05,236.9571075439453,2023-02-12,234.37657165527344,-0.01089030801995794,D2,"[{""date"": ""20230205022900"", ""headline"": ""Top 3 Corporate Events To Look For In 2023 (That Aren't Earnings Dates)"", ""summary"": ""We\u00e2\u0080\u0099re in the midst of the fourth quarter earnings season and already we\u00e2\u0080\u0099re seeing a cautionary setup for 2023 as corporations find ways to cut back.""}, {""date"": ""20230205120000"", ""headline"": ""AbbVie: The Dreaded Humira Cliff Is Here: Time To Sell?"", ""summary"": ""The day has arrived: Biosimilars for AbbVie's blockbuster drug Humira are now being sold in the US. See whether it's not time to sell ABBV?""}, {""date"": ""20230206070017"", ""headline"": ""Is Amgen (NASDAQ:AMGN) Using Too Much Debt?"", ""summary"": ""Warren Buffett famously said, 'Volatility is far from synonymous with risk.' It's only natural to consider a company's...""}, {""date"": ""20230206113600"", ""headline"": ""Amgen Inc. stock outperforms market despite losses on the day"", ""summary"": ""Shares of Amgen Inc. shed 0.54% to $243.85 Monday, on what proved to be an all-around rough trading session for the stock market, with the S&P 500 Index...""}, {""date"": ""20230207113600"", ""headline"": ""Amgen Inc. stock rises Tuesday, still underperforms market"", ""summary"": ""Shares of Amgen Inc. inched 0.06% higher to $244.00 Tuesday, on what proved to be an all-around positive trading session for the stock market, with the S&P...""}, {""date"": ""20230208055000"", ""headline"": ""Beat the Dow Jones With This Unstoppable Dividend Stock"", ""summary"": ""The Dow Jones Industrial Average contains 30 of the highest quality businesses in the world.  A $10,000 investment in the stock made 10 years ago would now be worth $37,000 with dividends reinvested.  For context, that is nearly double the $20,000 that the same investment made in the Dow Jones would be worth after 10 years with dividends reinvested.""}, {""date"": ""20230208082559"", ""headline"": ""Amgen Inc. (NASDAQ:AMGN) Q4 2022 Earnings Call Transcript"", ""summary"": ""Amgen Inc. (NASDAQ:AMGN) Q4 2022 Earnings Call Transcript January 31, 2023 Amgen Inc. misses on earnings expectations. Reported EPS is $4.09 EPS, expectations were $4.1. Operator: My name is Jason and I will be the conference facilitator today for Amgen\u2019s Fourth Quarter Full Year 2022 Financial Results Conference Call. I would now like to introduce [\u2026]""}, {""date"": ""20230208095109"", ""headline"": ""Mirati Therapeutics: Suddenly A Battleground Stock"", ""summary"": ""Mirati Therapeutics is focused on developing product candidates to address the genetic and immunological promoters of cancer. Read my analysis of MRTX stock.""}, {""date"": ""20230209025700"", ""headline"": ""AbbVie`s stock gains on Q4 results"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230209030400"", ""headline"": ""AbbVie\u2019s stock gains on Q4 results"", ""summary"": ""Shares of AbbVie Inc. gained 2.4% in premarket trading on Thursday after the company beat earnings expectations for the fourth quarter of 2022. AbbVie had a...""}, {""date"": ""20230209051326"", ""headline"": ""There's A Lot To Like About Amgen's (NASDAQ:AMGN) Upcoming US$2.13 Dividend"", ""summary"": ""It looks like Amgen Inc. ( NASDAQ:AMGN ) is about to go ex-dividend in the next four days. The ex-dividend date is one...""}, {""date"": ""20230209064400"", ""headline"": ""AbbVie gains after revising estimates for Humira sales erosion"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230209093718"", ""headline"": ""How To Profit From Amgen Stock's Plunge Using Options"", ""summary"": ""Amgen (AMGN) stock has had a difficult few weeks, with the stock dropping from 295 to 240. It is currently the most oversold stock in the Dow Jones Industrial Average. When a quality company has a big drop like this, I like to use a strategy called a diagonal put spread. This option strategy is an advanced strategy because it...""}, {""date"": ""20230209113704"", ""headline"": ""AbbVie (ABBV) Beats Q4 Earnings Estimates, Misses on Sales"", ""summary"": ""AbbVie's Q4 earnings (ABBV) beat estimates, while sales miss the same. Full-year 2023 EPS falls short of estimates.""}, {""date"": ""20230209134655"", ""headline"": ""9 Upcoming Dividend Increases"", ""summary"": ""I've tracked 35 dividend increases in 2023 for your consideration. There are nine increases for next week, up from two last week. Click here to read more.""}, {""date"": ""20230209160000"", ""headline"": ""AMGEN TO PRESENT AT THE 2023 SVB SECURITIES GLOBAL BIOPHARMA CONFERENCE"", ""summary"": ""Amgen (NASDAQ:AMGN) will present at the 2023 SVB Securities Global Biopharma Conference at 10:40 a.m. ET on Tuesday, February 14, 2023. Susan Sweeney, senior vice president, Global Marketing, Access and Capabilities at Amgen will present at the conference. The webcast will be broadcast over the internet simultaneously and will be available to members of the news media, investors and the general public.""}, {""date"": ""20230209223700"", ""headline"": ""Amgen Inc. stock outperforms market on strong trading day"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230210000915"", ""headline"": ""High Yield Stock Watchlist - February 2023"", ""summary"": ""The majority of the stocks on my watchlist are undervalued based on dividend yield theory. Click here for a detailed analysis.""}, {""date"": ""20230210011800"", ""headline"": ""Medicare mulls rebates in 2025 for drug prices rising faster than inflation"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230210041200"", ""headline"": ""Chevron, Amgen share gains contribute to Dow`s 66-point jump"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230210042912"", ""headline"": ""BME: Well-Positioned Healthcare CEF For Monthly Income"", ""summary"": ""BlackRock Health Sciences Trust is a top healthcare CEF with long tenure that offers monthly distributions and an average yield. See why I'm bullish on BME CEF.""}, {""date"": ""20230211040000"", ""headline"": ""How This Income Method Could Lead To Financial Freedom"", ""summary"": ""We will go over our thesis as to how a diversified income method with low volatility could make you financially independent. Click here for our strategy.""}, {""date"": ""20230211222216"", ""headline"": ""Dividend Champion, Contender, And Challenger Highlights: Week Of February 12"", ""summary"": ""A weekly summary of dividend activity for Dividend Champions, Contenders, and Challengers. Click here to read the update for the week of February 12.""}, {""date"": ""20230212153456"", ""headline"": ""12 Most Undervalued Dow Stocks To Buy According To Hedge Funds"", ""summary"": ""In this article, we will take a look at the 12 most undervalued dow stocks to buy according to hedge funds. To see more such companies, go directly to 5 Most Undervalued Dow Stocks To Buy According To Hedge Funds. The stock market bloodbath that started in 2022 has forced investors to shun the so-called [\u2026]""}]",{}
5,2023-02-12,234.37657165527344,2023-02-19,234.52267456054688,0.0006233682156948639,U1,"[{""date"": ""20230211222216"", ""headline"": ""Dividend Champion, Contender, And Challenger Highlights: Week Of February 12"", ""summary"": ""A weekly summary of dividend activity for Dividend Champions, Contenders, and Challengers. Click here to read the update for the week of February 12.""}, {""date"": ""20230212153456"", ""headline"": ""12 Most Undervalued Dow Stocks To Buy According To Hedge Funds"", ""summary"": ""In this article, we will take a look at the 12 most undervalued dow stocks to buy according to hedge funds. To see more such companies, go directly to 5 Most Undervalued Dow Stocks To Buy According To Hedge Funds. The stock market bloodbath that started in 2022 has forced investors to shun the so-called [\u2026]""}, {""date"": ""20230212202100"", ""headline"": ""OmniAb initiated with a buy at H.C. Wainwright on antibody collaborations, partnerships"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230212205300"", ""headline"": ""ARK Invest: The 7 Words That Explain Why Wall Street Can`t Stand Cathie Wood"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230213012600"", ""headline"": ""Truist Financial Sticks to Their Hold Rating for Amgen (AMGN)"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230213022200"", ""headline"": ""Amgen price target lowered to $260 from $280 at Truist"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230213032800"", ""headline"": ""Don`t Buy Viatris And Organon Just Because Of The Dividends"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230213042736"", ""headline"": ""Don't Buy Viatris And Organon Just Because Of The Dividends"", ""summary"": ""Viatris and Organon are what can currently be described as deep value plays in the pharmaceutical sector. Click for more on OGN and VTRS.""}, {""date"": ""20230213070021"", ""headline"": ""Amgen's (NASDAQ:AMGN) investors will be pleased with their notable 52% return over the last five years"", ""summary"": ""While Amgen Inc. ( NASDAQ:AMGN ) shareholders are probably generally happy, the stock hasn't had particularly good run...""}, {""date"": ""20230213113600"", ""headline"": ""Amgen Inc. stock rises Monday, still underperforms market"", ""summary"": ""Shares of Amgen Inc. inched 0.48% higher to $243.66 Monday, on what proved to be an all-around positive trading session for the stock market, with the S&P...""}, {""date"": ""20230213214400"", ""headline"": ""Tuesday Talk: My Sweet CPI"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230214035400"", ""headline"": ""Amgen Inc. (AMGN) SVB Securities Global Biopharma Conference (Transcript)"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230214050100"", ""headline"": ""Top 5 4th Quarter Trades of Compagnie Lombard Odier SCmA"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230214111004"", ""headline"": ""Top Research Reports for Chevron, Novo Nordisk & Amgen"", ""summary"": ""Today's Research Daily features new research reports on 16 major stocks, including Chevron Corporation (CVX), Novo Nordisk A/S (NVO) and Amgen Inc. (AMGN).""}, {""date"": ""20230214121853"", ""headline"": ""Health Rounds: Pancreas cancer rising faster among younger U.S. women"", ""summary"": ""Pancreas cancer rates are climbing in the U.S., but they\u2019re rising faster in younger women than in their male counterparts, a large study shows.  In other news, a drug that delivers a cancer-killing virus directly into tumors may be an effective new alternative for patients with a hard-to-treat form of breast cancer.  Pancreas cancer rates in the United States are increasing faster in younger women than in their male counterparts, a large study has found.""}, {""date"": ""20230214143800"", ""headline"": ""Amgen plans mega bond deal to help fund $28 billion Horizon Therapeutics acquisition"", ""summary"": ""Amgen Inc. plans to finance its acquisition of Horizon Therapeutics in the corporate bond market, underscoring how the Federal Reserve's inflation fight isn't drying up mega deals on Wall Street.""}, {""date"": ""20230214201200"", ""headline"": ""Amgen bond offering to help fund Horizon Therapeutics acquisition"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230214210100"", ""headline"": ""FEDERATED HERMES, INC. Buys 1, Sells 4 in 4th Quarter"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230214210100"", ""headline"": ""Palouse Capital Management, Inc. Buys 2, Sells 3 in 4th Quarter"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230214233422"", ""headline"": ""Top Merger Stocks Held By Fund Managers, Mid-Q1 2023"", ""summary"": ""Form 13F filings show fund managers' top arbitrage stocks. Find out top M&A stocks of the 28 funds I follow and this quarter's top stock.""}, {""date"": ""20230215054300"", ""headline"": ""Why Billionaires Paul Tudor Jones and George Soros Bought Up Horizon (HZNP) Stock"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230215060100"", ""headline"": ""Amgen sees about $56 billion in demand for mega bond deal"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230215071700"", ""headline"": ""Medicare mulls limiting per month costs for generic drugs at $2"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230215082901"", ""headline"": ""The Zacks Analyst Blog Highlights Chevron, Novo Nordisk, Amgen, Starbucks and General Dynamics"", ""summary"": ""Chevron, Novo Nordisk, Amgen, Starbucks and General Dynamics are part of the Zacks top Analyst Blog.""}, {""date"": ""20230215110842"", ""headline"": ""5 Stocks In The Dividend Growth Sweet Spot"", ""summary"": ""Finding companies with a high initial yield and rapid dividend growth is difficult. Here's my criteria for finding such companies.""}, {""date"": ""20230215113600"", ""headline"": ""Amgen Inc. stock outperforms competitors despite losses on the day"", ""summary"": ""Shares of Amgen Inc. shed 0.40% to $240.07 Wednesday, on what proved to be an all-around great trading session for the stock market, with the S&P 500 Index...""}, {""date"": ""20230215142100"", ""headline"": ""Amgen to raise $24 billion after seeing about $90 billion in demand for mega bond deal"", ""summary"": ""Amgen looks to raise $24 billion on Wednesday, ranking in the top 10 in terms of largest U.S. corporate bond deals ever, according to Informa Global Markets.""}, {""date"": ""20230215200845"", ""headline"": ""Competition Coming For AbbVie's Blockbuster Humira"", ""summary"": ""It\u00e2\u0080\u0099s among the prohibitively expensive biologic pharmaceuticals being replaced by cheaper \u00e2\u0080\u009cbiosimilar\u00e2\u0080\u009d copycats. Read how price relief is on the way for Humira.""}, {""date"": ""20230216000200"", ""headline"": ""AMGN Near Buy Point With Strong Fundamentals And Rising Dividend"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230216042000"", ""headline"": ""O`Keefe Stevens Advisory Q4 2022 Update"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230216045116"", ""headline"": ""Renaissance Technologies Top Trades This Quarter Included Apple, Amazon, Taiwan Semiconductor And More Released Here"", ""summary"": """"}, {""date"": ""20230216050200"", ""headline"": ""Dow, Amgen share losses lead Dow`s 225-point fall"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230216052900"", ""headline"": ""Amgen Enters Oversold Territory"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230216060100"", ""headline"": ""Dow, Amgen share losses lead Dow's 225-point fall"", ""summary"": ""Behind declines for shares of Dow and Amgen, the Dow Jones Industrial Average is trading down Thursday morning. Shares of Dow and Amgen have contributed to...""}, {""date"": ""20230216063600"", ""headline"": ""Dow`s 139-point drop led by losses for Microsoft, Amgen stocks"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230216070900"", ""headline"": ""Competition Coming For AbbVie`s Blockbuster Humira"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230216073500"", ""headline"": ""Dow's 139-point drop led by losses for Microsoft, Amgen stocks"", ""summary"": ""Shares of Microsoft and Amgen are trading lower Thursday afternoon, dragging the Dow Jones Industrial Average into negative territory. The Dow was most...""}, {""date"": ""20230216074500"", ""headline"": ""2 Market-Beating Dividend Stocks to Buy With $500"", ""summary"": ""Dividend-paying corporations can be particularly great picks since the steady and reliable payouts they offer help boost total returns over the long run.  Let's consider two such stocks that you can buy for less than the relatively modest sum of $500: Amgen (NASDAQ: AMGN) and Merck (NYSE: MRK).  Amgen is a biotech leader with a plentiful and diverse lineup of medicines across multiple therapeutic areas.""}, {""date"": ""20230216113600"", ""headline"": ""Amgen Inc. stock falls Thursday, underperforms market"", ""summary"": ""Shares of Amgen Inc. slipped 2.43% to $234.22 Thursday, on what proved to be an all-around rough trading session for the stock market, with the S&P 500 Index...""}, {""date"": ""20230216130510"", ""headline"": ""Dow closes more than 100 points higher on Friday, but notches third straight week of losses on rate fears: Live updates"", ""summary"": ""A week of inflation and retail sales data has put the consumer in sharp focus. Recent comments from Fed officials have also spooked investors.""}, {""date"": ""20230216171500"", ""headline"": ""O'Keefe Stevens Advisory Q4 2022 Update"", ""summary"": ""O'Keefe Stevens Advisory recently published its Q4 2022 update. Click here to read the full fund letter.""}, {""date"": ""20230216202600"", ""headline"": ""Dow`s 60-point jump led by gains for Amgen, Merck stocks"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230216210200"", ""headline"": ""Catalyst watch: Spotlight on retail earnings, Lucid Group, Silvergate Capital and Radware"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230216221100"", ""headline"": ""S&P 500, Dow, Nasdaq finish mixed as Fed debate continues"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230216232200"", ""headline"": ""Amgen After FY22 Earnings: Ambition Is Commendable But Debt Is Problematic"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230217014500"", ""headline"": ""\u2018Biosimilars\u2019 Were Supposed to Tame Costs for Drugs Like Humira. It Isn\u2019t Working."", ""summary"": ""AbbVie's arthritis treatment Humira and other complex drugs account for almost half of annual U.S. drug spending\u2014but just 2% of prescriptions.""}, {""date"": ""20230217035500"", ""headline"": ""Early notable gainers among liquid option names on February 17th"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230217092500"", ""headline"": ""Dow's 60-point jump led by gains for Amgen, Merck stocks"", ""summary"": ""Shares of Amgen and Merck are trading higher Friday afternoon, sending the Dow Jones Industrial Average into positive territory. Shares of Amgen and Merck...""}, {""date"": ""20230217113600"", ""headline"": ""Amgen Inc. stock outperforms market on strong trading day"", ""summary"": ""Shares of Amgen Inc. rallied 2.69% to $240.53 Friday, on what proved to be an all-around mixed trading session for the stock market, with the Dow Jones...""}, {""date"": ""20230217140706"", ""headline"": ""Best Stocks To Buy Now? 2 Dow Jones Stocks To Watch In 2023"", ""summary"": ""Are these the best Dow Jones Industrial Average stocks to buy in 2023?""}, {""date"": ""20230217153700"", ""headline"": ""Endowments Soared in 2021. The Next Year Was Dramatically Different."", ""summary"": ""University endowments lost 8% in fiscal 20221, slightly better than the S&P 500 but the worst decline since 2009. It was a year of two markets: The first...""}, {""date"": ""20230219060400"", ""headline"": ""The next big wave of patent cliffs is ahead; expect biopharma M&A to rise \ufffd\ufffd\ufffd report"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230219160056"", ""headline"": ""25 Best Countries For A Comfortable Retirement"", ""summary"": ""In this article, we take a look at the 25 best countries for a comfortable retirement. You can skip our detailed analysis of the aging demographics and the resulting economic shifts and go directly to 10 Best Countries For A Comfortable Retirement. Retiree Population: By Numbers The UN estimates suggest that there are 703 million [\u2026]""}]",{}
6,2023-02-19,234.52267456054688,2023-02-26,227.8242645263672,-0.028561886592549324,D3,"[{""date"": ""20230219060400"", ""headline"": ""The next big wave of patent cliffs is ahead; expect biopharma M&A to rise \ufffd\ufffd\ufffd report"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230219160056"", ""headline"": ""25 Best Countries For A Comfortable Retirement"", ""summary"": ""In this article, we take a look at the 25 best countries for a comfortable retirement. You can skip our detailed analysis of the aging demographics and the resulting economic shifts and go directly to 10 Best Countries For A Comfortable Retirement. Retiree Population: By Numbers The UN estimates suggest that there are 703 million [\u2026]""}, {""date"": ""20230220004347"", ""headline"": ""What To Expect From Bristol-Myers Squibb In 2023"", ""summary"": ""Bristol-Myers Squibb's primary focus is developing and commercializing innovative products in various therapeutic areas. Click here to read why BMY stock is a Buy.""}, {""date"": ""20230220030342"", ""headline"": ""Amgen: Re-Rating Seems Fair"", ""summary"": ""Amgen has seen a near 15% pullback since the Horizon acquisition was announced in December. See why I am still a bit cautious on AMGN stock.""}, {""date"": ""20230220090013"", ""headline"": ""Possible bearish signals as Amgen Inc. (NASDAQ:AMGN) insiders disposed of US$5.2m worth of stock"", ""summary"": ""In the last year, many Amgen Inc. ( NASDAQ:AMGN ) insiders sold a substantial stake in the company which may have...""}, {""date"": ""20230220103456"", ""headline"": ""25 Most Profitable NASDAQ Stocks Today"", ""summary"": ""In this article, we will look at the 25 most profitable NASDAQ stocks today. If you want to explore similar stocks, you can also take a look at 10 Most Profitable NASDAQ Stocks Today. 2022 was one of the worst years for the NASDAQ, primarily because it is dominated by tech, and tech stocks crashed as [\u2026]""}, {""date"": ""20230221030100"", ""headline"": ""Top 5 4th Quarter Trades of Palouse Capital Management, Inc."", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230221030100"", ""headline"": ""Top 5 4th Quarter Trades of BERKSHIRE ASSET MANAGEMENT LLC/PA"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230221062735"", ""headline"": ""Unusual Options Activity: BABA, INTC, F and 7 Others"", ""summary"": """"}, {""date"": ""20230221073220"", ""headline"": ""Bristol Myers: Looking Good For 2023"", ""summary"": ""Bristol Myers has seen a recent pullback in its share price, just like many other big pharma names. Check out why I'm bullish on BMY stock.""}, {""date"": ""20230221074500"", ""headline"": ""Mizuho Securities Remains a Hold on Amgen (AMGN)"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230221113600"", ""headline"": ""Amgen Inc. stock falls Tuesday, still outperforms market"", ""summary"": ""Shares of Amgen Inc. slipped 0.95% to $238.24 Tuesday, on what proved to be an all-around grim trading session for the stock market, with the S&P 500 Index...""}, {""date"": ""20230222051000"", ""headline"": ""Interesting AMGN Put And Call Options For October 20th"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230222073000"", ""headline"": ""This Recession-Proof Company Has a Best-in-Class Dividend"", ""summary"": ""Pfizer's highly attractive valuation, rock-solid dividend program, and enormous yield put it at the top of its big pharma peer group.""}, {""date"": ""20230222090000"", ""headline"": ""AMGEN ANNOUNCES CARDIOVASCULAR STUDY TO EVALUATE ASSOCIATION BETWEEN LIPOPROTEIN(a) AND CARDIOVASCULAR RISK IN AFRICAN AMERICANS"", ""summary"": ""Amgen (NASDAQ:AMGN) today announced the African American Heart Study, in collaboration with the Association of Black Cardiologists (ABC) and the Morehouse School of Medicine (MSM), which will measure the association between Lipoprotein(a), or Lp(a), and atherosclerotic cardiovascular disease (ASCVD) in 5,000 African American individuals across the United States. ASCVD is defined as the buildup of cholesterol plaque in arteries and includes events such as heart attack and stroke.""}, {""date"": ""20230222113600"", ""headline"": ""Amgen Inc. stock falls Wednesday, underperforms market"", ""summary"": ""Shares of Amgen Inc. slumped 0.87% to $236.16 Wednesday, on what proved to be an all-around grim trading session for the stock market, with the S&P 500 Index...""}, {""date"": ""20230222155133"", ""headline"": ""12 Most Profitable Pharmaceutical Stocks Now"", ""summary"": ""In this piece, we will take a look at 12 most profitable pharmaceutical stocks now. For more stocks, head on over to 5 Most Profitable Pharmaceutical Stocks Now. The pharmaceutical industry was the center of attention in 2020 and 2021 after the deadly coronavirus pandemic ravaged the globe and disrupted the way of living. As [\u2026]""}, {""date"": ""20230222203700"", ""headline"": ""Nicholas Ward`s Dividend Growth Portfolio: January 2023 Review"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230222213503"", ""headline"": ""Nicholas Ward's Dividend Growth Portfolio: January 2023 Review"", ""summary"": ""My dividend income rose by 9.56% on a y/y basis during January. My portfolio's value rose by approximately 6.9%. Here's a review of my portfolio for January 2023.""}, {""date"": ""20230223004700"", ""headline"": ""Top dividend stocks picked using a UBS machine-learning model"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230223113600"", ""headline"": ""Amgen Inc. stock outperforms competitors on strong trading day"", ""summary"": ""Shares of Amgen Inc. inched 0.62% higher to $237.62 Thursday, on what proved to be an all-around favorable trading session for the stock market, with the S&P...""}, {""date"": ""20230223200300"", ""headline"": ""Catalyst watch: Tesla event, Microsoft talks OpenAI, Rivian earnings and Chevron"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230224113600"", ""headline"": ""Amgen Inc. stock falls Friday, underperforms market"", ""summary"": ""Shares of Amgen Inc. slipped 1.67% to $233.66 Friday, on what proved to be an all-around rough trading session for the stock market, with the S&P 500 Index...""}, {""date"": ""20230224220200"", ""headline"": ""Pharmas, medtechs dominate list of innovation leaders thanks to patents"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230225040710"", ""headline"": ""Regeneron: Innovation And Disruption Done Right"", ""summary"": ""Regeneron Pharmaceuticals' collaborative energy is strong and the medium-term looks good. Check out why we rate REGN stock a Hold for now.""}, {""date"": ""20230226052100"", ""headline"": ""M&A activity in the Americas cooled in 2022 amid ongoing macro uncertainty"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230226080047"", ""headline"": ""Amgen Inc. (NASDAQ:AMGN) Shares Could Be 37% Below Their Intrinsic Value Estimate"", ""summary"": ""Key Insights The projected fair value for Amgen is US$371 based on 2 Stage Free Cash Flow to Equity Current share price...""}]",{}
7,2023-02-26,227.8242645263672,2023-03-05,228.94552612304688,0.004921607446031873,U1,"[{""date"": ""20230226052100"", ""headline"": ""M&A activity in the Americas cooled in 2022 amid ongoing macro uncertainty"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230226080047"", ""headline"": ""Amgen Inc. (NASDAQ:AMGN) Shares Could Be 37% Below Their Intrinsic Value Estimate"", ""summary"": ""Key Insights The projected fair value for Amgen is US$371 based on 2 Stage Free Cash Flow to Equity Current share price...""}, {""date"": ""20230227161157"", ""headline"": ""Top 10 Drug Companies in USA and Their China Reliance"", ""summary"": ""In this article, we will be taking a look at the top 10 drug companies in USA and their China reliance. To skip our detailed analysis of the pharmaceutical sector, you can go directly to see the Top 5 Drug Companies in USA and Their China Reliance. The US has long been reliant on China [\u2026]""}, {""date"": ""20230227230400"", ""headline"": ""The 20 worst U.S. stocks in February: the biggest loser dropped 35%"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230228003200"", ""headline"": ""Stocks most and least liked by hedge funds and mutual funds -  Goldman"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230228021927"", ""headline"": ""Royalty Pharma: Strong Q4 Results, Reiterating A Buy Rating"", ""summary"": ""Royalty Pharma recently reported positive FY 2022 earnings. We like its focus on Lpa class. Read to know why we maintain a buy rating on RPRX stock.""}, {""date"": ""20230228071307"", ""headline"": ""Horizon Therapeutics: Attractive 5.4% Upside To Amgen Offer"", ""summary"": ""Horizon Therapeutics is a $25 billion biotech that's being acquired by Amgen Inc. Click for my review of the HZNP deal prospects.""}, {""date"": ""20230228113600"", ""headline"": ""Amgen Inc. stock outperforms competitors despite losses on the day"", ""summary"": ""Shares of Amgen Inc. slid 1.19% to $231.66 Tuesday, on what proved to be an all-around poor trading session for the stock market, with the S&P 500 Index...""}, {""date"": ""20230228212200"", ""headline"": ""Tracking John Paulson`s Paulson & Company Portfolio - Q4 2022 Update"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230228222137"", ""headline"": ""Tracking John Paulson's Paulson & Company Portfolio - Q4 2022 Update"", ""summary"": ""John Paulson\u00e2\u0080\u0099s 13F portfolio value decreased from $1.37B to $1.11B this quarter. Read more about Paulson & Company's holdings and trades for Q4 2022.""}, {""date"": ""20230301011300"", ""headline"": ""Horizon Therapeutics reports Q4  EPS $1.21, consensus  $1.09"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230301030400"", ""headline"": ""Amgen to present new Repatha combined data from  Phase 3 FOURIER trials"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230301064553"", ""headline"": ""My $394k Portfolio Outperforms The Market Again In A Dreary February"", ""summary"": ""My portfolio, built specifically for my retirement ~20+ years from now, features growth, dividends, and risk stocks for a happy retirement. Click to read more.""}, {""date"": ""20230301084500"", ""headline"": ""3 Value Stocks You'll Regret Not Buying on the Dip"", ""summary"": ""Value stocks are poised for a strong decade.  The simple reason is that the Federal Reserve is highly unlikely to spur another growth stock boom by lowering interest rates to the effective floor in the years ahead.  Which value stocks are best positioned to capitalize on this favorable long-term dynamic?""}, {""date"": ""20230301090000"", ""headline"": ""AMGEN TO PRESENT NEW REPATHA\u00ae (EVOLOCUMAB) AND OLPASIRAN DATA AT ACC"", ""summary"": ""Amgen (NASDAQ: AMGN) today announced new Repatha\u00ae (evolocumab) combined data from the Phase 3 FOURIER and FOURIER Open Label Extension (OLE) studies and the Phase 2 OCEAN(a)-DOSE study of investigational olpasiran, an siRNA that reduces lipoprotein(a) [Lp(a)] by more than 90%. Additional data from Amgen's Center for Observational Research and Amgen funded investigator studies, including YELLOW-III from Mount Sinai will be presented at the American College of Cardiology's 72nd Annual Scientific S""}, {""date"": ""20230301113600"", ""headline"": ""Amgen Inc. stock outperforms competitors on strong trading day"", ""summary"": ""Shares of Amgen Inc. rallied 1.96% to $236.19 Wednesday, on what proved to be an all-around mixed trading session for the stock market, with the Dow Jones...""}, {""date"": ""20230301211600"", ""headline"": ""Barclays Sticks to Its Sell Rating for Amgen (AMGN)"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230302081446"", ""headline"": ""Amgen Inc. 2022 Q4 - Results - Earnings Call Presentation"", ""summary"": ""The following slide deck was published by Amgen Inc.""}, {""date"": ""20230302090029"", ""headline"": ""With 78% institutional ownership, Amgen Inc. (NASDAQ:AMGN) is a favorite amongst the big guns"", ""summary"": ""Key Insights Institutions' substantial holdings in Amgen implies that they have significant influence over the...""}, {""date"": ""20230302113004"", ""headline"": ""Why Is Amgen (AMGN) Down 4.2% Since Last Earnings Report?"", ""summary"": ""Amgen (AMGN) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.""}, {""date"": ""20230302113600"", ""headline"": ""Amgen Inc. stock underperforms Thursday when compared to competitors"", ""summary"": ""Shares of Amgen Inc. slumped 0.61% to $234.74 Thursday, on what proved to be an all-around great trading session for the stock market, with the S&P 500 Index...""}, {""date"": ""20230302174510"", ""headline"": ""Amgen (AMGN) Stock Sinks As Market Gains: What You Should Know"", ""summary"": ""Amgen (AMGN) closed the most recent trading day at $234.74, moving -0.61% from the previous trading session.""}, {""date"": ""20230302202700"", ""headline"": ""March`s 17 Ideal 2023 Barrons/Bloomberg Dividend Dogs"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230302204733"", ""headline"": ""Tracking George Soros's Portfolio - Q4 2022 Update"", ""summary"": ""George Soros' 13F portfolio value increased from $5.86B to $7.26B this quarter. Click here to read the Q4 2022 Update on Soros Fund Management's portfolio.""}, {""date"": ""20230302212556"", ""headline"": ""March's 17 Ideal 2023 Barrons/Bloomberg Dividend Dogs"", ""summary"": ""Ten top 2023 Bar/BI-projected dividend yields ranged from 4.78% to 7.94%. Click here for a detailed analysis.""}, {""date"": ""20230303025000"", ""headline"": ""Analysts` Opinions Are Mixed on These Healthcare Stocks: Amgen (AMGN) and Dexcom (DXCM)"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230303060000"", ""headline"": ""Could This Humira Biosimilar Be a Winner for Amgen?"", ""summary"": ""At the end of January, Amgen (NASDAQ: AMGN) celebrated the U.S. launch of its biosimilar Amjevita to AbbVie's (NYSE: ABBV) star immunology drug called Humira.  Amgen's Amjevita received approval from the U.S. Food and Drug Administration (FDA) as a biosimilar in 2016.""}, {""date"": ""20230303063017"", ""headline"": ""7 Over-$100 Stocks That Are Worth Every Penny"", ""summary"": ""If searching out over-$100 stocks to buy seems arbitrary, take a step back and consider this. It\u2019s great to have a mix of stocks in your portfolio. There are all sorts of sizes and flavors of stocks from which to choose, including mega-cap stocks and even small-cap stocks. So it\u2019s understandable that when you\u2019re looking for stocks to buy, you may sometimes miss some obvious well-priced choices that are right in front of you. Some of the best names out there fall into the category of over-$100 st""}, {""date"": ""20230303075100"", ""headline"": ""Tracking George Soros`s Portfolio - Q4 2022 Update"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230303090723"", ""headline"": ""12 Most Profitable Biotech Stocks Today"", ""summary"": ""In this article, we will discuss the 12 Most Profitable Biotech Stocks Today. You can skip our industry overview and go directly to the 5 Most Profitable Biotech Stocks Today. The term \u201cbiotechnology\u201d refers to the utilization of living organisms or biological systems to create solutions that address various agricultural, industrial, and health-related problems. The most [\u2026]""}, {""date"": ""20230303100900"", ""headline"": ""U.S. companies embark on record borrowing spree, despite paying highest rates since 2009"", ""summary"": ""Higher interest rates aren't deterring companies with high credit ratings from borrowing in the U.S. corporate bond market at a record clip in 2023.""}, {""date"": ""20230303113600"", ""headline"": ""Amgen Inc. stock rises Friday, still underperforms market"", ""summary"": ""Shares of Amgen Inc. inched 0.03% higher to $234.81 Friday, on what proved to be an all-around great trading session for the stock market, with the S&P 500...""}, {""date"": ""20230303160000"", ""headline"": ""AMGEN TO PRESENT AT THE 43RD ANNUAL TD COWEN HEALTHCARE CONFERENCE"", ""summary"": ""Amgen (NASDAQ:AMGN) will present at the 2023 TD Cowen Healthcare Conference at 11:10 a.m. ET on Wednesday, March 8, 2023. Murdo Gordon, executive vice president of Global Commercial Operations and Peter H. Griffith, executive vice president and chief financial officer at Amgen will present at the conference. The webcast will be broadcast over the internet simultaneously and will be available to members of the news media, investors and the general public.""}, {""date"": ""20230303225353"", ""headline"": ""My Dividend Growth Portfolio February Update: Cash Is Not Trash"", ""summary"": ""Cash is yielding over 4%, so a dividend growth investor can afford to be patient. Click here to read the February Update on my dividend growth portfolio.""}, {""date"": ""20230304191534"", ""headline"": ""Dividend Champion, Contender, And Challenger Highlights: Week Of March 5"", ""summary"": ""A weekly summary of dividend activity for Dividend Champions, Contenders, and Challengers. Read more to see the companies with upcoming ex-dividend dates.""}, {""date"": ""20230305051100"", ""headline"": ""Spectrum`s Rolvedon: An Undifferentiated, Small Player In A Vast Market"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230305052000"", ""headline"": ""Cantor biopharma/biotech analysts to hold analyst/industry conference call"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230305180635"", ""headline"": ""Spectrum's Rolvedon: An Undifferentiated, Small Player In A Vast Market"", ""summary"": ""Spectrum Pharmaceuticals develops and commercializes cancer therapies, including Rolvedon. Read more to see why SPPI stock is a Sell.""}]",{}
8,2023-03-05,228.94552612304688,2023-03-12,222.17886352539062,-0.029555775612839508,D3,"[{""date"": ""20230304191534"", ""headline"": ""Dividend Champion, Contender, And Challenger Highlights: Week Of March 5"", ""summary"": ""A weekly summary of dividend activity for Dividend Champions, Contenders, and Challengers. Read more to see the companies with upcoming ex-dividend dates.""}, {""date"": ""20230305051100"", ""headline"": ""Spectrum`s Rolvedon: An Undifferentiated, Small Player In A Vast Market"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230305180635"", ""headline"": ""Spectrum's Rolvedon: An Undifferentiated, Small Player In A Vast Market"", ""summary"": ""Spectrum Pharmaceuticals develops and commercializes cancer therapies, including Rolvedon. Read more to see why SPPI stock is a Sell.""}, {""date"": ""20230306074900"", ""headline"": ""Merck to start phase 3 of oral PCSK9 inhibitor for cholesterol following mid-stage results"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230306120001"", ""headline"": ""Merck's drug boosts exercise capacity in pulmonary hypertension patients"", ""summary"": ""Merck & Co Inc said on Monday its experimental therapy, sotatercept, helped increase exercise capacity in patients with a deadly disease that causes high pressure in blood vessels of the heart and lungs in a late-stage study.  A second experimental heart drug, MK-0616, helped reduce levels of low-density lipoprotein (LDL) cholesterol by between 41.2% at a low 6 mg dose to 60.9% at a higher 30 mg dose in a mid-stage study, the drugmaker said.  Sotatercept, which Merck gained through its $11.5 billion buyout of Acceleron Pharma, combined with background therapy helped extend the distance that patients with pulmonary arterial hypertension could walk in six minutes by 40.8 meters.""}, {""date"": ""20230306223800"", ""headline"": ""Amgen Inc. stock falls Tuesday, underperforms market"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230307013700"", ""headline"": ""Biden to announce plan to keep Medicare solvent beyond 2050"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230307035500"", ""headline"": ""Amgen declares $2.13 dividend"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230307050000"", ""headline"": ""High Yield Stock Watchlist: March 2023"", ""summary"": ""There are 17 stocks on my high-yield watchlist for March 2023. Read why the stocks on my watchlist are undervalued based on dividend yield theory.""}, {""date"": ""20230307160000"", ""headline"": ""AMGEN ANNOUNCES 2023 SECOND QUARTER DIVIDEND"", ""summary"": ""Amgen (NASDAQ:AMGN) today announced that its Board of Directors declared a $2.13 per share dividend for the second quarter of 2023. The dividend will be paid on June 8, 2023, to all stockholders of record as of the close of business on May 18, 2023.""}, {""date"": ""20230307212100"", ""headline"": ""Noteworthy Wednesday Option Activity: AMGN, MET, LLY"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230307223800"", ""headline"": ""Amgen Inc. stock outperforms competitors despite losses on the day"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230308030145"", ""headline"": ""2 March Dogs Of The Dow To Buy, 4 More To Watch"", ""summary"": ""The highest-yield 10 are March\u00e2\u0080\u0099s Dogs of the Dow: JNJ, KO, CSCO, AMGN, CVX, DOW, IBM, WBA, MMM, and VZ, averaging a 4.41% annual yield.""}, {""date"": ""20230308051500"", ""headline"": ""A Bull Market Is Coming: 3 Stocks Near Their 52-Week Lows to Buy Now"", ""summary"": ""The stock market is struggling, but investors shouldn't bet against it in the long run.  Investing in stocks that are underperforming and that are good long-term investments, before a bull market arrives, can be a way to set yourself up for some great gains down the road.  Three stocks that are trading near 52-week lows that long-term investors should be eyeing right now are Amgen\u00a0(NASDAQ: AMGN),\u00a0Alphabet\u00a0(NASDAQ: GOOG) (NASDAQ: GOOGL), and Southern Company\u00a0(NYSE: SO).""}, {""date"": ""20230308061400"", ""headline"": ""Video: Daily Dividend Report: AMGN,JCI,AMOT,ZBH,FLXS"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230308070030"", ""headline"": ""Amgen (NASDAQ:AMGN) Has A Pretty Healthy Balance Sheet"", ""summary"": ""David Iben put it well when he said, 'Volatility is not a risk we care about. What we care about is avoiding the...""}, {""date"": ""20230308082904"", ""headline"": ""Amgen Inc. (AMGN) Presents at 43rd Annual TD Cowen Healthcare Conference (Transcript)"", ""summary"": ""Amgen Inc. (NASDAQ:NASDAQ:AMGN) 43rd Annual TD Cowen Healthcare Conference March 8, 2023 11:10 AM ETCompany ParticipantsPeter Griffith - Executive Vice President and Chief Financial...""}, {""date"": ""20230308174510"", ""headline"": ""Amgen (AMGN) Stock Sinks As Market Gains: What You Should Know"", ""summary"": ""Amgen (AMGN) closed the most recent trading day at $228.43, moving -0.13% from the previous trading session.""}, {""date"": ""20230308223700"", ""headline"": ""Amgen Inc. stock outperforms market despite losses on the day"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230309041706"", ""headline"": ""Amgen (AMGN) Declares $2.13 Dividend"", ""summary"": """"}, {""date"": ""20230309045500"", ""headline"": ""Cantor biopharma/biotech analysts to hold analyst/industry conference call"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230309094000"", ""headline"": ""New Drugs Are Coming to Market at Sky-High Prices"", ""summary"": ""A new  Amgen  lung-cancer treatment, Lumakras, carried a hefty price tag when it came out in 2021: $17,900 per patient monthly.  Just over a year later, in December 2022, a second drug for the same type of cancer, Krazati from  Mirati Therapeutics  had an even higher price: $19,750 a month\u2014a 10% premium.  As drugmakers face rising pressure to rein in repeat or annual price hikes on existing drugs, new brand-name medicines are coming to market with ever-higher price tags on day one.""}, {""date"": ""20230309122811"", ""headline"": ""Replimune: A Sell Ahead Of Cutaneous Squamous Cell Carcinoma Data"", ""summary"": ""Replimune's RP1 results are promising, but caution is warranted due to the limitations of the study. Learn why REPL stock is a 'Sell' & 'Short.'""}, {""date"": ""20230309164300"", ""headline"": ""New Drugs for Cancer, Rare Disease Can Now Cost More Than $20,000 a Month"", ""summary"": ""As drugmakers face pressure to rein in price hikes on existing drugs, new medicines arrive with ever-higher prices on day one, contributing to rising costs for patients and stretched budgets for insurers.""}, {""date"": ""20230309172000"", ""headline"": ""AMGEN TO PRESENT AT THE 33rd ANNUAL OPPENHEIMER HEALTHCARE CONFERENCE"", ""summary"": ""Amgen (NASDAQ:AMGN) will present at the 2023 Oppenheimer Healthcare Conference at 2:00 p.m. ET on Monday, March 13, 2023. Susan Sweeney, senior vice president, Global Marketing, Access and Capabilities at Amgen will present at the conference. The webcast will be broadcast over the internet simultaneously and will be available to members of the news media, investors and the general public.""}, {""date"": ""20230309223500"", ""headline"": ""Mizuho Securities Sticks to Its Hold Rating for Amgen (AMGN)"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230310034653"", ""headline"": ""Assuming No-Growth, Gilead Is The Safest Choice Among The Large Biotechs"", ""summary"": ""Gilead has a strong credit profile and a low cost of equity. Find out why for an investor seeking relative safety, GILD stock is worth a look.""}, {""date"": ""20230310113600"", ""headline"": ""Amgen Inc. stock outperforms market on strong trading day"", ""summary"": ""Shares of Amgen Inc. inched 0.92% higher to $227.87 Friday, on what proved to be an all-around grim trading session for the stock market, with the S&P 500...""}, {""date"": ""20230311040000"", ""headline"": ""The Near-Perfect Portfolio: Sleep Well During Turbulent Times"", ""summary"": ""With the economy going through the boom and bust cycles more frequently, the extreme ups and downs of the market are inevitable. Read more here.""}, {""date"": ""20230311072952"", ""headline"": ""Amgen's (NASDAQ:AMGN) Shareholders Will Receive A Bigger Dividend Than Last Year"", ""summary"": ""Amgen Inc. ( NASDAQ:AMGN ) has announced that it will be increasing its dividend from last year's comparable payment on...""}]",{}
9,2023-03-12,222.17886352539062,2023-03-19,224.0509033203125,0.008425823074335481,U1,"[{""date"": ""20230313001700"", ""headline"": ""Amgen upgraded to Overweight from Equal Weight at Wells Fargo"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230313032600"", ""headline"": ""Wells Fargo upgrades Amgen to Overweight, lowers target to $265"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230313051500"", ""headline"": ""Street Wrap: Today`s Top 15 Upgrades, Downgrades, Initiations"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230313054900"", ""headline"": ""Amgen, Procter & Gamble share gains lead the way, but Dow flat"", ""summary"": ""The Dow Jones Industrial Average is flat Monday morning with shares of Amgen and Procter & Gamble seeing positive momentum for the price-weighted average....""}, {""date"": ""20230313055100"", ""headline"": ""Amgen, Procter & Gamble share gains lead Dow`s 90-point climb"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230313065000"", ""headline"": ""Amgen, Procter & Gamble share gains lead Dow's 90-point climb"", ""summary"": ""Shares of Amgen and Procter & Gamble are trading higher Monday morning, sending the Dow Jones Industrial Average into positive territory. The Dow is trading...""}, {""date"": ""20230313065100"", ""headline"": ""Amgen upgraded at Wells Fargo citing a post-Horizon deal opportunity"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230313065300"", ""headline"": ""Amgen facing class action suit over owing more than $10B in back taxes and penalties"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230313075100"", ""headline"": ""Dow jumps nearly 200 points on gains for Amgen, Microsoft stocks"", ""summary"": ""Behind positive momentum for shares of Amgen and Microsoft, the Dow Jones Industrial Average is up Monday morning. The Dow was most recently trading 197...""}, {""date"": ""20230313085400"", ""headline"": ""Amgen, Microsoft share gains contribute to Dow`s nearly 100-point climb"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230313095300"", ""headline"": ""Amgen, Microsoft share gains contribute to Dow's nearly 100-point climb"", ""summary"": ""The Dow Jones Industrial Average is up Monday afternoon with shares of Amgen and Microsoft seeing positive momentum for the price-weighted average. Shares of...""}, {""date"": ""20230313112300"", ""headline"": ""Microsoft, Amgen share gains lead the way, but Dow flat"", ""summary"": ""The Dow Jones Industrial Average is flat Monday afternoon with shares of Microsoft and Amgen seeing positive growth for the price-weighted average. The Dow...""}, {""date"": ""20230313112706"", ""headline"": ""Amgen Inc. (AMGN) Oppenheimer 33rd Annual Healthcare Conference (Transcript)"", ""summary"": ""Amgen Inc. (NASDAQ:NASDAQ:AMGN) Oppenheimer 33rd Annual Healthcare Conference March 13, 2023 2:00 PM ETCompany ParticipantsArvind Sood - Vice President, Investor RelationsSusan Sweeney -...""}, {""date"": ""20230313130541"", ""headline"": ""15 Biggest Retirement Mistakes You Will Regret Forever"", ""summary"": ""In this article, we take a look at the 15 biggest retirement mistakes you will regret forever. For more such retirement mistakes, go to 5 Biggest Retirement Mistakes You Will Regret Forever. Retirement is an inevitable stage in every individual\u2019s life. After working for several years, people eventually reach a point where they want to [\u2026]""}, {""date"": ""20230313210338"", ""headline"": ""Wells Fargo Upgrades Amgen (AMGN)"", ""summary"": """"}, {""date"": ""20230314032659"", ""headline"": ""Wall Street Breakfast Podcast: Report: Another Auction Of SVB"", ""summary"": ""FDIC is reportedly planning another auction of Silicon Valley Bank. Credit Suisse discloses 'material weakness' in reporting procedures. CPI watch: All eyes on inflation data.""}, {""date"": ""20230314054000"", ""headline"": ""Video: Dow Movers: AMGN, CRM"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230314094500"", ""headline"": ""2 Stocks to Buy Near Their 52-Week Lows That Could Help You Beat The Market"", ""summary"": ""Digging deeper, though, reveals that Amgen and Match Group both have excellent prospects.  Amgen has been dealing with declining sales of some of its key products, causing the company's revenue to grow, if at all, at a pretty modest pace.""}, {""date"": ""20230314111522"", ""headline"": ""Amgen is sued for concealing $10.7 billion tax bill from investors"", ""summary"": ""Amgen Inc has been sued in a proposed class action accusing the drugmaker of waiting too long to tell investors it might owe the Internal Revenue Service $10.7 billion in taxes and penalties.""}, {""date"": ""20230314123600"", ""headline"": ""Amgen Inc. stock falls Tuesday, underperforms market"", ""summary"": ""Shares of Amgen Inc. shed 1.12% to $230.58 Tuesday, on what proved to be an all-around positive trading session for the stock market, with the S&P 500 Index...""}, {""date"": ""20230314164023"", ""headline"": ""Amgen Faces Lawsuit For Hiding Its Stupendous Tax Bill Of $10B"", ""summary"": ""In a complaint filed in Manhattan federal court, a Detroit-based pension fund said Amgen Inc (NASDAQ: AMGN) concealed the dispute over its international tax strategy between July 2020 and April 2022 and had its investors wait for too long on disclosing taxes and penalties bill of $10.7 billion. The Internal Revenue Service (IRS) accused Amgen of underreporting taxes from 2010 to 2015 by inappropriately attributing its U.S. profits to a Puerto Rico subsidiary. Though Puerto Rico is a U.S. territo""}, {""date"": ""20230314175009"", ""headline"": ""Amgen (AMGN) Stock Sinks As Market Gains: What You Should Know"", ""summary"": ""Amgen (AMGN) closed at $230.58 in the latest trading session, marking a -1.12% move from the prior day.""}, {""date"": ""20230314222005"", ""headline"": ""25 Biggest Pharmaceutical Companies in the World"", ""summary"": ""In this article, we will be taking a look at the 25 biggest pharmaceutical companies in the world. To skip our detailed analysis, you can go directly to see the 10 biggest pharmaceutical companies in the world. There is no need to emphasize the value of the pharmaceutical industry after the Covid-19 pandemic. Without the [\u2026]""}, {""date"": ""20230315093000"", ""headline"": ""2 Top Biotech Stocks to Buy Right Now"", ""summary"": ""A high dividend yield and powerful growth prospects are a rare combination for any single stock to offer.  On one hand, a high yield often comes with the trade-off of an elevated dividend payout ratio and lower resulting growth potential.  On the other hand, a company with adequate growth opportunities will generally have a lower payout ratio to retain the capital needed for growth.""}, {""date"": ""20230315123600"", ""headline"": ""Amgen Inc. stock outperforms competitors on strong trading day"", ""summary"": ""Shares of Amgen Inc. advanced 1.87% to $234.90 Wednesday, on what proved to be an all-around rough trading session for the stock market, with the S&P 500...""}, {""date"": ""20230315174509"", ""headline"": ""Amgen (AMGN) Gains As Market Dips: What You Should Know"", ""summary"": ""In the latest trading session, Amgen (AMGN) closed at $234.90, marking a +1.87% move from the previous day.""}, {""date"": ""20230316023114"", ""headline"": ""PBE: Healthcare Dashboard For March"", ""summary"": ""Healthcare equipment is the less attractive subsector regarding both valuation and quality. Click here to find out why PBE is a Hold.""}, {""date"": ""20230316050200"", ""headline"": ""Visa, Merck share losses lead Dow`s nearly 250-point drop"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230316065000"", ""headline"": ""Is It Time to Buy the Dow Jones' 3 Worst-Performing February (and Now March) Stocks?"", ""summary"": ""If you're a fan of buying beaten-up blue chip stocks, there's certainly no shortage of them now.  The Dow Jones Industrial Average (DJINDICES: ^DJI) is down nearly 8% from last month's high -- a sell-off that actually got going in mid-February.  Roughly half of the Dow's components are doing worse than the average -- and that can pose a tricky temptation for investors.""}, {""date"": ""20230316093832"", ""headline"": ""Buy And Hold Coffee Can Portfolio For The Next 15 Years"", ""summary"": ""This article covers topics from Christopher Mayer's book ""}, {""date"": ""20230316123600"", ""headline"": ""Amgen Inc. stock falls Thursday, underperforms market"", ""summary"": ""Shares of Amgen Inc. shed 0.14% to $234.57 Thursday, on what proved to be an all-around positive trading session for the stock market, with the S&P 500 Index...""}, {""date"": ""20230316193557"", ""headline"": ""BRIEF-Amgen Announces Workforce Reduction By About 450 Jobs"", ""summary"": ""* AMGEN - ANNOUNCED CHANGES THAT WILL RESULT IN A REDUCTION OF OUR WORKFORCE BY APPROXIMATELY 450 JOBS, REPRESENTING LESS THAN 2% OF OUR TOTAL WORKFORCE""}, {""date"": ""20230316204523"", ""headline"": ""UPDATE 2-Amgen to cut 450 jobs in second round of layoffs this year"", ""summary"": ""Amgen Inc said on Thursday it would cut 450 jobs, or less than 2% of its workforce, making it the company's second round of layoffs this year amid intensifying pressure on drug prices and high inflation.  \""We made these changes to realign our expense base in the face of intensifying pressure on drug prices and high levels of inflation,\"" a company spokeswoman said in a statement to Reuters.  The company had about 25,200 staff members in more than 50 countries as of Dec. 31, 2022, according to its latest annual regulatory filing with the U.S. Securities and Exchange Commission.""}, {""date"": ""20230316204746"", ""headline"": ""Amgen to cut 450 jobs in second round of layoffs this year"", ""summary"": ""\""We made these changes to realign our expense base in the face of intensifying pressure on drug prices and high levels of inflation,\"" a company spokeswoman said in a statement to Reuters.  The company had about 25,200 staff members in more than 50 countries as of Dec. 31, 2022, according to its latest annual regulatory filing with the U.S. Securities and Exchange Commission.  Amgen's decision to downsize its workforce underscores the impact of rapidly increasing interest rates on the healthcare industry.""}, {""date"": ""20230316230800"", ""headline"": ""Amgen to cut about 450 jobs in second round of layoffs this year"", ""summary"": ""Amgen Inc. on Thursday said it would lay off about 450 employees, or less than 2% of its workforce, as it faces increasing pressure from drug prices and high inflation.""}, {""date"": ""20230316231100"", ""headline"": ""Amgen (NASDAQ:AMGN) to Slash More Jobs in Second Round of Layoffs"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230316235200"", ""headline"": ""More U.S. companies layoffs as Amgen deepens job cuts amid pressure on drug prices and inflations woes"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230317001100"", ""headline"": ""More U.S. companies layoff as Amgen deepens job cuts amid pressure on drug prices and inflation woes"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230317054000"", ""headline"": ""Analysts Conflicted on These Healthcare Names: Amgen (AMGN) and Acurx Pharmaceuticals (ACXP)"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230317123600"", ""headline"": ""Amgen Inc. stock underperforms Friday when compared to competitors"", ""summary"": ""Shares of Amgen Inc. slipped 2.04% to $229.79 Friday, on what proved to be an all-around poor trading session for the stock market, with the S&P 500 Index...""}, {""date"": ""20230319011800"", ""headline"": ""The Tao Of The Dow, Simple Self-Indexing Strategy"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}]",{}
10,2023-03-19,224.0509033203125,2023-03-26,232.08511352539062,0.03585886102673763,U4,"[{""date"": ""20230319011800"", ""headline"": ""The Tao Of The Dow, Simple Self-Indexing Strategy"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230319224500"", ""headline"": ""Mirati`s Krazati: A Strong Competitor In The KRAS G12C-Mutated NSCLC Market"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230319234310"", ""headline"": ""Mirati's Krazati: A Strong Competitor In The KRAS G12C-Mutated NSCLC Market"", ""summary"": ""Mirati Therapeutics's Krazati could capture a significant share of the 2L KRAS G12C-mutated NSCLC market. Click here to read why MRTX stock is a Buy.""}, {""date"": ""20230320062300"", ""headline"": ""3 Dow Stocks Near 52-Week Lows That Look Like Bargains Now"", ""summary"": ""The past 15 months have been disastrous for the major stock market indexes, but one has fared better than its peers.  The Dow Jones Industrial Average has fallen around 12% since the end of 2021.  While traditionally filled with industrial and financial stocks, there aren't any specific rules that determine which companies become one of the Dow's 30 components.""}, {""date"": ""20230320104349"", ""headline"": ""3 Dow Jones Stocks To Watch Today"", ""summary"": ""Here are three Dow Jones stocks to keep on watch in the stock market now.""}, {""date"": ""20230320123600"", ""headline"": ""Amgen Inc. stock rises Monday, outperforms market"", ""summary"": ""Shares of Amgen Inc. rose 2.15% to $234.72 Monday, on what proved to be an all-around positive trading session for the stock market, with the S&P 500 Index...""}, {""date"": ""20230320161208"", ""headline"": ""Top Analyst Reports for Alphabet, Tesla & Amgen"", ""summary"": ""Today's Research Daily features new research reports on 16 major stocks, including Alphabet Inc. (GOOGL), Tesla, Inc. (TSLA) and Amgen Inc. (AMGN).""}, {""date"": ""20230320213500"", ""headline"": ""Amgen Announces More Layoffs - Why I`d Buy This Dip"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230320220200"", ""headline"": ""Altimmune leads obesity drug developers lower after data for lead asset"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230321065700"", ""headline"": ""Nvidia unveils language models, generative AI service to help Life Sciences R&D"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230321074311"", ""headline"": ""The Zacks Analyst Blog Highlights Alphabet, Tesla, Amgen, FedEx and Capital One Financial"", ""summary"": ""Alphabet, Tesla, Amgen, FedEx and Capital One Financial are part of the Zacks top Analyst Blog.""}, {""date"": ""20230321102931"", ""headline"": ""Amgen Announces More Layoffs - Why I'd Buy This Dip"", ""summary"": ""Amgen expects to lay off 3% of its entire workforce before 1H 2023 - around 750 staff. Read why, despite the dour news, AMGN stock may be a buy at current levels.""}, {""date"": ""20230321112932"", ""headline"": ""Horizon Therapeutics: Attractive 7.16% Upside To Amgen Deal"", ""summary"": ""Horizon Therapeutics Public Limited Company is a $25 billion biotech Amgen Inc. is acquiring. Click here to read our view of the HZNP-AMGN deal.""}, {""date"": ""20230321123600"", ""headline"": ""Amgen Inc. stock underperforms Tuesday when compared to competitors"", ""summary"": ""Shares of Amgen Inc. slumped 0.75% to $232.95 Tuesday, on what proved to be an all-around favorable trading session for the stock market, with the S&P 500...""}, {""date"": ""20230321175009"", ""headline"": ""Amgen (AMGN) Stock Sinks As Market Gains: What You Should Know"", ""summary"": ""In the latest trading session, Amgen (AMGN) closed at $232.95, marking a -0.75% move from the previous day.""}, {""date"": ""20230322055109"", ""headline"": ""Here's What is Driving Amgen (AMGN) Stock's Outperformance"", ""summary"": ""Amgen's (AMGN) key drugs like Prolia, Repatha and Otezla are driving sales. It is also rapidly advancing its robust pipeline.""}, {""date"": ""20230322100030"", ""headline"": ""Those who invested in Amgen (NASDAQ:AMGN) five years ago are up 59%"", ""summary"": ""While Amgen Inc. ( NASDAQ:AMGN ) shareholders are probably generally happy, the stock hasn't had particularly good run...""}, {""date"": ""20230322123600"", ""headline"": ""Amgen Inc. stock outperforms market despite losses on the day"", ""summary"": ""Shares of Amgen Inc. slipped 1.34% to $229.83 Wednesday, on what proved to be an all-around grim trading session for the stock market, with the S&P 500 Index...""}, {""date"": ""20230322174509"", ""headline"": ""Amgen (AMGN) Stock Moves -1.34%: What You Should Know"", ""summary"": ""In the latest trading session, Amgen (AMGN) closed at $229.83, marking a -1.34% move from the previous day.""}, {""date"": ""20230323065100"", ""headline"": ""Interesting AMGN Put And Call Options For May 5th"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230323070700"", ""headline"": ""See How Amgen Ranks Among Analysts` Top Dow 30 Picks"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230323070700"", ""headline"": ""Video: Dow Analyst Moves: AMGN"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230323123600"", ""headline"": ""Amgen Inc. stock outperforms competitors on strong trading day"", ""summary"": ""Shares of Amgen Inc. advanced 1.42% to $233.10 Thursday, on what proved to be an all-around great trading session for the stock market, with the S&P 500...""}, {""date"": ""20230323214700"", ""headline"": ""Amgen, Procter & Gamble share gains contribute to Dow`s 100-point jump"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230324002200"", ""headline"": ""Amgen: Questioning The Horizon Therapeutics Acquisition"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230324020200"", ""headline"": ""Amgen: Revenue Growth Potentials And Financial Performance"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230324030800"", ""headline"": ""Mizuho Securities Keeps Their Hold Rating on Amgen (AMGN)"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230324080400"", ""headline"": ""FDA draft guidance impacts companies using accelerated approval for oncology drugs"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230324084700"", ""headline"": ""Amgen, Procter & Gamble share gains lead the way, but Dow flat"", ""summary"": ""Shares of Amgen and Procter & Gamble are seeing positive growth Friday afternoon, though the Dow Jones Industrial Average remains roughly flat. The Dow is...""}, {""date"": ""20230324104600"", ""headline"": ""Amgen, Procter & Gamble share gains contribute to Dow's 100-point jump"", ""summary"": ""Powered by strong returns for shares of Amgen and Procter & Gamble, the Dow Jones Industrial Average is climbing Friday afternoon. Shares of Amgen and...""}, {""date"": ""20230324123600"", ""headline"": ""Amgen Inc. stock outperforms market on strong trading day"", ""summary"": ""Shares of Amgen Inc. rose 2.11% to $238.03 Friday, on what proved to be an all-around positive trading session for the stock market, with the S&P 500 Index...""}, {""date"": ""20230324141828"", ""headline"": ""Final Trades: AMGN, FHN, MLPX & WMT"", ""summary"": ""The final trades of the week. With CNBC's Melissa Lee and the Fast Money traders, Steve Grasso, Courtney Garcia, Tim Seymour and Guy Adami.""}]",{}
11,2023-03-26,232.08511352539062,2023-04-02,235.7122039794922,0.015628277053214568,U2,"[{""date"": ""20230327060000"", ""headline"": ""Amgen bid to revive cholesterol drug patents comes to U.S. Supreme Court"", ""summary"": ""The U.S. Supreme Court on Monday is set to hear a bid by Amgen Inc to revive patents on its cholesterol-lowering drug Repatha in a legal effort that rival Sanofi SA called a \""blatant attempt\"" to squeeze competitors out of the market.  Amgen is appealing a lower court's ruling that invalidated two of its patents on Repatha, a drug that can reduce risk of heart attack and stroke in people with heart disease, after a legal fight with French drugmaker Sanofi and its partner Regeneron Pharmaceuticals Inc.""}, {""date"": ""20230327085000"", ""headline"": ""Supreme Court hears arguments in Amgen Repatha patent case against Sanofi"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230327103502"", ""headline"": ""UPDATE 1-U.S. Supreme Court hears Amgen bid to revive cholesterol drug patents"", ""summary"": ""The U.S. Supreme Court on Monday began hearing a bid by Amgen Inc to revive patents on its cholesterol-lowering drug Repatha in a legal effort that rival Sanofi SA called a \""blatant attempt\"" to squeeze competitors out of the market.  Amgen is appealing a lower court's ruling that invalidated two of its patents on Repatha, a drug that can reduce risk of heart attack and stroke in people with heart disease, after a legal fight with French drugmaker Sanofi and its partner Regeneron Pharmaceuticals Inc.""}, {""date"": ""20230327121209"", ""headline"": ""U.S. Supreme Court mulls Amgen bid to revive cholesterol drug patents"", ""summary"": ""U.S. Supreme Court justices on Monday weighed a bid by Amgen Inc to revive patents on its cholesterol-lowering drug Repatha in a legal effort that rival Sanofi SA called a \""blatant attempt\"" to squeeze competitors out of the market.""}, {""date"": ""20230327123600"", ""headline"": ""Amgen Inc. stock underperforms Monday when compared to competitors"", ""summary"": ""Shares of Amgen Inc. shed 0.53% to $236.76 Monday, on what proved to be an all-around positive trading session for the stock market, with the S&P 500 Index...""}, {""date"": ""20230327191623"", ""headline"": ""Amgen-Sanofi patent case divides makers of antibody drugs"", ""summary"": ""Amgen Inc's battle with Sanofi and Regeneron at the U.S. Supreme Court over its cholesterol drug Repatha on Monday has some drugmakers hoping a ruling will reshape U.S. patent law and competition among companies that make antibody medicines.""}, {""date"": ""20230328012600"", ""headline"": ""Amgen (AMGN) Receives a Hold from SVB Securities"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230328123600"", ""headline"": ""Amgen Inc. stock outperforms market on strong trading day"", ""summary"": ""Shares of Amgen Inc. inched 0.73% higher to $238.48 Tuesday, on what proved to be an all-around rough trading session for the stock market, with the S&P 500...""}, {""date"": ""20230328175009"", ""headline"": ""Amgen (AMGN) Gains As Market Dips: What You Should Know"", ""summary"": ""Amgen (AMGN) closed at $238.48 in the latest trading session, marking a +0.73% move from the prior day.""}, {""date"": ""20230328231600"", ""headline"": ""Viridian Therapeutics initiated with a Buy at Stifel"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230329003200"", ""headline"": ""Amgen, AstraZeneca`s asthma therapy Tezspire gets UK`s NICE backing"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230329055300"", ""headline"": ""WHO to weigh adding obesity therapies to `essential` medicines list \ufffd\ufffd\ufffd Reuters"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230329070132"", ""headline"": ""Selling US$5.2m worth of stock earlier this year was a lucrative decision for Amgen Inc. (NASDAQ:AMGN) insiders"", ""summary"": ""Even though Amgen Inc. ( NASDAQ:AMGN ) stock gained 3.8% last week, insiders who sold US$5.2m worth of stock over the...""}, {""date"": ""20230329123600"", ""headline"": ""Amgen Inc. stock rises Wednesday, still underperforms market"", ""summary"": ""Shares of Amgen Inc. rallied 1.07% to $241.03 Wednesday, on what proved to be an all-around favorable trading session for the stock market, with the S&P 500...""}, {""date"": ""20230330073000"", ""headline"": ""This Blue Chip Dividend Stock Should Return to Form When the Risk Premium Flips"", ""summary"": ""T-bills may be the flavor of the month, but history has shown this top biotech stock is a far better long-term investment.""}, {""date"": ""20230330090001"", ""headline"": ""Why Investors Need to Take Advantage of These 2 Medical Stocks Now"", ""summary"": ""Finding stocks expected to beat quarterly earnings estimates becomes an easier task with our Zacks Earnings ESP.""}, {""date"": ""20230330123600"", ""headline"": ""Amgen Inc. stock rises Thursday, still underperforms market"", ""summary"": ""Shares of Amgen Inc. inched 0.19% higher to $241.50 Thursday, on what proved to be an all-around positive trading session for the stock market, with the S&P...""}, {""date"": ""20230331034100"", ""headline"": ""Analysts Offer Insights on Healthcare Companies: Amgen (AMGN) and Eledon Pharmaceuticals (ELDN)"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230331093700"", ""headline"": ""1 Dividend Growth Stock to Buy Hand Over Fist"", ""summary"": ""Investing in dividend stocks, particularly those that raise their payouts regularly, can pay off massively in time.""}, {""date"": ""20230331100000"", ""headline"": ""My Top 10 High Dividend Yield Stocks To Invest In April 2023"", ""summary"": ""In today\u00e2\u0080\u0099s article, I will present you with my top 10 high Dividend Yield stocks to invest in for April 2023. Read more here.""}, {""date"": ""20230331123600"", ""headline"": ""Amgen Inc. stock rises Friday, still underperforms market"", ""summary"": ""Shares of Amgen Inc. inched 0.10% higher to $241.75 Friday, on what proved to be an all-around favorable trading session for the stock market, with the S&P...""}, {""date"": ""20230331174509"", ""headline"": ""Amgen (AMGN) Gains But Lags Market: What You Should Know"", ""summary"": ""Amgen (AMGN) closed the most recent trading day at $241.75, moving +0.1% from the previous trading session.""}, {""date"": ""20230402050200"", ""headline"": ""Seagen/Pfizer deal spread becoming increasingly attractive, analyst says"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}]","{""assetTurnoverTTM"": 0.3784, ""bookValue"": 5348, ""cashRatio"": 2.2201899402040097, ""currentRatio"": 3.1448, ""ebitPerShare"": 3.7807, ""eps"": 5.2807, ""ev"": 159129.5, ""fcfMargin"": 0.1179, ""fcfPerShareTTM"": 14.103, ""grossMargin"": 0.7245, ""inventoryTurnoverTTM"": 1.3855, ""longtermDebtTotalAsset"": 0.6849, ""longtermDebtTotalCapital"": 0.9077, ""longtermDebtTotalEquity"": 11.3614, ""netDebtToTotalCapital"": 0.4487, ""netDebtToTotalEquity"": 5.6161, ""netMargin"": 0.4654, ""operatingMargin"": 0.3332, ""payoutRatioTTM"": 0.5372, ""pb"": 24.1388, ""peTTM"": 16.306, ""pfcfTTM"": 17.1417, ""pretaxMargin"": 0.5638, ""psTTM"": 4.9292, ""quickRatio"": 2.7923, ""receivablesTurnoverTTM"": 4.8442, ""roaTTM"": 0.1144, ""roeTTM"": 2.0999, ""roicTTM"": 0.1659, ""rotcTTM"": 0.1924, ""salesPerShare"": 11.3476, ""sgaToSale"": 0.2755, ""totalDebtToEquity"": 11.5174, ""totalDebtToTotalAsset"": 0.6943, ""totalDebtToTotalCapital"": 0.9201, ""totalRatio"": 1.0641, ""period"": ""2023-03-31""}"
12,2023-04-02,235.7122039794922,2023-04-09,246.99325561523438,0.04785942961495393,U5,"[{""date"": ""20230402050200"", ""headline"": ""Seagen/Pfizer deal spread becoming increasingly attractive, analyst says"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230403001214"", ""headline"": ""A March ~6% Gain In My 25 Stock $417k Portfolio Beats The Market For The Third Time In 2023"", ""summary"": ""My portfolio, built specifically for my retirement ~20 years from now, features growth, dividends, and risk stocks for a happy retirement. Click here for a detailed analysis.""}, {""date"": ""20230403053900"", ""headline"": ""3 Dow Stocks With Above-Average Dividends Yields to Buy in April"", ""summary"": ""Income-seeking investors are going to love the annual payout raises and yields of 2.9% or better that these legendary dividend payers offer right now.""}, {""date"": ""20230403120420"", ""headline"": ""High Yield Stock Watchlist: April 2023"", ""summary"": ""Click to see 19 stocks on my high-yield watchlist for April 2023. The majority of the stocks on my watchlist are undervalued based on dividend yield theory.""}, {""date"": ""20230403123600"", ""headline"": ""Amgen Inc. stock rises Monday, outperforms market"", ""summary"": ""Shares of Amgen Inc. rallied 1.11% to $244.44 Monday, on what proved to be an all-around great trading session for the stock market, with the S&P 500 Index...""}, {""date"": ""20230403140400"", ""headline"": ""Dogs Of The Dow Stumble In First Quarter"", ""summary"": ""The Dogs of the Dow strategy has the sole focus of investing in the highest dividend-yielding stocks in the Dow Jones Industrial Average Index.""}, {""date"": ""20230404033100"", ""headline"": ""Analysts Are Bullish on These Healthcare Stocks: Amgen (AMGN), OncoCyte (OCX)"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230404090001"", ""headline"": ""Why Investors Need to Take Advantage of These 2 Medical Stocks Now"", ""summary"": ""Finding stocks expected to beat quarterly earnings estimates becomes an easier task with our Zacks Earnings ESP.""}, {""date"": ""20230404121004"", ""headline"": ""Will Amgen (AMGN) Beat Estimates Again in Its Next Earnings Report?"", ""summary"": ""Amgen (AMGN) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.""}, {""date"": ""20230404123600"", ""headline"": ""Amgen Inc. stock rises Tuesday, outperforms market"", ""summary"": ""Shares of Amgen Inc. rallied 1.26% to $247.53 Tuesday, on what proved to be an all-around poor trading session for the stock market, with the S&P 500 Index...""}, {""date"": ""20230404150646"", ""headline"": ""April Dogs Of The Dow: 2 Buy, 3 Watch"", ""summary"": ""The highest-yield 10 stocks are April\u00e2\u0080\u0099s Dogs of the Dow: CSCO, GS, JPM, AMGN, CVX, IBM, DOW, WBA, MMM, VZ, averaging a 4.44% annual yield. Click here for our lists.""}, {""date"": ""20230404180145"", ""headline"": ""Tracking Baker Brothers Portfolio - Q4 2022 Update"", ""summary"": ""Baker Brothers\u00e2\u0080\u0099 13F portfolio value increased from $15.27B to $16.65B this quarter. Click here to see the Q4 2022 update on the portfolio.""}, {""date"": ""20230405045500"", ""headline"": ""Early notable gainers among liquid option names on April 5th"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230405054800"", ""headline"": ""Dow up nearly 100 points on gains for Johnson & Johnson, Amgen stocks"", ""summary"": ""The Dow Jones Industrial Average is climbing Wednesday morning with shares of Johnson & Johnson and Amgen leading the way for the index. Shares of Johnson &...""}, {""date"": ""20230405062651"", ""headline"": ""Amgen's (NASDAQ:AMGN) Upcoming Dividend Will Be Larger Than Last Year's"", ""summary"": ""Amgen Inc. ( NASDAQ:AMGN ) has announced that it will be increasing its dividend from last year's comparable payment on...""}, {""date"": ""20230405063500"", ""headline"": ""InflaRx upgraded to Buy at Guggenheim after Gohibic gets COVID EUA"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230405064100"", ""headline"": ""AMGN Makes Bullish Cross Above Critical Moving Average"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230405065800"", ""headline"": ""AbbVie downgraded to hold at Argus on Humira competition in US"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230405090603"", ""headline"": ""3 Must-Buy Dow Stocks for Your April Buy List"", ""summary"": ""The Dow is short for the Dow Jones Industrial Average, a stock index that tracks the largest highly-traded public companies. It is one of the most watched indicators of overall stock market direction and includes 30 of the largest publicly traded firms. Thus, Dow stocks tend to get their fair share of attention from investors, due to their size and importance to the economy. The Dow represents the most significant industrial components of the U.S. economy. Thus, this index is often viewed as a w""}, {""date"": ""20230405123600"", ""headline"": ""Amgen Inc. stock underperforms Wednesday when compared to competitors despite daily gains"", ""summary"": ""Shares of Amgen Inc. advanced 2.36% to $253.37 Wednesday, on what proved to be an all-around mixed trading session for the stock market, with the Dow Jones...""}, {""date"": ""20230406004000"", ""headline"": ""7 Very Undervalued Penny Stocks to Buy in April 2023"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230406054400"", ""headline"": ""Income Investors: These 2 Stocks Have Quadrupled Their Dividend Payouts Over the Past 10 Years"", ""summary"": ""While there are thousands of publicly traded companies available, not all are worth putting your hard-earned money into.  One of the more objective measures of quality in investing is a track record of outsized dividend growth.  Here are two dividend payers in the healthcare sector that have achieved huge payout growth in the past 10 years.""}, {""date"": ""20230406060900"", ""headline"": ""Morgan Stanley cuts Comcast, adds Becton Dickinson to its model portfolio"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230406073800"", ""headline"": ""FDA forces pre-term birth drug off the market after 12 years"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230406075700"", ""headline"": ""Nicholas Ward`s Dividend Growth Portfolio: Special Fixed Income Edition"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230406123600"", ""headline"": ""Amgen Inc. stock falls Thursday, underperforms market"", ""summary"": ""Shares of Amgen Inc. sank 0.02% to $253.32 Thursday, on what proved to be an all-around great trading session for the stock market, with the S&P 500 Index...""}, {""date"": ""20230406175009"", ""headline"": ""Amgen (AMGN) Stock Sinks As Market Gains: What You Should Know"", ""summary"": ""Amgen (AMGN) closed at $253.35 in the latest trading session, marking a -0.01% move from the prior day.""}, {""date"": ""20230406205614"", ""headline"": ""Nicholas Ward's Dividend Growth Portfolio: Special Fixed Income Edition"", ""summary"": ""My passive income stream grew by 22.63% in February and by 46.87% in March. Read more as I review my February and March results in this piece.""}, {""date"": ""20230406211700"", ""headline"": ""Catalyst Watch: Eyes on inflation data, big bank earnings"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230407044500"", ""headline"": ""Mizuho Securities Keeps Their Hold Rating on Amgen (AMGN)"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230407045200"", ""headline"": ""Analysts Conflicted on These Healthcare Names: Alnylam Pharma (ALNY), Amgen (AMGN) and Regeneron (REGN)"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230407212000"", ""headline"": ""Week In Review: Suzhou Duality Out-Licenses Two ADCs To BioNTech In $1.7 Billion Deal"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230409052700"", ""headline"": ""Love Dividends? These 3 Stocks Are Smart Buys Right Now"", ""summary"": ""Receiving cash payments every three months is one obvious attraction.  If you're looking for businesses that can make and raise dividend payments regardless of an uncooperative economic environment, it's hard to do better than the healthcare sector.  While you're most likely familiar with CVS Health's (NYSE: CVS) chain of retail pharmacies, most don't realize that retail is a small part of this company's overall business.""}, {""date"": ""20230409070100"", ""headline"": ""Premier cancer research event, AACR is starting this week; Here is what to expect"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}]","{""assetTurnoverTTM"": 0.3784, ""bookValue"": 5348, ""cashRatio"": 2.2201899402040097, ""currentRatio"": 3.1448, ""ebitPerShare"": 3.7807, ""eps"": 5.2807, ""ev"": 159129.5, ""fcfMargin"": 0.1179, ""fcfPerShareTTM"": 14.103, ""grossMargin"": 0.7245, ""inventoryTurnoverTTM"": 1.3855, ""longtermDebtTotalAsset"": 0.6849, ""longtermDebtTotalCapital"": 0.9077, ""longtermDebtTotalEquity"": 11.3614, ""netDebtToTotalCapital"": 0.4487, ""netDebtToTotalEquity"": 5.6161, ""netMargin"": 0.4654, ""operatingMargin"": 0.3332, ""payoutRatioTTM"": 0.5372, ""pb"": 24.1388, ""peTTM"": 16.306, ""pfcfTTM"": 17.1417, ""pretaxMargin"": 0.5638, ""psTTM"": 4.9292, ""quickRatio"": 2.7923, ""receivablesTurnoverTTM"": 4.8442, ""roaTTM"": 0.1144, ""roeTTM"": 2.0999, ""roicTTM"": 0.1659, ""rotcTTM"": 0.1924, ""salesPerShare"": 11.3476, ""sgaToSale"": 0.2755, ""totalDebtToEquity"": 11.5174, ""totalDebtToTotalAsset"": 0.6943, ""totalDebtToTotalCapital"": 0.9201, ""totalRatio"": 1.0641, ""period"": ""2023-03-31""}"
13,2023-04-09,246.99325561523438,2023-04-16,243.7561492919922,-0.01310605147974142,D2,"[{""date"": ""20230409052700"", ""headline"": ""Love Dividends? These 3 Stocks Are Smart Buys Right Now"", ""summary"": ""Receiving cash payments every three months is one obvious attraction.  If you're looking for businesses that can make and raise dividend payments regardless of an uncooperative economic environment, it's hard to do better than the healthcare sector.  While you're most likely familiar with CVS Health's (NYSE: CVS) chain of retail pharmacies, most don't realize that retail is a small part of this company's overall business.""}, {""date"": ""20230409070100"", ""headline"": ""Premier cancer research event, AACR is starting this week; Here is what to expect"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230409233000"", ""headline"": ""Diving Into the Smead Value Fund`s Top Holdings as Value Conference Approaches"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230410051400"", ""headline"": ""Horizon posts positive Phase 4 data for thyroid eye disease therapy Tepezza"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230410123600"", ""headline"": ""Amgen Inc. stock falls Monday, underperforms market"", ""summary"": ""Shares of Amgen Inc. slumped 0.96% to $250.90 Monday, on what proved to be an all-around positive trading session for the stock market, with the S&P 500...""}, {""date"": ""20230410232500"", ""headline"": ""Barclays Keeps Their Sell Rating on Amgen (AMGN)"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230411064752"", ""headline"": ""Stable growth companies aren't priced in to this market: Goldman's David Kostin"", ""summary"": ""David Kostin, Goldman Sachs Chief U.S. Equity Strategist, joins 'Squawk on the Street' to give his thoughts on the upcoming earnings season, where the surprises will be, and more.""}, {""date"": ""20230411100018"", ""headline"": ""Amgen Inc. (NASDAQ:AMGN) is a favorite amongst institutional investors who own 78%"", ""summary"": ""Key Insights Given the large stake in the stock by institutions, Amgen's stock price might be vulnerable to their...""}, {""date"": ""20230411123600"", ""headline"": ""Amgen Inc. stock outperforms competitors on strong trading day"", ""summary"": ""Shares of Amgen Inc. inched 0.21% higher to $251.43 Tuesday, on what proved to be an all-around mixed trading session for the stock market, with the S&P 500...""}, {""date"": ""20230411201100"", ""headline"": ""DivHut Portfolio Update: March 2023"", ""summary"": ""The system is clearly broken, and has been for a while; however, I could find comfort in one thing, my dividends. Four figures in a month is a win in my book.""}, {""date"": ""20230411222628"", ""headline"": ""Why Healthcare Stocks Are A Prescription For Investors In Q2 2023"", ""summary"": ""The recent drop in biopharma stocks presents a buying opportunity for investors. Find out why XLV seems like the best fit.""}, {""date"": ""20230412123600"", ""headline"": ""Amgen Inc. stock falls Wednesday, underperforms market"", ""summary"": ""Shares of Amgen Inc. shed 0.77% to $249.50 Wednesday, on what proved to be an all-around grim trading session for the stock market, with the S&P 500 Index...""}, {""date"": ""20230412162057"", ""headline"": ""Medical research has driven 'the last 200 years of economic expansion': Michael Milken"", ""summary"": ""Health investment and innovation has been on a roller coaster as a result of the pandemic. But the momentum needs to continue, according to Michael Milken.""}, {""date"": ""20230413041200"", ""headline"": ""Editas Medicine appoints Reeve as Chair of Board, Levy as new director"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230413120000"", ""headline"": ""How Horizon Therapeutics sold to Amgen for $27.8 billion without ever licensing a drug of its own"", ""summary"": ""Horizon grew large by snapping up cheap drugs from other companies, marketing them to perfection, and jacking up prices.""}, {""date"": ""20230413123600"", ""headline"": ""Amgen Inc. stock rises Thursday, still underperforms market"", ""summary"": ""Shares of Amgen Inc. inched 0.78% higher to $251.44 Thursday, on what proved to be an all-around favorable trading session for the stock market, with the S&P...""}, {""date"": ""20230413175009"", ""headline"": ""Amgen (AMGN) Gains But Lags Market: What You Should Know"", ""summary"": ""Amgen (AMGN) closed the most recent trading day at $251.44, moving +0.78% from the previous trading session.""}, {""date"": ""20230413232500"", ""headline"": ""Amgen (AMGN) Receives a Sell from Barclays"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230414003100"", ""headline"": ""Amgen price target lowered to $227 from $230 at Barclays"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230414003700"", ""headline"": ""Ghana 1st in world to approve new malaria vaccine by Oxford"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230414034600"", ""headline"": ""Amgen (AMGN) Receives a Hold from Mizuho Securities"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230414035000"", ""headline"": ""Horizon announces FDA label update for thyroid eye disease therapy"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230414123600"", ""headline"": ""Amgen Inc. stock falls Friday, underperforms market"", ""summary"": ""Shares of Amgen Inc. slid 0.57% to $250.00 Friday, on what proved to be an all-around grim trading session for the stock market, with the S&P 500 Index...""}, {""date"": ""20230414175403"", ""headline"": ""Barclays Maintains Amgen (AMGN) Underweight Recommendation"", ""summary"": """"}, {""date"": ""20230416010050"", ""headline"": ""Better Buy For Retiring With Dividends: VYM Or SCHD?"", ""summary"": ""VYM and SCHD provide an all-in-one solution by offering attractive and growing dividend income streams. Check out which is the better buy at the moment.""}, {""date"": ""20230416052100"", ""headline"": ""Is Arrowhead Pharmaceuticals a Buy Now?"", ""summary"": ""The clinical-stage drug developer is attracting a lot of positive attention from investment bank analysts.""}, {""date"": ""20230416145257"", ""headline"": ""7 Dividend Stocks to Buy That Are Backed by Strong Cash Flows"", ""summary"": ""Many investors have heard the phrase \u201ccash is king\u201d relative to the current banking crisis. But it also has significance for dividend investors. A company\u2019s cash flow, and particularly its free cash flow, is an important indicator for investors trying to determine how safe a dividend payout is. This article highlights seven dividend stocks with strong cash flows. And I\u2019ve put an emphasis on free cash flow. Free cash flow is simply the money a company has left (or free to use) after it has paid o""}, {""date"": ""20230416182000"", ""headline"": ""Merck to Acquire Prometheus Biosciences"", ""summary"": ""Merck  & Co. said it agreed to acquire  Prometheus Biosciences  for $10.8 billion, a push into the lucrative market for immune-disease treatments.  Merck said Sunday it would acquire Prometheus at $200 a share, a roughly 75% premium to where shares closed on Friday, at $114.01.  The Wall Street Journal reported earlier Sunday that Merck was in late-stage talks with Prometheus for an acquisition.""}]","{""assetTurnoverTTM"": 0.3784, ""bookValue"": 5348, ""cashRatio"": 2.2201899402040097, ""currentRatio"": 3.1448, ""ebitPerShare"": 3.7807, ""eps"": 5.2807, ""ev"": 159129.5, ""fcfMargin"": 0.1179, ""fcfPerShareTTM"": 14.103, ""grossMargin"": 0.7245, ""inventoryTurnoverTTM"": 1.3855, ""longtermDebtTotalAsset"": 0.6849, ""longtermDebtTotalCapital"": 0.9077, ""longtermDebtTotalEquity"": 11.3614, ""netDebtToTotalCapital"": 0.4487, ""netDebtToTotalEquity"": 5.6161, ""netMargin"": 0.4654, ""operatingMargin"": 0.3332, ""payoutRatioTTM"": 0.5372, ""pb"": 24.1388, ""peTTM"": 16.306, ""pfcfTTM"": 17.1417, ""pretaxMargin"": 0.5638, ""psTTM"": 4.9292, ""quickRatio"": 2.7923, ""receivablesTurnoverTTM"": 4.8442, ""roaTTM"": 0.1144, ""roeTTM"": 2.0999, ""roicTTM"": 0.1659, ""rotcTTM"": 0.1924, ""salesPerShare"": 11.3476, ""sgaToSale"": 0.2755, ""totalDebtToEquity"": 11.5174, ""totalDebtToTotalAsset"": 0.6943, ""totalDebtToTotalCapital"": 0.9201, ""totalRatio"": 1.0641, ""period"": ""2023-03-31""}"
14,2023-04-16,243.7561492919922,2023-04-23,237.76951599121094,-0.024559927280480398,D3,"[{""date"": ""20230416010050"", ""headline"": ""Better Buy For Retiring With Dividends: VYM Or SCHD?"", ""summary"": ""VYM and SCHD provide an all-in-one solution by offering attractive and growing dividend income streams. Check out which is the better buy at the moment.""}, {""date"": ""20230416052100"", ""headline"": ""Is Arrowhead Pharmaceuticals a Buy Now?"", ""summary"": ""The clinical-stage drug developer is attracting a lot of positive attention from investment bank analysts.""}, {""date"": ""20230416145257"", ""headline"": ""7 Dividend Stocks to Buy That Are Backed by Strong Cash Flows"", ""summary"": ""Many investors have heard the phrase \u201ccash is king\u201d relative to the current banking crisis. But it also has significance for dividend investors. A company\u2019s cash flow, and particularly its free cash flow, is an important indicator for investors trying to determine how safe a dividend payout is. This article highlights seven dividend stocks with strong cash flows. And I\u2019ve put an emphasis on free cash flow. Free cash flow is simply the money a company has left (or free to use) after it has paid o""}, {""date"": ""20230416182000"", ""headline"": ""Merck to Acquire Prometheus Biosciences"", ""summary"": ""Merck  & Co. said it agreed to acquire  Prometheus Biosciences  for $10.8 billion, a push into the lucrative market for immune-disease treatments.  Merck said Sunday it would acquire Prometheus at $200 a share, a roughly 75% premium to where shares closed on Friday, at $114.01.  The Wall Street Journal reported earlier Sunday that Merck was in late-stage talks with Prometheus for an acquisition.""}, {""date"": ""20230417005000"", ""headline"": ""Bassem Elmankabadi, M.D. joins Foresee Pharmaceuticals as a Senior Vice President of Clinical Development"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230417070000"", ""headline"": ""Amgen Has Long-Term Staying Power"", ""summary"": """"}, {""date"": ""20230417085033"", ""headline"": ""15 Cheapest Countries for Retirement"", ""summary"": ""In this article, we will explore the 15 cheapest countries for retirement. You can skip our detailed analysis and go directly to 5 Cheapest Countries for Retirement. The Costs of Living in Retirement On average, a comfortable retirement in the USA costs an estimated $1 million. With Americans spending $50,220 annually post-retirement, 25% have already [\u2026]""}, {""date"": ""20230417115217"", ""headline"": ""Johnson & Johnson: 4 Key Areas Of Focus Ahead Of Q1 Earnings"", ""summary"": """"}, {""date"": ""20230417123600"", ""headline"": ""Amgen Inc. stock underperforms Monday when compared to competitors"", ""summary"": ""Shares of Amgen Inc. dropped 0.77% to $248.07 Monday, on what proved to be an all-around positive trading session for the stock market, with the S&P 500...""}, {""date"": ""20230418010200"", ""headline"": ""Analysts Conflicted on These Healthcare Names: Amgen (AMGN), Resmed (RMD) and Travere Therapeutics (TVTX)"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230418080023"", ""headline"": ""These 4 Measures Indicate That Amgen (NASDAQ:AMGN) Is Using Debt Reasonably Well"", ""summary"": ""Warren Buffett famously said, 'Volatility is far from synonymous with risk.' So it seems the smart money knows that...""}, {""date"": ""20230418123700"", ""headline"": ""Amgen Inc. stock outperforms competitors despite losses on the day"", ""summary"": ""Shares of Amgen Inc. slid 0.80% to $246.09 Tuesday, on what proved to be an all-around mixed trading session for the stock market, with the S&P 500 Index...""}, {""date"": ""20230418232100"", ""headline"": ""Amgen wins appeals court ruling in patent dispute over psoriasis drug Otezla"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230418234700"", ""headline"": ""Amgen wins patent appeal on Otezla"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230419123600"", ""headline"": ""Amgen Inc. stock underperforms Wednesday when compared to competitors despite daily gains"", ""summary"": ""Shares of Amgen Inc. inched 0.05% higher to $246.21 Wednesday, on what proved to be an all-around grim trading session for the stock market, with the S&P 500...""}, {""date"": ""20230419131742"", ""headline"": ""Amgen wins appeal in US patent case over generic psoriasis drugs"", ""summary"": ""Amgen Inc convinced a U.S. appeals court on Wednesday to uphold patents that barred generic versions of its blockbuster psoriasis drug Otezla proposed by Zydus Pharmaceuticals and Novartis' Sandoz Inc.""}, {""date"": ""20230419164500"", ""headline"": ""AMGEN WINS PATENT APPEAL ON OTEZLA\u00ae (APREMILAST)"", ""summary"": ""Amgen (NASDAQ:AMGN) today announced that the U.S. Court of Appeals for the Federal Circuit has affirmed the judgment of the U.S. District Court for the District of New Jersey in a patent infringement lawsuit against Sandoz Inc. (\""Sandoz\"") and Zydus Pharmaceuticals (USA), Inc. (\""Zydus\""). Today's decision affirms the permanent injunction entered by the district court prohibiting Sandoz and Zydus from making, using, selling, offering to sell, or importing each of their generic versions of Otezla un""}, {""date"": ""20230419173822"", ""headline"": ""UPDATE 1-US Amgen ruling keeps generic psoriasis drug off market until 2028"", ""summary"": ""Amgen Inc convinced a U.S. appeals court on Wednesday to uphold patents that bar generic versions of its blockbuster psoriasis drug Otezla proposed by Zydus Pharmaceuticals and Novartis AG's Sandoz Inc until 2028.  The U.S. Court of Appeals for the Federal Circuit affirmed a New Jersey federal court's ruling that Amgen patents covering the drug were valid and that the proposed generics would infringe them.  The Federal Circuit also upheld a decision to invalidate one of Amgen's patents that Sandoz said would have barred its generics until 2034.""}, {""date"": ""20230419175009"", ""headline"": ""Amgen (AMGN) Gains As Market Dips: What You Should Know"", ""summary"": ""In the latest trading session, Amgen (AMGN) closed at $246.21, marking a +0.05% move from the previous day.""}, {""date"": ""20230419221600"", ""headline"": ""Amgen (AMGN) Receives a Sell from Barclays"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230420002600"", ""headline"": ""Amgen (NASDAQ:AMGN) Wins Patent Appeal on Key Psoriasis Drug"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230420081200"", ""headline"": ""See Which Of The Latest 13F Filers Holds Amgen"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230420081312"", ""headline"": ""Amgen (AMGN) Wins Patent Appeal for Blockbuster Psoriasis Drug"", ""summary"": ""The Appeal Court's decision upholding the patents for Amgen's (AMGN) blockbuster psoriasis drug Otezla will prevent drug-makers from selling a generic version till February 2028.""}, {""date"": ""20230420100302"", ""headline"": ""Amgen (AMGN) Expected to Beat Earnings Estimates: Can the Stock Move Higher?"", ""summary"": ""Amgen (AMGN) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.""}, {""date"": ""20230420123600"", ""headline"": ""Amgen Inc. stock underperforms Thursday when compared to competitors"", ""summary"": ""Shares of Amgen Inc. shed 1.12% to $243.46 Thursday, on what proved to be an all-around grim trading session for the stock market, with the S&P 500 Index...""}, {""date"": ""20230420224900"", ""headline"": ""VMware/Broadcom deal spread widens amid notice of FTC closed door meetings"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230421030600"", ""headline"": ""Amgen (AMGN) Receives a Hold from Mizuho Securities"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230421071341"", ""headline"": ""XBI: Uncorrelated Growth Capitalizing On The M&A Tidal Wave In Pharma"", ""summary"": """"}, {""date"": ""20230421121642"", ""headline"": ""12 Best Pharma Dividend Stocks To Buy in 2023"", ""summary"": ""In this article, we discuss 12 best pharma dividend stocks to buy in 2023. You can skip our detailed analysis of the pharmaceutical sector and its outlook this year, and go directly to read 5 Best Pharma Dividend Stocks To Buy in 2023. The pharmaceutical industry in the US is one of the largest in [\u2026]""}, {""date"": ""20230421123600"", ""headline"": ""Amgen Inc. stock rises Friday, outperforms market"", ""summary"": ""Shares of Amgen Inc. inched 0.16% higher to $243.86 Friday, on what proved to be an all-around positive trading session for the stock market, with the S&P...""}, {""date"": ""20230421130756"", ""headline"": ""11 Best Fast Money Stocks To Buy According To Hedge Funds"", ""summary"": ""In this article, we will discuss the 11 best Fast Money stocks to buy now according to hedge funds. If you want to explore similar stocks, you can also take a look at 5 Best Fast Money Stocks To Buy According To Hedge Funds. \u201cTrendlines Over Headlines\u201d On April 12 Piper Sandler\u2019s chief market technician, [\u2026]""}, {""date"": ""20230421160000"", ""headline"": ""AMGEN ANNOUNCES WEBCAST OF 2023 FIRST QUARTER FINANCIAL RESULTS"", ""summary"": ""Amgen (NASDAQ:AMGN) today announced that it will report its first quarter financial results on Thursday, April 27, 2023, after the close of the U.S. financial markets. The announcement will be followed by a conference call with the investment community at 1:30 p.m. PT. Participating in the call from Amgen will be Robert A. Bradway, chairman and chief executive officer, and other members of Amgen's senior management team.""}, {""date"": ""20230421185700"", ""headline"": ""China\u2019s Consumer-Led Growth Looks More Like a Bounce, Not a Recovery"", ""summary"": ""China\u2019s first-quarter GDP grew faster than expected after a Covid-racked 2022. But some strategists question whether it has the strength to drive a sustainable recovery.""}, {""date"": ""20230422201500"", ""headline"": ""ClearBridge SMID Cap Growth Strategy Q1 2023 Portfolio Manager Commentary"", ""summary"": """"}, {""date"": ""20230423021500"", ""headline"": ""Nautilus Biotechnology: The Rubber Will Soon Meet The Road"", ""summary"": """"}, {""date"": ""20230423090021"", ""headline"": ""Investing in Amgen (NASDAQ:AMGN) five years ago would have delivered you a 59% gain"", ""summary"": ""If you buy and hold a stock for many years, you'd hope to be making a profit. Furthermore, you'd generally like to see...""}]",{}
15,2023-04-23,237.76951599121094,2023-04-30,233.75241088867188,-0.01689495428290122,D2,"[{""date"": ""20230422201500"", ""headline"": ""ClearBridge SMID Cap Growth Strategy Q1 2023 Portfolio Manager Commentary"", ""summary"": """"}, {""date"": ""20230423021500"", ""headline"": ""Nautilus Biotechnology: The Rubber Will Soon Meet The Road"", ""summary"": """"}, {""date"": ""20230423090021"", ""headline"": ""Investing in Amgen (NASDAQ:AMGN) five years ago would have delivered you a 59% gain"", ""summary"": ""If you buy and hold a stock for many years, you'd hope to be making a profit. Furthermore, you'd generally like to see...""}, {""date"": ""20230424083812"", ""headline"": ""4 Pharma, Biotech Stocks Poised to Beat Q1 Earnings Estimates"", ""summary"": ""We look at a few pharma/biotech companies, SNY, AMGN, REGN, ACAD, which are poised to beat on earnings in the first quarter.""}, {""date"": ""20230424102606"", ""headline"": ""Oppenheimer Maintains AMGEN (AMGN) Outperform Recommendation"", ""summary"": """"}, {""date"": ""20230424105102"", ""headline"": ""Can Amgen (AMGN) Keep the Earnings Streak Alive in Q1?"", ""summary"": ""Volume growth from Amgen's (AMGN) key drugs like Prolia, Repatha and Evenity, among others is expected to have been partially offset by biosimilar/generic competition for mature drugs.""}, {""date"": ""20230424123600"", ""headline"": ""Amgen Inc. stock outperforms market on strong trading day"", ""summary"": ""Shares of Amgen Inc. inched 0.24% higher to $244.45 Monday, on what proved to be an all-around great trading session for the stock market, with the S&P 500...""}, {""date"": ""20230424220113"", ""headline"": ""Top Biotech Stocks For Q2 2023: First Gem Is BioNTech"", ""summary"": """"}, {""date"": ""20230425022643"", ""headline"": ""Is Amgen A Buy Ahead Of The Q1 Results?"", ""summary"": ""Amgen will publish its Q1 results in a couple of days, followed by an earnings call post-market hours. Click here to read a detailed analysis of AMGN stock.""}, {""date"": ""20230425083100"", ""headline"": ""Analysts Offer Insights on Healthcare Companies: Amgen (AMGN), Bluebird Bio (BLUE) and InMode (INMD)"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230425123600"", ""headline"": ""Amgen Inc. stock underperforms Tuesday when compared to competitors despite daily gains"", ""summary"": ""Shares of Amgen Inc. inched 0.17% higher to $244.87 Tuesday, on what proved to be an all-around poor trading session for the stock market, with the S&P 500...""}, {""date"": ""20230425210200"", ""headline"": ""Dow`s 182-point fall led by losses in Merck, Honeywell shares"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230425225500"", ""headline"": ""Will Amgen`s streak of EPS beats continue in Q1?"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230426023746"", ""headline"": ""14 Best Income Stocks To Invest In"", ""summary"": ""In this article, we discuss 14 best income stocks to invest in. You can skip our detailed analysis of income stocks and the performance of dividend stocks over the years, and go directly to read 5 Best Income Stocks To Invest In. Income stocks are picking up steam this year because they offer a relatively [\u2026]""}, {""date"": ""20230426043200"", ""headline"": ""EU publishes proposed reforms for pharma industry"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230426073500"", ""headline"": ""Will Humira competition impact AbbVie Q1 results?"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230426082600"", ""headline"": ""Democratic senators introduce bill to enhance CMS drug price negotiations"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230426090001"", ""headline"": ""These 2 Medical Stocks Could Beat Earnings: Why They Should Be on Your Radar"", ""summary"": ""The Zacks Earnings ESP is a great way to find potential earnings surprises. Why investors should take advantage now.""}, {""date"": ""20230426123600"", ""headline"": ""Amgen Inc. stock underperforms Wednesday when compared to competitors"", ""summary"": ""Shares of Amgen Inc. slipped 2.48% to $238.80 Wednesday, on what proved to be an all-around poor trading session for the stock market, with the S&P 500 Index...""}, {""date"": ""20230426203000"", ""headline"": ""GLOBAL BRIEFING: Samsung posts weakest profit in 14 years in Q1"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230426211100"", ""headline"": ""Notable companies reporting after market close"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230426223600"", ""headline"": ""Noteworthy Thursday Option Activity: AMGN, COOP, OXY"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230426230100"", ""headline"": ""Amgen reports Q1 adjusted EPS $3.98, consensus $3.85"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230426230400"", ""headline"": ""Amgen raises FY23 adjusted EPS view to $17.60-$18.70 from $17.40-$18.60"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230426230800"", ""headline"": ""Amgen Non-GAAP EPS of $3.98 in-line, revenue of $6.1B misses by $140M"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230426235400"", ""headline"": ""Amgen 2023 revenue, earnings outlook include consensus estimates"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230427000500"", ""headline"": ""Mizuho Securities Sticks to Their Hold Rating for Amgen (AMGN)"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230427014500"", ""headline"": ""Fly Intel: After-Hours Movers"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230427015800"", ""headline"": ""Lilly obesity therapy shows ~16% weight loss in Phase 3 trial"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230427054523"", ""headline"": ""Revenue Headwinds Pull Amgen Into Neutral"", ""summary"": ""Amgen is a large biotechnology constituent of the Dow Jones Industrial Average index. Learn why AMGN is no longer a Buy.""}, {""date"": ""20230427103000"", ""headline"": ""Time To Sound The Warning Bells For AbbVie?"", ""summary"": ""AbbVie reported Q1 results that investors found underwhelming. Read more to know why I rate ABBV stock as a hold.""}, {""date"": ""20230427122300"", ""headline"": ""Amgen 1Q Net Income Surges Despite 2% Dip in Revenue"", ""summary"": ""By Denny Jacob Amgen Inc. net income surged in the latest quarter even as revenue declined slightly. The biotechnology company logged net income of $2.84...""}, {""date"": ""20230427122500"", ""headline"": ""Amgen: Q1 Earnings Snapshot"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230427122700"", ""headline"": ""Amgen Raises 2023 Revenue, EPS Outlook"", ""summary"": ""By Denny Jacob Amgen Inc. on Thursday raised its 2023 outlook after volume grew in the latest quarter. The biotechnology company guided for revenue between...""}, {""date"": ""20230427131500"", ""headline"": ""Amgen sales drop due to lower Covid-19 manufacturing collaboration"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230427131938"", ""headline"": ""Stocks making the biggest moves after hours: Amazon, Intel, Snap, Pinterest and more"", ""summary"": ""These are the stocks posting the largest moves in extended trading.""}, {""date"": ""20230427160100"", ""headline"": ""AMGEN REPORTS FIRST QUARTER FINANCIAL RESULTS"", ""summary"": ""Amgen (NASDAQ:AMGN) today announced financial results for the first quarter of 2023.""}, {""date"": ""20230427160221"", ""headline"": ""Amgen 1st quarter profit falls as costs rise, sales flatten"", ""summary"": ""Amgen Inc on Thursday reported lower first-quarter profit as expenses rose and a 2% increase in sales of its own drugs was offset by lower revenue from its deal to manufacture COVID-19 antibody treatments for Eli Lilly and Co.  Product sales by volume grew 14% from a year earlier, but was partially offset by a 5% decline in net selling prices due to unfavorable foreign exchange and sales deductions, such as rebates.  Amgen reported revenue of $6.1 billion for the quarter, down 2% from a year earlier, but in line with analysts' estimates of $6.13 billion, according to Refinitiv data.""}, {""date"": ""20230427165438"", ""headline"": ""UPDATE 1-Amgen 1st quarter profit falls as costs rise, sales flatten"", ""summary"": ""Amgen Inc on Thursday reported lower first-quarter profit as expenses rose and a 2% increase in sales of its own drugs was offset by lower revenue from its deal to manufacture COVID-19 antibody treatments for Eli Lilly and Co.  Product sales by volume grew 14% from a year earlier, but net selling prices fell 5%, while foreign exchange rates and other factors also limited sales revenue gains, Amgen said.  Amgen is seeing prescription trends return to prepandemic levels and \""demand for medicines is resilient despite current macroeconomic challenges,\"" Amgen Chief Executive Robert Bradway said on a conference call with investors.""}, {""date"": ""20230427172802"", ""headline"": ""Amgen Inc. (AMGN) Q1 2023 Earnings Call Transcript"", ""summary"": ""Amgen Inc. (NASDAQ:NASDAQ:AMGN) Q1 2023 Earnings Conference Call April 27, 2023 4:30 PM ETCompany ParticipantsArvind Sood - Vice President of Investor RelationsBob Bradway - Chairman and...""}, {""date"": ""20230427173509"", ""headline"": ""Amgen (AMGN) Q1 Earnings Beat Estimates"", ""summary"": ""Amgen (AMGN) delivered earnings and revenue surprises of 3.65% and 0.66%, respectively, for the quarter ended March 2023. Do the numbers hold clues to what lies ahead for the stock?""}, {""date"": ""20230427180023"", ""headline"": ""Amgen 1st quarter profit falls as costs rise, sales up 2%"", ""summary"": ""Amgen Inc on Thursday reported lower first-quarter profit as expenses rose and a 2% increase in sales of its own drugs was offset by lower revenue from its deal to manufacture COVID-19 antibody treatments for Eli Lilly and Co.""}, {""date"": ""20230427203700"", ""headline"": ""GLOBAL BRIEFING: BoJ leaves rates unchanged; Intel swings to loss"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230427220600"", ""headline"": ""Catalyst watch: FOMC, Apple earnings, Kenvue IPO and jobs report are on tap"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230427232600"", ""headline"": ""Goldman Sachs Reaffirms Their Buy Rating on Amgen (AMGN)"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230428022000"", ""headline"": ""Analysts` Top Healthcare Picks: Amgen (AMGN), Dexcom (DXCM)"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230428024900"", ""headline"": ""Amgen price target lowered to $288 from $293 at Piper Sandler"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230428033000"", ""headline"": ""Analysts Offer Insights on Healthcare Companies: Amgen (AMGN), Dexcom (DXCM) and Merck & Company (MRK)"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230428052600"", ""headline"": ""Video: Dow Movers: AMGN, INTC"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230428100331"", ""headline"": ""Weight loss drug market is just beginning to take off, says Mizuho's Jared Holz"", ""summary"": ""Jared Holz, Mizuho healthcare equity strategist, joins 'The Exchange' to discuss new weight loss drugs coming to market, forecasts for market expansion in weight loss drugs, and key players in the weight loss drug sector.""}, {""date"": ""20230428105841"", ""headline"": ""Why Amgen Shares Are Trading Lower Today"", ""summary"": ""Amgen Inc (NASDAQ: AMGN) reported Q1 FY23 sales of $6.11 billion, down 2% Y/Y, resulting from lower revenue from COVID-19 manufacturing collaboration, partially offset by a 2% increase in product sales. The consensus estimate stood at $6.17 billion. Product sales growth was driven by 14% volume growth, partially offset by 5% lower net selling price, 3% unfavorable changes to estimated sales deductions, 2% lower inventory levels, and 2% negative impact from foreign exchange. Excluding the 2% nega""}, {""date"": ""20230428115203"", ""headline"": ""Amgen (AMGN) Q1 Earnings Beat Estimates, 2023 View Raised"", ""summary"": ""Amgen (AMGN) beats estimates for earnings but misses the same for sales. It raises its earnings and sales guidance for 2023.""}, {""date"": ""20230428123600"", ""headline"": ""Amgen Inc. stock falls Friday, underperforms market"", ""summary"": ""Shares of Amgen Inc. shed 0.25% to $239.74 Friday, on what proved to be an all-around favorable trading session for the stock market, with the S&P 500 Index...""}, {""date"": ""20230428142506"", ""headline"": ""What To Expect After The Failed AbbVie Drug Sales"", ""summary"": ""AbbVie's revenue amounted to $12,225 million in the first three months of 2023, 9.7% less than the previous year. Find out my recent analysis of ABBV stock.""}, {""date"": ""20230428200245"", ""headline"": ""Piper Sandler Maintains AMGEN (AMGN) Overweight Recommendation"", ""summary"": """"}, {""date"": ""20230429080016"", ""headline"": ""Possible bearish signals as Amgen Inc. (NASDAQ:AMGN) insiders disposed of US$5.2m worth of stock"", ""summary"": ""Many Amgen Inc. ( NASDAQ:AMGN ) insiders ditched their stock over the past year, which may be of interest to the...""}, {""date"": ""20230429215306"", ""headline"": ""27 Largest Biotech Companies in the US"", ""summary"": ""In this article, we take a look at 27 largest biotech companies in the US. You can skip our detailed analysis of the biotech industry and go directly to the 5 Largest Biotech Companies in the US. The largest biotech companies in the US have a total market cap of $88 trillion. Latest Developments in [\u2026]""}]",{}
16,2023-04-30,233.75241088867188,2023-05-07,230.62258911132812,-0.01338947378315758,D2,"[{""date"": ""20230429215306"", ""headline"": ""27 Largest Biotech Companies in the US"", ""summary"": ""In this article, we take a look at 27 largest biotech companies in the US. You can skip our detailed analysis of the biotech industry and go directly to the 5 Largest Biotech Companies in the US. The largest biotech companies in the US have a total market cap of $88 trillion. Latest Developments in [\u2026]""}, {""date"": ""20230501000800"", ""headline"": ""Amgen price target lowered to $225 from $227 at Barclays"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230501001500"", ""headline"": ""Amgen (AMGN) Gets a Sell from Barclays"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230501021700"", ""headline"": ""Galera Therapeutics expands commercial leadership team"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230501022200"", ""headline"": ""Coherus Biosciences initiated with a Buy at Truist"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230501044700"", ""headline"": ""RBC Capital Keeps Their Hold Rating on Amgen (AMGN)"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230501052000"", ""headline"": ""Coherus spikes as Truist starts at Buy on biosimilar business"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230501054500"", ""headline"": ""Robert W. Baird Remains a Sell on Amgen (AMGN)"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230501055600"", ""headline"": ""SVB Securities Remains a Hold on Amgen (AMGN)"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230501123600"", ""headline"": ""Amgen Inc. stock underperforms Monday when compared to competitors"", ""summary"": ""Shares of Amgen Inc. dropped 0.35% to $238.90 Monday, on what proved to be an all-around dismal trading session for the stock market, with the S&P 500 Index...""}, {""date"": ""20230501140326"", ""headline"": ""Barclays Maintains AMGEN (AMGN) Underweight Recommendation"", ""summary"": """"}, {""date"": ""20230501195308"", ""headline"": ""Healthcare And Facebook Help Propel My 25 Stock ~$424K Portfolio To New Highs In April"", ""summary"": ""My portfolio, built specifically for my retirement ~20 years from now, features growth, dividends and risk stocks for. See how it performed in April 2023.""}, {""date"": ""20230501211000"", ""headline"": ""Market Briefing For Tuesday, May 2 `23"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230502034700"", ""headline"": ""Upcoming Dividend Run For AMGN?"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230502094500"", ""headline"": ""2 Incredibly Cheap Dividend Stocks to Buy in May"", ""summary"": ""While the impact of an economic downturn on stocks is hard to predict, high-quality dividend stocks have a proven track record of delivering above market gains during turbulent periods.  Here are two dividend-paying pharmaceutical stocks that ought to hold up well in a recessionary environment, are proven passive income vehicles, and trade at extremely attractive valuations.  Amgen (NASDAQ: AMGN) is a global biotechnology company.""}, {""date"": ""20230502123600"", ""headline"": ""Amgen Inc. stock falls Tuesday, underperforms market"", ""summary"": ""Shares of Amgen Inc. slid 1.23% to $235.97 Tuesday, on what proved to be an all-around rough trading session for the stock market, with the S&P 500 Index...""}, {""date"": ""20230502183456"", ""headline"": ""Amgen sues Novartis to block generic osteoporosis, bone cancer drugs"", ""summary"": ""Amgen Inc sued Novartis AG's Sandoz in New Jersey federal court Monday, accusing Sandoz's proposed versions of its multibillion-dollar bone-strengthening drugs Prolia and Xgeva of infringing several patents.""}, {""date"": ""20230502221000"", ""headline"": ""Walgreens Boots, Amgen share losses lead Dow`s 85-point fall"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230503020000"", ""headline"": ""Amgen price target raised to $214 from $208 at Mizuho"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230503110025"", ""headline"": ""Amgen vs. Sandoz: Legal Battle Erupts Over Bone-Strengthening Drug Patents"", ""summary"": ""Amgen Inc (NASDAQ: AMGN) has reportedly sued Novartis AG's (NYSE: NVS) Generic arm Sandoz on proposed versions of its bone-strengthening drugs Prolia and Xgeva containing denosumab, infringing several patents. Amgen said the proposed biosimilars infringe 21 patents covering Prolia and Xgeva. Also Read: Amgen Faces Lawsuit For Hiding Its Stupendous Tax Bill Of $10B. Prolia is indicated for a high risk of bone fracture in certain settings, for example, osteoporosis. XGEVA is prescribed to prevent""}, {""date"": ""20230503110900"", ""headline"": ""Walgreens Boots, Amgen share losses lead Dow's 85-point fall"", ""summary"": ""Dragged down by declines for shares of Walgreens Boots and Amgen, the Dow Jones Industrial Average is falling Wednesday afternoon. The Dow was most recently...""}, {""date"": ""20230503123600"", ""headline"": ""Amgen Inc. stock underperforms Wednesday when compared to competitors"", ""summary"": ""Shares of Amgen Inc. shed 2.82% to $229.31 Wednesday, on what proved to be an all-around grim trading session for the stock market, with the S&P 500 Index...""}, {""date"": ""20230503160000"", ""headline"": ""AMGEN TO PRESENT AT THE 2023 BANK OF AMERICA MERRILL LYNCH GLOBAL HEALTHCARE CONFERENCE"", ""summary"": ""Amgen (NASDAQ:AMGN) will present at the 2023 Bank of America Merrill Lynch Global Healthcare Conference at 11:00 a.m. ET on Tuesday, May 9, 2023. David M. Reese, M.D., executive vice president of Research and Development and Peter H. Griffith, executive vice president and chief financial officer at Amgen will present at the conference. The webcast will be broadcast over the internet simultaneously and will be available to members of the news media, investors and the general public.""}, {""date"": ""20230503165231"", ""headline"": ""Dow Jones Today: Index Falls Following Rate Hike"", ""summary"": ""The Dow dropped 250 points with Walgreens taking the index lower after rival CVS cut its profit outlook.""}, {""date"": ""20230503182710"", ""headline"": ""Why Amgen Stock Was Sickly Today"", ""summary"": ""What happened Investors are often encouraged when one of their companies bulks up by acquiring a peer. But that sentiment can turn sour if the takeover target stumbles. This was the impetus behind Amgen's (NASDAQ: AMGN) nearly 3% decline on the stock market Wednesday.""}, {""date"": ""20230503213000"", ""headline"": ""Weight-Loss Drugs Will Be Blockbusters. Here\u2019s the Stock to Buy."", ""summary"": ""Everyone is talking about Eli Lilly\u2019s Mounjaro and Novo Nordisk\u2019s Ozempic. Now, the drugs are poised to go from conversation starters to profit makers.""}, {""date"": ""20230504093847"", ""headline"": ""Assertio Holdings: A Little More Risk, A Lot Higher Reward"", ""summary"": ""Assertio acquired a future blockbuster which may likely generate sales by itself are more than half the current market cap. Read why ASRT stock is a strong buy.""}, {""date"": ""20230504123600"", ""headline"": ""Amgen Inc. stock rises Thursday, outperforms market"", ""summary"": ""Shares of Amgen Inc. rose 1.13% to $231.89 Thursday, on what proved to be an all-around dismal trading session for the stock market, with the S&P 500 Index...""}, {""date"": ""20230504180133"", ""headline"": ""7 Blue-Chip Stocks to Buy in May 2023"", ""summary"": ""While large-capitalization enterprises don\u2019t offer much excitement, current circumstances may call for the best blue-chip stocks to buy. Frankly, it\u2019s getting a little bit toasty on Wall Street, which is why stability may come at a premium. Naturally, the failure of First Republic \u2013 the third such collapse of a banking enterprise this year \u2013 generated plenty of jitters. Despite JPMorgan Chase (NYSE:JPM) CEO Jamie Dimon\u2019s encouraging words that the FRC takeover averted a crisis, circumstances sti""}, {""date"": ""20230505005315"", ""headline"": ""High Yield Stock Watchlist: May 2023"", ""summary"": ""The majority of the stocks on my watchlist are undervalued based on dividend yield theory. Click here for a detailed analysis.""}, {""date"": ""20230505094500"", ""headline"": ""2 Magnificent Dividend Stocks to Buy Before the Next Recession"", ""summary"": ""Let's look at two great dividend stocks to consider buying before the economy worsens: Gilead Sciences (NASDAQ: GILD) and Amgen (NASDAQ: AMGN).  Gilead Sciences is a biotech company with a particular focus on developing HIV medicines.  It has helped Gilead Sciences' revenue stay afloat as the company failed to earn approval for important candidates.""}, {""date"": ""20230505123600"", ""headline"": ""Amgen Inc. stock outperforms competitors on strong trading day"", ""summary"": ""Shares of Amgen Inc. rose 2.00% to $236.53 Friday, on what proved to be an all-around positive trading session for the stock market, with the S&P 500 Index...""}, {""date"": ""20230506075500"", ""headline"": ""2 Best Biotech Stocks to Buy Right Now"", ""summary"": ""Buying pharmaceutical companies with all-around drug portfolios and pipelines is the key to success as an investor.""}]",{}
17,2023-05-07,230.62258911132812,2023-05-14,227.13198852539062,-0.015135553717387507,D2,"[{""date"": ""20230507212600"", ""headline"": ""Amgen, Entera end research collaboration"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230508012836"", ""headline"": ""DICE Therapeutics: Worth A Roll At The Right Price"", ""summary"": ""DICE Therapeutics recently posted encouraging Phase 1c data from its lead candidate, psoriasis therapy DC-806. Check out my recommendation on DICE stock.""}, {""date"": ""20230508040700"", ""headline"": ""Amgen investors given opportunity to lead securities fraud class action"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230508050000"", ""headline"": ""Amgen highlights benefit of Prolia over Fosamax in fracture risk"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230508051100"", ""headline"": ""Amgen osteoporosis drug Prolia outperforms commonly used therapy"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230508051200"", ""headline"": ""Walgreens Boots, Amgen share losses lead Dow`s 84-point fall"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230508061100"", ""headline"": ""Walgreens Boots, Amgen share losses lead Dow's 84-point fall"", ""summary"": ""The Dow Jones Industrial Average is down Monday morning with shares of Walgreens Boots and Amgen seeing the biggest declines for the blue-chip average....""}, {""date"": ""20230508065400"", ""headline"": ""Video: Dow Movers: AMGN, DIS"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230508090000"", ""headline"": ""NEW DATA FROM AMGEN'S PROLIA\u00ae (DENOSUMAB) DEMONSTRATES SIGNIFICANT REDUCTION IN OSTEOPOROTIC FRACTURE RISK COMPARED TO ALENDRONATE"", ""summary"": ""Amgen (NASDAQ:AMGN) today announced new data from a real-world study of nearly half of a million postmenopausal women with osteoporosis in the U.S. medicare program showing Prolia\u00ae (denosumab) injection reduced fracture risk in patients versus oral alendronate, a frequently prescribed bisphosphonate treatment. Treatment with Prolia was also associated with greater reductions in fracture risk over time. The data were presented during an oral presentation at the World Congress on Osteoporosis, Ost""}, {""date"": ""20230508093243"", ""headline"": ""WTV: A Shareholder Yield ETF With Great Valuation"", ""summary"": ""WisdomTree U.S. Value Fund ETF is an actively managed fund focused on dividends, buybacks and quality. Click for my review of the WTV ETF.""}, {""date"": ""20230508123600"", ""headline"": ""Amgen Inc. stock underperforms Monday when compared to competitors"", ""summary"": ""Shares of Amgen Inc. slipped 0.81% to $234.62 Monday, on what proved to be an all-around mixed trading session for the stock market, with the S&P 500 Index...""}, {""date"": ""20230509040400"", ""headline"": ""Amgen and TScan Therapeutics partner for Crohn`s Disease target identification"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230509040500"", ""headline"": ""Amgen, TScan Therapeutics announce collaboration to identify targets in Crohn`s"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230509041600"", ""headline"": ""TScan Therapeutics stock soars after Amgen collaboration on Crohn`s disease treatment that could bring in more than $500 million"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230509050000"", ""headline"": ""AMGEN AND TSCAN THERAPEUTICS ANNOUNCE COLLABORATION TO IDENTIFY NOVEL TARGETS IN CROHN'S DISEASE"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230509051200"", ""headline"": ""TScan jumps 102% after deal with Amgen for Crohn`s disease"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230509051500"", ""headline"": ""TScan Therapeutics stock soars after Amgen collaboration on Crohn\u2019s disease treatment that could bring in more than $500 million"", ""summary"": ""Shares of TScan Therapeutics Inc. powered up 43.1% in premarket trading Tuesday, after the biopharmaceutical company announced a collaboration with Amgen...""}, {""date"": ""20230509051800"", ""headline"": ""Amgen, TScan Therapeutics Set Crohn's Disease Collaboration"", ""summary"": ""By Colin Kellaher Amgen on Tuesday said it has signed onto a multi-year collaboration with clinical-stage biopharmaceutical company TScan Therapeutics...""}, {""date"": ""20230509053800"", ""headline"": ""TScan Therapeutics Shares Take Flight on Amgen Pact >TCRX"", ""summary"": ""By Colin Kellaher TScan Therapeutics shares surged on Tuesday after the clinical-stage biopharmaceutical company said it entered a collaboration potentially...""}, {""date"": ""20230509060600"", ""headline"": ""TScan Therapeutics More than Doubles Following Deal with Amgen"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230509064900"", ""headline"": ""O`Keefe Stevens Advisory Q1 2023 Update"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230509073000"", ""headline"": ""Analysts Offer Insights on Healthcare Companies: Amgen (AMGN), Axsome Therapeutics (AXSM) and Shockwave Medical (SWAV)"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230509090000"", ""headline"": ""Amgen and TScan Therapeutics Announce Collaboration to Identify Novel Targets in Crohn\u2019s Disease"", ""summary"": ""Collaboration Brings Together TScan\u2019s Proprietary Target Discovery Platform and Amgen\u2019s Inflammation Therapeutic Expertise and Research Capabilities TScan to Receive $30 Million Upfront With Potential Development and Commercial Milestone Payments of Over $500 Million THOUSAND OAKS, Calif. and WALTHAM, Mass., May 09, 2023 (GLOBE NEWSWIRE) -- Amgen (NASDAQ:AMGN) and TScan Therapeutics, Inc. (NASDAQ:TCRX), today announced a multi-year collaboration that will use TScan\u2019s proprietary target discovery""}, {""date"": ""20230509100012"", ""headline"": ""Amgen Inc. (NASDAQ:AMGN) Shares Could Be 42% Below Their Intrinsic Value Estimate"", ""summary"": ""Key Insights Amgen's estimated fair value is US$405 based on 2 Stage Free Cash Flow to Equity Amgen's US$235 share...""}, {""date"": ""20230509110358"", ""headline"": ""RBC Capital Reiterates AMGEN (AMGN) Sector Perform Recommendation"", ""summary"": """"}, {""date"": ""20230509123600"", ""headline"": ""Amgen Inc. stock outperforms competitors despite losses on the day"", ""summary"": ""Shares of Amgen Inc. sank 0.08% to $234.43 Tuesday, on what proved to be an all-around grim trading session for the stock market, with the S&P 500 Index...""}, {""date"": ""20230509132920"", ""headline"": ""Why Are TScan Therapeutics Shares Are Shooting Higher Today"", ""summary"": ""Amgen Inc (NASDAQ: AMGN) and TScan Therapeutics Inc (NASDAQ: TCRX) announced a multi-year collaboration to use TScan's proprietary target discovery platform, TargetScan, to identify the antigens recognized by T cells in patients with Crohn's disease. Under the terms of the agreement, TScan will receive a $30 million upfront payment and is eligible to earn over $500 million in milestones and tiered single-digit royalty payments. Amgen will evaluate a variety of modalities to create therapeutics b""}, {""date"": ""20230509160959"", ""headline"": ""15 Biggest Immunotherapy Companies in the World"", ""summary"": ""In this article, we will take a look at the 15 biggest immunotherapy companies in the world. If you want to see more companies in this selection, go to the 5 Biggest Immunotherapy Companies in the World. The immunotherapy industry is a rapidly growing field that is focused on developing treatments that harness the power [\u2026]""}, {""date"": ""20230509194500"", ""headline"": ""O'Keefe Stevens Advisory Q1 2023 Update"", ""summary"": ""O'Keefe Stevens Advisory released its Q1 2023 update recently. Click here to read the full fund letter. ""}, {""date"": ""20230510045200"", ""headline"": ""Dow`s 100-point fall led by losses for shares of Travelers, Chevron"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230510123600"", ""headline"": ""Amgen Inc. stock falls Wednesday, underperforms market"", ""summary"": ""Shares of Amgen Inc. slipped 0.14% to $234.11 Wednesday, on what proved to be an all-around mixed trading session for the stock market, with the S&P 500...""}, {""date"": ""20230510151203"", ""headline"": ""May Dogs Of The Dow: Buy 2, Watch 4"", ""summary"": ""The Dow adds a stock if the company has an excellent reputation, demonstrates sustained growth, and is of interest to a large number of investors. Click for our lists.""}, {""date"": ""20230510154153"", ""headline"": ""Novartis CEO criticizes US, EU efforts to curb drug company power"", ""summary"": ""Novartis CEO pushes back against government attempts to direct pharma RD""}, {""date"": ""20230510220100"", ""headline"": ""Walt Disney, Intel share losses contribute to Dow`s 234-point drop"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230511090741"", ""headline"": ""GOP law cut Big Pharma tax rates by 40%, Senate report says"", ""summary"": ""Senate Finance Committee Democrats said the Republican bill resulted in billion of dollars in tax savings for pharmaceutical companies.\u00a0""}, {""date"": ""20230511123600"", ""headline"": ""Amgen Inc. stock underperforms Thursday when compared to competitors"", ""summary"": ""Shares of Amgen Inc. slid 0.78% to $232.29 Thursday, on what proved to be an all-around rough trading session for the stock market, with the S&P 500 Index...""}, {""date"": ""20230511225800"", ""headline"": ""Horizon Therapeutics ticks higher amid report FTC meeting unrelated to Amgen deal"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230512060832"", ""headline"": ""Amgen Inc. (NASDAQ:AMGN) Pays A US$2.13 Dividend In Just Four Days"", ""summary"": ""Regular readers will know that we love our dividends at Simply Wall St, which is why it's exciting to see Amgen Inc...""}, {""date"": ""20230512123600"", ""headline"": ""Amgen Inc. stock outperforms market on strong trading day"", ""summary"": ""Shares of Amgen Inc. inched 0.28% higher to $232.95 Friday, on what proved to be an all-around poor trading session for the stock market, with the S&P 500...""}, {""date"": ""20230513050000"", ""headline"": ""How To Invest $100,000 Today: The Near-Perfect Portfolio Strategy"", ""summary"": ""With the economy going through boom and bust cycles more frequently, extreme market ups and downs are inevitable. Click here for more.""}, {""date"": ""20230513150011"", ""headline"": ""Amgen Inc. (AMGN) Presents at BofA Securities 2023 Health Care Conference (Transcript)"", ""summary"": ""Amgen Inc. (NASDAQ:NASDAQ:AMGN) BofA Securities 2023 Health Care Conference May 9, 2023 11:00 AM ETCompany ParticipantsPeter Griffith - CFODave Reese - EVP, R&DConference Call...""}, {""date"": ""20230513193317"", ""headline"": ""Dividend Champion, Contender, And Challenger Highlights: Week Of May 14"", ""summary"": ""A weekly summary of dividend activity for Dividend Champions, Contenders, and Challengers. Read more to see the companies with upcoming ex-dividend dates.""}]",{}
18,2023-05-14,227.13198852539062,2023-05-21,219.89537048339844,-0.03186084923120913,D4,"[{""date"": ""20230515022907"", ""headline"": ""BridgeBio Pharma: A Lot Of Paths To Potential Success"", ""summary"": ""BridgeBio has had some positive recent trial developments and executed a needed capital raise in March. Find out a full investment analysis of BBIO stock.""}, {""date"": ""20230515030400"", ""headline"": ""FTC looks to blow Horizon Therapeutics acquisition by Amgen, Capitol Forum says"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230515032300"", ""headline"": ""FTC looks to block Horizon Therapeutics deal with Amgen, Capitol Forum says"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230515050200"", ""headline"": ""Ex-Dividend Reminder: Amgen, Select Medical Holdings and Laboratory Corporation of America Holdings"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230515123600"", ""headline"": ""Amgen Inc. stock rises Monday, still underperforms market"", ""summary"": ""Shares of Amgen Inc. inched 0.25% higher to $233.53 Monday, on what proved to be an all-around great trading session for the stock market, with the S&P 500...""}, {""date"": ""20230515155401"", ""headline"": ""Lightning Round: 'I don't like companies that pick fights with the SEC', says Jim Cramer on Coinbase"", ""summary"": ""'Mad Money' host Jim Cramer weighs in on stocks including: Chewy, Enterprise Products, Coinbase, Triple Flag Precious Metals, Amgen, GSK, IONQ, Southern Co., and Snowflake.""}, {""date"": ""20230515155803"", ""headline"": ""Cramer's Lightning Round: I am not a believer in Coinbase"", ""summary"": ""\""Mad Money\"" host Jim Cramer rings the lightning round bell, which means he's giving his answers to callers' stock questions at rapid speed.""}, {""date"": ""20230515172800"", ""headline"": ""Horizon shares sink on report that FTC will sue to block takeover by Amgen"", ""summary"": ""Shares of Horizon Therapeutics Inc. plunged 15% in extended trading Monday after Bloomberg News reported the FTC is expected to file a lawsuit to block Amgen...""}, {""date"": ""20230515210800"", ""headline"": ""FTC suit against Horizon deal may have chilling effect on biotech M&A"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230515211900"", ""headline"": ""FTC Surprise Challenge Of Amgen`s Acquisition Of Horizon Therapeutics"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230515213527"", ""headline"": ""UPDATE 2-FTC to block Amgen's $27.8 billion deal for Horizon Therapeutics - source"", ""summary"": ""The U.S. Federal Trade Commission is expected to file a lawsuit as early as Tuesday to block Amgen Inc's $27.8 billion deal to buy Horizon Therapeutics PLC, a person familiar with the matter told Reuters.  Amgen struck a deal last year to buy Horizon to strengthen its rare diseases drugs portfolio.  Amgen said on Monday it wasn't aware of any decision made by the agency.""}, {""date"": ""20230515213700"", ""headline"": ""Pfizer bond offering to fund Seagen deal said to among largest on record"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230515214900"", ""headline"": ""Pfizer bond offering to fund Seagen deal said to be among largest on record"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230515221000"", ""headline"": ""Dow falls, Nasdaq edges up with U.S. debt-ceiling talks in focus"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230515221129"", ""headline"": ""FTC to block Amgen's $27.8 billion deal for Horizon Therapeutics - source"", ""summary"": ""The U.S. Federal Trade Commission is expected to file a lawsuit as early as Tuesday to block Amgen Inc's $27.8 billion deal to buy Horizon Therapeutics PLC, a person familiar with the matter told Reuters.""}, {""date"": ""20230516002400"", ""headline"": ""FTC will sue to block Horizon Therapeutics takeover by Amgen, Bloomberg says"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230516004525"", ""headline"": ""Amgen\u2019s $28 Billion Horizon Buy Will Be Challenged by FTC"", ""summary"": ""(Bloomberg) -- Amgen Inc.\u2019s $27.8 billion deal to buy Horizon Therapeutics Plc, the largest in the biotechnology company\u2019s history, will be challenged by federal regulators who argue the tie-up would hamper innovation and slow the pace of drug development, according to a person familiar with the matter.Most Read from BloombergTurkey Latest: Erdogan Says Unclear If Vote Will Go to RunoffMichael Burry Doubles Alibaba Stake in Big Bet on China TechTurkey Set for Runoff as Erdogan Falls Just Short o""}, {""date"": ""20230516012500"", ""headline"": ""Capital One stock rallies and Home Depot shares dips, and other companies on the move"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230516013200"", ""headline"": ""Seagen, impacted by FTC Amgen/Horizon suit, closes down 6%"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230516014100"", ""headline"": ""Amgen-Horizon Deal: A Major Roadblock in Sight"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230516015900"", ""headline"": ""Horizon Shares Slide Premarket on Report That FTC to Fight Amgen Deal"", ""summary"": ""By Colin Kellaher Horizon Therapeutics tumbled in premarket trading Tuesday following a published report that U.S. regulators will move to block the $27.8...""}, {""date"": ""20230516020900"", ""headline"": ""Home Depot`s stock selloff would cut nearly 80 points off the Dow`s price"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230516021800"", ""headline"": ""Capital One stock rallies and Home Depot shares dip, and other companies on the move"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230516025400"", ""headline"": ""Jefferies thinks Amgen-Horizon deal still gets done after `speed bump`"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230516030700"", ""headline"": ""Home Depot\u2019s stock selloff would cut nearly 80 points off the Dow\u2019s price"", ""summary"": ""Shares of Home Depot Inc. took a 4.0% dive, to pace the Dow Jones Industrial Average\u2019s premarket decliners, after the home improvement retailer missed fiscal...""}, {""date"": ""20230516032159"", ""headline"": ""Wall Street Breakfast Podcast: 13F Filings: Berkshire Takes New Stakes In COF, DEO"", ""summary"": ""Warren Buffett's Berkshire takes new stakes in COF, Diageo, exits RH. Daniel Loeb's Third Point amasses new stakes in Alphabet, Micron, AMD, Alibaba. Rumble buys Callin.""}, {""date"": ""20230516033100"", ""headline"": ""Analysts Offer Insights on Healthcare Companies: Amgen (AMGN), Compugen (CGEN) and Eli Lilly & Co (LLY)"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230516033900"", ""headline"": ""What You Missed On Wall Street On Tuesday"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230516034300"", ""headline"": ""Seagen, Prometheus Biosciences fall amid news of FTC planned block of Horizon/Amgen deal"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230516035400"", ""headline"": ""AstraZeneca to exit leading U.S. drug industry group PhRMA"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230516035900"", ""headline"": ""Fly Intel: Pre-market Movers"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230516043700"", ""headline"": ""HZNP Stock Alert: Why Is Horizon Therapeutics Plunging Today"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230516054000"", ""headline"": ""FTC files suit to block Amgen acquisition of Horizon Therapeutics"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230516055700"", ""headline"": ""FTC sues to block Amgen, Horizon Therapeutics deal on monopoly concerns"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230516063400"", ""headline"": ""Amgen remains committed to closing Horizon Therapeutics deal by mid-December"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230516063400"", ""headline"": ""Amgen `disappointed` in FTC`s decision to block Horizon Therapeutics deal"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230516063400"", ""headline"": ""Amgen responds to FTC action on proposed acquisition of Horizon Therapeutics"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230516063500"", ""headline"": ""Amgen: Horizon Therapeutics deal poses `no legitimate competitive issues`"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230516065000"", ""headline"": ""Horizon Therapeutics responds to FTC`s action to block acquisition by Amgen"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230516065959"", ""headline"": ""FTC sues to block Amgen acquisition of Horizon Therapeutics"", ""summary"": ""The Federal Trade Commission on Tuesday said it has sued to block Amgen's $27.8 billion acquisition of Horizon Therapeutics. CNBC's David Faber reports.""}, {""date"": ""20230516070500"", ""headline"": ""What You Missed On Wall Street This Morning"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230516071100"", ""headline"": ""FTC sues to block Amgen`s acquisition of Horizon Therapeutics"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230516072200"", ""headline"": ""Tracking George Soros`s Portfolio - Q1 2023 Update"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230516073100"", ""headline"": ""AMGEN RESPONDS TO FTC ACTION RE: PROPOSED ACQUISITION OF HORIZON THERAPEUTICS"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230516075400"", ""headline"": ""Prometheus, Seagen slip after FTC sues to block Horizon acquisition"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230516075600"", ""headline"": ""Monopoly concerns push FTC to sue to block Amgen's more than $26B deal for Horizon"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230516080200"", ""headline"": ""Hot Stocks: SE and IQ slip after earnings; HZNP down on FTC lawsuit; VOD fall on job cuts; AMD and VKTX gain"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230516083500"", ""headline"": ""Seagen likely to stay `distanced` from deal price after FTC action, says Stifel"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230516083826"", ""headline"": ""Stocks making the biggest moves midday: Horizon Therapeutics, Capital One, RH, Home Depot and more "", ""summary"": ""These are the stocks posting the largest moves midday.""}, {""date"": ""20230516085800"", ""headline"": ""Trade commission fights Amgen's $28B purchase of Horizon Therapeutics"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230516100556"", ""headline"": ""US STOCKS-Wall St falls as Home Depot, retail sales data weigh "", ""summary"": ""U.S. stocks fell on Tuesday after a dour forecast from Home Depot and April retail sales data pointed to consumers feeling the pinch from rising prices and interest rates, ahead of crucial debt limit talks.""}, {""date"": ""20230516100620"", ""headline"": ""Wall St falls as Home Depot, retail sales data weigh"", ""summary"": ""U.S. stocks fell on Tuesday after a dour forecast from Home Depot and April retail sales data pointed to consumers feeling the pinch from rising prices and interest rates, ahead of crucial debt limit talks.""}, {""date"": ""20230516101631"", ""headline"": ""FTC Surprise Challenge Of Amgen's Acquisition Of Horizon Therapeutics"", ""summary"": ""Amgen is facing a suit from the FTC to block its acquisition of Horizon Therapeutics. Check out my key takeaways for AMGN and HZNP investors.""}, {""date"": ""20230516102956"", ""headline"": ""Jefferies' Michael Yee expects Amgen's Horizon Therapeutics deal will go through despite FTC block"", ""summary"": ""Michael Yee, Jefferies managing director, joins 'Power Lunch' to discuss the FTC's move to block Amgen's $27.8 billion deal for Horizon Therapeutics.""}, {""date"": ""20230516103936"", ""headline"": ""FTC Commissioners yet to meet on Amgen-Horizon deal - CNBC"", ""summary"": ""Commissioners at the U.S. Federal Trade Commission (FTC) have not yet met to discuss Amgen's acquisition of Horizon Therapeutics, CNBC reported on Tuesday.""}, {""date"": ""20230516105219"", ""headline"": ""FTC sues to block Amgen's $27.8 bln deal for Horizon Therapeutics -statement"", ""summary"": ""The U.S. Federal Trade Commission said on Tuesday that it would sue to stop Amgen Inc's $27.8 billion deal to buy Horizon Therapeutics Plc .""}, {""date"": ""20230516110000"", ""headline"": ""US sues to block USD28 billion Amgen biopharma acquisition"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230516115537"", ""headline"": ""Factbox-Amgen-Horizon deal joins mega mergers facing regulatory heat"", ""summary"": ""A U.S. antitrust regulator said on Tuesday it will sue to stop Amgen's $27.8 billion deal for Horizon Therapeutics Plc, as it would give Amgen \""monopoly positions\"" in treatments for thyroid eye disease and chronic refractory gout.""}, {""date"": ""20230516122125"", ""headline"": ""US FTC sues to block Amgen's $27.8 billion deal for Horizon Therapeutics"", ""summary"": ""The U.S. Federal Trade Commission said on Tuesday it would sue to stop Amgen Inc's $27.8 billion acquisition of Horizon Therapeutics Plc in a rare move to block a large pharmaceutical deal.""}, {""date"": ""20230516123600"", ""headline"": ""Why These 2 Large-Cap Stocks Dropped 10%-Plus on Tuesday"", ""summary"": ""Although the Nasdaq Composite managed to post modest gains, the Dow Jones Industrial Average and S&P 500 were both lower.  Sea Limited (NYSE: SE) raised some concerns about the strength of consumers in the Asia-Pacific region, while shareholders in Horizon Therapeutics (NASDAQ: HZNP) had to deal with a threat that could bring hopes for a lucrative acquisition to a grinding halt.  Shares of Sea Limited dropped 15% on Tuesday morning following the release of the Southeast Asian e-commerce and video game specialist's latest financial results.""}, {""date"": ""20230516123700"", ""headline"": ""Amgen Inc. stock underperforms Tuesday when compared to competitors"", ""summary"": ""Shares of Amgen Inc. slipped 2.42% to $227.88 Tuesday, on what proved to be an all-around poor trading session for the stock market, with the S&P 500 Index...""}, {""date"": ""20230516124100"", ""headline"": ""FTC Sues to Block Amgen\u2019s $27.8 Billion Acquisition of Horizon Therapeutics"", ""summary"": ""Amgen reached an agreement to buy Horizon in December, and at the time said it expected the deal to be completed in the first half of 2023.""}, {""date"": ""20230516125002"", ""headline"": ""US STOCKS-Dow, S&P 500 fall as Home Depot, retail sales data weigh"", ""summary"": ""The Dow and the S&P 500 fell on Tuesday after a dour forecast from Home Depot and April retail sales data pointed to consumers feeling the pinch from rising prices and interest rates, ahead of crucial debt limit talks.""}, {""date"": ""20230516134906"", ""headline"": ""FTC Sues to Block Amgen\u2019s Acquisition of Horizon Therapeutics"", ""summary"": ""The Federal Trade Commission is suing to block Amgen Inc.'s $28 billion acquisition of Horizon Therapeutics to prevent a monopoly in the market for d.rugs that treat critical ailments""}, {""date"": ""20230516144014"", ""headline"": ""Horizon Therapeutics Stock Plunges as FTC Plans to Block Amgen Deal"", ""summary"": ""Amgen\u2019s nearly $28 billion cash deal to buy Horizon Therapeutics is in jeopardy.  Horizon shares were recently down around 15% on the news that the Federal Trade Commission is planning a lawsuit to [block the deal](https://www.wsj.com/articles/ftc-poised-to-block-amgens-27-8-billion-deal-for-horizon-therapeutics-a9c1b499).  Horizon closed Monday at $112.25 a share, which is a less than 4% discount to the planned acquisition price.""}, {""date"": ""20230516144701"", ""headline"": ""US STOCKS-S&P 500, Dow fall, dragged by Home Depot outlook, US retail sales"", ""summary"": ""The Dow and the S&P 500 retreated on Tuesday after a disappointing forecast from Home Depot and U.S. retail sales data for April pointed to softer consumer spending, while uncertainty about interest rates and debt limit negotiations weighed on sentiment.""}, {""date"": ""20230516151607"", ""headline"": ""FTC May Reportedly Block Amgen's (AMGN) $28B Horizon Buyout"", ""summary"": ""Unconfirmed reports suggest that the FTC may challenge the $28-billion buyout of Horizon Therapeutics (HZNP) by Amgen.""}, {""date"": ""20230516153317"", ""headline"": ""UPDATE 5-US FTC sues to block Amgen's $27.8 bln deal for Horizon Therapeutics"", ""summary"": ""The U.S. Federal Trade Commission said on Tuesday it has filed a lawsuit to stop Amgen Inc's $27.8 billion acquisition of Horizon Therapeutics Plc in a rare move to block a large pharmaceutical deal.  The FTC said it opposed the deal because of concern that Amgen would leverage its big selling drugs to pressure insurance companies and pharmacy benefit managers to give favorable terms for Horizon's two key products - the fast-growing thyroid eye disease treatment Tepezza and gout drug Krystexxa.  The FTC decision to stop this acquisition marks a change.""}, {""date"": ""20230516153348"", ""headline"": ""FTC sues to block Amgen's $27.8 billion deal to acquire Horizon Therapeutics"", ""summary"": ""Yahoo Finance healthcare reporter Anjalee Khemlani joins the Live Show to discuss details surrounding the FTC suing biopharmaceutical giant Amgen Inc and its plan to block Amgen's $27.8 billion deal to acquire Horizon Therapeutics.""}, {""date"": ""20230516153808"", ""headline"": ""FTC sues to stop Amgen\u2019s $27.8B deal for Horizon Therapeutics"", ""summary"": ""The FTC said in its complaint that Amgen would be able to leverage its position with insurance companies and pharmacy benefit managers wanting access to its blockbuster drugs.""}, {""date"": ""20230516160040"", ""headline"": ""US STOCKS-Wall Street declines after Home Depot outlook, US retail sales"", ""summary"": ""U.S. stock indexes closed lower on Tuesday after a disappointing forecast from Home Depot and U.S. retail sales data for April pointed to softer consumer spending, while uncertainty about interest rates and debt limit negotiations weighed on sentiment.""}, {""date"": ""20230516161636"", ""headline"": ""Horizon Tumbles \u2014 Taking Seagen, Prometheus With It \u2014 As FTC Blocks Amgen Takeover"", ""summary"": ""The FTC plans to block Amgen's takeover of Horizon. The move reverberated across biotechs, with an HZNP stock crash leading the way.""}, {""date"": ""20230516161837"", ""headline"": ""CORRECTED-US STOCKS-Wall Street closes lower after Home Depot outlook, US retail sales"", ""summary"": ""U.S. stock indexes closed lower on Tuesday after a disappointing forecast from Home Depot and U.S. retail sales data for April pointed to softer consumer spending, while uncertainty about interest rates and debt limit negotiations weighed on sentiment.  Home Depot declined 2.15% as one of the biggest drag on both the Dow Industrials and S&P 500 after the home improvement retailer cut its annual sales forecast and projected a steeper-than-expected decline in profit.""}, {""date"": ""20230516162153"", ""headline"": ""Lowe's, Horizon Therapeutics, AMD: Stocks moving ahead of the close"", ""summary"": ""The Yahoo Finance Live team discusses stocks to watch at the closing bell, including Lowe's, Horizon Therapeutics, AMD, and Nvidia.""}, {""date"": ""20230516164851"", ""headline"": ""Markets Fall on Home Depot Warning, Debt Talks"", ""summary"": ""U.S. equities fell on Tuesday, May 16, 2023 as Home Depot\u2019s revenue warning raised concerns about economic growth, and as President Biden met with congressional leaders on the debt ceiling to avoid a government default.""}, {""date"": ""20230516170440"", ""headline"": ""Dow Jones Today: Index Falls on Retail Sales Slump"", ""summary"": ""The Dow Jones Industrial Average fell 1%, or 336 points, on a day of disappointing earnings and macroeconomic reports. Nike lost the most, while Microsoft led a small pack of gainers.""}, {""date"": ""20230516170719"", ""headline"": ""Pfizer Sells $31 Billion of Bonds in Fourth-Largest Deal Ever"", ""summary"": ""(Bloomberg) -- Pfizer Inc. sold $31 billion of debt in the fourth-largest US bond sale ever, according to a person with knowledge of the matter.Most Read from BloombergA 32-Year-Old Nears Billionaire Status by Using AI to Broker Japan MergersHere\u2019s How Much Wealth You Need to Join the Richest 1% GloballyDebt-Limit Talks to Intensify as Biden Set to Depart for JapanGoldman Banker Wins Promotion, Then Leaves for Rival Two Weeks LaterGoogle Billionaire Sergey Brin Gifts $600 Million in Surging Shar""}, {""date"": ""20230516170838"", ""headline"": ""Home Depot, FTC blocks Amgen deal, Comcast's Hulu stake: Tuesday's top headlines"", ""summary"": ""The Yahoo Finance Live team breaks down Tuesday's biggest stories, including Home Depot earnings report, the FTC suing to block Amgen's deal to buy Horizon Therapeutics, and Comcast's talks to sell its Hulu stake to Disney.""}, {""date"": ""20230516171556"", ""headline"": ""FTC Sues Over Amgen\u2019s $28 Billion Horizon Therapeutics Deal"", ""summary"": ""(Bloomberg) -- The Federal Trade Commission sued to block Amgen Inc.\u2019s $27.8 billion deal to buy Horizon Therapeutics Plc Tuesday, arguing the tie-up would stifle competition for the development of treatments for serious illnesses. Most Read from BloombergA 32-Year-Old Nears Billionaire Status by Using AI to Broker Japan MergersHere\u2019s How Much Wealth You Need to Join the Richest 1% GloballyDebt-Limit Talks to Intensify as Biden Set to Depart for JapanGoldman Banker Wins Promotion, Then Leaves fo""}, {""date"": ""20230516172400"", ""headline"": ""FTC Moves to Block Amgen\u2019s $27.8 Billion Deal for Horizon Therapeutics"", ""summary"": ""The FTC hasn\u2019t often challenged mergers involving drugmakers, but under Chair Lina Khan it has taken a stricter stance on deals.""}, {""date"": ""20230516200006"", ""headline"": ""The FTC Wants to Block the $28 Billion Amgen-Horizon Therapeutics Deal"", ""summary"": ""Big Pharma needs an antitrust antidote. The Federal Trade Commission and its hard-nosed chair Lina Khan have struck again, this time filing a...""}, {""date"": ""20230516201941"", ""headline"": ""Tracking George Soros's Portfolio - Q1 2023 Update"", ""summary"": ""Soros' 13F portfolio value decreased from $7.26B to $6.49B this quarter. Click here to see an update on the portfolio's trades for Q1 2023.""}, {""date"": ""20230516203346"", ""headline"": ""Wall Street closes lower after Home Depot outlook, US retail sales"", ""summary"": ""U.S. stock indexes closed lower on Tuesday after a disappointing forecast from Home Depot and U.S. retail sales data for April pointed to softer consumer spending, while uncertainty about interest rates and debt limit negotiations weighed on sentiment.""}, {""date"": ""20230516220600"", ""headline"": ""Amgen-Horizon Deal Stumbles on FTC`s Lawsuit"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230516221500"", ""headline"": ""U.S. stocks are falling after Home Depot report, weak retail sales"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230516221500"", ""headline"": ""Midday movers: Home Depot, Capital One Financial, Tesla and more"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230516225500"", ""headline"": ""Regeneron CEO backs regulators attempt to block Amgen deal, FT reports"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230517000100"", ""headline"": ""Regeneron boss backs attempt to block $28bn Amgen acquisition"", ""summary"": ""The Regeneron chief executive has backed an attempt by US regulators to block Amgen\u2019s $28bn acquisition of Horizon Therapeutics as he accused some pharmaceutical companies of abusing their market power to prevent competition.  Leonard Schleifer said he supported the US Federal Trade Commission\u2019s decision to tackle a \u201cnew area\u201d after the agency made its first attempt to block a pharma deal in over a decade by filing a novel lawsuit against the Amgen transaction.  Drugmakers pay rebates to ensure their treatment is placed on the lists of drugs covered by insurance companies.""}, {""date"": ""20230517001031"", ""headline"": ""US sues to block drug merger"", ""summary"": ""This is an audio transcript of the FT News Briefing podcast episode: \u2018US sues to block drug merger\u2019Marc Filippino Good morning from the Financial Times. Today is Wednesday, May 17th, and this is your FT News Briefing.""}, {""date"": ""20230517022100"", ""headline"": ""Analysts Conflicted on These Healthcare Names: Amgen (AMGN) and ReShape Lifesciences (RSLS)"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230517033038"", ""headline"": ""Wall Street Breakfast: Retail On The Radar"", ""summary"": ""Listen on the go! A daily podcast of Wall Street Breakfast will be available by 8:00 a.m. on Seeking Alpha, iTunes, Stitcher and Spotify.""}, {""date"": ""20230517050600"", ""headline"": ""Is This Dow Jones Stock a Buy for Income Investors?"", ""summary"": ""Replacing Pfizer (NYSE: PFE) as a component of the Dow Jones Industrial Average nearly three years ago, the pharmaceutical company Amgen (NASDAQ: AMGN) is among the best dividend payers in its industry.  Let's dig into Amgen's fundamentals and valuation to get an answer to this question.  With around 24,000 employees in total, Amgen is a major drugmaker with a $124 billion market capitalization.""}, {""date"": ""20230517051300"", ""headline"": ""FTC Seeks to Block Amgen's Acquisition of Horizon Therapeutics: What's Next for Both Stocks?"", ""summary"": ""Deal or no deal? That's now the big question for investors concerning Amgen's (NASDAQ: AMGN) pending $28 billion acquisition of Horizon Therapeutics (NASDAQ: HZNP). The Federal Trade Commission (FTC) announced on Tuesday that it has filed a lawsuit to prevent this buyout from happening.""}, {""date"": ""20230517060730"", ""headline"": ""Analysis-Amgen's antitrust woes spur wider pharmaceutical deal fears"", ""summary"": ""Investors are scrambling to assess the fallout of a U.S. regulatory challenge against Amgen Inc's proposed $27.8 billion acquisition of Horizon Therapeutics Plc, with some fearing a spillover to other big deals in the drug sector.  While investors are accustomed to regulators under U.S. President Joe Biden citing potential harm to consumers in objecting to many large mergers, the U.S. Federal Trade Commission's (FTC) lawsuit filed on Tuesday surprised those who had brushed off the antitrust risk in Amgen's deal because of its limited business overlap with Horizon.""}, {""date"": ""20230517062400"", ""headline"": ""Applied Materials, Lowe`s added to Jefferies franchise picks list"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230517062900"", ""headline"": ""Debt Ceiling Negotiations Turn a Corner. Why The Risk Isn\u2019t Over Yet."", ""summary"": ""Still no debt-ceiling deal as Biden shortens G-7 trip, UBS takes $35 billion gain from Credit Suisse takeover, Musk hints at two new vehicles and starts advertising campaign, and other news to start your day.""}, {""date"": ""20230517063500"", ""headline"": ""Amgen deal for Horizon likely to go through despite FTC objection: Guggenheim"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230517065100"", ""headline"": ""Video: Dow Movers: AMGN, BA"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230517065200"", ""headline"": ""Amgen Becomes Oversold"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230517082400"", ""headline"": ""Noteworthy Wednesday Option Activity: AMGN, LKQ, LYV"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230517083226"", ""headline"": ""Pfizer to raise $31 billion in debt offering to fund Seagen acquisition, SEC filing shows"", ""summary"": ""The debt offering by Pfizer to buy cancer drug maker Seagen comes as Apple, Merck and T-Mobile tap the U.S. bond market ahead of the debt ceiling standoff.\u00a0""}, {""date"": ""20230517083800"", ""headline"": ""Pfizer, Amgen, and 7 More Cheap Healthcare Stocks for Investors to Consider"", ""summary"": ""The stocks our screen found are cheap, relative to highfliers like Eli Lilly, and many are cheap for a reason.""}, {""date"": ""20230517093601"", ""headline"": ""Pfizer (PFE) to Raise $31B in Debt to Fund Seagen (SGEN) Deal"", ""summary"": ""Pfizer (PFE) offers bonds worth $31 billion to fund its pending acquisition of cancer drugmaker, Seagen (SGEN).""}, {""date"": ""20230517123600"", ""headline"": ""Amgen Inc. stock falls Wednesday, underperforms market"", ""summary"": ""Shares of Amgen Inc. sank 0.32% to $225.02 Wednesday, on what proved to be an all-around favorable trading session for the stock market, with the S&P 500...""}, {""date"": ""20230517132630"", ""headline"": ""Amgen/FTC: deal bar ignores realities of pharma food chain"", ""summary"": ""No deal is fully inoculated against regulatory intervention.  In December, biopharmaceutical firm Amgen announced the acquisition of biotech star Horizon Therapeutics for $116.50 per share or $28bn in aggregate.  On Tuesday, the US Federal Trade Commission sued to block the deal.""}, {""date"": ""20230517141006"", ""headline"": ""FTC Challenges Amgen's (AMGN) $28B Acquisition of Horizon"", ""summary"": ""Per the FTC, Amgen's (AMGN) acquisition of Horizon (HZNP) would entrench the monopoly positions for the latter's medications for thyroid eye disease and chronic refractory gout.""}, {""date"": ""20230517150329"", ""headline"": ""M&A crackdown a \u2018disaster\u2019 for pharma sector, Pfizer executive warns"", ""summary"": ""A senior Pfizer executive has warned that a crackdown on mergers and acquisitions by antitrust regulators would be a \u201cdisaster\u201d for the system of innovation that underpins the pharmaceutical industry.  William Pao, Pfizer\u2019s chief development officer, said M&A is an important part of the funding ecosystem that supports the development of innovative therapies by scientists.  \u201cIf you can\u2019t get those M&A [deals] and then get those molecules distributed across the globe, it stifles innovation for sure,\u201d said Pao, who heads the Pfizer arm responsible for clinical development of drugs and ensuring a pipeline of new therapies.""}, {""date"": ""20230517162659"", ""headline"": ""Fed, labor market concerns showing 'some dents in the armor of the consumer': Strategist"", ""summary"": ""Hennion & Walsh CIO Kevin Mahn joins Yahoo Finance Live to discuss the state of the consumer amid retail earnings, Target Q1 earnings, Walmart earnings preview, Fed rate hikes, inflation, and the impact on consumer spending.""}, {""date"": ""20230517171813"", ""headline"": ""Dow Jones Today: Index Jumps on Debt Talk Hopes"", ""summary"": ""Home Depot and Boeing help lead the Dow more than 400 points higher, while Intel continued its losing streak""}, {""date"": ""20230517182949"", ""headline"": ""Unusual Put Option Trade in AMGEN (AMGN)  Worth $9,481.50K"", ""summary"": """"}, {""date"": ""20230517183552"", ""headline"": ""Unusual Put Option Trade in AMGEN (AMGN)  Worth $6,563.75K"", ""summary"": """"}, {""date"": ""20230517224200"", ""headline"": ""Top 5 1st Quarter Trades of INTERNATIONAL BIOTECHNOLOGY TRUST PLC"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230517231300"", ""headline"": ""The FTC, Amgen, And Horizon: A New Hurdle For Biotech Deal Making Or Regulatory Overreach?"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230518050900"", ""headline"": ""Supreme Court upholds Sanofi patent victory over Amgen"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230518051200"", ""headline"": ""Supreme Court upholds Sanofi PCSK9 drug patent victory over Amgen"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230518060000"", ""headline"": ""Anticompetitive Behavior At United Therapeutics, Regeneron, And The FTC"", ""summary"": ""Much of what the FTC attacks isn\u00e2\u0080\u0099t anticompetitive, it\u00e2\u0080\u0099s competitive. Click here to find out more on HZNP and LQDA.""}, {""date"": ""20230518061600"", ""headline"": ""Supreme Court rules against Amgen in Rapatha patent dispute with Sanofi/ Regeneron"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230518062200"", ""headline"": ""Supreme Court rules against Amgen in Repatha patent dispute with Sanofi/ Regeneron"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230518063004"", ""headline"": ""Horizon Therapeutics says Amgen deal could close earlier than planned if FTC fails to block it"", ""summary"": ""The new timeline is earlier than what Amgen, Horizon Therapeutics and Wall Street analysts were initially expecting after the FTC sued to block the deal. ""}, {""date"": ""20230518064900"", ""headline"": ""Regeneron `applauds` Supreme Court`s striking down Amgen`s patent claims"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230518065900"", ""headline"": ""Sanofi `pleased` with Supreme Court`s ruling on Amgen`s asserted patent claims"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230518083000"", ""headline"": ""Regeneron Says Supreme Court Ruling Ends Patent Dispute With Amgen"", ""summary"": ""By Denny Jacob Regeneron Pharmaceuticals on Thursday said a U.S. Supreme Court opinion affirms a lower court opinion that held Amgen's asserted U.S. PCSK9...""}, {""date"": ""20230518084800"", ""headline"": ""Amgen`s Horizon Deal Won`t Close before September"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230518084906"", ""headline"": ""U.S. court issues temporary restraining order on $27.8 bln Amgen-Horizon deal"", ""summary"": ""A U.S. district court has issued a temporary restraining order on Amgen Inc's $27.8 billion acquisition of Horizon Therapeutics following a submission for it by the two companies and the U.S. Federal Trade Commission, Amgen said on Wednesday.""}, {""date"": ""20230518095552"", ""headline"": ""UPDATE 1-Amgen agrees not to seek quick close to Horizon acquisition"", ""summary"": ""Amgen Inc has agreed not to quickly close on its $27.8 billion acquisition of Horizon Therapeutics after the U.S. Federal Trade Commission (FTC) filed suit to block the deal.  A U.S. district court judge issued a temporary restraining order late on Wednesday after the two companies and the FTC reached an agreement that both sides said in a joint filing would permit a full briefing and \""less-compressed consideration\"" by the court of the FTC request.  Absent an agreement, Amgen could have sought to close the deal as early as Monday.""}, {""date"": ""20230518102002"", ""headline"": ""UPDATE 1-U.S. Supreme Court rules against Amgen bid to revive cholesterol drug patents"", ""summary"": ""The U.S. Supreme Court on Thursday ruled against Amgen Inc in its bid to revive patents on its cholesterol-lowering drug Repatha over a legal challenge by French rival Sanofi SA.  The nine justices unanimously upheld a lower court's ruling that had invalidated Amgen's patents on the grounds that the Thousand Oaks, California-based drugmaker had failed to provide a roadmap for recreating the full scope of its claimed innovation.  Amgen has waged a years-long court battle to restore two of its patents on Repatha, a drug that can reduce the risk of heart attack and stroke in people with heart disease, stemming from a legal fight with Sanofi and its partner Regeneron Pharmaceuticals Inc.""}, {""date"": ""20230518115434"", ""headline"": ""Amgen agrees not to seek quick close to Horizon acquisition"", ""summary"": ""Amgen Inc has agreed not to quickly close on its $27.8 billion acquisition of Horizon Therapeutics after the U.S. Federal Trade Commission (FTC) filed suit to block the deal.""}, {""date"": ""20230518120559"", ""headline"": ""FTC effort to stop Amgen's Horizon takeover faces uphill fight"", ""summary"": ""The Federal Trade Commission (FTC) faces an uphill battle in its fight against Amgen Inc's $27.8 billion acquisition of Horizon Therapeutics with an untested argument before a Trump-appointed judge, three antitrust experts said.""}, {""date"": ""20230518123600"", ""headline"": ""Amgen Inc. stock falls Thursday, underperforms market"", ""summary"": ""Shares of Amgen Inc. slid 0.35% to $224.23 Thursday, on what proved to be an all-around positive trading session for the stock market, with the S&P 500 Index...""}, {""date"": ""20230518124000"", ""headline"": ""Sanofi Wins Supreme Court Patent Dispute With Amgen"", ""summary"": ""The court said Amgen patents relating to its cholesterol drug Repatha shouldn\u2019t have been granted by the patent office, handing a victory to rival pharmaceutical firm Sanofi.""}, {""date"": ""20230518124728"", ""headline"": ""U.S. Supreme Court rules against Amgen bid to revive cholesterol drug patents"", ""summary"": ""The U.S. Supreme Court on Thursday ruled against Amgen Inc in its bid to revive patents on its cholesterol-lowering drug Repatha in a legal clash with French rival Sanofi SA.""}, {""date"": ""20230518140000"", ""headline"": ""5 High Yield Stocks With Steady Dividend Growth And An Attractive Valuation"", ""summary"": ""I consider companies that combine a relatively high Dividend Yield and Dividend Growth Rate to be particularly attractive for dividend income investors. Read more here.""}, {""date"": ""20230518140408"", ""headline"": ""Blocking the Horizon-Amgen deal will be worse for pharma than for biotech, says Mizuho's Jared Holz"", ""summary"": ""Jared Holz, Mizuho healthcare sector strategist, joins 'Fast Money' to discuss merger and acquisition crackdowns in the biotech space, government regulation in the space, and more.""}, {""date"": ""20230518145258"", ""headline"": ""Why Viking Therapeutics Stock Is Buckling Today"", ""summary"": ""Shares of the clinical-stage metabolic disorder specialist Viking Therapeutics (NASDAQ: VKTX) were down by 6.45% on moderate volume as of 1:42 p.m. ET Thursday afternoon.  Small- and mid-cap biotech stocks are under pressure today following the Federal Trade Commission's (FTC) decision to sue over the proposed merger between Amgen\u00a0and Horizon Therapeutics\u00a0earlier this week.  Before investors get too concerned, however, it's important to understand what's actually driving this takeover speculation.""}, {""date"": ""20230518193117"", ""headline"": ""Oppenheimer Reiterates AMGEN (AMGN) Outperform Recommendation"", ""summary"": """"}, {""date"": ""20230518203200"", ""headline"": ""GLOBAL BRIEFING: Japanese inflation hits 3.4%; new sanctions on Russia"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230518214300"", ""headline"": ""Amgen (NASDAQ:AMGN) Loses Patent Battle to Sanofi, Regeneron"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230519053500"", ""headline"": ""3 Safe Dividend Stocks to Beat Inflation"", ""summary"": ""Inflation rates may finally be cooling down from last year's unnerving levels.  Plenty of dividend-paying companies are dishing out -- and growing -- their dividend payments generously enough to outpace inflation's impact.  Here's a closer look at three such dividend stocks to consider adding to the income-paying portion of your portfolio.""}, {""date"": ""20230519071522"", ""headline"": ""5 Things to Know Before Markets Open"", ""summary"": ""President Biden said he was confident that negotiators would reach a deal on the debt ceiling and Fed Chair Jerome Powell is set to speak on monetary policy. Here\u2019s what investors need to know today.""}, {""date"": ""20230519123600"", ""headline"": ""Amgen Inc. stock underperforms Friday when compared to competitors"", ""summary"": ""Shares of Amgen Inc. dropped 0.36% to $223.42 Friday, on what proved to be an all-around rough trading session for the stock market, with the S&P 500 Index...""}, {""date"": ""20230519134240"", ""headline"": ""A global antitrust alliance battles Microsoft and Amgen"", ""summary"": ""As the EU approved Microsoft\u2019s $75bn bid to buy Activision Blizzard, the US Federal Trade Commission sued to block Amgen\u2019s $28.3bn deal to acquire Horizon Therapeutics and warned of \u201crampant consolidation\u201d in pharmaceuticals.  Margrethe Vestager, EU competition commissioner, is known as the nemesis of Big Tech but others are taking her place.  The Amgen suit epitomises the tough approach adopted by Lina Khan, chair of the FTC, and Khan has a new ally: Sarah Cardell, chief executive of the UK Competition and Markets Authority.""}, {""date"": ""20230519135600"", ""headline"": ""Washington Is Coming Down Hard on Deal Making. What It Means for Stocks."", ""summary"": ""FTC Chair Khan now seems less interested in ensuring competition than in blocking all linkups on principle. And that includes acquisitions that wouldn\u2019t have earned more than a passing look under previous regimes""}, {""date"": ""20230519175000"", ""headline"": ""Walmart, Tesla, Micron: Stocks That Defined the Week"", ""summary"": ""Retail giant  Walmart  posted stronger-than-expected profit and revenue and raised its full-year profit outlook, as the company\u2019s stores attract price-sensitive customers who have curtailed spending elsewhere.  Walmart said it continued to gain grocery market share, including among higher-income shoppers.  Walmart shares rose 1.3% Thursday.""}, {""date"": ""20230520070042"", ""headline"": ""We Think Amgen (NASDAQ:AMGN) Can Stay On Top Of Its Debt"", ""summary"": ""Howard Marks put it nicely when he said that, rather than worrying about share price volatility, 'The possibility of...""}, {""date"": ""20230521033258"", ""headline"": ""Viridian Therapeutics Has Promise"", ""summary"": ""Shares of Viridian Therapeutics are off some 40% since setting an all-time high in January following a positive readout on VRDN-001. Click for more on VRDN.""}, {""date"": ""20230521051933"", ""headline"": ""4 big deal reports: Amgen-Horizon merger on the ropes"", ""summary"": ""Here is your Pro Recap of 4 head-turning deal dispatches you may have missed this week: potential block of Horizon/Amgen transaction, merger deals at Magellan Midstream/Oneok and Urstadt Biddle/Regency Centers, and New Relic\u2019s potential $5B acquisition.  InvestingPro subscribers got this news before anyone else.  Horizon Therapeutics (NASDAQ:HZNP) shares plunged more than 14% on Tuesday after the report that the U.S. Federal Trade Commission (FTC) is expected to introduce a lawsuit to block the proposed $27.8 billion merger with Amgen (NASDAQ:AMGN).""}, {""date"": ""20230521070100"", ""headline"": ""Billions of dollars at stake as FDA shortcut allows half-proven drugs - report"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}]",{}
19,2023-05-21,219.89537048339844,2023-05-28,213.50775146484375,-0.029048447016018164,D3,"[{""date"": ""20230521033258"", ""headline"": ""Viridian Therapeutics Has Promise"", ""summary"": ""Shares of Viridian Therapeutics are off some 40% since setting an all-time high in January following a positive readout on VRDN-001. Click for more on VRDN.""}, {""date"": ""20230521051933"", ""headline"": ""4 big deal reports: Amgen-Horizon merger on the ropes"", ""summary"": ""Here is your Pro Recap of 4 head-turning deal dispatches you may have missed this week: potential block of Horizon/Amgen transaction, merger deals at Magellan Midstream/Oneok and Urstadt Biddle/Regency Centers, and New Relic\u2019s potential $5B acquisition.  InvestingPro subscribers got this news before anyone else.  Horizon Therapeutics (NASDAQ:HZNP) shares plunged more than 14% on Tuesday after the report that the U.S. Federal Trade Commission (FTC) is expected to introduce a lawsuit to block the proposed $27.8 billion merger with Amgen (NASDAQ:AMGN).""}, {""date"": ""20230521070100"", ""headline"": ""Billions of dollars at stake as FDA shortcut allows half-proven drugs - report"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230522211800"", ""headline"": ""Check Out What Whales Are Doing With AMGN"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230522213100"", ""headline"": ""Amgen, J&J settle lawsuit over Stelara biosimilar"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230522233900"", ""headline"": ""Amgen Takes Over #60 Spot From Union Pacific"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230523022615"", ""headline"": ""SGEN, ACAD & BMEA Drove Baker Brothers Advisors' Q1 Returns as ASND and HZNP Were Culled"", ""summary"": """"}, {""date"": ""20230523074600"", ""headline"": ""Amgen, J&J settle patent lawsuit over Stelara biosimilar, Reuters reports"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230523082000"", ""headline"": ""Bayer, Amgen looked at Iveric before agreeing to Astellas sale - report"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230523084100"", ""headline"": ""10 Health Care Stocks Whale Activity In Today's Session"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230523102739"", ""headline"": ""Amgen settles J&J patent lawsuit over drug similar to blockbuster Stelara"", ""summary"": ""Johnson & Johnson's Janssen Biotech Inc has settled its lawsuit against Amgen Inc over Amgen's proposed similar version of J&J's top-selling drug Stelara, according to a filing Monday in Delaware federal court.""}, {""date"": ""20230523110127"", ""headline"": ""UPDATE 2-Amgen settles patent lawsuit over biosimilar of J&J's  big-selling Stelara"", ""summary"": ""Johnson & Johnson has settled its lawsuit over Amgen Inc's proposed biosimilar version of J&J's top-selling treatment Stelara for psoriasis and other autoimmune conditions,  according to a filing in Delaware federal court.  Amgen said in a statement on Tuesday that the settlement terms are confidential, but it will allow the company to sell its biosimilar of Stelara \""no later than January 1st, 2025.\""""}, {""date"": ""20230523113543"", ""headline"": ""Amgen settles patent lawsuit over biosimilar of J&J's  big-selling Stelara"", ""summary"": ""Johnson & Johnson has settled its lawsuit over Amgen Inc's proposed biosimilar version of J&J's top-selling treatment Stelara for psoriasis and other autoimmune conditions, according to a filing in Delaware federal court.""}, {""date"": ""20230523114506"", ""headline"": ""UPDATE 1-US judge hearing fight over Amgen deal for Horizon eyes September trial"", ""summary"": ""The judge who will decide if Amgen can go forward with its $27.8 billion purchase of Horizon Therapeutics on Tuesday said he was considering an evidentiary hearing on the matter in September.  Judge John Kness said he would likely take about four weeks after the hearing ends to make a ruling.  The case is being heard in federal court in Chicago.""}, {""date"": ""20230523115310"", ""headline"": ""US judge hearing fight over Amgen deal for Horizon eyes September trial"", ""summary"": ""The judge who will decide if Amgen can go forward with its $27.8 billion purchase of Horizon Therapeutics on Tuesday said he was considering an evidentiary hearing on the matter in September.""}, {""date"": ""20230523123600"", ""headline"": ""Amgen Inc. stock outperforms market on strong trading day"", ""summary"": ""Shares of Amgen Inc. inched 0.20% higher to $224.44 Tuesday, on what proved to be an all-around rough trading session for the stock market, with the S&P 500...""}, {""date"": ""20230523222100"", ""headline"": ""Noteworthy Wednesday Option Activity: AMGN, GPRE, RETA"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230524051500"", ""headline"": ""FTC Wants to Block the Amgen-Horizon Deal: Is Pfizer's Acquisition of Seagen at Risk, Too?"", ""summary"": ""The Federal Trade Commission (FTC) has been taking a much more adversarial approach to mergers and acquisitions lately.  For instance, it recently said it plans to block the pending deal between pharmaceutical companies Horizon Therapeutics (NASDAQ: HZNP) and Amgen (NASDAQ: AMGN).  Does the FTC's recent tough stance on big deals increase the chances that Pfizer's (NYSE: PFE) acquisition of Seagen (NASDAQ: SGEN) will also run into problems?""}, {""date"": ""20230524070000"", ""headline"": ""Elizabeth Warren and the FTC Are the Least of Amgen\u2019s Problems"", ""summary"": ""The Internal Revenue Service has gone after the biotech for billions of dollars in back taxes.  Lina Khan\u2019s Federal Trade Commission is seeking to block its $27.8 billion acquisition of  Horizon Therapeutics  (a move some insiders think was at least partly prompted by a blistering letter from Sen. Elizabeth Warren).""}, {""date"": ""20230524093342"", ""headline"": ""14 Best Healthcare Dividend Stocks to Buy"", ""summary"": ""In this article, we will take a look at 14 best healthcare dividend stocks to buy. You can skip our detailed analysis of the healthcare sector and dividend stocks, and go directly to read 5 Best Healthcare Dividend Stocks to Buy. The healthcare sector in the US encompasses a wide range of providers, facilities, and [\u2026]""}, {""date"": ""20230524123600"", ""headline"": ""Amgen Inc. stock underperforms Wednesday when compared to competitors"", ""summary"": ""Shares of Amgen Inc. slid 1.39% to $221.32 Wednesday, on what proved to be an all-around grim trading session for the stock market, with the S&P 500 Index...""}, {""date"": ""20230524220400"", ""headline"": ""Dow's 90-point fall led by losses for shares of Intel, Walgreens Boots"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230525000700"", ""headline"": ""Novartis' Sandoz gets EMA review for biosimilar to Amgen's Prolia, Xgeva"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230525040352"", ""headline"": ""14 Best Biotech Stocks To Buy According To Hedge Funds"", ""summary"": ""In this piece, we will take a look at 14 best biotechnology stocks to buy according to hedge funds. For more stocks, head on over to 5 Best Biotech Stocks To Buy According To Hedge Funds. Biotechnology is one of the hottest sectors these days. A handful of industries, such as space exploration, artificial intelligence, [\u2026]""}, {""date"": ""20230525065200"", ""headline"": ""Dow drops 175 points on losses in Intel, Walgreens Boots shares"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230525080700"", ""headline"": ""Intel, Verizon share losses lead Dow's nearly 100-point drop"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230525121909"", ""headline"": ""3 Dogs of the Dow for High-Yield Investors"", ""summary"": ""The \u201cDogs of the Dow\u201d strategy consists of investing in the 10 highest-yielding stocks in the Dow Jones Industrial Average. Purchasing the Dogs of the Dow creates higher dividend income by focusing on high-yielding stocks. This is a simple strategy for value investors looking to purchase high-yield dividend stocks with reasonable valuations. The following three stocks are part of the 10 Dogs of the Dow. They have high dividend yields and strong business models and should maintain their dividends""}, {""date"": ""20230525123600"", ""headline"": ""Amgen Inc. stock underperforms Thursday when compared to competitors"", ""summary"": ""Shares of Amgen Inc. slipped 1.74% to $217.46 Thursday, on what proved to be an all-around mixed trading session for the stock market, with the S&P 500 Index...""}, {""date"": ""20230526053000"", ""headline"": ""A Challenger to J&J's Top Blockbuster Is on the Way. Here's What You Need to Know."", ""summary"": ""When you think of Johnson & Johnson (NYSE: JNJ), you may think of shampoo and Band-Aids.  In fact, J&J is in the process of spinning off that business into an entity called Kenvue.  What is J&J's top revenue driver?""}, {""date"": ""20230526054800"", ""headline"": ""Nvidia Pops 25% on Super Guidance"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230526083400"", ""headline"": ""Is the Options Market Predicting a Spike in Amgen (AMGN) Stock?"", ""summary"": ""Investors need to pay close attention to Amgen (AMGN) stock based on the movements in the options market lately.""}, {""date"": ""20230526123600"", ""headline"": ""Amgen Inc. stock underperforms Friday when compared to competitors"", ""summary"": ""Shares of Amgen Inc. dropped 0.24% to $216.93 Friday, on what proved to be an all-around positive trading session for the stock market, with the S&P 500...""}, {""date"": ""20230526160000"", ""headline"": ""AMGEN TO PRESENT AT THE TD COWEN 4TH ANNUAL ONCOLOGY INNOVATION SUMMIT"", ""summary"": ""Amgen (NASDAQ: AMGN) will present at the TD Cowen 4th Annual Oncology Innovation Summit at 11:00 a.m. ET on Wednesday, May 31, 2023. David M. Reese, M.D., executive vice president of Research and Development at Amgen will present at the conference. The webcast will be broadcast over the internet simultaneously and will be available to members of the news media, investors and the general public.""}]",{}
20,2023-05-28,213.50775146484375,2023-06-04,214.62979125976562,0.005255264912977342,U1,"[{""date"": ""20230529010200"", ""headline"": ""Top-Ranked Dividend Stocks: A Smarter Way To Boost Your Retirement Income"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230529013615"", ""headline"": ""Amgen: Appeal Becomes Visible Despite Uncertainty On The 'Horizon'"", ""summary"": ""Amgen's stock has seen a further pullback since it announced acquisition of Horizon Therapeutics in December. Check out my thoughts on AMGN stock.""}, {""date"": ""20230529080020"", ""headline"": ""Amgen's (NASDAQ:AMGN) underlying earnings growth outpaced the notable return generated for shareholders over the past five years"", ""summary"": ""When you buy and hold a stock for the long term, you definitely want it to provide a positive return. Better yet, you'd...""}, {""date"": ""20230529233200"", ""headline"": ""Quant Ratings Updated on 107 Stocks"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230530050500"", ""headline"": ""Amgen: Now At A Record High Yield"", ""summary"": ""Amgen (AMGN) stock is trading near its 52-week low, presenting a potential opportunity for long-term investors.""}, {""date"": ""20230530060000"", ""headline"": ""LABU: 2 Requirements For Making Money In This Leveraged Biotech Fund"", ""summary"": ""LABU is 3X leveraged fund that has disappointed the biotech bulls. It can work for medium term returns if two requirements are met. See more on this ETF here.""}, {""date"": ""20230530060100"", ""headline"": ""Viridian an outperform at RBC on thyroid eye disease candidate"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230530063049"", ""headline"": ""Top Merger Stocks Held By Fund Managers, Mid-Q2 2023"", ""summary"": ""Merger arbitrage in mid-2023 faces regulatory hurdles, with agencies attempting to block deals across industries. Read more here.""}, {""date"": ""20230530110246"", ""headline"": ""Iveric bio, Still A 5+% Opportunity"", ""summary"": ""Iveric bio, focused on developing treatments for retinal diseases, has announced its acquisition by Astellas Pharma Inc. Find out our thoughts on ISEE stock.""}, {""date"": ""20230530123600"", ""headline"": ""Amgen Inc. stock rises Tuesday, outperforms market"", ""summary"": ""Shares of Amgen Inc. inched 0.74% higher to $218.53 Tuesday, on what proved to be an all-around mixed trading session for the stock market, with the S&P 500...""}, {""date"": ""20230530180000"", ""headline"": ""AMGEN PRESENTS NEW RESEARCH ON OTEZLA\u00ae (APREMILAST) IN PSORIATIC ARTHRITIS AT EULAR 2023"", ""summary"": ""Amgen (NASDAQ:AMGN) today announced new research examining the use of Otezla\u00ae (apremilast) in psoriatic arthritis, including the Phase 4 MOSAIC study and an exploratory analysis of cardiometabolic risk factors, which are commonly elevated in patients with psoriatic disease. The findings will be presented at the 2023 European Congress of Rheumatology (EULAR), taking place May 31-June 3 in Milan, Italy.""}, {""date"": ""20230531102024"", ""headline"": ""Amgen Inc. (AMGN) 4th Annual Oncology Innovation Summit: Insights for ASCO & EHA (Transcript)"", ""summary"": ""Amgen Inc. (NASDAQ:NASDAQ:AMGN) 4th Annual Oncology Innovation Summit: Insights for ASCO & EHA May 31, 2023 11:00 AM ETCompany ParticipantsDavid Reese - Executive Vice President of...""}, {""date"": ""20230531123600"", ""headline"": ""Amgen Inc. stock rises Wednesday, outperforms market"", ""summary"": ""Shares of Amgen Inc. inched 0.97% higher to $220.65 Wednesday, on what proved to be an all-around poor trading session for the stock market, with the S&P 500...""}, {""date"": ""20230531162915"", ""headline"": ""2 Large Cap Biotech Stocks To Watch Right Now"", ""summary"": ""Large-cap biotech stocks to check out in the stock market today.""}, {""date"": ""20230531223900"", ""headline"": ""Amgen (AMGN) Shares Cross 4% Yield Mark"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230601011601"", ""headline"": ""Tracking Baker Brothers Portfolio - Q1 2023 Update"", ""summary"": ""Baker Brothers' 13F portfolio value increased from $16.65B to $18.38B. Click here to read the portfolio's full Q1 2023 update.""}, {""date"": ""20230601042500"", ""headline"": ""Mark Cuban online pharmacy to offer AbbVie Humira biosimilar"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230601054500"", ""headline"": ""Salesforce, Amgen share losses contribute to Dow's nearly 150-point fall"", ""summary"": ""Shares of Salesforce and Amgen are trading lower Thursday morning, dragging the Dow Jones Industrial Average into negative territory. Shares of Salesforce...""}, {""date"": ""20230601061300"", ""headline"": ""Wells says Coherus' Humira biosimilar pricing 'actually good news' for AbbVie"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230601063900"", ""headline"": ""AMGN July 14th Options Begin Trading"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230601071700"", ""headline"": ""House Committee starts probe into FTC Chair Lina Khan"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230601083400"", ""headline"": ""Notable Thursday Option Activity: AMGN, ABBV, RCL"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230601090000"", ""headline"": ""AMGEN PRESENTS NEW SCIENTIFIC AND CLINICAL RESEARCH ACROSS ITS DIVERSE ONCOLOGY PORTFOLIO AND PIPELINE AT ASCO 2023"", ""summary"": ""Amgen (NASDAQ:AMGN) today announced the presentation of new scientific and clinical research across its diverse oncology portfolio and pipeline at the American Society of Clinical Oncology (ASCO) Annual Meeting, taking place from June 2-6 in Chicago. More than 25 abstracts from Amgen-sponsored and collaborative studies, including three oral presentations and two poster discussions, will feature data in hard-to-treat tumor types, including non-small cell lung cancer (NSCLC), colorectal cancer (CR""}, {""date"": ""20230601120000"", ""headline"": ""Is Amgen a Good Dividend Stock?"", ""summary"": ""Biotech pioneer Amgen (NASDAQ: AMGN) has several key elements of a good dividend stock.  Amgen is also a component of the Dow Jones Industrial Average and Nasdaq-100 index, making its shares highly liquid.  Amgen is moving into a highly uncertain period, characterized by high levels of competition from biosimilars (generic biologics) for many of its aging blockbusters, pushback from the Federal Trade Commission over its proposed takeover of Horizon Therapeutics (NASDAQ: HZNP), and serious question marks surrounding the rationale of this $28 billion buyout.""}, {""date"": ""20230601123700"", ""headline"": ""Amgen Inc. stock falls Thursday, underperforms market"", ""summary"": ""Shares of Amgen Inc. slid 2.89% to $214.27 Thursday, on what proved to be an all-around great trading session for the stock market, with the S&P 500 Index...""}, {""date"": ""20230601125020"", ""headline"": ""Why AbbVie and Amgen Are Moving Lower Today"", ""summary"": ""Shares of the immunology juggernaut AbbVie (NYSE: ABBV) were down by 4% on sky-high volume as of 11 a.m. ET Thursday.  The big loss came after Coherus Biosciences\u00a0announced a partnership with billionaire Mark Cuban's pharmaceuticals start-up -- known as the Mark Cuban Cost Plus Drug Company -- to sell a biosimilar (a generic biologic) version of AbbVie's flagship anti-inflammatory medication, Humira, at an 85% discount.  Coherus' biosimilar will be branded as Yusimry.""}, {""date"": ""20230601165529"", ""headline"": ""Dow Jones Today: Debt Vote Drives Index Higher"", ""summary"": ""The Dow Jones Industrial Average moved higher by more than 0.5%, or 153 points, as investors celebrated the House of Representatives passage of the debt-ceiling bill, which now goes to the Senate.""}, {""date"": ""20230602070026"", ""headline"": ""Possible Bearish Signals With Amgen Insiders Disposing Stock \\"", ""summary"": ""Over the past year, many Amgen Inc. ( NASDAQ:AMGN ) insiders sold a significant stake in the company which may have...""}, {""date"": ""20230602074329"", ""headline"": ""High Yield Stock Watchlist: June 2023"", ""summary"": ""There are 20 stocks on my high yield watchlist for June 2023. The majority of the stocks on my watchlist are undervalued based on dividend yield theory. Read more here.""}, {""date"": ""20230602075532"", ""headline"": ""3 Undervalued Biotech Stocks to Buy Before They Blast Off"", ""summary"": ""When investors hear the words \u201cundervalued biotech stocks to buy,\u201d they frequently think of companies in the clinical trial stage. That\u2019s understandable. If you can buy a company\u2019s stock before it releases a game-changing drug or therapeutic into the market, you can make a fortune. That line of thinking was displayed in 2020 when many biotech companies raced to produce a Covid-19 vaccine. But every investor also knows that many of those moonshots never pan out. That\u2019s not the kind of uncertainty""}, {""date"": ""20230602123900"", ""headline"": ""Amgen Inc. stock outperforms competitors on strong trading day"", ""summary"": ""Shares of Amgen Inc. advanced 1.77% to $218.07 Friday, on what proved to be an all-around positive trading session for the stock market, with the S&P 500...""}, {""date"": ""20230602131733"", ""headline"": ""The Biotech Buying Bonanza: Why The FTC's Amgen Battle Won't Chill The Spree"", ""summary"": ""Big Pharma has a problem, and buying up biotech companies helps solve it. But the FTC has its own ideas about industry mergers. Here's where things stand.""}, {""date"": ""20230603034100"", ""headline"": ""Analysts Conflicted on These Healthcare Names: Amgen (AMGN) and Natera (NTRA)"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230603050000"", ""headline"": ""How To Build Wealth: Buy Low And Sell High Consistently"", ""summary"": ""The strategy discussed is about buying or selling small quantities of shares when certain thresholds are met. Click here to read more about that strategy.""}, {""date"": ""20230603222807"", ""headline"": ""Dividend Champion, Contender, And Challenger Highlights: Week Of June 4"", ""summary"": ""A weekly summary of dividend activity for Dividend Champions, Contenders, and Challengers. Companies which changed their dividends. Click here to read the complete list.""}, {""date"": ""20230604034800"", ""headline"": ""Amgen presents new LUMAKRAS CodeBreaK 200 CNS data at ASCO"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230604080000"", ""headline"": ""AMGEN PRESENTS NEW LUMAKRAS\u00ae (SOTORASIB) CODEBREAK 200 CNS DATA AT ASCO 2023"", ""summary"": ""Amgen (NASDAQ:AMGN) today announced the presentation of new data from the CodeBreaK clinical trial program, the most comprehensive global development program in patients with KRAS G12C-mutated cancers, at the American Society of Clinical Oncology (ASCO) Annual Meeting taking place June 2-6 in Chicago. The research presented reinforces the efficacy of LUMAKRAS\u00ae/LUMYKRAS\u00ae (sotorasib) in advanced non-small cell lung cancer (NSCLC) and metastatic colorectal cancer (mCRC). Additionally, data from SCA""}]",{}
21,2023-06-04,214.62979125976562,2023-06-11,215.3088836669922,0.003164017461139146,U1,"[{""date"": ""20230603222807"", ""headline"": ""Dividend Champion, Contender, And Challenger Highlights: Week Of June 4"", ""summary"": ""A weekly summary of dividend activity for Dividend Champions, Contenders, and Challengers. Companies which changed their dividends. Click here to read the complete list.""}, {""date"": ""20230604034800"", ""headline"": ""Amgen presents new LUMAKRAS CodeBreaK 200 CNS data at ASCO"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230604080000"", ""headline"": ""AMGEN PRESENTS NEW LUMAKRAS\u00ae (SOTORASIB) CODEBREAK 200 CNS DATA AT ASCO 2023"", ""summary"": ""Amgen (NASDAQ:AMGN) today announced the presentation of new data from the CodeBreaK clinical trial program, the most comprehensive global development program in patients with KRAS G12C-mutated cancers, at the American Society of Clinical Oncology (ASCO) Annual Meeting taking place June 2-6 in Chicago. The research presented reinforces the efficacy of LUMAKRAS\u00ae/LUMYKRAS\u00ae (sotorasib) in advanced non-small cell lung cancer (NSCLC) and metastatic colorectal cancer (mCRC). Additionally, data from SCA""}, {""date"": ""20230604222500"", ""headline"": ""Biotech stocks could soon get a M&A boost. Here are 3 likely takeover plays."", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230605061450"", ""headline"": ""Analysis-Stelara patent deal puts J&J back on path to $57 billion 2025 revenue forecast"", ""summary"": ""Johnson & Johnson's legal settlement with Amgen Inc to delay a biosimilar version of its blockbuster psoriasis treatment Stelara until January 2025 could make the  drug a larger contributor to J&J\u2019s 2024 and 2025 sales than Wall Street is forecasting.  Stelara, introduced in 2009, has been J&J\u2019s top-selling drug since 2019, with sales reaching $9.7 billion in 2022.  Its patents begin to expire this year, opening the door to a cheaper biosimilar entering the market, and raising expectations that the company would need to lower the $13,000 per month price of Stelara.""}, {""date"": ""20230605080000"", ""headline"": ""Even Mark Cuban Can\u2019t Fix This Broken Drug System"", ""summary"": ""Coherus BioSciences\u2019 partnership to offer deeply discounted biosimilar Humira can go only so far in reducing overall prices.""}, {""date"": ""20230605083200"", ""headline"": ""Here's How Much $1000 Invested In Amgen 15 Years Ago Would Be Worth Today"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230605085300"", ""headline"": ""Iveric Bio gains after holder vote on Astellas takeover set for July 6"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230605085535"", ""headline"": ""Stocks making the biggest moves midday: Palo Alto Networks, 3M, Amedisys, Target and more"", ""summary"": ""These are among the stocks posting the largest moves in midday trading Monday. ""}, {""date"": ""20230605123800"", ""headline"": ""Amgen Inc. stock outperforms competitors on strong trading day"", ""summary"": ""Shares of Amgen Inc. advanced 1.75% to $221.88 Monday, on what proved to be an all-around grim trading session for the stock market, with the S&P 500 Index...""}, {""date"": ""20230605164340"", ""headline"": ""Dow Jones Today: Apple Headset Can\u2019t Lift Index"", ""summary"": ""The Dow Jones Industrial Average fell 0.6%, or about 200 points, as markets cooled off from Friday's blistering rally. Amgen rose more than any other stock, but Intel led the index lower.""}, {""date"": ""20230606080000"", ""headline"": ""Lina Khan Is Upending One of Wall Street\u2019s Favorite Trades"", ""summary"": ""(Bloomberg) -- Lina Khan is the most aggressive trustbuster the US has had in decades. Roughly two years into her tenure, Wall Street is still learning the hard way just how far she\u2019ll take her fight against some of America\u2019s most powerful businesses.Most Read from BloombergUkraine Dam Blast Blamed on Russia Tips War Into New PhasePGA Tour Bows to Saudi Rival in Shock Combination With LIV GolfSEC\u2019s Coinbase Lawsuit Heralds Deepening US Crypto CrackdownApple Headset Looks Sleek in Person But Batt""}, {""date"": ""20230606082512"", ""headline"": ""U.S. Wide-Moat Stocks On Sale - The June 2023 Heat Map"", ""summary"": ""Our 3-step process focuses on wide-moat stocks (as per Morningstar\u00e2\u0080\u0099s rating). Click here to see the heat map of the most investable candidates for June 2023.""}, {""date"": ""20230606094007"", ""headline"": ""Are You a Value Investor? This 1 Stock Could Be the Perfect Pick"", ""summary"": ""The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.""}, {""date"": ""20230606123900"", ""headline"": ""Amgen Inc. stock falls Tuesday, underperforms market"", ""summary"": ""Shares of Amgen Inc. shed 0.30% to $221.22 Tuesday, on what proved to be an all-around great trading session for the stock market, with the S&P 500 Index...""}, {""date"": ""20230606144425"", ""headline"": ""Buy 3 June Dogs Of The Dow, Watch 4"", ""summary"": ""Analyst one-year targets showed ten highest-yield Dow stocks producing 13.64% more gain from $5k invested in the lowest-priced five. Learn more about our stock lists.""}, {""date"": ""20230607065200"", ""headline"": ""See How Amgen Ranks Among Analysts' Top Dow 30 Picks"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230607065200"", ""headline"": ""Video: Dow Analyst Moves: AMGN"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230607123900"", ""headline"": ""Amgen Inc. stock underperforms Wednesday when compared to competitors despite daily gains"", ""summary"": ""Shares of Amgen Inc. inched 0.01% higher to $221.25 Wednesday, on what proved to be an all-around mixed trading session for the stock market, with the Dow...""}, {""date"": ""20230607234000"", ""headline"": ""Amgen Inc. stock underperforms Thursday when compared to competitors"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230608013900"", ""headline"": ""The 3 Best Long-Term Dividend Stocks to Buy in June"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230608050123"", ""headline"": ""DJD: Attractive Valuation, Average Quality And Return"", ""summary"": ""DJD holds 27 stocks of the Dow Jones paying a dividend. Valuation and dividend growth look attractive, but quality and historical return are average. Read more here.""}, {""date"": ""20230608063500"", ""headline"": ""July 28th Options Now Available For Amgen (AMGN)"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230608121500"", ""headline"": ""Is AbbVie or Amgen the Better Bargain Buy Right Now?"", ""summary"": ""Due to the highly competitive nature of the pharmaceutical industry, it is no easy task to replace the aging stars in a drug portfolio.  Teva Pharmaceutical (NYSE: TEVA) illustrates this point nicely.  In the middle of the last decade, Teva lost exclusivity for its multiple sclerosis medication Copaxone.""}, {""date"": ""20230608132708"", ""headline"": ""Ideaya Biosciences: Lots Of 'Shots On Goal' And Upcoming Potential Catalysts"", ""summary"": ""Ideaya Biosciences is moving forward a large pipeline of drug candidates based on its focus on synthetic lethality. Click here to read more on IDYA stock.""}, {""date"": ""20230608192136"", ""headline"": ""Amgen: Big Yield And Dividend Growth On Sale Now"", ""summary"": ""Amgen's products are inelastic and should grow with the population over time. Click here to see why AMGN stock is a Buy.""}, {""date"": ""20230608215700"", ""headline"": ""Seagen gains as antitrust deadline for Pfizer purchase nears on Monday"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230608234000"", ""headline"": ""Amgen Inc. stock falls Friday, underperforms market"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230609100030"", ""headline"": ""Amgen Inc. (NASDAQ:AMGN) Shares Could Be 44% Below Their Intrinsic Value Estimate"", ""summary"": ""Key Insights Amgen's estimated fair value is US$394 based on 2 Stage Free Cash Flow to Equity Current share price of...""}, {""date"": ""20230609160000"", ""headline"": ""AMGEN TO PRESENT AT THE GOLDMAN SACHS 44TH ANNUAL GLOBAL HEALTHCARE CONFERENCE"", ""summary"": ""Amgen (NASDAQ:AMGN) will present at the Goldman Sachs 44th Annual Global Healthcare Conference at 2:20 p.m. ET on Wednesday, June 14, 2023. Robert A. Bradway, chairman and chief executive officer at Amgen will present at the conference. The webcast will be broadcast over the internet simultaneously and will be available to members of the news media, investors, and the general public.""}, {""date"": ""20230609175023"", ""headline"": ""Amgen (AMGN) Stock Sinks As Market Gains: What You Should Know"", ""summary"": ""Amgen (AMGN) closed at $218.82 in the latest trading session, marking a -0.88% move from the prior day.""}]",{}
22,2023-06-11,215.3088836669922,2023-06-18,226.0369415283203,0.049826359593785785,U5,"[{""date"": ""20230612000048"", ""headline"": ""Big Pharma dealmaking recovers with $85bn M&A splurge"", ""summary"": ""Pharmaceutical and biotech companies spent $85bn on acquisitions in the first five months of the year, marking a dramatic recovery in dealmaking as they seek to replenish their drug pipelines.  The surge in M&A, compared to just $35.6bn in deals in the same period of 2022 and $49.1bn the year before, according to Stifel, an investment bank, is being fuelled by large cash reserves amassed by Big Pharma during the coronavirus pandemic and investor concerns about future growth prospects.  At the start of year, the world\u2019s largest pharmaceutical companies held more than $1.4tn in dealmaking firepower, according to an analysis by EY.""}, {""date"": ""20230612030300"", ""headline"": ""Teva, Alvotech in pact with Johnson & Johnson over Stelara knockoff"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230612051800"", ""headline"": ""Video: Dow Movers: AMGN, CRM"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230612065500"", ""headline"": ""5 Stocks to Buy With Explosive 500% Potential"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230612103053"", ""headline"": ""Pharma: M&A strategy gets dose of bitter medicine"", ""summary"": ""Medicines price gouger Martin Shkreli was one of a kind.  Illumina bought cancer test developer Grail for $8bn in 2021, even though US and EU authorities complained the US gene sequencer could deny crucial inputs to Grail\u2019s rivals.  On Monday, its boss Francis deSouza resigned after a proxy fight with activist investor Carl Icahn over Illumina\u2019s decision to proceed.""}, {""date"": ""20230612123900"", ""headline"": ""Amgen Inc. stock falls Monday, underperforms market"", ""summary"": ""Shares of Amgen Inc. dropped 0.64% to $217.36 Monday, on what proved to be an all-around positive trading session for the stock market, with the S&P 500...""}, {""date"": ""20230612225700"", ""headline"": ""Deep Value Moments"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230613035003"", ""headline"": ""Nicholas Ward's Dividend Growth Portfolio: April And May Review"", ""summary"": ""My passive income stream increased by 25.59% YoY in April 2023 and 40.02% YoY in May 2023, with a YTD growth of 29.99%. See the full April & May update here.""}, {""date"": ""20230613065215"", ""headline"": ""Top 20 Most Profitable Pharmaceutical Companies In The World"", ""summary"": ""In this article, we will be covering the top 20 most profitable pharmaceutical companies in the world. If you wish to see the top ones, head straight to the Top 5 Most Profitable Pharmaceutical Companies In The World. Undoubtedly, the pharmaceutical industry stands as one of the most financially rewarding and essential sectors worldwide, leading [\u2026]""}, {""date"": ""20230613164527"", ""headline"": ""Dow Jones Today: Inflation Down, Index Up"", ""summary"": ""The Dow Jones Industrial Average rose 0.4%, or about 145 points, after May\u2019s inflation report encouraged investors the Federal Reserve will keep interest rates steady at least until July.""}, {""date"": ""20230614030300"", ""headline"": ""BTIG starts Virdian at buy, cites market potential for thyroid eye drug"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230614035700"", ""headline"": ""Amgen reportedly hires Moderna chief medical officer as new CMO"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230614105000"", ""headline"": ""Medifast: A Revamp Is Necessary, An Embrace Of GLP-1s Can Help"", ""summary"": ""Medifast is currently deploying positive cash flow dollars to maintenance of over 8% yielding dividend and to share repurchases. Find out why MED stock is a Strong Buy.""}, {""date"": ""20230614122906"", ""headline"": ""Amgen Inc. (AMGN) Goldman Sachs 44th Annual Global Healthcare Conference (Transcript)"", ""summary"": ""Amgen Inc. (NASDAQ:NASDAQ:AMGN) Goldman Sachs 44th Annual Global Healthcare Conference June 14, 2023 2:20 PM ETCompany ParticipantsRobert Bradway - Chairman and Chief Executive...""}, {""date"": ""20230614123900"", ""headline"": ""Amgen Inc. stock outperforms market on strong trading day"", ""summary"": ""Shares of Amgen Inc. inched 0.13% higher to $222.28 Wednesday, on what proved to be an all-around mixed trading session for the stock market, with the S&P...""}, {""date"": ""20230615103800"", ""headline"": ""Microsoft, Amgen share gains lead Dow's nearly 450-point rally"", ""summary"": ""Led by strong returns for shares of Microsoft and Amgen, the Dow Jones Industrial Average is rallying Thursday afternoon. The Dow is trading 445 points...""}, {""date"": ""20230615123900"", ""headline"": ""Amgen Inc. stock rises Thursday, outperforms market"", ""summary"": ""Shares of Amgen Inc. rose 2.77% to $228.44 Thursday, on what proved to be an all-around great trading session for the stock market, with the S&P 500 Index...""}, {""date"": ""20230615164126"", ""headline"": ""Dow Jones Today: Microsoft Leads Index Higher"", ""summary"": ""The Dow Jones Industrial Average rose 1.3%, or about 430 points, after retail sales data showed Americans are still upping their spending, a sign of resilience amid slowing inflation.""}, {""date"": ""20230615201512"", ""headline"": ""How Amgen Makes Money"", ""summary"": ""Amgen produces drugs to treat several conditions and markets them worldwide. Learn its revenue-earning structure and how it makes money.""}, {""date"": ""20230615224000"", ""headline"": ""Noteworthy Friday Option Activity: AMGN, WW, SCHW"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230616074500"", ""headline"": ""AbbVie's (ABBV) Skyrizi Meets Ulcerative Colitis Study Goals"", ""summary"": ""AbbVie's (ABBV) Skyrizi achieves statistical significance with its primary endpoint of clinical remission in a late-stage study as a maintenance treatment for ulcerative colitis.""}, {""date"": ""20230616083000"", ""headline"": ""This Biotech Is About to Eat AbbVie's Market Share, but Is It a Buy?"", ""summary"": ""Assuming it does, it's not going to be stealing a fry from the corner of AbbVie's plate -- it's going for a big-mouth chomp of the cheeseburger with all the fixings.  AbbVie shareholders are doubtless bracing themselves.  Coherus develops new oncology drugs with a combination of in-licensing candidates and its own research and development (R&D) activities, but it also currently sells biosimilar drugs that are copies of medicines developed by other companies.""}, {""date"": ""20230616123900"", ""headline"": ""Amgen Inc. stock outperforms competitors on strong trading day"", ""summary"": ""Shares of Amgen Inc. inched 0.53% higher to $229.66 Friday, on what proved to be an all-around rough trading session for the stock market, with the S&P 500...""}, {""date"": ""20230616175018"", ""headline"": ""Amgen (AMGN) Gains As Market Dips: What You Should Know"", ""summary"": ""In the latest trading session, Amgen (AMGN) closed at $229.66, marking a +0.53% move from the previous day.""}, {""date"": ""20230617000933"", ""headline"": ""Verizon: Fear, Greed, Top Dividend Dog Of The Dow"", ""summary"": ""Verizon shares offer a well-covered 7.2% dividend yield and currently trade at an attractive price relative to the value. Click here to read more on VZ stock.""}, {""date"": ""20230617080036"", ""headline"": ""A great week that adds to Amgen Inc.'s (NASDAQ:AMGN) one-year returns, institutional investors who own 77% must be happy"", ""summary"": ""Key Insights Institutions' substantial holdings in Amgen implies that they have significant influence over the...""}, {""date"": ""20230618165610"", ""headline"": ""How to Retire Rich: Biotech Stocks Edition"", ""summary"": ""Among the most difficult endeavors when it comes to deciphering the best retirement planning stocks is to identify companies that will remain relevant for years, if not decades to come. While no guarantees exist for anything, those who focus on investing in biotech own a clear advantage. Almost surely, the underlying sector \u2013 which falls under the broad healthcare industry \u2013 is permanently relevant. Further, I submitted a query on ChatGPT to extract key reasons why biotech stocks for retirement""}]",{}
23,2023-06-18,226.0369415283203,2023-06-25,223.52716064453125,-0.011103410207285114,D2,"[{""date"": ""20230618165610"", ""headline"": ""How to Retire Rich: Biotech Stocks Edition"", ""summary"": ""Among the most difficult endeavors when it comes to deciphering the best retirement planning stocks is to identify companies that will remain relevant for years, if not decades to come. While no guarantees exist for anything, those who focus on investing in biotech own a clear advantage. Almost surely, the underlying sector \u2013 which falls under the broad healthcare industry \u2013 is permanently relevant. Further, I submitted a query on ChatGPT to extract key reasons why biotech stocks for retirement""}, {""date"": ""20230619050000"", ""headline"": ""Tech Ruled The First Half Of 2023, The Industry You Need To Watch In The Second Half"", ""summary"": ""Tech stocks have staged a massive comeback in 2023, but value investors should consider looking into currently unloved sectors like healthcare. See my top picks.""}, {""date"": ""20230620030002"", ""headline"": ""Drugmakers aim to strike down Medicare drug-price negotiations at Supreme Court "", ""summary"": ""The lawsuits are the opening salvo in a historic and potentially decisive battle over Medicare's efforts to bring rising drug prices under control. ""}, {""date"": ""20230620080200"", ""headline"": ""Cantor Fitzgerald biotech/biopharma to hold a luncheon meeting"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230620080500"", ""headline"": ""Cantor Fitzgerald biotech/biopharma to hold analyst/industry conference call"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230620123900"", ""headline"": ""Amgen Inc. stock falls Tuesday, still outperforms market"", ""summary"": ""Shares of Amgen Inc. slid 0.47% to $228.59 Tuesday, on what proved to be an all-around rough trading session for the stock market, with the S&P 500 Index...""}, {""date"": ""20230620173946"", ""headline"": ""Tracking John Paulson's Paulson & Company Portfolio - Q1 2023 Update"", ""summary"": ""John Paulson's 13F portfolio value increased by around 8% from approximately $1.11B to $1.20B in Q1 2023. Read more on stake increases and decreases here.""}, {""date"": ""20230621040400"", ""headline"": ""Amgen's Blincyto granted full approval for leukemia by FDA"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230621043200"", ""headline"": ""Amgen wins full approval for leukemia therapy Blincyto"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230621053100"", ""headline"": ""Amgen Gets FDA Approval for Blincyto Supplemental Biologics License Application"", ""summary"": ""By Chris Wack Amgen said Wednesday that the U.S. Food and Drug Administration has approved its supplemental biologics license application for Blincyto, a...""}, {""date"": ""20230621060800"", ""headline"": ""Top pharma lobby sues U.S. govt. over Medicare drug pricing negotiations"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230621081200"", ""headline"": ""IN BRIEF: Amgen jubilant as FDA approves Blincyto leukemia drug"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230621083500"", ""headline"": ""If You Invested $1000 In This Stock 15 Years Ago, You Would Have $4,900 Today"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230621090000"", ""headline"": ""FDA GRANTS FULL APPROVAL FOR BLINCYTO\u00ae (BLINATUMOMAB) TO TREAT MINIMAL RESIDUAL DISEASE-POSITIVE B-CELL PRECURSOR ACUTE LYMPHOBLASTIC LEUKEMIA"", ""summary"": ""Amgen (NASDAQ:AMGN) today announced that the U.S. Food and Drug Administration (FDA) has approved the supplemental Biologics License Application (sBLA) for BLINCYTO\u00ae (blinatumomab) for the treatment of adults and pediatric patients with CD19-positive B-cell precursor acute lymphoblastic leukemia (B-ALL) in first or second complete remission with minimal residual disease (MRD) greater than or equal to 0.1%, based on additional data from two Phase 3 studies that were submitted. The approval conver""}, {""date"": ""20230621123900"", ""headline"": ""Amgen Inc. stock falls Wednesday, underperforms market"", ""summary"": ""Shares of Amgen Inc. dropped 0.68% to $227.04 Wednesday, on what proved to be an all-around dismal trading session for the stock market, with the S&P 500...""}, {""date"": ""20230621131012"", ""headline"": ""Leveraging AI in Drug Discovery: Elizabeth Schwarzbach of BigHat Biosciences, Live from NYSE"", ""summary"": ""IPO Edge hosted a fireside chat from the floor of the New York Stock Exchange with Elizabeth Schwarzbach, Chief Business Officer of BigHat Biosciences. She spoke to IPO Edge Editor-in-Chief [\u2026]""}, {""date"": ""20230622064000"", ""headline"": ""August 4th Options Now Available For Amgen (AMGN)"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230622094000"", ""headline"": ""Amgen's (AMGN) Blincyto sBLA Gets FDA Nod in Treating Leukemia"", ""summary"": ""Amgen (AMGN) announces full approval of its sBLA for Blincyto as an immune-oncology therapy for treating adults and pediatric patients with CD19-positive B-cell precursor acute lymphoblastic leukemia.""}, {""date"": ""20230622123900"", ""headline"": ""Amgen Inc. stock outperforms market on strong trading day"", ""summary"": ""Shares of Amgen Inc. rallied 1.15% to $229.66 Thursday, on what proved to be an all-around mixed trading session for the stock market, with the S&P 500 Index...""}, {""date"": ""20230622154602"", ""headline"": ""Spectrum's Rolvedon A Differentiator In A $3B/Yr Market"", ""summary"": ""Spectrum and Assertio's merger would lead to a diversified product portfolio and a combination of two unique marketing strategies. Click here to read more.""}, {""date"": ""20230622164817"", ""headline"": ""California, other states join FTC bid to block Amgen deal"", ""summary"": ""The states of California, New York, Illinois, Minnesota,  Washington and Wisconsin have joined a Federal Trade Commission (FTC) lawsuit to stop Amgen's $27.8 billion deal to buy Horizon Therapeutics, according to a court filing on Thursday.  Washington Attorney General Bob Ferguson said his state had joined the lawsuit because \""monopolies harm consumers\"" and the merger could allow Amgen to \""dominate\"" prescription drug markets.  The group of six states filed an amended complaint Thursday, joining the FTC which last month filed suit opposing the deal because it would give Amgen \""monopoly positions\"" for medicines used to treat thyroid eye disease and chronic refractory gout.""}, {""date"": ""20230622190024"", ""headline"": ""UPDATE 1-California, other states join FTC bid to block Amgen deal"", ""summary"": ""The states of California, New York, Illinois, Minnesota,  Washington and Wisconsin have joined a Federal Trade Commission (FTC) lawsuit to stop Amgen's $27.8 billion deal to buy Horizon Therapeutics, according to a court filing on Thursday.  Washington Attorney General Bob Ferguson said his state had joined the lawsuit because \""monopolies harm consumers\"" and the merger could allow Amgen to \""dominate\"" prescription drug markets.  The group of six states filed an amended complaint Thursday, joining the FTC which last month filed suit opposing the deal because it would give Amgen \""monopoly positions\"" for medicines used to treat thyroid eye disease and chronic refractory gout.""}, {""date"": ""20230622234000"", ""headline"": ""What You Missed On Wall Street On Friday"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230623044300"", ""headline"": ""California, others join FTC challenge of Amgen deal to buy Horizon Therapeutics"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230623070100"", ""headline"": ""What You Missed On Wall Street This Morning"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230623121632"", ""headline"": ""UnitedHealth unit to add Boehringer's Humira biosimilar to reimbursement list"", ""summary"": ""Boehringer Ingelheim's biosimilar of AbbVie Inc's blockbuster arthritis drug Humira will be included in the reimbursement list of UnitedHealth Group Inc's OptumRx unit, the German drugmaker said on Friday.  It will be offered on OptumRx's commercial formulary as a preferred brand, Boehringer said.""}, {""date"": ""20230623123900"", ""headline"": ""Amgen Inc. stock underperforms Friday when compared to competitors"", ""summary"": ""Shares of Amgen Inc. slipped 1.11% to $227.11 Friday, on what proved to be an all-around grim trading session for the stock market, with the S&P 500 Index...""}, {""date"": ""20230623175023"", ""headline"": ""Amgen (AMGN) Dips More Than Broader Markets: What You Should Know"", ""summary"": ""Amgen (AMGN) closed the most recent trading day at $227.11, moving -1.11% from the previous trading session.""}, {""date"": ""20230624072000"", ""headline"": ""4 Stocks That Can Turn $100,000 Into $500,000 by the Time You Retire"", ""summary"": ""Buy 'em and then just get out of the way. Time and these companies' long-term strength will take care of the rest.""}, {""date"": ""20230625005900"", ""headline"": ""Russian Insurrection Crushed: 5 Stocks That Continue To Have Exposure To The Country"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230625070300"", ""headline"": ""What is behind big pharma's underperformance?"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}]",{}
24,2023-06-25,223.52716064453125,2023-07-02,218.5174560546875,-0.02241206203039703,D3,"[{""date"": ""20230625005900"", ""headline"": ""Russian Insurrection Crushed: 5 Stocks That Continue To Have Exposure To The Country"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230625070300"", ""headline"": ""What is behind big pharma's underperformance?"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230626000400"", ""headline"": ""7 Analysts Have This to Say About Amgen"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230626035700"", ""headline"": ""Amgen price target lowered to $260 from $270 at Argus"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230626051500"", ""headline"": ""Video: Dow Movers: AMGN, NKE"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230626064000"", ""headline"": ""Dow falls 109 points on losses for Amgen, Johnson & Johnson shares"", ""summary"": ""Behind losses for shares of Amgen and Johnson & Johnson, the Dow Jones Industrial Average is down Monday morning. The Dow was most recently trading 109...""}, {""date"": ""20230626071700"", ""headline"": ""A Look Into Amgen Inc's Price Over Earnings"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230626123900"", ""headline"": ""Amgen Inc. stock falls Monday, underperforms market"", ""summary"": ""Shares of Amgen Inc. slid 1.05% to $224.73 Monday, on what proved to be an all-around rough trading session for the stock market, with the S&P 500 Index...""}, {""date"": ""20230626170300"", ""headline"": ""Why Amgen Stock Slumped on Monday"", ""summary"": ""Amgen (NASDAQ: AMGN) stock came under renewed pressure on Monday, several days after more regulators piled on to block a major acquisition announced by the company.  As a result, Amgen's share price sank by slightly over 1%, which was more than double the percentage-rate decline of the S&P 500 index on the day.  The person taking the scissors to his Amgen price target was Argus Research's David Toung.""}, {""date"": ""20230626224000"", ""headline"": ""Notable Tuesday Option Activity: AMGN, GIS, AMKR"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230626232300"", ""headline"": ""Eli Lilly (NYSE:LLY) Touts Superior Results of Weight Loss Shot"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230627005300"", ""headline"": ""Next-Gen Weight-Loss Drugs Set To Up The Game From Ozempic  And Mounjaro: WSJ"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230627011300"", ""headline"": ""Pharmaceutical companies are developing drugs to surpass Ozempic, WSJ reports"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230627020100"", ""headline"": ""Analysts Have Conflicting Sentiments on These Healthcare Companies: Alnylam Pharma (ALNY) and Amgen (AMGN)"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230627070040"", ""headline"": ""Does Amgen (NASDAQ:AMGN) Have A Healthy Balance Sheet?"", ""summary"": ""Howard Marks put it nicely when he said that, rather than worrying about share price volatility, 'The possibility of...""}, {""date"": ""20230627123900"", ""headline"": ""Amgen Inc. stock underperforms Tuesday when compared to competitors"", ""summary"": ""Shares of Amgen Inc. sank 0.94% to $222.61 Tuesday, on what proved to be an all-around positive trading session for the stock market, with the S&P 500 Index...""}, {""date"": ""20230627135035"", ""headline"": ""Argus Research Maintains AMGEN (AMGN) Buy Recommendation"", ""summary"": """"}, {""date"": ""20230627164158"", ""headline"": ""Dow Jones Today: Index Ends 6-Day Losing Streak"", ""summary"": ""Tech and retail stocks helped lift the Dow Jones, while Walgreens plummeted after lowering its earnings outlook""}, {""date"": ""20230627225200"", ""headline"": ""How Is The Market Feeling About Amgen?"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230628062500"", ""headline"": ""Cantor Fitzgerald biotech/biopharma to hold a luncheon meeting"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230628072500"", ""headline"": ""Cantor Fitzgerald biotech/biopharma to hold analyst/industry conference call"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230628074500"", ""headline"": ""Cantor biotech/biopharma analysts hold analyst/industry conference call"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230628121016"", ""headline"": ""Avantor: Promising Long-Term Buy With Potential For Opportunistic Entry"", ""summary"": ""Avantor faces near-term challenges amid macro headwinds and revenue growth uncertainties due to continuing COVID roll-off. Read my analysis of AVTR stock here.""}, {""date"": ""20230628123900"", ""headline"": ""Amgen Inc. stock falls Wednesday, underperforms market"", ""summary"": ""Shares of Amgen Inc. slid 0.58% to $221.31 Wednesday, on what proved to be an all-around poor trading session for the stock market, with the S&P 500 Index...""}, {""date"": ""20230628130107"", ""headline"": ""The New M&A Rules That Would Delay Million-Dollar Deals"", ""summary"": ""(Bloomberg) -- The US antitrust agencies are requiring firms to turn over much more information about their transactions than before in an overhaul to merger rules that could delay deals by months. Most Read from BloombergPutin Claims He\u2019s Back in Control. Russia\u2019s Elite Isn\u2019t SureSwitzerland Blocks Sale of Leopard 1 Tanks Bound for UkraineQatar Group Now Confident of Winning Manchester United RaceSweden Police Give Permit to Koran Burning Near Stockholm MosqueUBS Preparing to Cut Over Half of C""}, {""date"": ""20230628224600"", ""headline"": ""Pfizer sees second request as likely in FTC's review of Seagen deal - analyst"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230629001200"", ""headline"": ""Morgan Stanley shakes up its global dividend portfolio"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230629081000"", ""headline"": ""Amgen Out, Rio Tinto In As Morgan Stanley Shuffles Dividend Deck"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230629084100"", ""headline"": ""10 Health Care Stocks Whale Activity In Today's Session"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230629100000"", ""headline"": ""5 High-Yielding Dividend Stocks That Are Bargain Buys"", ""summary"": ""If you're in search of bargain stocks to buy, the healthcare industry is a great place to start looking.  Among them are Johnson & Johnson (NYSE: JNJ),\u00a0AbbVie\u00a0(NYSE: ABBV), Bristol Myers Squibb (NYSE: BMY),\u00a0Amgen (NASDAQ: AMGN), and\u00a0Pfizer (NYSE: PFE) -- all of which pay dividends and offer great value.""}, {""date"": ""20230629123900"", ""headline"": ""Amgen Inc. stock falls Thursday, underperforms market"", ""summary"": ""Shares of Amgen Inc. dropped 0.07% to $221.16 Thursday, on what proved to be an all-around favorable trading session for the stock market, with the S&P 500...""}, {""date"": ""20230629124500"", ""headline"": ""What Will Amgen Buy Next?"", ""summary"": ""Biotech heavyweight Amgen (NASDAQ: AMGN) will probably continue to be an active player in the merger and acquisition (M&A) scene, regardless of what happens with its proposed $28 billion buyout of Horizon Therapeutics (NASDAQ: HZNP).  If this acquisition goes through, for instance, Amgen will probably be limited to smaller deals under $10 billion.""}, {""date"": ""20230629141706"", ""headline"": ""Moody's: Pharma outlook stable for next 12-18 months, but with caveats"", ""summary"": ""Moody's, in a note, sees a stable outlook for the drug industry. But there are a few headwinds that might mess up the semi-optimistic picture.""}, {""date"": ""20230630000117"", ""headline"": ""Cheaper competition for Humira is hitting the market, but savings will depend on your insurance"", ""summary"": ""Patients who take the autoimmune disease treatment Humira may see some price relief when several lower-cost, biosimilar versions of the AbbVie drug reach the U.S. market in July. \n  But lower pharmacy bills may not happen right away \u2014 or at all ...""}, {""date"": ""20230630000300"", ""headline"": ""Amgen Inc. Dividend Stock Analysis"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230630042548"", ""headline"": ""Amgen: A Healthcare Bargain With A 4% Yield"", ""summary"": ""Amgen's stock price decline has already priced in much of the bad news, making it an attractive investment. Click here to read my analysis of the AMGN stock.""}, {""date"": ""20230630070800"", ""headline"": ""15 Stocks Up, 15 Stocks Down: A Look At The Dow Jones Industrial Average Halfway Through 2023"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230630074500"", ""headline"": ""Medicare revises guidance on drug price negotiations amid lawsuits"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230630084200"", ""headline"": ""10 Health Care Stocks With Whale Alerts In Today's Session"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230630123900"", ""headline"": ""Amgen Inc. stock rises Friday, still underperforms market"", ""summary"": ""Shares of Amgen Inc. inched 0.39% higher to $222.02 Friday, on what proved to be an all-around favorable trading session for the stock market, with the S&P...""}, {""date"": ""20230630175019"", ""headline"": ""Amgen (AMGN) Gains But Lags Market: What You Should Know"", ""summary"": ""In the latest trading session, Amgen (AMGN) closed at $222.02, marking a +0.39% move from the previous day.""}, {""date"": ""20230701060900"", ""headline"": ""Organon launches biosimilar of AbbVie's Humira"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230702100012"", ""headline"": ""Insiders At Amgen Sold US$1.9m In Stock, Alluding To Potential Weakness"", ""summary"": ""Many Amgen Inc. ( NASDAQ:AMGN ) insiders ditched their stock over the past year, which may be of interest to the...""}]","{""assetTurnoverTTM"": 0.3454, ""bookValue"": 6781, ""cashRatio"": 2.0031584488506757, ""currentRatio"": 2.7712, ""ebitPerShare"": 4.9981, ""eps"": 2.568, ""ev"": 146076.7, ""fcfMargin"": 0.5494, ""fcfPerShareTTM"": 18.1028, ""grossMargin"": 0.7405, ""inventoryTurnoverTTM"": 1.4331, ""longtermDebtTotalAsset"": 0.6578, ""longtermDebtTotalCapital"": 0.869, ""longtermDebtTotalEquity"": 8.7564, ""netDebtToTotalCapital"": 0.3995, ""netDebtToTotalEquity"": 4.0254, ""netMargin"": 0.1974, ""operatingMargin"": 0.3842, ""payoutRatioTTM"": 0.5457, ""pb"": 17.5167, ""peTTM"": 14.8867, ""pfcfTTM"": 12.2644, ""pretaxMargin"": 0.231, ""psTTM"": 4.4685, ""quickRatio"": 2.4801, ""receivablesTurnoverTTM"": 4.7651, ""roaTTM"": 0.1037, ""roeTTM"": 1.6415, ""roicTTM"": 0.1449, ""rotcTTM"": 0.1759, ""salesPerShare"": 13.0093, ""sgaToSale"": 0.2595, ""totalDebtToEquity"": 9.0759, ""totalDebtToTotalAsset"": 0.6818, ""totalDebtToTotalCapital"": 0.9008, ""totalRatio"": 1.0812, ""period"": ""2023-06-30""}"
25,2023-07-02,218.5174560546875,2023-07-09,215.2006072998047,-0.015178873188294473,D2,"[{""date"": ""20230702100012"", ""headline"": ""Insiders At Amgen Sold US$1.9m In Stock, Alluding To Potential Weakness"", ""summary"": ""Many Amgen Inc. ( NASDAQ:AMGN ) insiders ditched their stock over the past year, which may be of interest to the...""}, {""date"": ""20230703031000"", ""headline"": ""Not A Market For The Dogs Of The Dow"", ""summary"": ""With the first half of 2023 coming to a close this past Friday, the equity markets rewarded investors with strong performance.""}, {""date"": ""20230703124900"", ""headline"": ""Top Analyst Reports for Apple, Verizon & Amgen"", ""summary"": ""Today's Research Daily features new research reports on 16 major stocks, including Apple Inc. (AAPL), Verizon Communications Inc. (VZ) and Amgen Inc. (AMGN).""}, {""date"": ""20230703135145"", ""headline"": ""India's Biocon Biologics launches biosimilar for AbbVie's Humira in US"", ""summary"": ""India's Biocon Biologics said on Monday it has launched a biosimilar version of AbbVie's blockbuster rheumatoid arthritis drug Humira in the United States.  The launch of the copycat version, branded as Hulio, adds to a list of biosimilars introduced by drugmakers on Monday by Coherus Biosciences and Germany's Fresenius.  Boehringer Ingelheim and Swiss drugmaker Sandoz launched their Humira biosimilars on Saturday.""}, {""date"": ""20230704061409"", ""headline"": ""FTC : Amgen-Horizon Deal Would Cement Monopoly For Treatment Of Two Diseases"", ""summary"": ""Commission pauses major biopharma transaction involving drugs priced in the hundreds of thousands of dollars. As part of the Federal Trade Commission's promised campaign to protect competition in the...""}, {""date"": ""20230705020900"", ""headline"": ""Why the 5 Highest-Yielding Nasdaq Stocks Could Rip Higher With the Red-Hot Summer Rally"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230705054200"", ""headline"": ""5 Top Dividend Stocks For July 2023"", ""summary"": ""The S&P 500 gained 16% through the first half of 2023. Click here to read more about the five dividend stocks to consider buying in July 2023.""}, {""date"": ""20230705060000"", ""headline"": ""Why I'm Buying DIA This Month Instead Of VOO"", ""summary"": ""We explore the idea of alternating new investments between VOO and DIA to make tax loss harvesting easier. Explore more about tax loss harvesting here.""}, {""date"": ""20230705080100"", ""headline"": ""Celltrion launches biosimilar of AbbVie's Humira in US"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230705082800"", ""headline"": ""The Zacks Analyst Blog Highlights Apple, Verizon Communications, Amgen, Charles Schwab and The Cigna Group"", ""summary"": ""Apple, Verizon Communications, Amgen, Charles Schwab and The Cigna Group are part of the Zacks top Analyst Blog.""}, {""date"": ""20230705123900"", ""headline"": ""Amgen Inc. stock rises Wednesday, outperforms market"", ""summary"": ""Shares of Amgen Inc. inched 0.39% higher to $225.88 Wednesday, on what proved to be an all-around dismal trading session for the stock market, with the S&P...""}, {""date"": ""20230705152041"", ""headline"": ""Cramer examines the worst performers from the first half of 2023, explains why the market seems narrow"", ""summary"": ""CNBC's Jim Cramer told investors on Wednesday that if they're waiting for the market to broaden for a rally, they might be waiting forever.""}, {""date"": ""20230705155852"", ""headline"": ""Go with what's working instead of waiting for what is not working, says Jim Cramer"", ""summary"": ""'Mad Money' host Jim Cramer takes a closer look at market underperformers and what they say about the economy at large.""}, {""date"": ""20230705202453"", ""headline"": ""3 Biotech Stocks That AI Predicts Will Deliver Triple-Digit Returns in 2025"", ""summary"": ""Investing in the biotech sector is mostly about risk and reward. When a company achieves FDA approval on a drug or therapeutic, it frequently has a source of revenue and profit that can last for years. And investors who buy and hold these stocks are typically rewarded with handsome total returns. Even penny stocks can become triple-digit return biotech stocks. However, that payoff can take a long time. Just getting a drug through the clinical trial stage can take several years. And some candidat""}, {""date"": ""20230706011400"", ""headline"": ""Amgen: Are Its Golden Days Over?"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230706053103"", ""headline"": ""U.S. Wide-Moat Stocks On Sale - The July 2023 Heat Map"", ""summary"": ""Our 3-step process focuses on wide-moat stocks. We're only interested in targets attractively valued in historical comparison. Read what investors need to know.""}, {""date"": ""20230706063200"", ""headline"": ""AMGN August 25th Options Begin Trading"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230706065100"", ""headline"": ""Treasury Yields Spiking As Market Looks Ahead To Jobs Data, Raising Valuation Concerns"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230706065300"", ""headline"": ""4 Big Pharma Stocks On Sale Right Now "", ""summary"": ""The key is to buy a basket of the cheap ones, so that gains in a few of them can offset disappointing performance in others.""}, {""date"": ""20230706105300"", ""headline"": ""4 Big Pharma Stocks On Sale Right Now"", ""summary"": ""The key is to buy a basket of the cheap ones, so that gains in a few of them can offset disappointing performance in others.""}, {""date"": ""20230706123900"", ""headline"": ""Amgen Inc. stock falls Thursday, underperforms market"", ""summary"": ""Shares of Amgen Inc. slid 1.28% to $222.98 Thursday, on what proved to be an all-around dismal trading session for the stock market, with the S&P 500 Index...""}, {""date"": ""20230706231200"", ""headline"": ""Rose's Income Garden 80 Stock Portfolio: Update H1 2023 Green With 7 June Raises"", ""summary"": ""Rose's Income Garden portfolio saw 39 companies pay dividends in June, with seven raises and one cut. Click here for a detailed analysis.""}, {""date"": ""20230707002613"", ""headline"": ""Amgen: Is The 3.79% Dividend Yield Worth The Fuss?"", ""summary"": ""Amgen offers an attractive 3.79% dividend yield, with a dividend payout that reached $4.2 billion in FY 2022. Read more about AMGN stock here.""}, {""date"": ""20230707031300"", ""headline"": ""Wall Street Analysts Are Bullish on Top Healthcare Picks"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230707035900"", ""headline"": ""Amgen price target lowered to $275 from $325 at Jefferies"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230707073857"", ""headline"": ""Bristol-Myers Squibb: Battling Exclusivity Headwinds"", ""summary"": ""Bristol-Myers Squibb Company is battling the loss of exclusivity of Revlimid with some new product growth engines. Click for more on BMY stock.""}, {""date"": ""20230707080038"", ""headline"": ""Amgen (NASDAQ:AMGN) shareholders have earned a 5.8% CAGR over the last five years"", ""summary"": ""Amgen Inc. ( NASDAQ:AMGN ) shareholders might be concerned after seeing the share price drop 12% in the last quarter...""}, {""date"": ""20230707082100"", ""headline"": ""What Does Amgen's Debt Look Like?"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230707094500"", ""headline"": ""2 Struggling Dividend Growth Stocks That Could Make You Richer"", ""summary"": ""Despite lingering economic issues, the broader stock market has recovered this year.  Take AbbVie (NYSE: ABBV) and Amgen (NASDAQ: AMGN), two drugmakers that have significantly underperformed the stock market this year.  AbbVie started the year with a lot to prove.""}, {""date"": ""20230707123900"", ""headline"": ""Amgen Inc. stock falls Friday, underperforms market"", ""summary"": ""Shares of Amgen Inc. slid 1.94% to $218.65 Friday, on what proved to be an all-around grim trading session for the stock market, with the S&P 500 Index...""}, {""date"": ""20230707131840"", ""headline"": ""Buy 3 July Dogs Of The Dow, Watch 6"", ""summary"": ""Analyst 1-year targets showed 10 highest-yield Dow stocks producing 1.62% LESS gain from $5k invested in the lowest-priced 5. Click for our exclusive stock lists.""}, {""date"": ""20230707175022"", ""headline"": ""Amgen (AMGN) Dips More Than Broader Markets: What You Should Know"", ""summary"": ""In the latest trading session, Amgen (AMGN) closed at $218.65, marking a -1.94% move from the previous day.""}, {""date"": ""20230709030200"", ""headline"": ""Fly Intel: Top five weekend stock stories"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230709032600"", ""headline"": ""Pfizer among big pharma stocks on sale right now, Barron's says"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230709040500"", ""headline"": ""New M&A rules likely to delay deals by months, add significant costs"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230709070000"", ""headline"": ""Goldman Sachs sees rays of hope in underperforming health sector"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}]","{""assetTurnoverTTM"": 0.3454, ""bookValue"": 6781, ""cashRatio"": 2.0031584488506757, ""currentRatio"": 2.7712, ""ebitPerShare"": 4.9981, ""eps"": 2.568, ""ev"": 146076.7, ""fcfMargin"": 0.5494, ""fcfPerShareTTM"": 18.1028, ""grossMargin"": 0.7405, ""inventoryTurnoverTTM"": 1.4331, ""longtermDebtTotalAsset"": 0.6578, ""longtermDebtTotalCapital"": 0.869, ""longtermDebtTotalEquity"": 8.7564, ""netDebtToTotalCapital"": 0.3995, ""netDebtToTotalEquity"": 4.0254, ""netMargin"": 0.1974, ""operatingMargin"": 0.3842, ""payoutRatioTTM"": 0.5457, ""pb"": 17.5167, ""peTTM"": 14.8867, ""pfcfTTM"": 12.2644, ""pretaxMargin"": 0.231, ""psTTM"": 4.4685, ""quickRatio"": 2.4801, ""receivablesTurnoverTTM"": 4.7651, ""roaTTM"": 0.1037, ""roeTTM"": 1.6415, ""roicTTM"": 0.1449, ""rotcTTM"": 0.1759, ""salesPerShare"": 13.0093, ""sgaToSale"": 0.2595, ""totalDebtToEquity"": 9.0759, ""totalDebtToTotalAsset"": 0.6818, ""totalDebtToTotalCapital"": 0.9008, ""totalRatio"": 1.0812, ""period"": ""2023-06-30""}"
26,2023-07-09,215.2006072998047,2023-07-16,223.84210205078125,0.04015553143369033,U5,"[{""date"": ""20230709030200"", ""headline"": ""Fly Intel: Top five weekend stock stories"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230709032600"", ""headline"": ""Pfizer among big pharma stocks on sale right now, Barron's says"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230709040500"", ""headline"": ""New M&A rules likely to delay deals by months, add significant costs"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230709070000"", ""headline"": ""Goldman Sachs sees rays of hope in underperforming health sector"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230709214500"", ""headline"": ""B. Riley biotechnology analysts to hold an analyst/industry conference call"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230710044700"", ""headline"": ""Amgen (AMGN) Gets a Hold from RBC Capital"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230710055100"", ""headline"": ""AbbVie's R&D Pipeline: Driving Long-Term Growth"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230710055800"", ""headline"": ""Dow up 182 points on gains for Amgen, Walgreens Boots stocks"", ""summary"": ""The Dow Jones Industrial Average is climbing Monday morning with shares of Amgen and Walgreens Boots leading the way for the index. The Dow is trading 182...""}, {""date"": ""20230710060800"", ""headline"": ""These companies have beaten the Rule of 40 year after year"", ""summary"": ""Morgan Stanley applied a VC filter to the stock market. Here's what it found.""}, {""date"": ""20230710071600"", ""headline"": ""Dow up nearly 100 points on gains in shares of Amgen, Walgreens Boots"", ""summary"": ""Buoyed by positive momentum for shares of Amgen and Walgreens Boots, the Dow Jones Industrial Average is climbing Monday morning. Shares of Amgen and...""}, {""date"": ""20230710084700"", ""headline"": ""AbbVie slips as Cigna adds more Humira biosimilars for coverage"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230711002100"", ""headline"": ""Amgen price target lowered to $210 from $225 at Barclays"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230711003500"", ""headline"": ""Barclays Sticks to Its Sell Rating for Amgen (AMGN)"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230711053900"", ""headline"": ""European Regulator Expands Ozempic Probe To Include Other Weight Loss Drugs Over Suicide Risks"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230711064100"", ""headline"": ""iRobot, Seagen, Horizon gain amid Microsoft win in Activision case"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230711082705"", ""headline"": ""Barclays Maintains AMGEN (AMGN) Underweight Recommendation"", ""summary"": """"}, {""date"": ""20230711090017"", ""headline"": ""Is There An Opportunity With Amgen Inc.'s (NASDAQ:AMGN) 45% Undervaluation?"", ""summary"": ""Key Insights The projected fair value for Amgen is US$407 based on 2 Stage Free Cash Flow to Equity Amgen is estimated...""}, {""date"": ""20230711121320"", ""headline"": ""EU expands Wegovy, Ozempic probe over suicide risks to include other weight loss, diabetes drugs"", ""summary"": ""The European Medicines Agency didn't specify which additional GLP-1 drugs are now being investigated, but it could potentially include Eli Lilly's Mounjaro. ""}, {""date"": ""20230711123900"", ""headline"": ""Amgen Inc. stock falls Tuesday, underperforms market"", ""summary"": ""Shares of Amgen Inc. slipped 0.39% to $223.86 Tuesday, on what proved to be an all-around great trading session for the stock market, with the S&P 500 Index...""}, {""date"": ""20230711132324"", ""headline"": ""We've only seen the beginning of Moderna's story, says Goldman Sachs' Salveen Richter"", ""summary"": ""Salveen Richter, Goldman Sachs lead biotech analyst, joins 'Closing Bell Overtime' to discuss the biotech sector and how investors should play in the space.""}, {""date"": ""20230711210600"", ""headline"": ""Analyst Expectations for Amgen's Future"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230712013300"", ""headline"": ""Amgen price target lowered to $200 from $220 at Credit Suisse"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230712020000"", ""headline"": ""ClearBridge Small Cap Growth Strategy Q2 2023 Portfolio Manager Commentary"", ""summary"": ""The growth rally expanded to smaller stocks in the second quarter. Click here to read the full fund letter.""}, {""date"": ""20230712090007"", ""headline"": ""Investors Heavily Search Amgen Inc. (AMGN): Here is What You Need to Know"", ""summary"": ""Recently, Zacks.com users have been paying close attention to Amgen (AMGN). This makes it worthwhile to examine what the stock has in store.""}, {""date"": ""20230712112252"", ""headline"": ""Credit Suisse Maintains AMGEN (AMGN) Outperform Recommendation"", ""summary"": """"}, {""date"": ""20230712115900"", ""headline"": ""Drugmakers\u2019 deal making will plow ahead despite antitrust scrutiny, analysts say"", ""summary"": ""Big pharma goes shopping as \""patent cliff\"" puts more than $225 billion in revenues at risk.""}, {""date"": ""20230712141900"", ""headline"": ""Let's Check the Safety and Efficacy of Amgen's Charts Ahead of Earnings"", ""summary"": ""AMGN's quarterly report is due in early August, so will buying the stock now pose any side effects?""}, {""date"": ""20230713021309"", ""headline"": ""Preserving The Patent Bargain : U.S. Supreme Court Limits Amgen's Monopoly"", ""summary"": ""Amgen Inc. et al. v Sanofi et al, No. 21-757  On May 18, 2023, the Supreme Court of the United States  issued a long-awaited decision regarding the scope of the enablement requirement in Section 112...""}, {""date"": ""20230713091417"", ""headline"": ""Lucy Scientific Scores Richard Nanula as CEO After Senior Roles at Disney, Amgen, Starwood"", ""summary"": ""By Daniella Parra Psychotropic industry innovator Lucy Scientific Discovery Inc. (Nasdaq: LSDI), has appointed Richard Nanula, former CFO at Amgen Inc. (Nasdaq: AMGN) and The Walt Disney Co. (NYSE: DIS), as its new CEO. With a career spanning senior executive positions at global giants like Starwood Hotels and Resorts, now part of Marriott International, Inc. [\u2026]""}, {""date"": ""20230713124000"", ""headline"": ""Amgen Inc. stock outperforms market on strong trading day"", ""summary"": ""Shares of Amgen Inc. inched 0.88% higher to $227.66 Thursday, on what proved to be an all-around favorable trading session for the stock market, with the S&P...""}, {""date"": ""20230713133744"", ""headline"": ""The Blazing Weight-Loss Drug Battle: Can Anyone Unseat Undisputed Leaders Novo Nordisk And Lilly?"", ""summary"": ""An overweight world is hungry for obesity treatments, driving big forecasts for weight loss drugs. For now, two pharmaceutical stocks own the market.""}, {""date"": ""20230713141053"", ""headline"": ""Is Amgen's Dividend Safe?"", ""summary"": ""Despite multiple headwinds, the biotech's dividend appears to be a safe play for income investors.""}, {""date"": ""20230713180020"", ""headline"": ""Amgen (AMGN) Outpaces Stock Market Gains: What You Should Know"", ""summary"": ""Amgen (AMGN) closed the most recent trading day at $227.66, moving +0.88% from the previous trading session.""}, {""date"": ""20230713212600"", ""headline"": ""SCHD vs. VYM: Which is the Better Dividend ETF?"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230713220200"", ""headline"": ""Catalyst Watch: Microsoft-Activision Blizzard drama, Splunk event and Nasdaq 100 rebalancing countdown"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230713232200"", ""headline"": ""Venturing Beyond The Magic Kingdom: Former Disney CFO And Fortune 500 Veteran Takes The Reins At Lucy Scientific"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230713235503"", ""headline"": ""Nicholas Ward's Dividend Growth Portfolio: June 2023 Review"", ""summary"": ""The significant dividend growth is attributed to rapid rise in interest rates over past 12-18 months, with cash position now yielding nearly 5%. Read more here.""}, {""date"": ""20230714005900"", ""headline"": ""ClearBridge Large Cap Value Strategy Q2 2023 Portfolio Manager Commentary"", ""summary"": ""U.S. equities continued to make gains in Q2, driven by excitement over generative AI and improving market sentiment.""}, {""date"": ""20230714023300"", ""headline"": ""Zai Lab treats first patient in mainland China in Phase 3 FORTITUDE-101 study"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230714075100"", ""headline"": ""(AMGN) - Analyzing Amgen's Short Interest"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230714085000"", ""headline"": ""2 Best Biotech Stocks to Buy Right Now"", ""summary"": ""Many investors appreciate and rely on the regular cash flow that dividend stocks can generate for them.  Investors should seek out businesses with current products that can finance dividends, and future products that can sustain those dividends.  Here are two companies that could do just that, which income seeking investors should consider purchasing for their portfolios.""}, {""date"": ""20230714120003"", ""headline"": ""MOORE KUEHN ENCOURAGES AMGEN INC. INVESTORS TO CONTACT LAW FIRM"", ""summary"": ""NEW YORK, July 14, 2023 /PRNewswire/ -- Moore Kuehn, PLLC, a securities and shareholder law firm located on Wall Street, is investigating potential claims against:\n\n    \n                \n           ...""}, {""date"": ""20230714124000"", ""headline"": ""Amgen Inc. stock outperforms market despite losses on the day"", ""summary"": ""Shares of Amgen Inc. slumped 0.10% to $227.43 Friday, on what proved to be an all-around mixed trading session for the stock market, with the Dow Jones...""}, {""date"": ""20230714161500"", ""headline"": ""Dividend Income Update June 2023"", ""summary"": ""The beginning of every month is exciting for all dividend income investors as we look back at the previous month and see how much passive dividend income our portfolios generated. ""}, {""date"": ""20230716070100"", ""headline"": ""Eli Lilly, Merck among top pharma picks in Barclays Q2 preview"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}]","{""assetTurnoverTTM"": 0.3454, ""bookValue"": 6781, ""cashRatio"": 2.0031584488506757, ""currentRatio"": 2.7712, ""ebitPerShare"": 4.9981, ""eps"": 2.568, ""ev"": 146076.7, ""fcfMargin"": 0.5494, ""fcfPerShareTTM"": 18.1028, ""grossMargin"": 0.7405, ""inventoryTurnoverTTM"": 1.4331, ""longtermDebtTotalAsset"": 0.6578, ""longtermDebtTotalCapital"": 0.869, ""longtermDebtTotalEquity"": 8.7564, ""netDebtToTotalCapital"": 0.3995, ""netDebtToTotalEquity"": 4.0254, ""netMargin"": 0.1974, ""operatingMargin"": 0.3842, ""payoutRatioTTM"": 0.5457, ""pb"": 17.5167, ""peTTM"": 14.8867, ""pfcfTTM"": 12.2644, ""pretaxMargin"": 0.231, ""psTTM"": 4.4685, ""quickRatio"": 2.4801, ""receivablesTurnoverTTM"": 4.7651, ""roaTTM"": 0.1037, ""roeTTM"": 1.6415, ""roicTTM"": 0.1449, ""rotcTTM"": 0.1759, ""salesPerShare"": 13.0093, ""sgaToSale"": 0.2595, ""totalDebtToEquity"": 9.0759, ""totalDebtToTotalAsset"": 0.6818, ""totalDebtToTotalCapital"": 0.9008, ""totalRatio"": 1.0812, ""period"": ""2023-06-30""}"
27,2023-07-16,223.84210205078125,2023-07-23,231.11553955078125,0.03249360791988076,U4,"[{""date"": ""20230716070100"", ""headline"": ""Eli Lilly, Merck among top pharma picks in Barclays Q2 preview"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230717124100"", ""headline"": ""Amgen Inc. stock rises Monday, still underperforms market"", ""summary"": ""Shares of Amgen Inc. inched 0.18% higher to $227.84 Monday, on what proved to be an all-around favorable trading session for the stock market, with the S&P...""}, {""date"": ""20230717175021"", ""headline"": ""Amgen (AMGN) Gains But Lags Market: What You Should Know"", ""summary"": ""In the latest trading session, Amgen (AMGN) closed at $227.84, marking a +0.18% move from the previous day.""}, {""date"": ""20230718062203"", ""headline"": ""3 Biotech Stocks for Getting Rich in 2023"", ""summary"": ""The biotech industry is constantly evolving due to being on the cutting edge of the healthcare industry\u2019s research and development. Large biotech companies such as Johnson and Johnson (NYSE:JNJ), Merck (NYSE:MRK), and AbbVie (NYSE:ABBV) offer investors steady and continual growth as well as decent dividends. But, a large portion of the industry involves much more volatile stocks. Many companies\u2019 significant volatility in the biotech market attracts investors looking for a stock that will experie""}, {""date"": ""20230718124000"", ""headline"": ""Amgen Inc. stock rises Tuesday, outperforms market"", ""summary"": ""Shares of Amgen Inc. rose 2.08% to $232.57 Tuesday, on what proved to be an all-around great trading session for the stock market, with the S&P 500 Index...""}, {""date"": ""20230718131521"", ""headline"": ""Regional banks, Dow Theory: Key technical levels to watch"", ""summary"": ""PNC Financial kicked off regional bank earnings with a mixed report. Freedom Capital Markets Chief Global Strategist Jay Woods breaks down what price levels he is watching for the regional banks. For the broader market, with the Dow Jones Industrials Average and the Dow Transports making new 52-week highs, Woods says \""that's as bullish as you can get\"" for stocks.""}, {""date"": ""20230718162356"", ""headline"": ""Softbank, Amgen-Backed Neumora Therapeutics Unveils Plans For Three Phase 3 Studies For Major Depressive Disorder"", ""summary"": ""Neumora Therapeutics unveiled plans for three late-stage studies for its major depressive disorder (MDD) candidate Navacaprant. The U.S.-based clinical-stage biopharmaceutical is backed by Softbank Group Corp (OTC: SFTBY) (OTC: SFTBF) and Amgen Inc (NASDAQ: AMGN) via a $100 million equity investment. Neumora's KOASTAL Phase 3 program, comprising three Phase 3 studies, is designed to evaluate 80 mg of the once-daily navacaprant (NMRA-140) oral monotherapy for MDD. The U.S. trial, the KOASTAL-1 st""}, {""date"": ""20230718212500"", ""headline"": ""Amgen, FTC said they are no ongoing talks to settle over Horizon Therapeutics deal"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230718213600"", ""headline"": ""Amgen, FTC said there are no ongoing talks to settle over Horizon Therapeutics deal"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230718214100"", ""headline"": ""Amgen, FTC said there are no ongoing talks, though open to settlement over Horizon"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230718224300"", ""headline"": ""Tesla On Tap: \""Mega-cap\"" Reporting Season Gets Underway After Close With EV Giant's Earnings"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230719043000"", ""headline"": ""ClearBridge Large Cap Value ESG Strategy Q3 2023 Portfolio Manager Commentary"", ""summary"": ""ClearBridge takes a fundamental-driven approach to proxies. Click here to read the full fund letter.""}, {""date"": ""20230719053000"", ""headline"": ""Prediction: This Beaten-Down Stock Will Be a Biotech Giant by 2030"", ""summary"": ""When you think of biotech giants, you may think of Amgen or Biogen. These companies have brought significant treatments to market over time -- and have generated billions of dollars in earnings, too. Most investors would be happy to find the next company set to follow in their footsteps.""}, {""date"": ""20230719123900"", ""headline"": ""Amgen Inc. stock falls Wednesday, underperforms market"", ""summary"": ""Shares of Amgen Inc. dropped 0.22% to $232.05 Wednesday, on what proved to be an all-around favorable trading session for the stock market, with the S&P 500...""}, {""date"": ""20230719172104"", ""headline"": ""12 Highest Yielding Dow Jones Dividend Stocks"", ""summary"": ""In this article, we discuss 12 highest yielding Dow Jones dividend stocks. You can skip our detailed analysis of dividend stocks and their performance in the past, and go directly to read 5 Highest Yielding Dow Jones Dividend Stocks. The Dow Jones Industrial Average, commonly referred to as the Dow, is one of the most [\u2026]""}, {""date"": ""20230719210100"", ""headline"": ""Lawmakers reintroduce bill to offer Medicare coverage for weight loss drugs"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230719210400"", ""headline"": ""See Which Of The Latest 13F Filers Holds Amgen"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230719212900"", ""headline"": ""Key Horizon drug Tepezza has hearing loss warning added to labeling"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230720124000"", ""headline"": ""Amgen Inc. stock outperforms market on strong trading day"", ""summary"": ""Shares of Amgen Inc. inched 0.51% higher to $233.23 Thursday, on what proved to be an all-around mixed trading session for the stock market, with the Dow...""}, {""date"": ""20230720231500"", ""headline"": ""M&A Scrutiny May Constrain Large Companies"", ""summary"": ""The FTC\u00e2\u0080\u0099s recent push against some large M&A deals may ultimately limit the ability of major companies to take advantage of business development opportunities.""}, {""date"": ""20230721021300"", ""headline"": ""Mirati fails to win EU backing for lung cancer therapy"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230721080054"", ""headline"": ""Amgen Inc. (NASDAQ:AMGN) is largely controlled by institutional shareholders who own 77% of the company"", ""summary"": ""Key Insights Institutions' substantial holdings in Amgen implies that they have significant influence over the...""}, {""date"": ""20230721123900"", ""headline"": ""Amgen Inc. stock underperforms Friday when compared to competitors despite daily gains"", ""summary"": ""Shares of Amgen Inc. inched 0.68% higher to $234.82 Friday, on what proved to be an all-around great trading session for the stock market, with the S&P 500...""}, {""date"": ""20230721153128"", ""headline"": ""The 3 Most Undervalued Pharma Stocks to Buy Now: July 2023"", ""summary"": ""Pharma stocks experienced an abysmal first half due to various factors. Rotation from defensive to cyclical sectors, drug price negotiations and upcoming patent cliffs have muddied the outlook. As a result, they have underperformed, creating undervalued pharma stocks to buy. Overall, the VanEck Pharmaceutical ETF (NASDAQ:PPH) is flat for the year. Only a few stocks have performed well. For instance, as of this writing, Eli Lilly (NYSE:LLY) and Novo Nordisk A/S (NYSE:NVO) are up 23% and 16.67%, r""}]",{}
28,2023-07-23,231.11553955078125,2023-07-30,232.6410675048828,0.006600715629363263,U1,"[{""date"": ""20230724083834"", ""headline"": ""Amgen: Huge Potential With Biosimilars And GLP-1"", ""summary"": ""Amgen is now down nearly 20% since last November as money continues to rotate from defensive sectors into tech. Click here to read my latest analysis of AMGN stock.""}, {""date"": ""20230724090006"", ""headline"": ""Amgen Inc. (AMGN) Is a Trending Stock: Facts to Know Before Betting on It"", ""summary"": ""Amgen (AMGN) has received quite a bit of attention from Zacks.com users lately. Therefore, it is wise to be aware of the facts that can impact the stock's prospects.""}, {""date"": ""20230724112300"", ""headline"": ""Mirati (MRTX) Down 7% on CHMP's Opinion on Krazati Filing"", ""summary"": ""Per the CHMP, Mirati's (MRTX) regulatory filing for Krazati in KRASG12C mutated NSCLC does not fulfill certain requirements to support a conditional marketing authorization.""}, {""date"": ""20230724124000"", ""headline"": ""Amgen Inc. stock rises Monday, still underperforms market"", ""summary"": ""Shares of Amgen Inc. inched 0.26% higher to $235.42 Monday, on what proved to be an all-around favorable trading session for the stock market, with the S&P...""}, {""date"": ""20230724175021"", ""headline"": ""Amgen (AMGN) Gains But Lags Market: What You Should Know"", ""summary"": ""Amgen (AMGN) closed the most recent trading day at $235.42, moving +0.26% from the previous trading session.""}, {""date"": ""20230725052715"", ""headline"": ""Bicara Therapeutics Expands Management Team with the Appointment of David Raben, M.D., as Chief Medical Officer"", ""summary"": ""CAMBRIDGE - Bicara Therapeutics, a clinical-stage biotechnology company developing dual-action biologics to elicit a potent and durable immune response, today announced the appointment of David...""}, {""date"": ""20230725072100"", ""headline"": ""Analysts Offer Insights on Healthcare Companies: Amgen (AMGN) and Biogen (BIIB)"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230725075609"", ""headline"": ""Janux: Merck Deal, Loads Of Cash, Solid Early Data"", ""summary"": ""Janux Therapeutics is a small company with a deal from Merck & Co. and some solid early data. Click here for my look at JANX stock prospects.""}, {""date"": ""20230725104959"", ""headline"": ""Oppenheimer Reiterates AMGEN (AMGN) Outperform Recommendation"", ""summary"": """"}, {""date"": ""20230725111500"", ""headline"": ""2 Cheap High-Yield Dividend Stocks to Buy Now"", ""summary"": ""High-yield dividend stocks can offer remarkable benefits for investors who aim to maximize their returns over the long run.  One sector that has many attractive high-yield dividend stocks is healthcare.  Many healthcare companies can afford to pay generous dividends to their shareholders and still invest in growth opportunities.""}, {""date"": ""20230725124000"", ""headline"": ""Amgen Inc. stock falls Tuesday, underperforms market"", ""summary"": ""Shares of Amgen Inc. slumped 0.05% to $235.31 Tuesday, on what proved to be an all-around favorable trading session for the stock market, with the S&P 500...""}, {""date"": ""20230726033900"", ""headline"": ""AbbVie says Skyrizi beat Amgen\u2019s Otezla in plaque psoriasis trial"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230726041200"", ""headline"": ""Seven Humira Biosimilars: Increased Competition In Arthritis Drug Market Sparks Need For Reform Of Drug Pricing Intermediaries"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230726070200"", ""headline"": ""AbbVie under pressure ahead of Q2 results amid Humira cliff"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230726073100"", ""headline"": ""AbbVie's Skyrizi Achieves Superiority Versus Amgen's Drug In Head-to-Head Study In Moderate Plaque Psoriasis"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230726120646"", ""headline"": ""AbbVie may see less pain from Humira sales decline as rival lags"", ""summary"": ""AbbVie Inc is likely to beat Wall Street sales estimates for Humira in the second quarter as the only copycat in the U.S. market for the blockbuster arthritis drug struggled to gain traction.  Humira sales are likely to decline when the company reports on Thursday but that would mostly be due to the discounts AbbVie has offered to shield itself from prescription share erosion, analysts have said.  The first biosimilar of one of the world's biggest selling drug, Amjevita from Amgen Inc, has not been able to switch Humira patients as much as analysts had estimated since its launch in January.""}, {""date"": ""20230726124000"", ""headline"": ""Amgen Inc. stock underperforms Wednesday when compared to competitors"", ""summary"": ""Shares of Amgen Inc. dropped 0.04% to $235.21 Wednesday, on what proved to be an all-around mixed trading session for the stock market, with the Dow Jones...""}, {""date"": ""20230726180349"", ""headline"": ""Building The Dividend Growth Portfolio In 2023"", ""summary"": ""My US dividend growth portfolio, constructed in 2015, has outperformed the market by over 2% annually. Check out my dividend growth portfolio in 2023.""}, {""date"": ""20230726223300"", ""headline"": ""Check Out What Whales Are Doing With AMGN"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230727041300"", ""headline"": ""Inside AbbVie: Signs of stabilization in Humira sales?"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230727063300"", ""headline"": ""AMGN September 8th Options Begin Trading"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230727114500"", ""headline"": ""How AbbVie\u2019s Humira Still Reigns, Despite New Competition"", ""summary"": ""Revenue for blockbuster arthritis drug declined in the second quarter, largely due to discounts for middlemen.""}, {""date"": ""20230727124000"", ""headline"": ""Amgen Inc. stock underperforms Thursday when compared to competitors despite daily gains"", ""summary"": ""Shares of Amgen Inc. inched 0.36% higher to $236.05 Thursday, on what proved to be an all-around dismal trading session for the stock market, with the S&P...""}, {""date"": ""20230727130500"", ""headline"": ""AbbVie (ABBV) Beats on Q2 Earnings & Sales, Raises '23 View"", ""summary"": ""AbbVie's (ABBV) second-quarter 2023 earnings and sales beat estimates. The company raises its EPS guidance. Stock rises post the announcement.""}, {""date"": ""20230727141601"", ""headline"": ""INVESTIGATION ALERT : Scott+Scott Attorneys at Law LLP Investigates Amgen Inc's Directors and Officers for Breach of Fiduciary Duties \u2013 AMGN"", ""summary"": ""Scott+Scott Attorneys at Law LLP , an international securities and consumer rights litigation firm, is investigating whether certain directors and officers of Amgen Inc.   breached their fiduciary...""}, {""date"": ""20230727210400"", ""headline"": ""Catalyst watch: Amazon earnings, jobs report and will Apple talk AI?"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230727210900"", ""headline"": ""Catalyst Watch: Amazon earnings, jobs report, and will Apple talk AI?"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230727213800"", ""headline"": ""Earnings week ahead: Amazon, Apple, Pfizer, Starbucks, Uber and more"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230727231100"", ""headline"": ""The Dow Breaks 13-Day Winning Streak, Fed Raises Interest Rates To 2001 Levels And AI Is The Buzzword For Big Tech Earnings: The Week In The Markets"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230728061211"", ""headline"": ""Big Pharma's Balancing Act : Navigating Patent Thickets In The Age Of Biosimilars"", ""summary"": ""The rise of biosimilars is transforming the pharmaceutical landscape, and Big Pharma is keenly aware that the fate of their blockbuster biologic drugs' exclusivity is at stake. These drugs, which...""}, {""date"": ""20230728080046"", ""headline"": ""Amgen (NASDAQ:AMGN) Seems To Use Debt Quite Sensibly"", ""summary"": ""Some say volatility, rather than debt, is the best way to think about risk as an investor, but Warren Buffett famously...""}, {""date"": ""20230728082014"", ""headline"": ""Unveiling AbbVie's Hidden Risks: Cautionary Notes For Investors"", ""summary"": ""AbbVie's Q2 2023 financial results exceeded expectations, driven by strong sales of innovative drugs Skyrizi and Rinvoq. Click here to read more.""}, {""date"": ""20230728124000"", ""headline"": ""Amgen Inc. stock rises Friday, still underperforms market"", ""summary"": ""Shares of Amgen Inc. inched 0.14% higher to $236.37 Friday, on what proved to be an all-around positive trading session for the stock market, with the S&P...""}, {""date"": ""20230728160200"", ""headline"": ""With Hurricane Season Looming, Florida Faces an Insurance Meltdown "", ""summary"": ""Florida has long had hurricanes. But climate change is kicking in, the population of the state is growing, and private insurers are leaving the state. The...""}]",{}
29,2023-07-30,232.6410675048828,2023-08-06,239.4420623779297,0.029233853446378966,U3,"[{""date"": ""20230731005100"", ""headline"": ""Analysts Offer Insights on Healthcare Companies: Amgen (AMGN), Icon (ICLR) and Edwards Lifesciences (EW)"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230731011300"", ""headline"": ""Amgen To Report Q2 Earnings: Here's What To Expect"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230731062400"", ""headline"": ""Rising Stars, Falling Trends: July's Industry ETF Winners And Losers"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230731104342"", ""headline"": ""August MDA Breakout Stocks Week 31 - 2023: High-Frequency Gainers To Give You An Edge"", ""summary"": ""Breakout Stocks for Week 31 curated by the MDA model for 10% short-term upside and additional model selections. Read more to see the full update.""}, {""date"": ""20230731110900"", ""headline"": ""Amgen (AMGN) to Report Q2 Earnings: Here's What to Expect"", ""summary"": ""Volume growth from Amgen's (AMGN) key drugs like Prolia, Repatha and Evenity, among others, is expected to have been partially offset by biosimilar/generic competition for mature drugs.""}, {""date"": ""20230731124000"", ""headline"": ""Amgen Inc. stock falls Monday, underperforms market"", ""summary"": ""Shares of Amgen Inc. dropped 0.94% to $234.15 Monday, on what proved to be an all-around favorable trading session for the stock market, with the S&P 500...""}, {""date"": ""20230731124500"", ""headline"": ""Pfizer Stock Wavers Despite Earnings Beat. Revenue and Outlook Aren\u2019t So Good."", ""summary"": ""The company is seeking new sources of revenue because patent expirations are expected to hit seven of its key products by the end of the decade.""}, {""date"": ""20230731160000"", ""headline"": ""AMGEN ANNOUNCES WEBCAST OF 2023 SECOND QUARTER FINANCIAL RESULTS"", ""summary"": ""Amgen (NASDAQ:AMGN) today announced that it will report its second quarter financial results on Thursday, August 3, 2023, after the close of the U.S. financial markets. The announcement will be followed by a conference call with the investment community at 1:30 p.m. PT. Participating in the call from Amgen will be Robert A. Bradway, chairman and chief executive officer, and other members of Amgen's senior management team.""}, {""date"": ""20230731221700"", ""headline"": ""Looking At Amgen's Recent Unusual Options Activity"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230731234100"", ""headline"": ""Amgen Inc. stock underperforms Tuesday when compared to competitors"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230731234800"", ""headline"": ""Amgen declares $2.13 dividend"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230801160000"", ""headline"": ""AMGEN ANNOUNCES 2023 THIRD QUARTER DIVIDEND"", ""summary"": ""Amgen (NASDAQ:AMGN) today announced that its Board of Directors declared a $2.13 per share dividend for the third quarter of 2023. The dividend will be paid on September 8, 2023, to all stockholders of record as of the close of business on August 18, 2023.""}, {""date"": ""20230801212600"", ""headline"": ""Amgen looks to Q2 top, bottom line beats after missing in Q1"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230801234400"", ""headline"": ""Amgen Inc. stock outperforms market despite losses on the day"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230802073100"", ""headline"": ""Video: Daily Dividend Report: AMGN, SYK, GD, KHC, KMB"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230802121600"", ""headline"": ""NEW YORK MARKET CLOSE: Fitch downgrade sparks retreat on Wall Street"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230802203400"", ""headline"": ""GLOBAL BRIEFING: China's services see strong growth in July"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230802210000"", ""headline"": ""Stocks Mitigate Losses Ahead Of Apple, Amazon Earnings; Treasury Yields Rocket On Debt Frenzy: Thursday's Market Drivers"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230802213600"", ""headline"": ""Notable companies reporting after market close"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230802215700"", ""headline"": ""September 22nd Options Now Available For Amgen (AMGN)"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230802230200"", ""headline"": ""Amgen reports Q2 adjusted EPS $5.00, consensus $4.08"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230802230300"", ""headline"": ""Amgen raises FY23 adjusted EPS view to $17.80-$18.80 from $17.60-$18.70"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230802230500"", ""headline"": ""Amgen sees FY23 CapEx about $925M"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230802231100"", ""headline"": ""Amgen Non-GAAP EPS of $5.00 beats by $0.51, revenue of $6.98B beats by $300M"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230802231500"", ""headline"": ""Amgen stock jumps after the biotech\u2019s record earnings beats expectations, and full-year outlook is raised"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230802234100"", ""headline"": ""Amgen Inc. stock underperforms Thursday when compared to competitors despite daily gains"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230802235600"", ""headline"": ""Amgen (AMGN) Gets a Hold from Mizuho Securities"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230803000000"", ""headline"": ""Amgen guides 2023 EPS above consensus while revenue in-line"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230803000200"", ""headline"": ""Amgen stock jumps after record earnings beat expectations, and biotech raises full-year outlook"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230803001100"", ""headline"": ""Amgen says FTC has ignored commitments it made to address Horizon deal concerns"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230803010400"", ""headline"": ""Amgen says FTC has ignored commitments it made to address Horizon deal concerns (update)"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230803015700"", ""headline"": ""US Stock Futures Dip As Apple, Amazon Earnings Loom: Analyst Warns Of 'Perfectly Normal' 5% Pullback This Month"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230803070012"", ""headline"": ""Amgen Insiders Sold US$1.9m Of Shares Suggesting Hesitancy"", ""summary"": ""Over the past year, many Amgen Inc. ( NASDAQ:AMGN ) insiders sold a significant stake in the company which may have...""}, {""date"": ""20230803080000"", ""headline"": ""3 Dividend Stocks That Hiked Payouts by 60% in Just 5 Years"", ""summary"": ""Want a good dividend stock to own?  When it comes to long-term dividend income, it's important to consider businesses that are growing and that have the potential to increase their payouts, allowing your dividend income to rise over the years.  Three companies that have been generously increasing their dividend payments over the past five years include Amgen\u00a0(NASDAQ: AMGN),\u00a0Microsoft\u00a0(NASDAQ: MSFT), and\u00a0Mondelez International (NASDAQ: MDLZ).""}, {""date"": ""20230803121300"", ""headline"": ""Amgen stock jumps after record earnings beat expectations, and biotech raises full-year outlook "", ""summary"": ""Amgen's stock jumped in after-hours trading Thursday, after the biotechnology giant reported record second-quarter earnings that rose above expectations.""}, {""date"": ""20230803122105"", ""headline"": ""Amgen 2Q Profit Up as Revenue Rises 6%"", ""summary"": ""By Brenda Le\u00f3n \n\n\n  Amgen posted higher profit and revenue in the second quarter, helped by an increase in product sales across most therapeutic categories. \n\n  The Thousand Oaks, Calif.-based...""}, {""date"": ""20230803130816"", ""headline"": ""Stocks making the biggest moves after hours: Apple, Amazon, Airbnb, Coinbase and more"", ""summary"": ""These are the stocks posting the largest moves in extended trading. ""}, {""date"": ""20230803140250"", ""headline"": ""Stock futures rise slightly as investors weigh Big Tech earnings, await key jobs data: Live updates"", ""summary"": ""The three major indexes are on pace for week-to-date losses.""}, {""date"": ""20230803160100"", ""headline"": ""AMGEN REPORTS SECOND QUARTER FINANCIAL RESULTS"", ""summary"": ""Amgen (NASDAQ:AMGN) today announced financial results for the second quarter of 2023.""}, {""date"": ""20230803160347"", ""headline"": ""Amgen quarterly revenue rises 6%, profit beats Street estimates"", ""summary"": ""(Reuters) -Amgen, which is facing U.S. Federal Trade Commission (FTC) delays to its planned acquisition of Horizon Therapeutics, on Thursday reported higher quarterly profit on strong sales of treatments for cholesterol, osteoporosis and other drugs.  The biotech company, which slightly raised its outlook for full-year revenue and profit, said it currently expects the Horizon deal to close by mid-December.  For the second quarter, Amgen reported revenue of $6.99 billion, up 6% from a year earlier, exceeding analysts' estimates of $6.68 billion, according to Refinitiv data.""}, {""date"": ""20230803170302"", ""headline"": ""Amgen earnings beat estimates on revenue, adjusted EPS"", ""summary"": ""Amgen beat on estimates with its Q2 earnings. Yahoo Finance Health Care Reporter Anjalee Khemlani joins the Live show to discuss the report, including Amjevita and LUMAKRAS sales numbers.""}, {""date"": ""20230803171605"", ""headline"": ""Amgen Inc. (AMGN) Q2 2023 Earnings Call Transcript"", ""summary"": ""Amgen Inc. (NASDAQ:NASDAQ:AMGN) Q2 2023 Earnings Conference Call August 3, 2023 4:30 PM ETCompany ParticipantsArvind Sood \u00e2\u0080\u0093 Vice President of Investor RelationsBob Bradway \u00e2\u0080\u0093 Chairman and...""}, {""date"": ""20230803172445"", ""headline"": ""UPDATE 1-Amgen quarterly revenue rises 6%, profit beats Street estimates"", ""summary"": ""Amgen, which is facing U.S. Federal Trade Commission (FTC) delays to its planned acquisition of Horizon Therapeutics, on Thursday reported higher quarterly profit on strong sales of treatments for cholesterol, osteoporosis and other drugs.  The biotech company, which slightly raised its outlook for full-year revenue and profit, said it currently expects the Horizon deal to close by mid-December.  For the second quarter, Amgen reported revenue of $6.99 billion, up 6% from a year earlier, exceeding analysts' estimates of $6.68 billion, according to Refinitiv data.""}, {""date"": ""20230803173224"", ""headline"": ""The Small Drawback In Amgen's Earnings Beat, According To One Analyst"", ""summary"": ""Amgen beat second-quarter expectations Thursday and raised its outlook for the year, helping push Amgen stock higher in late action.""}, {""date"": ""20230803173516"", ""headline"": ""Amgen (AMGN) Q2 Earnings and Revenues Top Estimates"", ""summary"": ""Amgen (AMGN) delivered earnings and revenue surprises of 12.61% and 5.41%, respectively, for the quarter ended June 2023. Do the numbers hold clues to what lies ahead for the stock?""}, {""date"": ""20230803193006"", ""headline"": ""Amgen (AMGN) Reports Q2 Earnings: What Key Metrics Have to Say"", ""summary"": ""While the top- and bottom-line numbers for Amgen (AMGN) give a sense of how the business performed in the quarter ended June 2023, it could be worth looking at how some of its key metrics compare to Wall Street estimates and year-ago values.""}, {""date"": ""20230803214000"", ""headline"": ""Amazon shares rally 10%, but Apple\u2019s dip, and other stocks on the move"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230803215000"", ""headline"": ""Looking Into Amgen's Recent Short Interest"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230803224717"", ""headline"": ""Amgen Inc. 2023 Q2 - Results - Earnings Call Presentation"", ""summary"": ""The following slide deck was published by Amgen Inc.""}, {""date"": ""20230803230600"", ""headline"": ""Amgen (AMGN) Gets a Sell from Barclays"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230803234100"", ""headline"": ""Amgen Inc. stock outperforms market on strong trading day"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230804021800"", ""headline"": ""Dividend Roundup: IBM, Walmart, BP, Kimberly-Clark, and more"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230804024600"", ""headline"": ""Amgen (AMGN) Gets a Hold from BMO Capital"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230804025200"", ""headline"": ""Amgen second quarter profit grows amid Repatha and Evenity boost"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230804040921"", ""headline"": ""Amgen raises full-year earnings and revenue outlook"", ""summary"": ""Investing.com -- Shares in Amgen (NASDAQ:AMGN) rose in premarket U.S. trading on Friday after the U.S. biotech company improved its annual earnings and revenue forecast, and said it expects to close its planned multibillion-dollar acquisition of Horizon Therapeutics (NASDAQ:HZNP) by mid-December.""}, {""date"": ""20230804042300"", ""headline"": ""Amgen Raises FY23 Outlook, Discloses Brief Readout From Tarlatamab Lung Cancer, Lumakras Colorectal Cancer Studies"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230804044600"", ""headline"": ""Amgen, Microsoft share gains lead Dow's 175-point climb"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230804073100"", ""headline"": ""Amgen, Microsoft share gains contribute to Dow's 265-point jump"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230804085700"", ""headline"": ""Amgen, Intel share gains contribute to Dow's 175-point jump"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230804094324"", ""headline"": ""Amgen Is 'Confident' It Can Wrap The Horizon Takeover By December"", ""summary"": ""Amgen stock jumped Friday after topping Wall Street's second-quarter views, but investors remain zeroed in on the takeover of Horizon.""}, {""date"": ""20230804094500"", ""headline"": ""If You Had Invested $5,000 in Amgen in 2013, This Is How Much You Would Have Today"", ""summary"": ""Pharmaceutical giant Amgen (NASDAQ: AMGN)\u00a0is a component within the S&P 500 index.  Since its founding in 1980, Amgen has devoted itself to fostering a culture of innovation.  In fact, Amgen's total revenue has steadily grown from $18.7 billion in 2013 to a projected $26.6 billion in 2023.""}, {""date"": ""20230804121200"", ""headline"": ""Amgen (AMGN) Q2 Earnings Beat Estimates, 2023 View Raised"", ""summary"": ""Amgen (AMGN) beats Q2 estimates for earnings and sales. It slightly raises its earnings and sales guidance for 2023.""}, {""date"": ""20230804122052"", ""headline"": ""US STOCKS-Wall St rises on Amazon boost; bond yields fall"", ""summary"": ""Wall Street rose and bond yields fell on Friday after July jobs data showed a slowing in the U.S. labor market with wage gains, while Amazon's stellar earnings countered Apple's tepid sales forecast.  The yield on the 10-year benchmark note dipped on Friday after the jobs data, but still remained above 4%, partly boosting some megacap stocks.  \""At this point in some ways the jobs data doesn't do much to the Fed. The drama is now pivoting from the Fed to the Treasury,\"" said David Russell, vice president of market intelligence at TradeStation.""}, {""date"": ""20230804123258"", ""headline"": ""Is Amgen Inc (AMGN) Stock Fairly Valued? An In-depth Analysis"", ""summary"": ""Amgen Inc (NASDAQ:AMGN) recently recorded a daily gain of 5.81%, with an Earnings Per Share (EPS) (EPS) of $14.71.  Given these figures, a pertinent question arises: is Amgen (NASDAQ:AMGN) fairly valued?  Amgen is a leading biotechnology company specializing in human therapeutics, notably in renal disease and cancer supportive-care products.""}, {""date"": ""20230804132458"", ""headline"": ""RBC Capital Maintains AMGEN (AMGN) Sector Perform Recommendation"", ""summary"": """"}, {""date"": ""20230804135805"", ""headline"": ""Amgen Inc: A Strong Contender in the Drug Manufacturers Industry with a GF Score of 85"", ""summary"": ""Amgen Inc (NASDAQ:AMGN), a leading player in the drug manufacturers industry, is currently trading at $245.67 with a market capitalization of $131.27 billion.  According to the GF Score, Amgen has a score of 85 out of 100, indicating good outperformance potential.  This article will delve into the components of the GF Score and compare Amgen's performance with its main competitors.""}, {""date"": ""20230804141250"", ""headline"": ""US STOCKS-U.S. stocks rises on Amazon boost; bond yields fall"", ""summary"": ""Wall Street gained and bond yields fell on Friday after July jobs data showed a slowing in the U.S. labor market with wage gains.  Data for June additions was revised lower to 185,000 jobs, from 209,000 reported previously.""}, {""date"": ""20230804151232"", ""headline"": ""Dow Jones Reverses Lower On Reports Of Cyberattack; Fortinet Slammed After Earnings"", ""summary"": ""The Dow Jones faded off highs on reports that hospital systems in multiple states were hit by a cyberattack. Apple tanked on earnings.""}, {""date"": ""20230804164220"", ""headline"": ""US STOCKS-Wall Street ends lower after US jobs report; Apple weighs"", ""summary"": ""Wall Street closed lower on Friday after a report of slowing U.S. labor market growth, and all three major indexes posted weekly losses as investors braced for more possible downside surprises a day after disappointing earnings from Apple.  Apple's shares fell 4.8%, its biggest daily percentage decline since Sept. 29, 2022 that dented the S&P 500 by about 16 points the day after the iPhone maker forecast a continued slide in sales.  A partial counterweight to Apple for the S&P 500 and Nasdaq was Amazon.com.""}, {""date"": ""20230805080533"", ""headline"": ""Amgen's (NASDAQ:AMGN) Dividend Will Be Increased To $2.13"", ""summary"": ""Amgen Inc. ( NASDAQ:AMGN ) will increase its dividend from last year's comparable payment on the 8th of September to...""}, {""date"": ""20230805084500"", ""headline"": ""1 Top Dividend Growth Stock to Buy on the Dip"", ""summary"": ""Its shares are down by 12% since 2023 started, and the company has faced several issues recently that have harmed its financial results, leading many investors to abandon the stock.  Let's find out why income seekers should strongly consider adding shares of Amgen to their portfolios now.  Amgen is one of the largest biotechnology companies in the world, with a presence in dozens of countries and a portfolio that boasts more than 20 products.""}, {""date"": ""20230805224100"", ""headline"": ""2023 shaping up to be biggest year for biopharma M&A since pandemic"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230806013200"", ""headline"": ""Is Amgen (AMGN) Stock Fairly Valued? A Comprehensive Analysis"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230806053100"", ""headline"": ""Analysts Have Conflicting Sentiments on These Healthcare Companies: Amgen (AMGN), Cigna (CI) and Ultragenyx Pharmaceutical (RARE)"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230806070100"", ""headline"": ""Nearly half of U.S. adults want weight-loss drugs \u2013 KFF poll"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230806140211"", ""headline"": ""Stock futures rise as Wall Street comes off a losing week: Live updates"", ""summary"": ""Last week was the worst for the S&P 500 and Nasdaq Composite since March.""}]",{}
30,2023-08-06,239.4420623779297,2023-08-13,258.36871337890625,0.07904480446339957,U5+,"[{""date"": ""20230805224100"", ""headline"": ""2023 shaping up to be biggest year for biopharma M&A since pandemic"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230806013200"", ""headline"": ""Is Amgen (AMGN) Stock Fairly Valued? A Comprehensive Analysis"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230806053100"", ""headline"": ""Analysts Have Conflicting Sentiments on These Healthcare Companies: Amgen (AMGN), Cigna (CI) and Ultragenyx Pharmaceutical (RARE)"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230806070100"", ""headline"": ""Nearly half of U.S. adults want weight-loss drugs \u2013 KFF poll"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230806140211"", ""headline"": ""Stock futures rise as Wall Street comes off a losing week: Live updates"", ""summary"": ""Last week was the worst for the S&P 500 and Nasdaq Composite since March.""}, {""date"": ""20230806210200"", ""headline"": ""Dow up 425 points on gains in shares of Amgen, Boeing"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230806234000"", ""headline"": ""Amgen Inc. stock rises Monday, outperforms market"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230807030600"", ""headline"": ""Longeveron Announces Key Additions To Its Leadership Team And Board As It Gears Up For Phase 2 Trials For Its Lead Drug Candidate For Several Conditions"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230807042000"", ""headline"": ""Amgen Gives You Growth, Dividend Growth, And Value"", ""summary"": ""Amgen appears to remain undervalued for value and income investors. Read more to see a detailed analysis of AMGN stock.""}, {""date"": ""20230807042500"", ""headline"": ""Monday\u2019s Top Wall Street Analyst Upgrades and Downgrades: Amazon, Apple, Block, Coinbase, Datadog, Fortinet, Gilead Sciences, Moderna, Nvidia, PayPal, Petrobras and More"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230807055000"", ""headline"": ""Boeing, Amgen share gains lead Dow's 337-point jump"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230807062600"", ""headline"": ""Amgen (AMGN) Shares Cross Above 200 DMA"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230807071100"", ""headline"": ""Amgen Inc: A Strong Contender in the Drug Manufacturers Industry with a High GF Score"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230807074056"", ""headline"": ""Amgen Is Back!"", ""summary"": ""Amgen's stock has rebounded by 10% and is showing improving fundamentals, with strong volume and revenue growth in core drugs. Find out why AMGN stock is a Buy.""}, {""date"": ""20230807083700"", ""headline"": ""10 Health Care Stocks With Whale Alerts In Today's Session"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230807094721"", ""headline"": ""August MDA Breakout Stocks Week 32 - 2023: High-Frequency Gainers To Give You An Edge"", ""summary"": ""Two new Breakout Stocks for Week 32 curated by the MDA model for 10% short-term upside and additional model selections. Click here to read more.""}, {""date"": ""20230807152303"", ""headline"": ""CNBC Daily Open: Playing the T-bill game"", ""summary"": ""The U.S. economy has remained resilient and seemingly largely impervious to the Fed's highest rates in more than two decades.""}, {""date"": ""20230807164251"", ""headline"": ""Dow Jones Today: Index Rebounds with 400-Point Gain"", ""summary"": ""Following last week\u2019s downward turn, the Dow Jones Industrial Average bounced back, rising 407 points, or 1.2%, as investors readied for new inflation data to close out the week.""}, {""date"": ""20230807223001"", ""headline"": ""CNBC Daily Open: Treasury bets"", ""summary"": ""The U.S. economy has remained resilient and seemingly largely impervious to the Fed's highest rates in more than two decades.""}, {""date"": ""20230807234100"", ""headline"": ""Amgen Inc. stock rises Tuesday, outperforms market"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230808001600"", ""headline"": ""Amgen (AMGN) Receives a Sell from Robert W. Baird"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230808055300"", ""headline"": ""Watch weight loss stocks after cardiovascular data for Wegovy"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230808055900"", ""headline"": ""Amgen a Top 25 Dividend Giant With 3.37% Yield (AMGN)"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230808060000"", ""headline"": ""Amgen a Top Socially Responsible Dividend Stock With 3.4% Yield (AMGN)"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230808123340"", ""headline"": ""Is Amgen Inc (AMGN) Stock Fairly Valued?"", ""summary"": ""An In-depth Analysis of Amgen's Current Valuation""}, {""date"": ""20230808135804"", ""headline"": ""Amgen Inc: A Strong Contender in the Drug Manufacturers Industry with a GF Score of 85"", ""summary"": ""Amgen Inc (NASDAQ:AMGN), a leading player in the Drug Manufacturers industry, is currently trading at $262.57 with a market cap of $140.87 billion.  According to the GF Score, a stock performance ranking system developed by GuruFocus, Amgen Inc has a score of 85 out of 100, indicating good outperformance potential.  This rank measures the robustness of a company's financial situation, taking into account factors such as its debt burden, debt to revenue ratio, and Altman Z-Score.""}, {""date"": ""20230808152318"", ""headline"": ""Buy 2 August Dogs Of The Dow, Watch 5"", ""summary"": ""Discover the criteria for stocks to be added to the Dow, the highest-yield stocks in August, and analyst predictions for stocks' performance. Read more here.""}, {""date"": ""20230808222800"", ""headline"": ""Barclays Sticks to Its Sell Rating for Amgen (AMGN)"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230808233739"", ""headline"": ""3 Biotech Stocks You\u2019ll Regret Not Buying Soon"", ""summary"": ""The biotech industry proved itself resilient in the face of the COVID-19 pandemic. With research from Mckinsey, venture capitalist (VC) companies increased investments from 2,200 in 2016 to 3,100 in 2021 in biotechnology (biotech) startups. These startups have advanced medicine overall, improving cell therapy, tissue regeneration, genetic medicine, and more. With increasing innovation, we see an ongoing cycle. VC companies will continue to invest by providing resources and funding for these comp""}, {""date"": ""20230808234000"", ""headline"": ""Amgen Inc. stock outperforms market despite losses on the day"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230809062200"", ""headline"": ""Amgen Reaches Analyst Target Price"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230809083500"", ""headline"": ""Looking At Amgen's Recent Unusual Options Activity"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230809160001"", ""headline"": ""The 3 Best Biotech Stocks to Buy in August"", ""summary"": ""Many healthcare stocks suffer from COVID fatigue as profits fall amid a global decline in the virus\u2019 spread. But medical innovations and technological breakthroughs are rapidly transforming the healthcare landscape, and biotech stocks are garnering unprecedented attention in the investment community. These companies, operating at the intersection of biology and technology, promise groundbreaking treatments, therapies and solutions to some of the world\u2019s most persistent medical challenges. As the""}, {""date"": ""20230809215700"", ""headline"": ""Dow up 181 points on gains in shares of Walt Disney, Amgen"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230809233800"", ""headline"": ""Here's How Much You Would Have Made Owning Amgen Stock In The Last 15 Years"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230810022100"", ""headline"": ""Ideaya Biosciences price target raised to $35 from $30 at Oppenheimer"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230810055900"", ""headline"": ""Want Rising Dividend Income? Buy Amgen Stock"", ""summary"": ""Pharmaceutical company Amgen (NASDAQ: AMGN)\u00a0is a favorite among income investors.  Here are four reasons that the stock could have a special place in a portfolio centered around dividend growth.  In the second quarter ended June 30, Amgen's total revenue increased by 5.9% year over year to $7 billion.""}, {""date"": ""20230810065900"", ""headline"": ""Walt Disney, Amgen share gains contribute to Dow's 200-point climb"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230810070103"", ""headline"": ""Amgen (NASDAQ:AMGN) jumps 13% this week, though earnings growth is still tracking behind five-year shareholder returns"", ""summary"": ""When you buy and hold a stock for the long term, you definitely want it to provide a positive return. But more than...""}, {""date"": ""20230810090006"", ""headline"": ""Amgen Inc. (AMGN) is Attracting Investor Attention: Here is What You Should Know"", ""summary"": ""Amgen (AMGN) has been one of the stocks most watched by Zacks.com users lately. So, it is worth exploring what lies ahead for the stock.""}, {""date"": ""20230810092152"", ""headline"": ""These 10 medications are likely targets for Medicare price negotiations this fall"", ""summary"": ""It's still unclear which drugs Medicare will select, but several companies have revealed in court filings that four of their medications are targets.""}, {""date"": ""20230810112637"", ""headline"": ""3 Dow Jones Stocks To Watch In August 2023"", ""summary"": ""Dow Jones Industrial Average stocks to check out in the stock market today.""}, {""date"": ""20230810230800"", ""headline"": ""Nasdaq Suffers Second Straight Week of Losses, Breaks Key Support Level As Tech Bears Return: Is This Time Different?"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230810234000"", ""headline"": ""Amgen Inc. stock outperforms market on strong trading day"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230810235700"", ""headline"": ""Uber Crowded, Battleground and Sweet 16 stock portfolios from Jefferies"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230812050000"", ""headline"": ""How To Invest $100,000 Today: 5 Strategies Including The Near-Perfect Portfolio Strategy"", ""summary"": ""Discover five investment strategies, including the Near-Perfect Portfolio, aimed at capital preservation, sustainable income, and long-term growth. Click for more.""}, {""date"": ""20230812080344"", ""headline"": ""Amgen (NASDAQ:AMGN) Could Be A Buy For Its Upcoming Dividend"", ""summary"": ""Amgen Inc. ( NASDAQ:AMGN ) is about to trade ex-dividend in the next four days. The ex-dividend date is one business...""}, {""date"": ""20230812210300"", ""headline"": ""Pharma under threat from bill to expand drug price negotiations"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230813043100"", ""headline"": ""Horizon Therapeutics, Activision among best bets for M&A deals to close"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230813052322"", ""headline"": ""Dividend Champion, Contender, And Challenger Highlights: Week Of August 13"", ""summary"": ""A weekly summary of dividend activity for Dividend Champions, Contenders, and Challengers. Read more to see the full August 13 weekly update.""}]",{}
31,2023-08-13,258.36871337890625,2023-08-20,259.7774658203125,0.005452488511410003,U1,"[{""date"": ""20230812210300"", ""headline"": ""Pharma under threat from bill to expand drug price negotiations"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230813043100"", ""headline"": ""Horizon Therapeutics, Activision among best bets for M&A deals to close"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230813052322"", ""headline"": ""Dividend Champion, Contender, And Challenger Highlights: Week Of August 13"", ""summary"": ""A weekly summary of dividend activity for Dividend Champions, Contenders, and Challengers. Read more to see the full August 13 weekly update.""}, {""date"": ""20230813230700"", ""headline"": ""The Latest Analyst Ratings for Amgen"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230813234000"", ""headline"": ""Amgen Inc. stock falls Monday, underperforms market"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230814015300"", ""headline"": ""Amgen price target raised to $223 from $214 at Mizuho"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230814023500"", ""headline"": ""Amgen price target raised to $310 from $275 at Jefferies"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230814030900"", ""headline"": ""QUALCOMM, AIG And 2 Other Stocks Insiders Are Selling"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230814035503"", ""headline"": ""Tracking George Soros's Portfolio - Q2 2023 Update"", ""summary"": ""George Soros's 13F portfolio value decreased slightly from $6.49B to $6.41B, with 172 positions. Click here to read the portfolio's Q2 2023 update.""}, {""date"": ""20230814105331"", ""headline"": ""Jefferies Maintains AMGEN (AMGN) Buy Recommendation"", ""summary"": """"}, {""date"": ""20230814105336"", ""headline"": ""Mizuho Maintains AMGEN (AMGN) Neutral Recommendation"", ""summary"": """"}, {""date"": ""20230814112200"", ""headline"": ""August MDA Breakout Stocks Week 33 - 2023: Facing The Largest Negative Signal Since February"", ""summary"": ""The Momentum Gauges and S&P 500 Gauges have turned negative. Read why this indicates a shift in market momentum and the need for caution in stock selection.""}, {""date"": ""20230814234000"", ""headline"": ""Amgen Inc. stock outperforms competitors on strong trading day"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230815040500"", ""headline"": ""Tuesday\u2019s Top Wall Street Analyst Upgrades and Downgrades: Amgen, Coterra Energy, Eaton, Marriott, Monster Beverage, Mosaic, Urban Outfitters, Wayfair and More"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230815045800"", ""headline"": ""Tudor Investment boosts stakes in Big Tech, exits VMware, BAH, HRL"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230815063300"", ""headline"": ""Is Amgen (AMGN) Stock Fairly Valued?"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230815073530"", ""headline"": ""15 Worst Performing Blue Chip Stocks in 2023"", ""summary"": ""In this piece, we will take a look at the 15 worst performing blue chip stocks in 2023. If you want to skip a background of what\u2019s been going on in this lucrative sector this year, then head on over to 5 Worst Performing Blue Chip Stocks in 2023. In traditional poker, a blue chip [\u2026]""}, {""date"": ""20230815074024"", ""headline"": ""I Got 99 Problems But A High Yield Ain't One (151 Trade Ideas)"", ""summary"": ""Discover how our Advanced cash covered put selling strategy can help you generate high yields while minimizing market risk. Click for our exclusive picks.""}, {""date"": ""20230815234000"", ""headline"": ""Amgen Inc. stock outperforms market despite losses on the day"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230816011700"", ""headline"": ""Horizon Therapeutics: Can Investors Profit From Amgen Deal Confusion?"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230816061500"", ""headline"": ""February 2024 Options Now Available For Amgen (AMGN)"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230816100028"", ""headline"": ""Is Now The Time To Put Amgen (NASDAQ:AMGN) On Your Watchlist?"", ""summary"": ""For beginners, it can seem like a good idea (and an exciting prospect) to buy a company that tells a good story to...""}, {""date"": ""20230816100753"", ""headline"": ""Could Amgen Stock Help You Become a Millionaire?"", ""summary"": ""Healthcare company Amgen (NASDAQ: AMGN) has been a reliable investment to own over what has been a turbulent year for the broader market.  A particularly promising drug involved in the deal is Tepezza, a treatment for thyroid eye disease which could bring in up to $4 billion in peak annual sales.""}, {""date"": ""20230816103130"", ""headline"": ""Improved Outlook For Horizon Therapeutics And Amgen"", ""summary"": ""Horizon Therapeutics' better-than-expected Q2 eases concerns about Amgen acquisition failing to close due to Horizon's business underperformance. Read more here.""}, {""date"": ""20230816140202"", ""headline"": ""Horizon Therapeutics - Can Investors Profit From Amgen Deal Confusion?"", ""summary"": ""Exploring the uncertain fate of the $28.5bn acquisition deal between Horizon Therapeutics and Amgen, and its potential impact on their share prices.""}, {""date"": ""20230816142500"", ""headline"": ""Amgen Stock Scores Relative Strength Rating Upgrade; Hits Key Benchmark"", ""summary"": ""Amgen shows rising price performance, earning an upgrade to its IBD Relative Strength Rating from 68 to 80.""}, {""date"": ""20230816181941"", ""headline"": ""Unusual Call Option Trade in AMGEN (AMGN)  Worth $4,395.60K"", ""summary"": """"}, {""date"": ""20230816233900"", ""headline"": ""Amgen Inc. stock underperforms Thursday when compared to competitors despite daily gains"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230817001300"", ""headline"": ""Jefferies starts BeiGene at buy, cites deep pipeline, Novartis partnership"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230817001800"", ""headline"": ""The 3 Most Undervalued Biotech Stocks to Buy Now: August 2023"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230817073700"", ""headline"": ""Looking At Amgen's Recent Unusual Options Activity"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230817233900"", ""headline"": ""Amgen Inc. stock outperforms competitors despite losses on the day"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230818081700"", ""headline"": ""AARP, Public Citizen file briefs in Medicare drug price negotiations case"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230820090029"", ""headline"": ""With 78% ownership of the shares, Amgen Inc. (NASDAQ:AMGN) is heavily dominated by institutional owners"", ""summary"": ""Key Insights Given the large stake in the stock by institutions, Amgen's stock price might be vulnerable to their...""}]",{}
32,2023-08-20,259.7774658203125,2023-08-27,254.37989807128906,-0.020777659570968776,D3,"[{""date"": ""20230820090029"", ""headline"": ""With 78% ownership of the shares, Amgen Inc. (NASDAQ:AMGN) is heavily dominated by institutional owners"", ""summary"": ""Key Insights Given the large stake in the stock by institutions, Amgen's stock price might be vulnerable to their...""}, {""date"": ""20230820230200"", ""headline"": ""Horizon Therapeutics gains amid speculation on potential FTC settlement on Amgen"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230820233900"", ""headline"": ""Amgen Inc. stock falls Monday, underperforms market"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230821053200"", ""headline"": ""Amgen's Lumakras facing FDA advisory panel for full approval"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230821074200"", ""headline"": ""First Week of September 15th Options Trading For Amgen (AMGN)"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230821081500"", ""headline"": ""Is Amgen Stock a Top Buy and Hold?"", ""summary"": ""One way to increase your odds of success is to buy shares of high-quality companies that sport strong competitive advantages, solid growth prospects, and attractive valuations.  Biotech giant Amgen (NASDAQ: AMGN) ticks many of these boxes.  Read on to find out more about this top dividend-paying biotech stock.""}, {""date"": ""20230821085200"", ""headline"": ""Peering Into Amgen's Recent Short Interest"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230821090005"", ""headline"": ""Is Trending Stock Amgen Inc. (AMGN) a Buy Now?"", ""summary"": ""Recently, Zacks.com users have been paying close attention to Amgen (AMGN). This makes it worthwhile to examine what the stock has in store.""}, {""date"": ""20230821104940"", ""headline"": ""11 Most Profitable Biotech Stocks Today"", ""summary"": ""In this piece, we will take a look at the 11 most profitable biotechnology stocks to buy today. If you want to skip our introduction to the biotechnology industry and want to take a look at the top five stocks in this list, then head on over to 5 Most Profitable Biotech Stocks Today. Biotechnology [\u2026]""}, {""date"": ""20230821125500"", ""headline"": ""IN BRIEF: US FDA to review Amgen's Lumakras for lung cancer"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230821125832"", ""headline"": ""Medicare drug price negotiations unlikely to be derailed by lawsuits: UBS"", ""summary"": ""UBS believes there is little chance the lawsuits brought on by pharma companies will delay Medicare pricing negotiations.""}, {""date"": ""20230821160000"", ""headline"": ""AMGEN TO DISCUSS APPLICATION FOR LUMAKRAS\u00ae (SOTORASIB) FOR THE TREATMENT OF KRAS G12C-POSITIVE NSCLC AT FDA ADVISORY COMMITTEE MEETING"", ""summary"": ""Amgen (NASDAQ:AMGN) today announced the U.S. Food and Drug Administration (FDA) Oncologic Drugs Advisory Committee (ODAC) will review data supporting the supplemental New Drug Application (sNDA) for the full approval of LUMAKRAS\u00ae (sotorasib) for adults with previously treated locally advanced or metastatic KRAS G12C-mutated non-small cell lung cancer (NSCLC) at a meeting on Oct. 5, 2023.""}, {""date"": ""20230821162038"", ""headline"": ""These Are the ONLY 3 Biotech Stocks to Consider in August 2023"", ""summary"": ""The world may be on the mend from the grip of the global pandemic, but the consistent drumbeat for medical innovation remains as unyielding as ever. Amid this backdrop, Biotech stocks present a beacon of hope for humanity and a compelling avenue for savvy investors. Delving into the best biotech stocks offers a chance to back businesses spearheading these life-altering breakthroughs and potentially reap massive dividends. American pharmaceutical giants, often overshadowed in global conversations""}, {""date"": ""20230822045500"", ""headline"": ""Amgen (AMGN) Gets a Buy from Jefferies"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230822053433"", ""headline"": ""AMGEN TO DISCUSS APPLICATION FOR LUMAKRAS FOR THE TREATMENT OF KRAS G12C-POSITIVE NSCLC AT FDA ADVISORY COMMITTEE MEETING"", ""summary"": ""THOUSAND OAKS - Amgen today announced the U.S. Food and Drug Administration Oncologic Drugs Advisory Committee will review data supporting the supplemental New Drug Application for the full...""}, {""date"": ""20230822064700"", ""headline"": ""See How Amgen Ranks Among Analysts' Top Dow 30 Picks"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230822064700"", ""headline"": ""Video: Dow Analyst Moves: AMGN"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230822123800"", ""headline"": ""Amgen Inc. stock underperforms Tuesday when compared to competitors"", ""summary"": ""Shares of Amgen Inc. slid 1.18% to $257.62 Tuesday, on what proved to be an all-around grim trading session for the stock market, with the S&P 500 Index...""}, {""date"": ""20230822132458"", ""headline"": ""Health care stocks: What the market technicals show"", ""summary"": ""Why are UnitedHealth (UNH), Merck & Company (MRK), Johnson & Johnson (JNJ), and Amgen (AMGN), this strategist's top health care stock picks? Freedom Capital Markets Chief Global Strategist Jay Woods joins Yahoo Finance Live to discuss and break down the market technicals of health care stocks.\u00a0 Woods says he focuses on those four health care stocks, \""because they're in Dow Jones Industrial Average. If you're looking for reasons why the Dow can rally, I give you health care.\""\u00a0 The Health Care Select Sector (XLV) \""continues to make higher lows, as it goes along,\"" Woods notes. \""If you're a little skittish on the overall market, health care is a safety sector,\"" Woods says.""}, {""date"": ""20230822155055"", ""headline"": ""12 Best Cheap Dividend Stocks To Buy Now"", ""summary"": ""In this article, we discuss 12 best cheap dividend stocks to buy now. You can skip our detailed analysis of dividend stocks and their performance, and go directly to read 5 Best Cheap Dividend Stocks To Buy Now. Investing in cheap stocks is like finding a great deal at a store \u2013 it\u2019s about picking [\u2026]""}, {""date"": ""20230822230400"", ""headline"": ""This Is What Whales Are Betting On Amgen"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230823063200"", ""headline"": ""Amgen says FTC case to block Horizon Therapeutics deal `defies logic'"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230823064503"", ""headline"": ""Amgen : Joins Forces with American Heart Association on Lower Your LDL Cholesterol Now\u2122"", ""summary"": ""A 2023 survey from the American Heart Association with The Harris Poll shows more than half of Americans who have had a heart attack or stroke don't prioritize lowering LDL or bad...""}, {""date"": ""20230823123800"", ""headline"": ""Amgen Inc. stock falls Wednesday, underperforms market"", ""summary"": ""Shares of Amgen Inc. slumped 0.10% to $257.36 Wednesday, on what proved to be an all-around great trading session for the stock market, with the S&P 500...""}, {""date"": ""20230823222026"", ""headline"": ""Bristol-Myers Squibb: Top Defensive Pick During Recessions With A Value Proposition"", ""summary"": ""Discover why Bristol-Myers is a strong investment, undervalued with a promising dividend yield. After a slow start, expect a bullish turnaround.""}, {""date"": ""20230823224855"", ""headline"": ""Tracking David Abrams' Abrams Capital Management Portfolio - Q2 2023 Update"", ""summary"": ""Abrams' 13F portfolio value increased from $3.16B to $3.48B this quarter. Click here for a detailed analysis.""}, {""date"": ""20230824005900"", ""headline"": ""Stock buybacks spur wealth inequality and stifle innovation. But should they be banned?"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230824032800"", ""headline"": ""GRI Bio Is Bringing Hope To Patients With Idiopathic Pulmonary Fibrosis And Lupus"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230824034104"", ""headline"": ""Akero Therapeutics: An Assessment"", ""summary"": ""Akero's lead candidate, EFX, has shown promising results in clinical trials for both compensated cirrhotic NASH and pre-cirrhotic NASH. Read more here.""}, {""date"": ""20230824034700"", ""headline"": ""Thursday\u2019s Top Analyst Upgrades and Downgrades: Amazon, Amgen, Duke Energy, General Mills, KeyCorp, Lowe\u2019s, Macy\u2019s, Marvell Technology, Netflix, Walmart and More"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230824044600"", ""headline"": ""Drugs picked for Medicare price negotiations to be announced on Tuesday \u2013 Politico"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230824071800"", ""headline"": ""FTC likely to lose its challenge to the Horizon/Amgen deal, legal experts say - analyst"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230824072741"", ""headline"": ""Eli Lilly And Novo Nordisk: Are Weight Loss Drugs A Global Revolution Or Short-Lived Fad?"", ""summary"": ""Eli Lilly (LLY) and Novo Nordisk's (NVO) current valuations are not sustainable and there exist numerous adverse factors. Learn what are those adverse factors.""}, {""date"": ""20230824080000"", ""headline"": ""October 6th Options Now Available For Amgen (AMGN)"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230824100000"", ""headline"": ""4 Surefire Stocks to Buy in the Next Bear Market"", ""summary"": ""Are stocks slipping back toward a new bear market?  The economic news is sending mixed messages.  Given the prospect of a return to bear market conditions, though, it wouldn't hurt to at least make some plans for the possibility.""}, {""date"": ""20230824110310"", ""headline"": ""CVS Health launches new brand Cordavis to target $100 billion biosimilar market"", ""summary"": ""CVS is launching a new business segment that will negotiate with drugmakers to produce private label products for it to sell, the healthcare giant said Wednesday.""}, {""date"": ""20230824123800"", ""headline"": ""Amgen Inc. stock falls Thursday, still outperforms market"", ""summary"": ""Shares of Amgen Inc. dropped 0.29% to $256.62 Thursday, on what proved to be an all-around poor trading session for the stock market, with the S&P 500 Index...""}, {""date"": ""20230824133259"", ""headline"": ""Top Merger Stocks Held By Fund Managers, Mid-Q3 2023"", ""summary"": ""Horizon Therapeutics remains top stock held by merger-focused funds for the third consecutive quarter. Read more about top merger stocks held by fund managers.""}, {""date"": ""20230824135600"", ""headline"": ""Stock buybacks spur wealth inequality and stifle innovation. Should they be banned?"", ""summary"": ""Stock buybacks have become a major source of wealth inequality and have stifled innovation in the U.S., according to this academic.""}, {""date"": ""20230824233000"", ""headline"": ""Horizon Therapeutics gains as FTC seeks delay of in-house trial on Amgen deal"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230824233700"", ""headline"": ""Horizon Therapeutics gains as FTC granted delay in-house trial on Amgen deal"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230824234800"", ""headline"": ""Horizon Therapeutics gains as FTC withdraws in-house trial on Amgen deal"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230824235900"", ""headline"": ""Horizon Therapeutics jumps as FTC withdraws in-house trial on $28B Amgen deal"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230825001100"", ""headline"": ""Horizon Therapeutics jumps as FTC withdraws in-house trial on $28B Amgen deal (update)"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230825054700"", ""headline"": ""Merck starts phase 3 program for oral PCSK9 inhibitor to lower cholesterol"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230825060200"", ""headline"": ""As Medicare picks 10 drugs for price negotiations, 50 million people stand to benefit \u2014 even if their drugs aren\u2019t on the list"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230825072318"", ""headline"": ""11 Most Undervalued Dow Stocks To Buy According To Hedge Funds"", ""summary"": ""In this piece, we will take a look at the 11 most undervalued Dow stocks to buy according to hedge funds. If you want to skip our introduction to one of the most historic stock indexes in America, then head on over to 5 Most Undervalued Dow Stocks To Buy According To Hedge Funds. The [\u2026]""}, {""date"": ""20230825123800"", ""headline"": ""Amgen Inc. stock falls Friday, underperforms market"", ""summary"": ""Shares of Amgen Inc. slid 0.09% to $256.38 Friday, on what proved to be an all-around great trading session for the stock market, with the S&P 500 Index...""}, {""date"": ""20230825173224"", ""headline"": ""Horizon Therapeutics Jumps On A New FTC Development In The Amgen Takeover Battle"", ""summary"": ""The FTC pulled back one of its efforts to block Amgen's Horizon buyout, according to a document released Friday that sent HZNP stock flying.""}, {""date"": ""20230825173943"", ""headline"": ""UPDATE 2-SoftBank-backed Neumora Therapeutics files paperwork for U.S. IPO"", ""summary"": ""The filing comes at a time of renewed investor interest in IPOs following a flurry of deals in the United States and European markets, which have over the last year seen many high-profile startups shelve their listing plans due to market volatility.  Neumora's lead drug candidate navacaprant is a potential oral treatment of major depressive disorder.  Neumora did not disclose the size, timetable or other details of the offering in its filing with the U.S. securities regulator.""}, {""date"": ""20230825210400"", ""headline"": ""Crohn's disease drugmakers set to benefit from expected rise in cases"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230826064500"", ""headline"": ""Amgen Presents Phase 2 OLPASIRan Data at ESC 2023"", ""summary"": ""Amgen announced data from the final analysis of the Phase 2 OCEAN-DOSE study of olpasiran, a small interfering RNA during the Late-Breaking Science Session at the European Society of Cardiology ...""}, {""date"": ""20230826073300"", ""headline"": ""FTC Takes A Rare Step Back, Pauses Legal Battle With Amgen Over $28B Horizon Deal"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230826074006"", ""headline"": ""US FTC suspends challenge to block Amgen's $27.8 bln deal for Horizon Therapeutics"", ""summary"": ""The U.S. Federal Trade Commission has suspended its challenge of Amgen's $27.8billion purchase of Horizon Therapeutics, allowing theFTC to consider whether the agency should settle the case,...""}, {""date"": ""20230826104500"", ""headline"": ""AMGEN PRESENTS LATE-BREAKING PHASE 2 OLPASIRAN DATA AT ESC 2023"", ""summary"": ""Amgen (NASDAQ:AMGN) today announced data from the final analysis of the Phase 2 OCEAN(a)-DOSE study of olpasiran, a small interfering RNA (siRNA) during the Late-Breaking Science Session at the European Society of Cardiology (ESC) Annual Meeting being held in Amsterdam. In the off-treatment extension period, olpasiran showed a lasting effect on Lp(a) reduction nearly a year after the last dose.""}, {""date"": ""20230826110900"", ""headline"": ""FTC Pauses Challenge to Amgen\u2019s $27.8 Billion Deal for Horizon Therapeutics"", ""summary"": ""The move gives the agency time to weigh a settlement that would allow the deal to close with conditions.""}, {""date"": ""20230826114006"", ""headline"": ""UPDATE 2-US FTC suspends challenge to block Amgen's $27.8 bln deal for Horizon Therapeutics"", ""summary"": ""The U.S. Federal Trade Commission (FTC) has suspended its challenge of Amgen's $27.8 billion purchase of Horizon Therapeutics, allowing the FTC to consider whether the agency should settle the case, a filing late on Friday showed.  Amgen said the company was aware of the move and is prepared to demonstrate that there is no legal or factual reason to prohibit the acquisition to the courts.  The agency had said it opposed the deal because of concern that Amgen would leverage its big selling drugs to pressure insurance companies and pharmacy benefit managers to give favorable terms for Horizon's two key products - the fast-growing thyroid eye disease treatment Tepezza and gout drug Krystexxa.""}, {""date"": ""20230826114316"", ""headline"": ""US FTC suspends challenge to block Amgen's $27.8 billion deal for Horizon Therapeutics"", ""summary"": ""Amgen said the company was aware of the move and is prepared to demonstrate that there is no legal or factual reason to prohibit the acquisition to the courts.  The agency had said it opposed the deal because of concern that Amgen would leverage its big selling drugs to pressure insurance companies and pharmacy benefit managers to give favorable terms for Horizon's two key products - the fast-growing thyroid eye disease treatment Tepezza and gout drug Krystexxa.  The Thousand Oaks, California-based company announced plans to buy Horizon in December last year, saying that its rare disease drugs would offer it some protection from the drug pricing provisions of the Inflation Reduction Act, which are aimed at drugs most widely used by the government's Medicare health plan.""}, {""date"": ""20230827030700"", ""headline"": ""Fly Intel: Top five weekend stock stories"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230827045100"", ""headline"": ""FTC pauses challenge to Amgen deal for Horizon Therapeutics, WSJ reports"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230827070100"", ""headline"": ""Wall Street lists potential targets for Medicare drug price negotiations"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}]",{}
33,2023-08-27,254.37989807128906,2023-09-03,254.70730590820312,0.0012870821924078069,U1,"[{""date"": ""20230827030700"", ""headline"": ""Fly Intel: Top five weekend stock stories"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230827045100"", ""headline"": ""FTC pauses challenge to Amgen deal for Horizon Therapeutics, WSJ reports"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230827070100"", ""headline"": ""Wall Street lists potential targets for Medicare drug price negotiations"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230827232400"", ""headline"": ""What You Missed On Wall Street On Monday"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230828004700"", ""headline"": ""Biggest stock movers today: XPeng, VinFast and more"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230828020545"", ""headline"": ""August MDA Breakout Stocks Week 35 - 2023: High-Frequency Gainers To Give You An Edge"", ""summary"": ""Two new sample Breakout Stocks for Week 35 curated by the MDA model for a 10% short-term upside along with a Dow pick. Click here for a detailed analysis.""}, {""date"": ""20230828022600"", ""headline"": ""US Stocks Seen Opening Firmer In New Week's 1st Session As Traders Look To Week's Key Data; Analyst Constructive Despite Bearish Signals"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230828031800"", ""headline"": ""Horizon Therapeutics jumps after FTC pauses Amgen challenge for settlement talks"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230828040300"", ""headline"": ""Horizon Therapeutics shares climb after FTC pauses challenge of deal with Amgen"", ""summary"": ""Shares of Horizon Therapeutics PLC gained more than 5% premarket on Monday after the Federal Trade Commission last week paused its legal challenge to Amgen...""}, {""date"": ""20230828043300"", ""headline"": ""Amgen could reach settlement with FTC over Horizon in next few weeks - report"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230828044500"", ""headline"": ""BMO Capital Issues a Hold Rating on Amgen (AMGN)"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230828053800"", ""headline"": ""Hawaiian Electric Says Power Lines Not Responsible For Deadly Lahaina Fire, China Targets Stock Market Revival, FTC Pauses Legal Battle With Amgen's $28B Horizon Deal: Today's Top Stories"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230828055600"", ""headline"": ""Biggest stock movers today: Hawaiian Electric, RPT Realty, VinFast Auto and more"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230828070913"", ""headline"": ""5 Things to Know Before Markets Open"", ""summary"": ""Horizon Therapeutics shares jumped after the Federal Trade Commission paused a challenge to its acquisition by Amgen and Chinese EV maker XPeng announced a partnership with ride-hailing provider Didi. Here\u2019s what investors need to know today.""}, {""date"": ""20230828083700"", ""headline"": ""US Stocks Grind Higher As China Cuts Taxes On Trading, Eyes Further Stimulus: What's Driving Markets Monday?"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230828084300"", ""headline"": ""Amgen-Horizon Deal: FTC Pauses Proceedings to Block the Acquisition"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230828085905"", ""headline"": ""Dow 30 Stocks List: Ranked By Hedge Fund Bullishness Index"", ""summary"": ""In this article, we discuss Dow 30 stocks ranked in accordance with the hedge fund bullishness index. If you want to skip our detailed discussion about the stock market performance, head directly to Top 10 Dow Stocks: Ranked By Hedge Fund Bullishness Index. Dow 30 is a stock index that takes into consideration the performance [\u2026]""}, {""date"": ""20230828094004"", ""headline"": ""Why Amgen (AMGN) is a Top Value Stock for the Long-Term"", ""summary"": ""The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.""}, {""date"": ""20230828104628"", ""headline"": ""Horizon Therapeutics Shares Surge As FTC Postpones Challenge to Merger"", ""summary"": ""Horizon Therapeutics shares jumped more than 5% early trading Monday after the FTC said it would suspend its challenge to Amgen's acquisition of the drug maker.""}, {""date"": ""20230828111100"", ""headline"": ""Horizon (HZNP) Up as FTC Pauses Acquisition by Amgen Lawsuit"", ""summary"": ""The Federal Trade Commission suspends its ongoing lawsuit to block Horizon's (HZNP) acquisition by Amgen until Sep 18, 2023. The company's stock rises 5.8% in response.""}, {""date"": ""20230828114255"", ""headline"": ""FTC suspends challenge to Amgen-Horizon Therapeutics deal"", ""summary"": ""The Federal Trade Commission is suspending its challenge to Amgen's (AMGN) $27.8 billion bid to acquire Horizon Therapeutics (HZNP). The FTC is concerned Amgen will be able to bundle its products to a couple of Horizon's, giving it an advantage over rivals. It's a notion Amgen rejects. The FTC is pausing its challenge in hopes of reaching a settlement that would allow the deal to close. Yahoo Finance Health Care Reporter Anjalee Khemlani breaks the story down.""}, {""date"": ""20230828123900"", ""headline"": ""Amgen Inc. stock rises Monday, still underperforms market"", ""summary"": ""Shares of Amgen Inc. inched 0.07% higher to $256.55 Monday, on what proved to be an all-around positive trading session for the stock market, with the S&P...""}, {""date"": ""20230828162041"", ""headline"": ""Amgen-Horizon Takeover Seen Close to a Lock After FTC Pauses Challenge"", ""summary"": ""(Bloomberg) -- Traders are almost 100% certain that Amgen Inc. will complete its $28 billion takeover of Horizon Therapeutics Plc after the Federal Trade Commission paused its in-house case to block the deal.Most Read from BloombergChina\u2019s Worsening Economic Slowdown Is Rippling Across the Globe3M Agrees to Pay More Than $5.5 Billion Over Combat EarplugsTraders Have S&P 500 Comebacks Fading at Historic PaceAuto Union Boss Wants 46% Raise, 32-Hour Work Week in \u2018War\u2019 Against Detroit CarmakersTrump""}, {""date"": ""20230828200400"", ""headline"": ""10 drugs targeted for Medicare price negotiations as Biden pitches cost reductions"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230828233500"", ""headline"": ""What You Missed On Wall Street On Tuesday"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230828235200"", ""headline"": ""Amgen Now #52 Largest Company, Surpassing NextEra Energy"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230829012100"", ""headline"": ""Nasdaq, S&P 500 Futures Flatline Ahead Of JOLTS, House Price Data; Why This Analyst Recommends 'Buying Weakness Than Selling Rallies'"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230829025000"", ""headline"": ""Medicare lists first ten drugs selected for pricing negotiations"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230829025100"", ""headline"": ""Biden unveils first 10 drugs subject to Medicare price negotiation"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230829035000"", ""headline"": ""Merck, Amgen, AbbVie products among first 10 drugs selected for Medicare price negotiations"", ""summary"": ""Medicare on Tuesday announced the first 10 drugs selected for price negotiations, launching a historic and highly contentious process with big implications...""}, {""date"": ""20230829043500"", ""headline"": ""Biden Targets Cancer, Diabetes Drugs In Controversial Medicare Price Battle"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230829055600"", ""headline"": ""Eliquis, Jardiance among first 10 drugs selected for Medicare price negotiations"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230829062900"", ""headline"": ""White House names first 10 drugs eligible for Medicare price negotiations"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230829074618"", ""headline"": ""Biden Administration targets drugs from J&J, Merck for controversial Medicare price negotiations"", ""summary"": ""The Biden administration revealed the first 10 drugs that will face the Medicare negotiation process under the Inflation Reduction Act.""}, {""date"": ""20230829092412"", ""headline"": ""Best Buy results, Medicare negotiations list, Hurricane Idalia: Top stories"", ""summary"": ""Best Buy (BBY) lowers its full-year sales outlook despite topping earnings estimates. The Biden administration has shared its list of ten prescription drugs that will be subject to pricing negotiations between manufacturers and Medicare. Tropical Storm Idalia has officially been upgraded to a hurricane. It's expected to make landfall on Florida's west coast on Wednesday.Yahoo Finance Live's Brad Smith highlights three of this morning's biggest stories.""}, {""date"": ""20230829104735"", ""headline"": ""Biden admin unveils ten drugs picked for Medicare price negotiations"", ""summary"": ""The Biden administration has released the list of the first ten drugs that will be subject to Medicare price negotiations. The Center for Medicare Director Dr. Meena Seshamani tells Yahoo Finance Live that they are looking at \""the benefits that a drug brings to populations. Does it address an unmet need? Does it address different populations that have needs?\"" When it comes to why some drugs were chosen Dr. Seshamani says the organization followed the criteria written in the Inflation Reduction Act, adding that the list will not change. These are the ten drugs Medicare will be negotiating the prices of:Eliquis- Bristol-Myers Squibb (BMY), Pfizer (PFE) Jardiance- Boehringer Ingelheim, Eli Lilly (LLY) Xarelto- Bayer (BAYRY), Johnson & Johnson (JNJ) Januvia- Merck (MRK) Farxiga- AstraZeneca (AZN) Entresto- Novartis (NVS) Enbrel- Amgen (AMGN) Imbruvica- Johnson & Johnson (JNJ), AbbVie (ABBV) Stelara- Johnson & Johnson (JNJ) Fiasp, NovoLog- Novo Nordisk (NVO)""}, {""date"": ""20230829113700"", ""headline"": ""Expensive Drugs Targeted for First U.S. Price Negotiations"", ""summary"": ""Lower prices would take effect in 2026 depending on the talks between the U.S. and drugmakers and the outcome of industry lawsuits.""}, {""date"": ""20230829123900"", ""headline"": ""Amgen Inc. stock rises Tuesday, still underperforms market"", ""summary"": ""Shares of Amgen Inc. rose 1.20% to $259.64 Tuesday, on what proved to be an all-around favorable trading session for the stock market, with the S&P 500 Index...""}, {""date"": ""20230829234900"", ""headline"": ""NuVasive/Globus Medical spread widens amid notice of FTC meeting (update)"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230830011700"", ""headline"": ""Court hearing on FTC's challenge to Horizon/Amgen rescheduled until next week"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230830070600"", ""headline"": ""NuVasive/Globus Medical spread widens amid notice of FTC closed door meeting"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230830113330"", ""headline"": ""Medicare price negotiation list: What it means for pharma companies"", ""summary"": ""On Tuesday, the Biden administration listed ten drugs subject to Medicare price negotiations. Yahoo Finance Health Care Reporter Anjalee Khemlani breaks down the list and how this may impact the pharmaceutical companies who profit from these drugs.\u00a0\u00a0 The ten drugs and pharma companies impacted are:\u00a0 Eliquis - Bristol-Myers Squibb (BMY), Pfizer (PFE) Jardiance - Boehringer Ingelheim, Eli Lilly (LLY) Xarelto- Bayer (BAYRY), Johnson & Johnson (JNJ) Januvia - Merck (MRK) Farxiga - AstraZeneca (AZN) Entresto - Novartis (NVS) Enbrel - Amgen (AMGN) Imbruvica - Johnson & Johnson (JNJ), AbbVie (ABBV) Stelara - Johnson & Johnson (JNJ) Fiasp, NovoLog - Novo Nordisk (NVO)""}, {""date"": ""20230830123900"", ""headline"": ""Amgen Inc. stock falls Wednesday, underperforms market"", ""summary"": ""Shares of Amgen Inc. sank 0.68% to $257.88 Wednesday, on what proved to be an all-around positive trading session for the stock market, with the S&P 500...""}, {""date"": ""20230830132549"", ""headline"": ""Medicare's drug pricing list didn't impact company stocks \u2014 here's why"", ""summary"": ""Company stocks were unaffected by the Biden Administration's historic announcement Tuesday of Medicare's first list of drugs for negotiating prices.""}, {""date"": ""20230831061700"", ""headline"": ""Rising High: Exclusive talk with psychotropics company Lucy Scientific Discovery"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230831073300"", ""headline"": ""$1000 Invested In This Stock 15 Years Ago Would Be Worth $4,200 Today"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230831075300"", ""headline"": ""Is This the Green Light Biotech Stocks Have Been Waiting For?"", ""summary"": ""It looks like the Federal Trade Commission will give up on its attempt to block Amgen's acquisition of Horizon Therapeutics.""}, {""date"": ""20230831112212"", ""headline"": ""Big Pharma's biggest ally gets trolled on X for attacking Medicare drug pricing list"", ""summary"": ""Drug lobbying firm PhRMA faced backlash on social media for its attempt to call Medicare pricing negotiations unfair.""}, {""date"": ""20230831123900"", ""headline"": ""Amgen Inc. stock falls Thursday, underperforms market"", ""summary"": ""Shares of Amgen Inc. slipped 0.60% to $256.34 Thursday, on what proved to be an all-around grim trading session for the stock market, with the S&P 500 Index...""}, {""date"": ""20230831193000"", ""headline"": ""AMGEN TO PRESENT AT THE 2023 WELLS FARGO HEALTHCARE CONFERENCE AND THE CITI GLOBAL HEALTHCARE CONFERENCE"", ""summary"": ""Amgen (NASDAQ:AMGN) will present at the 2023 Wells Fargo Healthcare Conference at 9:30 a.m. ET on Wednesday, Sept. 6, 2023. Amgen will also present at the Citi Global Healthcare Conference at 1:00 p.m. ET on Thursday, Sept. 7, 2023. Peter H. Griffith, executive vice president and chief financial officer at Amgen, and Murdo Gordon, executive vice president of global commercial operations at Amgen will present at both conferences. The webcasts from these events will be broadcast over the internet""}, {""date"": ""20230831231500"", ""headline"": ""What You Missed On Wall Street On Friday"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230901035200"", ""headline"": ""Amgen reaches settlement with FTC on Horizon Therapeutics takeover"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230901035900"", ""headline"": ""Horizon Therapeutics gains amid reports FTC settled with Amgen over $28B deal"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230901041100"", ""headline"": ""Amgen to settle FTC and state challenges to Horizon Therapeutics takeover"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230901042200"", ""headline"": ""Horizon Therapeutics gains after FTC settles with Amgen over $28B deal  (update)"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230901042400"", ""headline"": ""Amgen, Horizon Therapeutics confirm resolution of FTC lawsuit"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230901042600"", ""headline"": ""Amgen, Horizon enter consent order agreement with FTC to close acquisition"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230901042800"", ""headline"": ""Horizon Therapeutics gains afer FTC settles with Amgen over $28B deal  (update)"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230901052000"", ""headline"": ""FTC settles with Amgen over $27.8 billion takeover of Horizon Therapeutics"", ""summary"": ""The Federal Trade Commission reached a deal with Amgen to approve its $27.8 billion acquisition of Horizon Therapeutics plc the agency announced Friday.""}, {""date"": ""20230901055300"", ""headline"": ""Amgen-Horizon Therapeutics $28B Acquisition: Federal Trade Commission Gives Green Signal"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230901063300"", ""headline"": ""As Medicare drug-price negotiations inch forward, some states are flexing new powers to cut costs for a broader swath of drugs"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230901070900"", ""headline"": ""TOP NEWS: Amgen buy of Horizon closer as FTC lawsuit resolved"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230901071900"", ""headline"": ""What You Missed On Wall Street This Morning"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230901073000"", ""headline"": ""As Medicare drug-price negotiations inch forward, some states are flexing new powers to cut costs for a broader swath of drugs\u00a0"", ""summary"": ""States like Colorado are looking to set upper payment limits on certain drugs as soon as next year.""}, {""date"": ""20230901080200"", ""headline"": ""Horizon Therapeutics (NASDAQ:HZNP) Gains After FTC Settlement"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230901090006"", ""headline"": ""Here is What to Know Beyond Why Amgen Inc. (AMGN) is a Trending Stock"", ""summary"": ""Amgen (AMGN) has received quite a bit of attention from Zacks.com users lately. Therefore, it is wise to be aware of the facts that can impact the stock's prospects.""}, {""date"": ""20230901090440"", ""headline"": ""Amgen gets US FTC's go-ahead for $27.8 billion Horizon deal"", ""summary"": ""The U.S. Federal Trade Commission (FTC) has allowed Amgen to continue its $27.8 billion acquisition of Horizon Therapeutics, while preventing the drugmaker from using anticompetitive tactics to extend the market dominance of two Horizon drugs.  The agreement, announced on Friday, ends months of uncertainty over the deal since the FTC in May filed a lawsuit over concerns that Amgen would leverage its drugs to secure favorable insurance coverage terms for Horizon's thyroid eye disease treatment Tepezza and gout drug Krystexxa.  Under the FTC settlement, Amgen is prohibited from bundling any of its products with Tepezza or Krystexxa, and from using any product rebate or contract term to exclude or disadvantage products that would compete with those drugs.""}, {""date"": ""20230901092000"", ""headline"": ""AMGEN AND HORIZON THERAPEUTICS PLC RESOLVE FTC LAWSUIT, CLEARING PATH TO CLOSE ACQUISITION"", ""summary"": ""Amgen (NASDAQ:AMGN) and Horizon Therapeutics plc (NASDAQ:HZNP) today announced the entry into a consent order agreement with the Federal Trade Commission (FTC) that resolves the pending FTC administrative lawsuit. This clears the path to take the final steps to close Amgen's acquisition of Horizon.""}, {""date"": ""20230901092940"", ""headline"": ""Amgen\u2019s $27.8 Billion Horizon Takeover Allowed in FTC Accord"", ""summary"": ""(Bloomberg) -- Amgen Inc. can move forward with its $27.8 billion takeover of Horizon Therapeutics Plc after the US Federal Trade Commission said Friday that it accepted a binding settlement that the combined company won\u2019t bundle together two of Horizon\u2019s blockbuster drugs.Most Read from BloombergHuawei Teardown Shows Chip Breakthrough in Blow to US SanctionsMercedes Bets on Range Boost in Swipe at Tesla\u2019s EV LeadWhy China Is Avoiding Using \u2018Bazooka\u2019 to Spur EconomyDiamond Prices Are in Free Fal""}, {""date"": ""20230901094800"", ""headline"": ""Horizon Therapeutics Stock Rises After Settlement Clears Way for Amgen Deal"", ""summary"": ""Shares of Horizon Therapeutics rose Friday morning after the FTC said [it reached a settlement](https://www.wsj.com/us-news/law/ftc-settles-with-amgen-over-27-8-billion-deal-for-horizon-therapeutics-b96a2d69) with Amgen that would let it acquire the company.""}, {""date"": ""20230901100512"", ""headline"": ""Amgen resolves US regulator\u2019s challenge to $28bn Horizon deal"", ""summary"": ""Federal Trade Commission said it secured concessions from pharma company to resolve its competition concerns""}, {""date"": ""20230901101100"", ""headline"": ""Amgen and Horizon Therapeutics Stocks Rise After FTC Settlement Over $27.8 Billion Merger"", ""summary"": ""The Federal Trade Commission makes provision that prohibits \u201cbundling\u201d discounts for some medications.""}, {""date"": ""20230901103202"", ""headline"": ""Trending : FTC Ends Challenge of Amgen/Horizon Deal"", ""summary"": ""14:16 ET -- Amgen and Horizon Therapeutics are among the most mentioned companies in the U.S. across all news items in the last 12 hours, according to Factiva data. The Federal Trade Commission...""}, {""date"": ""20230901104852"", ""headline"": ""CDC: Dividend ETF With Unconventional Market Timing"", ""summary"": ""VictoryShares US EQ Income Enhanced Volatility Wtd is a defensive ETF with unconventional market timing and lower risk in drawdowns. Learn more about CDC here.""}, {""date"": ""20230901114438"", ""headline"": ""Why Amgen's $28 Billion Merger News Also Bodes Well For Pfizer, Biogen"", ""summary"": ""Amgen stock rose Friday after the FTC dropped its lawsuit, clearing the way for the biotech to buy Horizon Therapeutics for $28 billion.""}, {""date"": ""20230901121100"", ""headline"": ""NEW YORK MARKET CLOSE: Dow and dollar rise after mixed payrolls report"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230901121100"", ""headline"": ""Amgen\u2019s $27.8 Billion Deal for Horizon Therapeutics Clears Key Hurdle"", ""summary"": ""The Federal Trade Commission said it had agreed to end its legal challenge of the deal. The pact also dismisses the antitrust claims of six states that joined the FTC in May seeking to block the transaction.""}, {""date"": ""20230901123900"", ""headline"": ""Amgen Inc. stock rises Friday, still underperforms market"", ""summary"": ""Shares of Amgen Inc. inched 0.14% higher to $256.71 Friday, on what proved to be an all-around great trading session for the stock market, with the S&P 500...""}, {""date"": ""20230901140418"", ""headline"": ""Amgen gets green light from FTC for $27.8B Horizon Therapeutics deal"", ""summary"": ""The Federal Trade Commission will allow Amgen to continue a $27.8 billion purchase of Horizon Therapeutics. The companies anticipate closing the deal in the fourth quarter.""}, {""date"": ""20230901145400"", ""headline"": ""Amgen, FTC Settle Over $27.8 Billion Horizon Deal. Stocks Rise."", ""summary"": ""The Federal Trade Commission prohibited the merged company from \u201cbundling\u201d discounts for some medications.""}, {""date"": ""20230901171332"", ""headline"": ""Dow Jones Today: Index Moves Up on Jobs Report"", ""summary"": ""The Dow Jones finished higher by about 115 points, or 0.3%, on investors optimism that the latest employment report will help prompt the Fed to end its interest rate hikes.""}, {""date"": ""20230901210500"", ""headline"": ""Lilly, Novo Nordisk top pharma performers in August; AstraZeneca, Roche lag"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230902090000"", ""headline"": ""SCHD: The First Acquisition For The Dividend Income Accelerator Portfolio Is A Strategic Buy"", ""summary"": ""SCHD is highly attractive for investors due to its combination of dividend income and sustainable dividend growth. Read more about SCHD stock.""}, {""date"": ""20230903034900"", ""headline"": ""The 3 Most Promising Dow Stocks to Own Now"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230903041922"", ""headline"": ""Dividend Champion, Contender, And Challenger Highlights: Week Of September 3"", ""summary"": ""A weekly summary of dividend activity for Dividend Champions, Contenders, and Challengers. Click here to read the full September 3 weekly update.""}, {""date"": ""20230903070000"", ""headline"": ""Why is big pharma unmoved despite Medicare pricing threat?"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}]",{}
34,2023-09-03,254.70730590820312,2023-09-10,257.4060974121094,0.010595658001576469,U2,"[{""date"": ""20230903034900"", ""headline"": ""The 3 Most Promising Dow Stocks to Own Now"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230903041922"", ""headline"": ""Dividend Champion, Contender, And Challenger Highlights: Week Of September 3"", ""summary"": ""A weekly summary of dividend activity for Dividend Champions, Contenders, and Challengers. Click here to read the full September 3 weekly update.""}, {""date"": ""20230903070000"", ""headline"": ""Why is big pharma unmoved despite Medicare pricing threat?"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230904053820"", ""headline"": ""AMGEN AND HORIZON THERAPEUTICS PLC RESOLVE FTC LAWSUIT, CLEARING PATH TO CLOSE ACQUISITION"", ""summary"": ""THOUSAND OAKS - Amgen and Horizon Therapeutics plc today announced the entry into a consent order agreement with the Federal Trade Commission that resolves the pending FTC administrative...""}, {""date"": ""20230904095006"", ""headline"": ""Amgen (AMGN) is a Top-Ranked Momentum Stock: Should You Buy?"", ""summary"": ""Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.""}, {""date"": ""20230904121400"", ""headline"": ""FTC Allows Amgen (AMGN) to Proceed With $28B Horizon Buyout"", ""summary"": ""Per the settlement terms, Amgen (AMGN) is prohibited from bundling its products with Horizon's Tepezza or Krystexxa. Amgen expects to complete the Horizon acquisition before 2023-end.""}, {""date"": ""20230904234000"", ""headline"": ""Amgen Inc. stock underperforms Tuesday when compared to competitors"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230905020000"", ""headline"": ""FTC settlement could shelter Amgen from US price cuts, taxes"", ""summary"": ""The U.S. Federal Trade Commission'sdecision on Friday to allow Amgen's takeover of HorizonTherapeutics was the latest setback to its stated goal ofstricter antitrust enforcement, and instead paved...""}, {""date"": ""20230905032051"", ""headline"": ""September Dogs Of The Dow: Walgreens Now Tops All By Yield"", ""summary"": ""There were two Dow Index stocks showing dividends exceeding single share price this month. Click here for a detailed analysis.""}, {""date"": ""20230905044200"", ""headline"": ""Irish High Court hearing for Horizon's $28B sale to Amgen set for Oct. 5"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230905060517"", ""headline"": ""Analysis-FTC settlement could shelter Amgen from US price cuts, taxes"", ""summary"": ""The U.S. Federal Trade Commission's decision on Friday to allow Amgen's takeover of Horizon Therapeutics was the latest setback to its stated goal of stricter antitrust enforcement, and instead paved the way for Amgen to gain drugs not subject to new price negotiations and possibly lower the company's tax burden.  The move signals the FTC's uncertainty that a court would support its novel theory of future competition being disadvantaged by Amgen's \""bundling\"" of drugs in negotiations with insurers.  \""I think there is some skittishness on whether to pursue this and develop new case law,\"" said Abiel Garcia, a partner at Kesselman, Brantly & Stockinger and a former deputy attorney general in California's antitrust department.""}, {""date"": ""20230905085700"", ""headline"": ""Amgen's Horizon Acquisition Offers Multiple Advantages: Tax Breaks, Shield From Drug Pricing Negotiations"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230905091300"", ""headline"": ""Should You Still Buy the Dow Jones' Best-Performing August Stocks?"", ""summary"": ""They're rolling now, but this market has been too hot-and-cold of late to ignore any company's -- or company's stock's -- underlying bigger picture.""}, {""date"": ""20230905155533"", ""headline"": ""Truist Securities Reiterates AMGEN (AMGN) Hold Recommendation"", ""summary"": """"}, {""date"": ""20230905234000"", ""headline"": ""Amgen Inc. stock falls Wednesday, underperforms market"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230905234400"", ""headline"": ""Amgen initiated with a Buy at HSBC"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230906030800"", ""headline"": ""GLOBAL BROKER RATINGS: Shore Capital raises B&M; HSBC likes Amgen"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230906041108"", ""headline"": ""The FTC \""Settles\"" For A Conduct Consent Decree To Resolve Its Challenge To The Amgen-Horizon Merger"", ""summary"": ""For years, the antitrust enforcement agencies have indicated their antipathy toward resolving competition issues in proposed mergers by entering into consent decrees that prohibit certain conduct,...""}, {""date"": ""20230906073200"", ""headline"": ""Apple, Boeing share losses lead Dow's 265-point fall"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230906080000"", ""headline"": ""Biden FTC\u2019s Antitrust Bark Proves Worse Than Its Bite"", ""summary"": ""Federal Trade Commission Chair  Lina Khan  has been open about her willingness to take on hard cases and lose.  \u201cI\u2019m certainly not someone who thinks success is marked by a 100% court record,\u201d Khan has said.  Frequent defeats, including last week\u2019s settlement with  Amgen  are weakening the agency\u2019s hand, though.""}, {""date"": ""20230906094000"", ""headline"": ""Amgen (AMGN) Stock Outperforms Industry YTD: Here's Why"", ""summary"": ""Amgen (AMGN) expects strong sales growth of products like Tezspire, Evenity and Repatha to be offset by lower revenues from oncology biosimilars and Enbrel.""}, {""date"": ""20230906104051"", ""headline"": ""Is Amgen A Worthy Investment Despite President Biden's Inflation Reduction Act?"", ""summary"": ""Amgen discovers, develops, manufactures, and delivers human therapeutics worldwide. Find out why we initiate our coverage of AMGN stock with a hold rating.""}, {""date"": ""20230906104906"", ""headline"": ""Amgen Inc. (AMGN) Wells Fargo Securities Healthcare Conference (Transcript)"", ""summary"": ""Amgen Inc. (NASDAQ:NASDAQ:AMGN) Wells Fargo Securities Healthcare Conference September 6, 2023 9:30 AM ETCompany ParticipantsArvind Sood - VP of IRPeter Griffith - EVP and CFOConference...""}, {""date"": ""20230906111403"", ""headline"": ""12 Best Healthcare ETFs To Buy"", ""summary"": ""In this article, we discuss 12 best healthcare ETFs. If you want to skip our discussion on the healthcare market, head directly to 5 Best Healthcare ETFs To Buy. In December 2022, BlackRock highlighted concerns about the performance for the healthcare sector in 2023. The previous year was rather challenging for equity and fixed income [\u2026]""}, {""date"": ""20230906211000"", ""headline"": ""Meet Bullfrog AI: Fly exclusive interview with CEO Vin Singh"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230906234000"", ""headline"": ""Amgen Inc. stock outperforms market on strong trading day"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230906234838"", ""headline"": ""HSBC Initiates Coverage of AMGEN (AMGN) with Buy Recommendation"", ""summary"": """"}, {""date"": ""20230907034600"", ""headline"": ""Thursday\u2019s Top Analyst Upgrades and Downgrades: American Airlines, Amgen, Block, Chewy, First Solar, Nvidia, Southwest Airlines and More"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230907073548"", ""headline"": ""Amgen: Not An Investment Mistake, But It Was Better Before"", ""summary"": ""Amgen's solid quarterly results and potential as a good investment are overshadowed by concerns over the Horizon acquisition and high debt levels. Learn more on AMGN stock here.""}, {""date"": ""20230907091616"", ""headline"": ""High Times Ties Up with Lucy Scientific in Going-Public Transaction on Nasdaq"", ""summary"": ""-High Times Holdings Corp. to exchange core IP assets for 19.9% stake in Lucy Scientific Discovery (NASDAQ: LSDI) plus milestone payments -Transaction creates liquidity opportunity for High Times shareholders who [\u2026]""}, {""date"": ""20230907114308"", ""headline"": ""Amgen Inc. (AMGN) Citi Global Healthcare Conference (Transcript)"", ""summary"": ""Amgen Inc. (NASDAQ:NASDAQ:AMGN) Citi Global Healthcare Conference September 7, 2023 1:00 PM ETCompany ParticipantsPeter Griffith - Executive Vice President and Chief Financial OfficerJustin...""}, {""date"": ""20230907130647"", ""headline"": ""Healthcare Stocks Push the Dow Higher"", ""summary"": ""Healthcare stocks were gaining Thursday, helping to raise the Dow, while the Nasdaq and S&P 500 dropped. Shares of Amgen (ticker: AMGN) gained 1.7% as the biotechnology stock was the second-best performer in the Dow Jones Industrial Average.""}, {""date"": ""20230907160000"", ""headline"": ""AMGEN TO PRESENT AT THE MORGAN STANLEY GLOBAL HEALTHCARE CONFERENCE"", ""summary"": ""Amgen (NASDAQ:AMGN) will present at the Morgan Stanley Global Healthcare Conference at 8:50 a.m. ET on Tuesday, Sept. 12, 2023. Robert A. Bradway, chairman and chief executive officer at Amgen will present at the conference. The webcast will be broadcast over the internet simultaneously and will be available to members of the news media, investors and the general public.""}, {""date"": ""20230907234000"", ""headline"": ""Amgen Inc. stock rises Friday, outperforms market"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230908053400"", ""headline"": ""How Is The Market Feeling About Amgen?"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230908095800"", ""headline"": ""Biotech Stock Roundup: MRNA's Vaccine Update, AMGN & HZNP Clear FTC Lawsuit & More"", ""summary"": ""Pipeline and regulatory updates from (MRNA) and Amgen (AMGN) are in focus in the biotech sector.""}, {""date"": ""20230908175017"", ""headline"": ""Amgen (AMGN) Outpaces Stock Market Gains: What You Should Know"", ""summary"": ""In the latest trading session, Amgen (AMGN) closed at $259.43, marking a +1.98% move from the previous day.""}, {""date"": ""20230909000052"", ""headline"": ""Banker glee does not tell the whole story on Lina Khan setbacks"", ""summary"": ""Settlement over Amgen $28bn acquisition shows the antitrust chief still won concessions to protect consumers""}, {""date"": ""20230909032000"", ""headline"": ""Charting The Moat Index's Long-Term Track Record"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230909080000"", ""headline"": ""Big Pharma\u2019s Battle With the Biden Administration Could Have Legs"", ""summary"": ""Wall Street should pay attention as the pharma industry mounts a widening legal campaign against the Inflation Reduction Act.""}, {""date"": ""20230909212600"", ""headline"": ""Oppenheimer Keeps Their Buy Rating on Amgen (AMGN)"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230909222400"", ""headline"": ""HSBC bullish on IQVIA, Zoetis, bluebird, Actinium; bearish on Gilead"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230910041500"", ""headline"": ""Amgen presents new LUMAKRAS plus chemotherapy data in first-line KRAS G12C NSCLC"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230910070000"", ""headline"": ""Eli Lilly, Novo to lead $100B weight loss drug market in 2030: JPMorgan"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230910090000"", ""headline"": ""AMGEN PRESENTS NEW LUMAKRAS\u00ae (SOTORASIB) PLUS CHEMOTHERAPY DATA IN FIRST-LINE KRAS G12C NSCLC AT WCLC"", ""summary"": ""Amgen (NASDAQ:AMGN) today announced exciting data from a study arm of the CodeBreaK 101 clinical trial, a Phase 1b study evaluating LUMAKRAS\u00ae (sotorasib) with carboplatin and pemetrexed in adult patients with KRAS G12C-mutated advanced non-small cell lung cancer (NSCLC). These results were featured in an oral presentation at the International Association for the Study of Lung Cancer (IASLC) 2023 World Conference on Lung Cancer (WCLC) in Singapore on Sunday, September 10.""}]",{}
35,2023-09-10,257.4060974121094,2023-09-17,258.68603515625,0.004972445318929042,U1,"[{""date"": ""20230909212600"", ""headline"": ""Oppenheimer Keeps Their Buy Rating on Amgen (AMGN)"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230909222400"", ""headline"": ""HSBC bullish on IQVIA, Zoetis, bluebird, Actinium; bearish on Gilead"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230910041500"", ""headline"": ""Amgen presents new LUMAKRAS plus chemotherapy data in first-line KRAS G12C NSCLC"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230910070000"", ""headline"": ""Eli Lilly, Novo to lead $100B weight loss drug market in 2030: JPMorgan"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230910090000"", ""headline"": ""AMGEN PRESENTS NEW LUMAKRAS\u00ae (SOTORASIB) PLUS CHEMOTHERAPY DATA IN FIRST-LINE KRAS G12C NSCLC AT WCLC"", ""summary"": ""Amgen (NASDAQ:AMGN) today announced exciting data from a study arm of the CodeBreaK 101 clinical trial, a Phase 1b study evaluating LUMAKRAS\u00ae (sotorasib) with carboplatin and pemetrexed in adult patients with KRAS G12C-mutated advanced non-small cell lung cancer (NSCLC). These results were featured in an oral presentation at the International Association for the Study of Lung Cancer (IASLC) 2023 World Conference on Lung Cancer (WCLC) in Singapore on Sunday, September 10.""}, {""date"": ""20230910222119"", ""headline"": ""September Self-Indexing Strategies For A Possible Blue October"", ""summary"": ""Magic Formula is still one of my favorite broad-based indexing strategies. Find out the top 30 dividend paying Magic Formula stocks scored for September 2023.""}, {""date"": ""20230910231200"", ""headline"": ""Amgen's sotorasib cancer therapy shows positive data in phase 1"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230910234000"", ""headline"": ""Amgen Inc. stock rises Monday, outperforms market"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230911023300"", ""headline"": ""Big Institutions Grab \u2018Strong Buy\u2019 Dividend Stocks in a Sector Not Totally Driven by AI"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230911030303"", ""headline"": ""Neumora Therapeutics to Sell 14.7 Million Shares at $16-$18 Each in IPO"", ""summary"": ""By Colin Kellaher Neumora Therapeutics, a clinical-stage biopharmaceutical company backed by Amgen, on Monday said it plans to sell 14.7 million shares at between $16 and $18 apiece in its...""}, {""date"": ""20230911030800"", ""headline"": ""Longeveron (NASDAQ: LGVN) Reports 100% 5-Year Survival In Trial For Rare Pediatric Disease HLHS (Compared To 80% Survival In Historical Trials) To Market"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230911043700"", ""headline"": ""Another Arthritis Blockbuster Drug Faces Generic Competition: Novartis' Sandoz Inks Pact With Samsung Bioepis"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230911060623"", ""headline"": ""AMGEN PRESENTS NEW LUMAKRAS PLUS CHEMOTHERAPY DATA IN FIRST-LINE KRAS G12C NSCLC AT WCLC"", ""summary"": ""THOUSAND OAKS - Amgen today announced exciting data from a study arm of the CodeBreaK 101 clinical trial, a Phase 1b study evaluating LUMAKRAS with carboplatin and pemetrexed in adult patients with...""}, {""date"": ""20230911061309"", ""headline"": ""FTC, States Agree On Path Forward For Amgen's Horizon Therapeutics Deal"", ""summary"": ""Settlement said to resolve anticompetitive concerns over critical drugs. The Federal Trade Commission and attorneys general from six states - California, Illinois, Minnesota, New York, Washington,...""}, {""date"": ""20230911080100"", ""headline"": ""Take the Zacks Approach to Beat the Market: Shopify, Novo Nordisk, Amgen in Focus"", ""summary"": ""Last week, our time-tested methodologies served investors well in navigating the market. Check out some of our achievements from the past three months.""}, {""date"": ""20230911143700"", ""headline"": ""Amgen Stock Earns Relative Strength Rating Upgrade; Hits Key Threshold"", ""summary"": ""The Relative Strength (RS) Rating for Amgen stock entered a new percentile Monday, with a rise from 75 to 81.  When looking for the best stocks to buy and watch, one factor to watch closely is relative price strength.  Is Amgen Stock A Buy?""}, {""date"": ""20230911160000"", ""headline"": ""AMGEN TO PRESENT AT THE BANK OF AMERICA MERRILL LYNCH GLOBAL HEALTHCARE CONFERENCE"", ""summary"": ""Amgen (NASDAQ:AMGN) will present at the Bank of America Merrill Lynch Global Healthcare Conference at 11:40 a.m. BST on Thursday, Sept. 14, 2023. Peter H. Griffith, executive vice president and chief financial officer at Amgen will present at the conference. The webcast will be broadcast over the internet simultaneously and will be available to members of the news media, investors and the general public.""}, {""date"": ""20230911234000"", ""headline"": ""Amgen Inc. stock underperforms Tuesday when compared to competitors"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230912025000"", ""headline"": ""Horizon Therapeutics ticks higher as Amgen end date extended until December"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230912040600"", ""headline"": ""Horizon Therapeutics ticks higher as Amgen end date extended until December (update)"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230912051000"", ""headline"": ""Dow's nearly 100-point drop led by losses for shares of Amgen, Procter & Gamble"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230912090006"", ""headline"": ""Investors Heavily Search Amgen Inc. (AMGN): Here is What You Need to Know"", ""summary"": ""Amgen (AMGN) has received quite a bit of attention from Zacks.com users lately. Therefore, it is wise to be aware of the facts that can impact the stock's prospects.""}, {""date"": ""20230912095804"", ""headline"": ""Amgen Inc. (AMGN) Morgan Stanley 21st Annual Global Healthcare Conference 2023 (Transcript)"", ""summary"": ""Amgen Inc. (NASDAQ:NASDAQ:AMGN) Morgan Stanley 21st Annual Global Healthcare Conference 2023 September 12, 2023 8:50 AM ETCompany ParticipantsRobert Bradway - Chairman and Chief Executive...""}, {""date"": ""20230912212252"", ""headline"": ""The 3 Most Undervalued Biotech Stocks to Buy in September 2023"", ""summary"": ""It\u2019s been a difficult time for biotechnology stocks. After a boom during the Covid-19 pandemic, the entire sector appears to have been abandoned by investors. The Standards and Practices (S&P) 500 Biotechnology Select Industry Index has declined 11% throughout the past 12 months and is down 18% throughout the last five years. Companies large and small have seen their stock prices slump as investor confidence in the industry wanes. Of course, hurdles surrounding prescription drug makers and medic""}, {""date"": ""20230912213600"", ""headline"": ""$1000 Invested In This Stock 15 Years Ago Would Be Worth $4,200 Today"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230912230835"", ""headline"": ""BBH: Our Favorite Biotech ETF Can Keep Outperforming"", ""summary"": ""VanEck Biotech ETF outperforms other industry ETFs due to its focus on large-cap leaders and the potential of AI in R&D programs. Read more on BBH ETF here.""}, {""date"": ""20230912234000"", ""headline"": ""Amgen Inc. stock underperforms Wednesday when compared to competitors"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230913103000"", ""headline"": ""2 Top Dividend Stocks to Buy in September"", ""summary"": ""If you're looking for dividend stocks that can provide steady income and growth potential, you might want to consider adding Amgen (NASDAQ: AMGN) and American Express (NYSE: AXP) to your portfolio.  Read on to find out more about these top-shelf dividend stocks.  Amgen is one of biotech's original pioneers, with a diversified portfolio of drugs and biosimilars that treat various diseases, such as cancer, cardiovascular, inflammation, and bone health.""}, {""date"": ""20230913222100"", ""headline"": ""FTC warns pharma industry on improperly listed patents"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230913234000"", ""headline"": ""Amgen Inc. stock rises Thursday, outperforms market"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230914004400"", ""headline"": ""3 Quality Dividend Stocks For A Bear Market"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230914010200"", ""headline"": ""Primecap Odyssey Funds' 2023 Semiannual Letter"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230914061832"", ""headline"": ""Amgen-partnered AI biotech startup brings in $273M"", ""summary"": ""A biotech startup using generative AI to create new, protein-based medicines has closed on a $273 million round as it looks to expand its reach.""}, {""date"": ""20230914070000"", ""headline"": ""Variants in the genome interact with each other and with the environment to affect risk of cardiovascular disease"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230914071700"", ""headline"": ""Dow's 320-point rally led by gains in shares of JPMorgan Chase, Amgen"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230914083316"", ""headline"": ""Nvidia, Amgen back AI-driven drug firm Generate:Biomedicines' $273 mln fundraise"", ""summary"": ""Drug developer Generate:Biomedicines, which uses artificial intelligence (AI) to find new treatments, said on Thursday it has raised $273 million from investors including Nvidia's venture capital arm and Amgen.  Generate \u2014 founded by venture firm Flagship Pioneering, which has incubated biotech companies, most famously Moderna Inc \u2014 uses AI to replace trial-and-error drug discovery methods and create novel protein-based therapeutics.  Generate is testing a monoclonal antibody therapy for COVID-19, its first therapy to reach human testing.""}, {""date"": ""20230914084929"", ""headline"": ""Should You Consider Selling Amgen (AMGN)?"", ""summary"": ""ClearBridge Investments, an investment management company, released its \u201cClearBridge Large Cap Value Strategy\u201d second quarter 2023 investor letter. A copy of the same can be downloaded here. The strategy outperformed its Russell 1000 Value Index benchmark in the second quarter. The strategy benefited from nine of the 11 sectors in which it was invested for [\u2026]""}, {""date"": ""20230914175017"", ""headline"": ""Amgen (AMGN) Outpaces Stock Market Gains: What You Should Know"", ""summary"": ""In the latest trading session, Amgen (AMGN) closed at $262.30, marking a +1.97% move from the previous day.""}, {""date"": ""20230914234000"", ""headline"": ""Amgen Inc. stock outperforms market despite losses on the day"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230915075100"", ""headline"": ""Amgen Unusual Options Activity"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}]",{}
36,2023-09-17,258.68603515625,2023-09-24,265.6116027832031,0.026772097004656548,U3,"[{""date"": ""20230918024900"", ""headline"": ""Amgen price target raised to $280 from $260 at Argus"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230918084659"", ""headline"": ""SCHD: Stop The Madness"", ""summary"": ""Schwab U.S. Dividend Equity ETF offers a combination of slow growth blue chip names with consistent dividend hikes. Click here for a detailed analysis on SCHD.""}, {""date"": ""20230918202438"", ""headline"": ""Argus Research Maintains AMGEN (AMGN) Buy Recommendation"", ""summary"": """"}, {""date"": ""20230918234000"", ""headline"": ""Amgen Inc. stock outperforms market on strong trading day"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230919003707"", ""headline"": ""Tracking John Paulson's Paulson & Company Portfolio - Q2 2023 Update"", ""summary"": ""John Paulson's 13F portfolio value decreased by 15% to $1.02B this quarter. Click here to read the portfolio's full Q2 2023 update.""}, {""date"": ""20230919014800"", ""headline"": ""Amgen Reaches Analyst Target Price"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230919101104"", ""headline"": ""Healthcare: FTC Chair Lina Khan to crack down on 'below radar' deals"", ""summary"": ""FTC Chair Lina Khan wants to help create more competition in the market and avoid monopolies.""}, {""date"": ""20230919175201"", ""headline"": ""FTC chair targets deals that have fallen in agency's 'blind spots'"", ""summary"": ""FTC chair Lina Khan has her sights focused on challenging mergers & acquisitions in the healthcare and tech sectors, specifically those valued under $100 million. Khan argues that these mergers can snowball into larger monopolies when left unchecked. Senior Reporter for Yahoo Finance Anjalee Khemlani joins to breakdown Lina Khan's recent statement at the Oliver Wyman Health Innovation Summit in Chicago.""}, {""date"": ""20230919235500"", ""headline"": ""Cantor Fitzgerald biotech analysts to hold an analyst/industry conference call"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230920071300"", ""headline"": ""IBM, Amgen share gains contribute to Dow's nearly 200-point jump"", ""summary"": ""The Dow Jones Industrial Average is climbing Wednesday morning with shares of IBM and Amgen delivering strong returns for the price-weighted average. The Dow...""}, {""date"": ""20230920072000"", ""headline"": ""Check Out What Whales Are Doing With AMGN"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230920100100"", ""headline"": ""Dow's nearly 100-point rally led by gains for shares of Amgen, IBM"", ""summary"": ""Shares of Amgen and IBM are trading higher Wednesday afternoon, propelling the Dow Jones Industrial Average into positive territory. Shares of Amgen and IBM...""}, {""date"": ""20230920123800"", ""headline"": ""Amgen Inc. stock outperforms competitors on strong trading day"", ""summary"": ""Shares of Amgen Inc. rallied 2.71% to $271.46 Wednesday, on what proved to be an all-around dismal trading session for the stock market, with the S&P 500...""}, {""date"": ""20230920135744"", ""headline"": ""Best Dividend Stocks: Amgen Hits Buy Point, Offers Solid Dividend Growth"", ""summary"": ""Shares of Amgen have broken out of a cup-with-handle base, another reason why income investors should consider the dividend stock.  The biotech company \u2014 headquartered in Thousand Oaks, Calif. \u2014 has an assortment of drugs used to treat cancer and autoimmune disorders.  Amgen is best known for it its rheumatoid arthritis drug Enbrel, which contributed 17% of sales last year.""}, {""date"": ""20230920160000"", ""headline"": ""AMGEN LAUNCHES PARTNERS OF CHOICE NETWORK OF EIGHT LEADING ONCOLOGY ACADEMIC CENTERS"", ""summary"": ""Amgen (NASDAQ:AMGN) today announced the launch of Amgen Partners of Choice, a new network that brings together Amgen's oncology research and development experts and world-class clinical leaders at eight research centers across the globe. As part of Amgen's mission to improve care through partnerships across the healthcare ecosystem, the network fosters academic collaboration to advance new treatment options for patients with the greatest unmet needs. The member institutions are:""}, {""date"": ""20230920193255"", ""headline"": ""Amgen (AMGN)'s True Worth: A Complete Analysis of Its Market Value"", ""summary"": ""Is Amgen (AMGN) fairly valued? Let's delve into its financials and growth prospects to find out.""}, {""date"": ""20230921041644"", ""headline"": ""Nicholas Ward's Dividend Growth Portfolio: September 2023 Fair Value Update"", ""summary"": ""I've been building my cash position in preparation for a market crash and taking advantage of high interest rates. Read more here.""}, {""date"": ""20230921093700"", ""headline"": ""2 Dividend Growth Stocks to Buy Right Now"", ""summary"": ""Dividends are great. They're a reliable source of passive income for retirees (and others) or can help boost long-term returns for investors who choose to reinvest them. But what happens when a company decreases or suspends its payouts? No investor wants to run into this problem.""}, {""date"": ""20230921175020"", ""headline"": ""Amgen (AMGN) Stock Moves -0.76%: What You Should Know"", ""summary"": ""In the latest trading session, Amgen (AMGN) closed at $269.41, marking a -0.76% move from the previous day.""}, {""date"": ""20230921180604"", ""headline"": ""Why Shares of Neumora Therapeutics Slumped This Week"", ""summary"": ""Shares of Neumora Therapeutics (NASDAQ: NMRA) were down more than 32% for the week as of Thursday's market close, according to data provided by\u00a0S&P Global Market Intelligence.  The clinical-stage biotech just went public last Friday via an initial public offering (IPO).  The company priced its IPO shares at $17 a share, but it opened last Friday at $16.50 and only rose to as high as $17.74.""}, {""date"": ""20230921214300"", ""headline"": ""BCBSM modifying weight loss drug coverage to require 'lifestyle modifications'"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230922010000"", ""headline"": ""INSIGHT-Big Pharma bets on AI to speed up clinical trials"", ""summary"": ""Major drugmakers are using artificial intelligence to find patients for clinical trials quickly, or to reduce the number of people needed to test medicines, both accelerating drug development and potentially saving millions of dollars.  Human studies are the most expensive and time-consuming part of drug development as it can take years to recruit patients and trial new medicines in a process that can cost over a billion dollars from the discovery of a drug to the finishing line.  Pharmaceutical companies have been experimenting with AI for years, hoping machines can discover the next blockbuster drug.""}, {""date"": ""20230922010402"", ""headline"": ""Big Pharma bets on AI to speed up clinical trials"", ""summary"": ""Major drugmakers are using artificial intelligence to find patients for clinical trials quickly, or to reduce the number of people needed to test medicines, both accelerating drug development and potentially saving millions of dollars.  Human studies are the most expensive and time-consuming part of drug development as it can take years to recruit patients and trial new medicines in a process that can cost over a billion dollars from the discovery of a drug to the finishing line.  Pharmaceutical companies have been experimenting with AI for years, hoping machines can discover the next blockbuster drug.""}, {""date"": ""20230922025400"", ""headline"": ""From Years to Months: How AI is Shaping the Landscape of Clinical Trials"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230922075600"", ""headline"": ""AI To Revolutionize Clinical Trials And Diagnostics"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230922123800"", ""headline"": ""Amgen Inc. stock outperforms competitors despite losses on the day"", ""summary"": ""Shares of Amgen Inc. slumped 0.63% to $267.70 Friday, on what proved to be an all-around poor trading session for the stock market, with the S&P 500 Index...""}, {""date"": ""20230923233210"", ""headline"": ""Patience Is The Name Of This (Market) Game"", ""summary"": ""Market weakness continues due to concerns about the Fed and interest rates. Read why market weakness during earnings quiet periods may present buying opportunities.""}, {""date"": ""20230924000500"", ""headline"": ""The Hedge Fund That Made a Killing Betting Against Lina Khan"", ""summary"": ""The efforts by Federal Trade Commission Chair Lina Khan to protect Main Street are inadvertently enriching some on Wall Street, generating outsize profits for Pentwater Capital Management and other large hedge funds that bet on merger deals.  In both cases, the FTC\u2019s intervention spooked investors and sent shares of the target companies swinging.""}, {""date"": ""20230924080600"", ""headline"": ""GLP-1 drugs may already be impacting aesthetics sectors, survey finds"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230924193331"", ""headline"": ""Kyowa Kirin: High-Risk High-Return Call Reiterating Our Buy Rating"", ""summary"": ""Kyowa Kirin's recent track record for new drug trial success has been poor, but the partnership with Amgen provides reassurance. Read why KYKOF stock is a Buy.""}]",{}
37,2023-09-24,265.6116027832031,2023-10-01,266.663330078125,0.003959643644710464,U1,"[{""date"": ""20230923233210"", ""headline"": ""Patience Is The Name Of This (Market) Game"", ""summary"": ""Market weakness continues due to concerns about the Fed and interest rates. Read why market weakness during earnings quiet periods may present buying opportunities.""}, {""date"": ""20230924000500"", ""headline"": ""The Hedge Fund That Made a Killing Betting Against Lina Khan"", ""summary"": ""The efforts by Federal Trade Commission Chair Lina Khan to protect Main Street are inadvertently enriching some on Wall Street, generating outsize profits for Pentwater Capital Management and other large hedge funds that bet on merger deals.  In both cases, the FTC\u2019s intervention spooked investors and sent shares of the target companies swinging.""}, {""date"": ""20230924080600"", ""headline"": ""GLP-1 drugs may already be impacting aesthetics sectors, survey finds"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230924193331"", ""headline"": ""Kyowa Kirin: High-Risk High-Return Call Reiterating Our Buy Rating"", ""summary"": ""Kyowa Kirin's recent track record for new drug trial success has been poor, but the partnership with Amgen provides reassurance. Read why KYKOF stock is a Buy.""}, {""date"": ""20230924224000"", ""headline"": ""FDA Strikes Off Coherus BioSciences' New Injector Biosimilar Treatment For Cancer Patients"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230925020100"", ""headline"": ""Analysts\u2019 Top Healthcare Picks: Cytokinetics (CYTK), Amgen (AMGN)"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230925075000"", ""headline"": ""Beat the Market Like Zacks: Elementis, Novo Nordisk, Amgen in Focus"", ""summary"": ""Last week, our time-tested methodologies served investors well in navigating the market. Check out some of our achievements from the past three months.""}, {""date"": ""20230925090007"", ""headline"": ""Amgen Inc. (AMGN) Is a Trending Stock: Facts to Know Before Betting on It"", ""summary"": ""Amgen (AMGN) has been one of the stocks most watched by Zacks.com users lately. So, it is worth exploring what lies ahead for the stock.""}, {""date"": ""20230925123800"", ""headline"": ""Amgen Inc. stock falls Monday, underperforms market"", ""summary"": ""Shares of Amgen Inc. shed 0.31% to $266.86 Monday, on what proved to be an all-around positive trading session for the stock market, with the S&P 500 Index...""}, {""date"": ""20230925130206"", ""headline"": ""Dow Jones Biotech Giant Amgen, Meta Stock, Eye Buy Points In Stock Market Correction"", ""summary"": ""Dow Jones biotech leader Amgen and Meta stock are among the best stocks to watch in today's stock market action.""}, {""date"": ""20230926043800"", ""headline"": ""Wall Street analysts expect the S&P 500 to rise 19% over the next 12 months. Here are their 10 favorite stocks."", ""summary"": ""Outside of a handful of highflying technology stocks, U.S. stocks have been practically flat in 2023, but on Wall Street, some analysts remain as bullish as...""}, {""date"": ""20230926081800"", ""headline"": ""Akebia gains as Australia clears kidney disease therapy"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230926082020"", ""headline"": ""Big Pharma R&D Spending: The Secret Ingredient To Outperformance?"", ""summary"": ""High R&D spending by pharma companies does not necessarily lead to sales growth, let alone shareholder returns. See why bold M&A deals may be a different story.""}, {""date"": ""20230926123800"", ""headline"": ""Amgen Inc. stock rises Tuesday, outperforms market"", ""summary"": ""Shares of Amgen Inc. inched 0.82% higher to $269.04 Tuesday, on what proved to be an all-around poor trading session for the stock market, with the S&P 500...""}, {""date"": ""20230926210800"", ""headline"": ""Are We in a New Golden Age of Merger Arbitrage?"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230927043600"", ""headline"": ""Amgen discloses more than $400 million stake in recent IPO Neumora Therapeutics"", ""summary"": ""An Amgen disclosure of a large stake in Neumora Therapeutics indicated the value of its investment in the biotech, which recently went public, has tripled.""}, {""date"": ""20230927060000"", ""headline"": ""Amgen Could Get a Piece of the Obesity Market"", ""summary"": ""Amgen has a couple of shots on goal to break into one of the biggest markets the pharmaceutical industry has ever seen.""}, {""date"": ""20230927071000"", ""headline"": ""September's Shakeout: S&P 500, Nasdaq 100 See Just 13% Of Stocks Above 50-Day Average"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230927123700"", ""headline"": ""Amgen Inc. stock falls Wednesday, underperforms market"", ""summary"": ""Shares of Amgen Inc. shed 0.02% to $268.98 Wednesday, on what proved to be an all-around mixed trading session for the stock market, with the S&P 500 Index...""}, {""date"": ""20230927180020"", ""headline"": ""Amgen (AMGN) Stock Sinks As Market Gains: What You Should Know"", ""summary"": ""In the latest trading session, Amgen (AMGN) closed at $268.98, marking a -0.02% move from the previous day.""}, {""date"": ""20230927211400"", ""headline"": ""FDA Oncologic Drugs Advisory Committee holds virtual meeting"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230927232300"", ""headline"": ""Mirati stock climbs 10% ahead of data presentation, FDA meeting on rival drug"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230927233300"", ""headline"": ""Teva names Novartis exec to lead US commercial business"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230928050000"", ""headline"": ""Earn Double-Digit Income With Options (October 2023)"", ""summary"": ""Earning a decent income from investments higher than the inflation rate is challenging. Check out how we formulate a sustainable and repeatable options income strategy.""}, {""date"": ""20230928084504"", ""headline"": ""3 Biotech Stocks to Watch Ahead of Potential Obesity Drug Approvals"", ""summary"": ""The companies that already have obesity drugs can\u2019t keep up with the demand for their treatments, and the demand for the drugs is only likely to become more intense. That\u2019s because over 42% of the U.S. population was obese as of 2020, while the pervasive publicity around these drugs will make them more popular, and the social and political pressure for insurers to cover the treatments will become more intense. This has led to the rise of biotech stocks to buy. More specifically on the last point""}, {""date"": ""20230928085500"", ""headline"": ""DBS Remains a Buy on Amgen (AMGN)"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230928110015"", ""headline"": ""The Anti-obesity Drug Market Is About to Get More Crowded"", ""summary"": ""Obesity is an epidemic that affects more than 40% of all American adults, and it's creating a feeding frenzy for investors. With the rise of...""}, {""date"": ""20230928123700"", ""headline"": ""Amgen Inc. stock rises Thursday, outperforms market"", ""summary"": ""Shares of Amgen Inc. inched 0.68% higher to $270.82 Thursday, on what proved to be an all-around favorable trading session for the stock market, with the S&P...""}, {""date"": ""20230928175017"", ""headline"": ""Amgen (AMGN) Outpaces Stock Market Gains: What You Should Know"", ""summary"": ""In the latest trading session, Amgen (AMGN) closed at $270.82, marking a +0.68% move from the previous day.""}, {""date"": ""20230928210900"", ""headline"": ""Check Out What Whales Are Doing With AMGN"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230928220400"", ""headline"": ""Catalyst Watch: Tesla deliveries, Google event, Kellogg spinoff, Amgen drama and Ether ETFs"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230929021200"", ""headline"": ""GLP-1 drug developer Carmot Therapeutics reportedly mulling IPO or buyout"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230929052100"", ""headline"": ""As Merck, AstraZeneca and other drugmakers sign on, Medicare price negotiations face critical moment"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230929062000"", ""headline"": ""As Merck, AstraZeneca and other drugmakers sign on, Medicare price negotiations face critical moment\u00a0"", ""summary"": ""A deadline looms to sign drug-price negotiation agreements as industry watches for legal reprieve.""}, {""date"": ""20230929075100"", ""headline"": ""AskSlim Market Week - Friday, Sep. 29"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230929093400"", ""headline"": ""Amgen Stock Was a Winner in the Third Quarter. These Solar Shares Weren\u2019t."", ""summary"": ""Amgen was the best-performing stock in the Dow Jones Industrial Average in the third quarter, while Zions Bancorp, up 30%, was the top stock in the S&P 500.""}, {""date"": ""20230929123800"", ""headline"": ""Amgen Inc. stock falls Friday, underperforms market"", ""summary"": ""Shares of Amgen Inc. dropped 0.76% to $268.76 Friday, on what proved to be an all-around dismal trading session for the stock market, with the S&P 500 Index...""}, {""date"": ""20230929133400"", ""headline"": ""Amgen Stock Was a Winner in the Third Quarter. These Solar Shares Were Not."", ""summary"": ""Amgen was the best-performing stock in both the Dow Jones Industrial Average and Nasdaq 100 in the third quarter, while Zions Bancorp, up 32%, was the top stock in the S&P 500.""}]","{""assetTurnoverTTM"": 0.3207, ""bookValue"": 7656, ""cashRatio"": 2.0491329479768785, ""currentRatio"": 2.8593, ""ebitPerShare"": 3.8848, ""eps"": 3.2156, ""ev"": 168202.84, ""fcfMargin"": 0.3639, ""fcfPerShareTTM"": 17.5308, ""grossMargin"": 0.7385, ""inventoryTurnoverTTM"": 1.4407, ""longtermDebtTotalAsset"": 0.6521, ""longtermDebtTotalCapital"": 0.8667, ""longtermDebtTotalEquity"": 7.7116, ""netDebtToTotalCapital"": 0.3776, ""netDebtToTotalEquity"": 3.3604, ""netMargin"": 0.2506, ""operatingMargin"": 0.3028, ""payoutRatioTTM"": 0.589, ""pb"": 18.6097, ""peTTM"": 18.8311, ""pfcfTTM"": 15.1909, ""pretaxMargin"": 0.2821, ""psTTM"": 5.3097, ""quickRatio"": 2.5629, ""receivablesTurnoverTTM"": 4.6784, ""roaTTM"": 0.0904, ""roeTTM"": 1.2908, ""roicTTM"": 0.123, ""rotcTTM"": 0.147, ""salesPerShare"": 12.8309, ""sgaToSale"": 0.2615, ""totalDebtToEquity"": 7.8981, ""totalDebtToTotalAsset"": 0.6679, ""totalDebtToTotalCapital"": 0.8876, ""totalRatio"": 1.0924, ""period"": ""2023-09-30""}"
38,2023-10-01,266.663330078125,2023-10-08,265.38336181640625,-0.00479994103930137,D1,"[{""date"": ""20231001220100"", ""headline"": ""Drugmakers comply with Medicare pricing talks despite lawsuits"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20231001234500"", ""headline"": ""Horizon Therapeutics ticks higher amid Nasdaq delisting notice for sale to Amgen"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20231002065500"", ""headline"": ""Amgen price target raised to $230 from $210 at Barclays"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20231002123800"", ""headline"": ""Amgen Inc. stock underperforms Monday when compared to competitors"", ""summary"": ""Shares of Amgen Inc. slid 0.91% to $266.31 Monday, on what proved to be an all-around mixed trading session for the stock market, with the S&P 500 Index...""}, {""date"": ""20231002124952"", ""headline"": ""Drugmakers sign on to negotiate Medicare prices under protest"", ""summary"": ""All the drugmakers that make the 10 prescription medicines  subject to the first-ever price negotiations for the U.S. Medicare health program, including Amgen and Novartis, said they signed on to participate in the talks by the Oct. 1 deadline.  The penalties for not doing so would have been steep: drugmakers would have to pay 65% to 95% taxes on their drug's Medicare sales or withdraw all of their products from the Medicare and Medicaid programs, which together provide health benefits to 158 million Americans.  \""Merck will sign the initial agreement with CMS under protest,\"" the U.S. company said in a statement.""}, {""date"": ""20231002223500"", ""headline"": ""Is Amgen's Lung Cancer Drug Lumakras Up to the Mark? FDA Briefing Raises Concerns"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20231002234200"", ""headline"": ""Jones Research sees Amgen FDA issues reading through to Mirati"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20231003010000"", ""headline"": ""Dive Into Dividends: 14 Must-Have Stocks When Markets Dip"", ""summary"": ""Investors want income-producing investments amid rising interest and costs. Click here to learn about 14 Dividend Stocks with yield and strong dividend growth rates.""}, {""date"": ""20231003043600"", ""headline"": ""FDA staff voice concerns about whether Amgen's CodeBreaK 200 trial 'adequate'"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20231003074400"", ""headline"": ""Bad news for Amgen could be 'good' for Mirati Therapeutics, says Stifel"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20231003080000"", ""headline"": ""Drugmakers agree to US government price talks amid pushback"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20231003080700"", ""headline"": ""Amgen stock dips after FDA reveals concerns about Lumakras study"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20231003083900"", ""headline"": ""Drugmakers Agree To Participate For Medicare Drug Price Negotiation With Biden Administration"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20231003094830"", ""headline"": ""UPDATE 3-Amgen's late-stage data for lung cancer drug 'not adequate' - FDA staff"", ""summary"": ""The U.S. Food and Drug Administration staff reviewers said on Tuesday Amgen's late-stage study might not be sufficient to confirm the effectiveness for its lung cancer drug, as the firm pursues a traditional nod for the treatment.  Lumakras, which bought in sales of $285 million last year, targets a mutated form of a gene known as KRAS that occurs in about 13% of non-small cell lung cancers - the most common form of the disease.  Amgen's drug was granted accelerated approval by the U.S. FDA in 2021 for advanced lung cancer patients with KRAS mutations whose disease has worsened after treatment with chemotherapy or other medicines.""}, {""date"": ""20231003100806"", ""headline"": ""The 10 pharma companies participating in Medicare price negotiations"", ""summary"": ""Ten pharmaceutical manufacturers are signing the Inflation Reduction Act's Medicare drug price negotiation program. These companies are Bristol Myers Squibb (BMY), AstraZeneca (AZN), Boehringer Ingelheim, Immunex, Janssen Pharmaceuticals, Pharmacyclics, Merck & Company (MRK), Janssen Biotech, Novartis (NVS), and Novo Nordisk (NVO), according to the Biden administration. Yahoo Finance Health Care Reporter Anjalee Khemlani discusses the news. For more expert insight and the latest market action, click here to watch this full episode of Yahoo Finance Live.""}, {""date"": ""20231003121614"", ""headline"": ""October Dogs Of The Dow: 3 Buyable, 7 Watchable"", ""summary"": ""Discover how the Dow Jones adds and selects stocks, the highest-yielding stocks in October, and the leading performers in the Dow Industrial Index. Click for more.""}, {""date"": ""20231003123800"", ""headline"": ""Amgen Inc. stock falls Tuesday, underperforms market"", ""summary"": ""Shares of Amgen Inc. slipped 1.99% to $261.01 Tuesday, on what proved to be an all-around grim trading session for the stock market, with the S&P 500 Index...""}, {""date"": ""20231003222700"", ""headline"": ""Dow rallies nearly 100 points on gains in shares of Microsoft, Amgen"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20231003233900"", ""headline"": ""Amgen Inc. stock outperforms market on strong trading day"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20231004021100"", ""headline"": ""Analysts Offer Insights on Healthcare Companies: Amgen (AMGN) and Intellia Therapeutics (NTLA)"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20231004050011"", ""headline"": ""Gilead Sciences: A Healthy Buy With Solid Dividend"", ""summary"": ""Gilead Sciences has outperformed the S&P 500 with a 19% total return since my last Buy rating in August last year. Learn why GILD stock is a buy.""}, {""date"": ""20231004051000"", ""headline"": ""Should You Still Buy the Dow Jones' Best-Performing September Stocks?"", ""summary"": ""A handful of blue-chip tickers defied the bigger bearish tide last month, but that doesn't necessarily make these stocks a buy.""}, {""date"": ""20231004110000"", ""headline"": ""Large-scale proteomics in population-based studies from UK and Iceland"", ""summary"": ""In a paper released today, deCODE Genetics' scientists shared their findings from a plasma proteomics study performed using affinity-based methods. They analyzed the proteins in the context of diseases and diversity in the sequence of the genome and compared measurements made using two platforms of thousands of proteins in samples from large groups from the UK Biobank and Iceland.""}, {""date"": ""20231004155500"", ""headline"": ""Top Research Reports for Amgen, ServiceNow & RTX"", ""summary"": ""Today's Research Daily features new research reports on 16 major stocks, including Amgen Inc. (AMGN), ServiceNow, Inc. (NOW) and RTX Corporation (RTX).""}, {""date"": ""20231004180019"", ""headline"": ""Amgen (AMGN) Surpasses Market Returns: Some Facts Worth Knowing"", ""summary"": ""Amgen (AMGN) reachead $265.44 at the closing of the latest trading day, reflecting a +1.7% change compared to its last close.""}, {""date"": ""20231004190011"", ""headline"": ""Pharma Giants Combine Forces to Fight New M&A Rules"", ""summary"": ""Meet the anti-antitrust coalition. With a looming overhaul of US merger-and-acquisition law set to reshape the economics of the M&A-heavy...""}, {""date"": ""20231004221800"", ""headline"": ""FDA panel finds results from key Amgen Lumakras study unreliable"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20231004224100"", ""headline"": ""Analysts Offer Insights on Healthcare Companies: Intellia Therapeutics (NTLA), Veralto Corporation (VLTO) and Amgen (AMGN)"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20231004233900"", ""headline"": ""Amgen Inc. stock underperforms Thursday when compared to competitors"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20231005024600"", ""headline"": ""Horizon Therapeutics announces acquisition by Amgen approved in Ireland"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20231005025000"", ""headline"": ""Amgen wins Irish approval for planned Horizon Therapeutics purchase"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20231005035500"", ""headline"": ""FDA Oncologic Drugs Advisory Committee holds virtual meeting"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20231005045100"", ""headline"": ""Analysts Offer Insights on Healthcare Companies: Amgen (AMGN), Regeneron (REGN) and Alnylam Pharma (ALNY)"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20231005071600"", ""headline"": ""The Zacks Analyst Blog Highlights Amgen, ServiceNow, RTX, Automatic Data Processing and Canadian Pacific Kansas City"", ""summary"": ""Amgen, ServiceNow, RTX, Automatic Data Processing and Canadian Pacific Kansas City are included in this Analyst Blog.""}, {""date"": ""20231005075300"", ""headline"": ""Mirati stock up 9% amid FDA meeting on rival Amgen drug"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20231005145708"", ""headline"": ""UPDATE 2-US FDA panel says Amgen lung cancer drug data cannot be relied on"", ""summary"": ""Advisers to the U.S. Food and Drug Administration on Thursday found that data from a late-stage trial of Amgen's Lumakras could not be relied on, raising questions about the agency's upcoming decision on whether to grant traditional approval of the drug for a type of advanced lung cancer.  The drug was approved by the FDA in 2021 under an accelerated pathway, with confirmatory data a condition for gaining traditional approval.  The main goal of the confirmatory study was progression-free survival (PFS), or how long before the disease begins to worsen, but the FDA questioned some methods used in conducting the trial.""}, {""date"": ""20231005213800"", ""headline"": ""Biotech Sector: On The Verge Of Triumph Or Turmoil?"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20231005222800"", ""headline"": ""Here\u2019s Why Mirati Therapeutics Stock (NASDAQ:MRTX) Soared Yesterday"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20231005233000"", ""headline"": ""Confirmatory Trial Trouble In KRAS"", ""summary"": ""I wrote last year about KRAS-targeting drugs as cancer therapies, and that pretty much means G12C-KRAS targeting ones.""}, {""date"": ""20231005233900"", ""headline"": ""Amgen Inc. stock rises Friday, still underperforms market"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20231006022200"", ""headline"": ""Analysts Offer Insights on Healthcare Companies: Immunic (IMUX), Amgen (AMGN) and Neurocrine (NBIX)"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20231006025200"", ""headline"": ""Mirati Therapeutics price target raised to $72 from $31 at BMO Capital"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20231006030800"", ""headline"": ""Negative Amgen AdCom a positive for Mirati, says Jefferies"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20231006033300"", ""headline"": ""Amgen completes acquisition of Horizon Therapeutics"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20231006040100"", ""headline"": ""FDA Adcomm Gives Thumbs Down To Amgen's Lumakras For Advanced Form Of Lung Cancer"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20231006041100"", ""headline"": ""Analysts Are Bullish on These Healthcare Stocks: United Therapeutics (UTHR), Amgen (AMGN)"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20231006041200"", ""headline"": ""Amgen completes $27.8B acquisition of Horizon Therapeutics"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20231006043600"", ""headline"": ""Amgen to continue to seek full approval of Lumakras cancer drug after FDA panel criticizes trial"", ""summary"": ""Amgen will continue to seek full approval for its Lumakras cancer drug as a treatment for a form of lung cancer.""}, {""date"": ""20231006052300"", ""headline"": ""Amgen completes USD28 billion acquisition of Horizon Therapeutics"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20231006072400"", ""headline"": ""FDA AdCom Gives Thumbs Down To Late-Stage Data For Amgen's Lumakras In Advanced Form Of Lung Cancer (UPDATED)"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20231006074700"", ""headline"": ""Amgen's Adcomm Meeting Paves Way To Launch Boost For Mirati Therapeutics' Lung Cancer Drug: Analysts"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20231006083000"", ""headline"": ""AMGEN COMPLETES ACQUISITION OF HORIZON THERAPEUTICS PLC"", ""summary"": ""Amgen (NASDAQ: AMGN) today announced that it has completed its acquisition of Horizon Therapeutics plc for $116.50 per share in cash, representing a transaction equity value of approximately $27.8 billion.""}, {""date"": ""20231006090006"", ""headline"": ""Amgen Inc. (AMGN) is Attracting Investor Attention: Here is What You Should Know"", ""summary"": ""Recently, Zacks.com users have been paying close attention to Amgen (AMGN). This makes it worthwhile to examine what the stock has in store.""}, {""date"": ""20231006091100"", ""headline"": ""UPDATE 2-Amgen completes $27.8 bln Horizon Therapeutics deal"", ""summary"": ""Amgen said on Friday it had completed the $27.8 billion acquisition of Horizon Therapeutics after it received the go-ahead from the U.S. Federal Trade Commission (FTC) last month on certain conditions.  Under the settlement terms with the FTC following its lawsuit to block the deal, Amgen is prevented from using anti-competitive tactics to extend the market dominance of Horizon's fast-growing thyroid eye disease treatment Tepezza and gout drug Krystexxa.  The FTC's antitrust lawsuit had raised concerns over increased oversight on mergers and acquisitions in a sector that often turns to consolidation to power future growth as patents on older treatments expire.""}, {""date"": ""20231006091816"", ""headline"": ""Amgen completes $27.8 billion Horizon Therapeutics deal"", ""summary"": ""Under the settlement terms with the FTC following its lawsuit to block the deal, Amgen is prevented from using anti-competitive tactics to extend the market dominance of Horizon's fast-growing thyroid eye disease treatment Tepezza and gout drug Krystexxa.  The FTC's antitrust lawsuit had raised concerns over increased oversight on mergers and acquisitions in a sector that often turns to consolidation to power future growth as patents on older treatments expire.  The deal closure was within the fourth-quarter timeline set by the two companies, and is expected to add to Amgen's adjusted earnings from next year.""}, {""date"": ""20231006113400"", ""headline"": ""Mirati (MRTX) Surges 45% as Sanofi Reportedly Eyes Buyout"", ""summary"": ""A Bloomberg article suggests that pharma giant Sanofi (SNY) is exploring a potential acquisition deal for small cancer drugmaker Mirati Therapeutics (MRTX).""}, {""date"": ""20231006140647"", ""headline"": ""Hedge Funds Won Big on Bets Amgen-Horizon Deal Would Go Through"", ""summary"": ""(Bloomberg) -- Hedge funds Pentwater Capital Management, HBK Investments and Farallon Capital Management are reaping a windfall from bets that US regulators wouldn\u2019t be able to stop Amgen Inc. from completing its $28 billion takeover of Horizon Therapeutics Plc. Most Read from BloombergThe 5% Bond Market Means Pain Is Heading Everyone\u2019s WayThe Moral Case for No Longer Engaging With Elon Musk\u2019s XFake Mansions and Rent-Stabilized Units Emerge in Trump TrialCorporate America Is Ignoring Jay Powell""}, {""date"": ""20231006140948"", ""headline"": ""Biotech-Pharma Trade: Buying Opportunities On The Horizon"", ""summary"": ""Concerns over interest rates, pricing erosion, and Medicare's drug price negotiation plan weigh on biotech and pharma sectors. Learn what investors need to know.""}, {""date"": ""20231006175021"", ""headline"": ""Amgen (AMGN) Increases Yet Falls Behind Market: What Investors Need to Know"", ""summary"": ""Amgen (AMGN) closed at $267.47 in the latest trading session, marking a +0.9% move from the prior day.""}, {""date"": ""20231007222300"", ""headline"": ""As FDA mulls fate of Amgen drug, Sanofi could snap up rival Mirati"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20231008075801"", ""headline"": ""SCHD: A Magnificent Buy At This Time"", ""summary"": ""The Schwab U.S. Dividend Equity ETF holds well-diversified, high-quality stocks with economies of scale. Explore more details here.""}]","{""assetTurnoverTTM"": 0.3207, ""bookValue"": 7656, ""cashRatio"": 2.0491329479768785, ""currentRatio"": 2.8593, ""ebitPerShare"": 3.8848, ""eps"": 3.2156, ""ev"": 168202.84, ""fcfMargin"": 0.3639, ""fcfPerShareTTM"": 17.5308, ""grossMargin"": 0.7385, ""inventoryTurnoverTTM"": 1.4407, ""longtermDebtTotalAsset"": 0.6521, ""longtermDebtTotalCapital"": 0.8667, ""longtermDebtTotalEquity"": 7.7116, ""netDebtToTotalCapital"": 0.3776, ""netDebtToTotalEquity"": 3.3604, ""netMargin"": 0.2506, ""operatingMargin"": 0.3028, ""payoutRatioTTM"": 0.589, ""pb"": 18.6097, ""peTTM"": 18.8311, ""pfcfTTM"": 15.1909, ""pretaxMargin"": 0.2821, ""psTTM"": 5.3097, ""quickRatio"": 2.5629, ""receivablesTurnoverTTM"": 4.6784, ""roaTTM"": 0.0904, ""roeTTM"": 1.2908, ""roicTTM"": 0.123, ""rotcTTM"": 0.147, ""salesPerShare"": 12.8309, ""sgaToSale"": 0.2615, ""totalDebtToEquity"": 7.8981, ""totalDebtToTotalAsset"": 0.6679, ""totalDebtToTotalCapital"": 0.8876, ""totalRatio"": 1.0924, ""period"": ""2023-09-30""}"
39,2023-10-08,265.38336181640625,2023-10-15,281.8836364746094,0.06217524167780386,U5+,"[{""date"": ""20231007222300"", ""headline"": ""As FDA mulls fate of Amgen drug, Sanofi could snap up rival Mirati"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20231008075801"", ""headline"": ""SCHD: A Magnificent Buy At This Time"", ""summary"": ""The Schwab U.S. Dividend Equity ETF holds well-diversified, high-quality stocks with economies of scale. Explore more details here.""}, {""date"": ""20231009020315"", ""headline"": ""14 Best Cancer Stocks To Buy Now"", ""summary"": ""In this article, we discuss 14 best cancer stocks to buy. If you want to skip our detailed discussion on the oncology industry, head directly to 5 Best Cancer Stocks To Buy Now. The global oncology landscape continues to evolve, with ongoing efforts to discover, develop, and provide innovative treatments aimed at improving outcomes for [\u2026]""}, {""date"": ""20231009021500"", ""headline"": ""GCOW: An ETF for Dividend and Free Cash Flow Lovers"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20231009025202"", ""headline"": ""TPHD: A Dividend ETF With Biblical Aspirations"", ""summary"": ""Timothy Plan High Dividend Stock ETF holds mostly mid-cap stocks with industrials, utilities, and energy appearing as top sectors. Find out why TPHD is a Buy.""}, {""date"": ""20231009070600"", ""headline"": ""$100 Invested In This Stock 15 Years Ago Would Be Worth $500 Today"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20231009081300"", ""headline"": ""Will more bidders emerge or CVR ever be paid in Mirati takeover deal?"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20231009094900"", ""headline"": ""Coherus (CHRS) Stock Rises on BLA Re-Filing for Udenyca Onbody"", ""summary"": ""Coherus (CHRS) resubmits biologics license application for Udenyca Onbody, an on-body injector presentation of Udenyca to the FDA. Stock rises.""}, {""date"": ""20231009100100"", ""headline"": ""Mirati (MRTX) Gets Buyout Offer From Bristol Myers for $4.8B"", ""summary"": ""Sanofi (SNY) is set to acquire Mirati (MRTX) for $58 per share in cash along with a contingent value right of $12 per share, tied to a regulatory milestone.""}, {""date"": ""20231009101500"", ""headline"": ""2 Magnificent Dividend Stocks to Buy Hand Over Fist in October"", ""summary"": ""Investing in stocks may not look particularly appealing at the moment, given that the 10-year U.S. Treasury bond is offering a near 5% annualized yield.  The drugmaker also sports a moderate cash payout ratio of 42%, implying that it can comfortably support additional increases to the dividend in the years ahead.""}, {""date"": ""20231009204113"", ""headline"": ""Oppenheimer Maintains AMGEN (AMGN) Outperform Recommendation"", ""summary"": """"}, {""date"": ""20231010020700"", ""headline"": ""Neumora Therapeutics appoints Lenz as EVP, Head of Research, Development"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20231010050000"", ""headline"": ""SCHD: Still My Favorite Stagflation Hedge"", ""summary"": ""Schwab U.S. Dividend Equity ETF is an excellent hedge against possible stagflation due to its focus on dividends. Read why SCHD ETF is my stagflation hedge.""}, {""date"": ""20231010051400"", ""headline"": ""Video: Dow Movers: AMGN, KO"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20231010065300"", ""headline"": ""Should You Still Buy the Nasdaq's Best-Performing September Stocks?"", ""summary"": ""Stocks pulled back in September, primarily due to the Federal Reserve forecast that rates would stay higher for longer.  Unsurprisingly, the Nasdaq Composite took the news worse than the other two major indexes, as shown in the chart below.  Let's take a look at the three top performers on the Nasdaq to see whether any are worth buying.""}, {""date"": ""20231010082738"", ""headline"": ""High Yield Stock Watchlist - October 2023"", ""summary"": ""The majority of the stocks on my watchlist are undervalued based on dividend yield theory. Read more here.""}, {""date"": ""20231010113614"", ""headline"": ""Amgen (AMGN) Valuation: A Comprehensive Analysis of Its Market Value"", ""summary"": ""A deep dive into the intrinsic value and financial performance of Amgen Inc (AMGN)""}, {""date"": ""20231010123800"", ""headline"": ""Amgen Inc. stock falls Tuesday, underperforms market"", ""summary"": ""Shares of Amgen Inc. slipped 0.11% to $271.25 Tuesday, on what proved to be an all-around great trading session for the stock market, with the S&P 500 Index...""}, {""date"": ""20231010232900"", ""headline"": ""What You Missed On Wall Street on Wednesday"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20231011004500"", ""headline"": ""These Stocks Are Moving the Most Today: Exxon, Pioneer Natural, Silk Road Medical, DaVita, Amgen, Lilly, and More"", ""summary"": ""Exxon Mobil to purchase shale-drilling company Pioneer Natural Resources for $59.5 billion in stock, Silk Road Medical reduces full-year revenue guidance,...""}, {""date"": ""20231011013500"", ""headline"": ""Amgen upgraded to Outperform from Market Perform at Leerink"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20231011014600"", ""headline"": ""Analysts Conflicted on These Healthcare Names: Baxter International (BAX), Amgen (AMGN) and Alnylam Pharma (ALNY)"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20231011015000"", ""headline"": ""Amgen resumed with a Neutral at BofA"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20231011021100"", ""headline"": ""Axsome Therapeutics appoints Mahony to board of directors"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20231011034800"", ""headline"": ""Amgen\u2019s cancer-drug pipeline looks promising despite FDA setback, analysts say"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20231011044700"", ""headline"": ""Amgen's cancer-drug pipeline looks promising despite FDA setback, analysts say "", ""summary"": ""Strong oncology, obesity, and cardiovascular drug candidates behind rating upgrade""}, {""date"": ""20231011052500"", ""headline"": ""Amgen gains as Leerink upgrades on earnings upside and catalysts"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20231011070500"", ""headline"": ""What You Missed On Wall Street This Morning"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20231011070500"", ""headline"": ""Expert Ratings for Amgen"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20231011073940"", ""headline"": ""Amgen's Acquisition Of Horizon Means The Stock Is A Buy"", ""summary"": ""Amgen strengthens its inflammation portfolio and expands globally with the $27.8 billion acquisition of Horizon. Find out if AMGN stock is a buy.""}, {""date"": ""20231011084000"", ""headline"": ""10 Health Care Stocks Whale Activity In Today's Session"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20231011093738"", ""headline"": ""Amgen upgraded, Texas Instruments downgraded: Wall Street's top analyst calls"", ""summary"": ""Today's top research calls for upgrade, downgrade and initiate on stocks, as compiled by The Fly.""}, {""date"": ""20231011123800"", ""headline"": ""Amgen Inc. stock outperforms market on strong trading day"", ""summary"": ""Shares of Amgen Inc. advanced 4.55% to $283.60 Wednesday, on what proved to be an all-around positive trading session for the stock market, with the S&P 500...""}, {""date"": ""20231011130656"", ""headline"": ""Markets Rise at Midday as Bond Yields Fall Ahead of Fed Meeting Minutes"", ""summary"": ""U.S. equites rose at midday on Wednesday, Oct. 11, 2023, as bond yields extended their decline and ahead of the release of minutes from the latest Fed meeting.""}, {""date"": ""20231011132700"", ""headline"": ""Exxon\u2019s Deal for Pioneer Is No Big Payday for Arbitragers"", ""summary"": ""The arbitrage spread appears to be about 2.5% in the transaction but pros say they can enhance the return with dividends""}, {""date"": ""20231011155252"", ""headline"": ""Dow Jones Rises After Fed Minutes As House Vote On New Speaker Looms; Meta Breaks Out"", ""summary"": ""Dow Jones rose after the Fed meeting minutes for September were released and the House planned to vote on a new speaker. Meta broke out.""}, {""date"": ""20231011160856"", ""headline"": ""Amgen Stock Surges To 10-Month High, Up 5% On An Unexpected Upgrade"", ""summary"": ""Amgen stock snagged an upgrade Wednesday and surged to a 10-month high as one analyst examined the biotech behemoth's post-Horizon future.""}, {""date"": ""20231011162756"", ""headline"": ""Plug Power, ChargePoint, Amgen: Top Stocks"", ""summary"": ""Plug Power (PLUG) shares close Wednesday higher after raising its forward revenue outlook through 2027. EV infrastructure company ChargePoint's (CHPT) stock tumbles while raising $232 million in its path to profitability. Lastly, Leerink Partners upgrade Amgen (AMGN) to \""Outperform.\"" Yahoo Finance's Julie Hyman and Josh Lipton monitor several of the day's top trending stocks in the after-hours trading session. For more expert insight and the latest market action,\u00a0click here\u00a0to watch this full episode of Yahoo Finance Live.""}, {""date"": ""20231011163303"", ""headline"": ""B of A Securities Reiterates AMGEN (AMGN) Neutral Recommendation"", ""summary"": """"}, {""date"": ""20231011163303"", ""headline"": ""Leerink Partners Upgrades AMGEN (AMGN)"", ""summary"": """"}, {""date"": ""20231012012700"", ""headline"": ""Amgen price target raised to $320 from $265 at Wells Fargo"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20231012040000"", ""headline"": ""Better Passive Income Snowball: SCHD Or DIVO?"", ""summary"": ""We compare two potential core ETFs for building a passive income snowball. Click here to learn which one is a better fit for the investing strategy.""}, {""date"": ""20231012043200"", ""headline"": ""Jefferies 'optimistic' about Amgen PRMT5 data following embargo"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20231012055000"", ""headline"": ""Here\u2019s Why Amgen (AMGN) Outperformed in Q3"", ""summary"": ""Aristotle Capital Management, LLC, an investment management company, released its \u201cValue Equity Strategy\u201d third quarter 2023 investor letter. A copy of the same can be downloaded here. In the third quarter, the fund returned \u20102.99% gross of fees (\u20103.05% net of fees), outperforming the Russell 1000 Value Index\u2019s \u20103.16% return and the S&P 500 Index\u2019s \u20103.27% return. [\u2026]""}, {""date"": ""20231012063200"", ""headline"": ""Stocks to watch out in the Health Care sector as earnings close in"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20231012063600"", ""headline"": ""Interesting AMGN Put And Call Options For December 1st"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20231012064900"", ""headline"": ""Stocks to watch in the Health Care sector as earnings close in"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20231012070300"", ""headline"": ""Check Out What Whales Are Doing With AMGN"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20231012090000"", ""headline"": ""Global CAR T-cell Therapy Market Projected to Reach $83 Billion by 2032"", ""summary"": ""PALM BEACH, Fla., Oct. 12, 2023 (GLOBE NEWSWIRE) -- FinancialNewsMedia.com News Commentary - Significant influences driving the CAR T-cell therapy market is a rising demand for model therapeutics for treatment of cancer, increase in prevalence of cancer and an escalating awareness of CAR T-cell therapy medicines. The CAR T-cell therapy market is currently going through a rapid expansion, owing to rapidly expanding clinical trial activities and recent commercialization of CAR-T cell therapy, whic""}, {""date"": ""20231012094000"", ""headline"": ""Amgen: Is There More Upside to Come?"", ""summary"": ""Shares of the biopharmaceutical firm Amgen have been climbing higher. Let's check and see if there is more upside to come.    In this daily bar chart of Amgen, below, I can see that prices have charged higher from a low in early June.""}, {""date"": ""20231012115500"", ""headline"": ""Amgen's (AMGN) Stock Rallies Almost 5% on Broker Upgrade"", ""summary"": ""A Leerink Partner analyst expects accelerating pipeline news flow for Amgen (AMGN).""}, {""date"": ""20231012123800"", ""headline"": ""Amgen Inc. stock outperforms competitors on strong trading day"", ""summary"": ""Shares of Amgen Inc. inched 0.51% higher to $285.04 Thursday, on what proved to be an all-around poor trading session for the stock market, with the S&P 500...""}, {""date"": ""20231012175020"", ""headline"": ""(AMGN) Rises As Market Takes a Dip: Key Facts"", ""summary"": ""In the closing of the recent trading day, Amgen (AMGN) stood at $285.04, denoting a +0.51% change from the preceding trading day.""}, {""date"": ""20231012220600"", ""headline"": ""AMGN Crosses Above 3% Yield Territory"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20231013034535"", ""headline"": ""Jefferies Reiterates AMGEN (AMGN) Buy Recommendation"", ""summary"": """"}, {""date"": ""20231013050100"", ""headline"": ""Amgen's PRMT5 drug shows 5 partial respons from 31 patients, STATnews reports"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20231013050300"", ""headline"": ""Amgen's PRMT5 drug shows 5 partial responses from 31 patients, STATnews reports"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20231013052500"", ""headline"": ""Is Amgen Stock a Buy Now?"", ""summary"": ""The U.S. Federal Trade Commission (FTC) allowed Amgen's (NASDAQ: AMGN) purchase of Horizon Therapeutics to go through last month and the company announced the closing of the deal in a press release last week.  Now that the deal is complete investors can expect some enhanced growth potential on the horizon for Amgen.  The acquisition of Horizon Therapeutics gives Amgen access to an incredibly promising drug called Tepezza, which patients use for thyroid eye disease.""}, {""date"": ""20231013060000"", ""headline"": ""Sanofi reaps rewards of immunology investment with eczema results"", ""summary"": ""Pharmaceutical giant set to take on Amgen with atopic dermatitis treatment.""}, {""date"": ""20231013060300"", ""headline"": ""Ideaya has positive read from Amgen PRMT5 data, says Oppenheimer"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20231013062400"", ""headline"": ""Tango Therapeutics stock plunges amid data release for Amgen PRMT5 drug"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20231013064100"", ""headline"": ""Tango Therapeutics stock plunges amid Amgen PRMT5 drug data (update)"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20231013083000"", ""headline"": ""Is This Dividend Stock a Screaming Buy After Its Latest Acquisition?"", ""summary"": ""Large companies often turn to acquisitions to jump-start revenue and earnings growth or to speed up research and development, among other reasons.  With that said, let's look at the case of biotech giant Amgen (NASDAQ: AMGN), which just closed a blockbuster acquisition of Horizon Therapeutics.  What does Horizon Therapeutics bring?""}, {""date"": ""20231013085400"", ""headline"": ""Stifel disagrees with negative reaction in Ideaya shares after Amgen data"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20231013100000"", ""headline"": ""Amgen: Horizon's Pipeline May Be Too Expensive"", ""summary"": ""We believe that Amgen overpaid for Horizon's pipeline, since most of its upside potential is attributed to price increases instead of the expanding TAM. Read more here.""}, {""date"": ""20231013123800"", ""headline"": ""Amgen Inc. stock outperforms market despite losses on the day"", ""summary"": ""Shares of Amgen Inc. sank 0.33% to $284.10 Friday, on what proved to be an all-around mixed trading session for the stock market, with the Dow Jones...""}, {""date"": ""20231014040600"", ""headline"": ""Johnson & Johnson Stock: Is Now the Time to Sell?"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}]","{""assetTurnoverTTM"": 0.3207, ""bookValue"": 7656, ""cashRatio"": 2.0491329479768785, ""currentRatio"": 2.8593, ""ebitPerShare"": 3.8848, ""eps"": 3.2156, ""ev"": 168202.84, ""fcfMargin"": 0.3639, ""fcfPerShareTTM"": 17.5308, ""grossMargin"": 0.7385, ""inventoryTurnoverTTM"": 1.4407, ""longtermDebtTotalAsset"": 0.6521, ""longtermDebtTotalCapital"": 0.8667, ""longtermDebtTotalEquity"": 7.7116, ""netDebtToTotalCapital"": 0.3776, ""netDebtToTotalEquity"": 3.3604, ""netMargin"": 0.2506, ""operatingMargin"": 0.3028, ""payoutRatioTTM"": 0.589, ""pb"": 18.6097, ""peTTM"": 18.8311, ""pfcfTTM"": 15.1909, ""pretaxMargin"": 0.2821, ""psTTM"": 5.3097, ""quickRatio"": 2.5629, ""receivablesTurnoverTTM"": 4.6784, ""roaTTM"": 0.0904, ""roeTTM"": 1.2908, ""roicTTM"": 0.123, ""rotcTTM"": 0.147, ""salesPerShare"": 12.8309, ""sgaToSale"": 0.2615, ""totalDebtToEquity"": 7.8981, ""totalDebtToTotalAsset"": 0.6679, ""totalDebtToTotalCapital"": 0.8876, ""totalRatio"": 1.0924, ""period"": ""2023-09-30""}"
40,2023-10-15,281.8836364746094,2023-10-22,276.6348876953125,-0.018620267727990858,D2,"[{""date"": ""20231015233800"", ""headline"": ""Amgen resumed with an Equal Weight at Morgan Stanley"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20231016000700"", ""headline"": ""Amgen\u2019s Future: Evaluating Growth, Pipeline Progress and Risks Post-Horizon Acquisition"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20231016021200"", ""headline"": ""Xeris Biopharma  tightens FY23 revenue view to $155M-$165M from $145M-$165M"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20231016064428"", ""headline"": ""AbbVie: Successfully Navigating Humira's Patent Cliff With 4% Yield And 270% DGR Since 2014"", ""summary"": ""Despite declining Humira sales, AbbVie remains resilient, focusing on new therapies, M&A, and R&D for sustained growth. Find out why ABBV stock is a Hold.""}, {""date"": ""20231016070200"", ""headline"": ""$100 Invested In Amgen 15 Years Ago Would Be Worth This Much Today"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20231016090000"", ""headline"": ""AMGEN TO PRESENT NEW RESEARCH FROM ONCOLOGY PORTFOLIO AND PIPELINE AT ESMO 2023"", ""summary"": ""Amgen (NASDAQ:AMGN) today announced the presentation of new data across its broad oncology portfolio and pipeline at the European Society for Medical Oncology (ESMO) Congress 2023, taking place from October 20-24 in Madrid. Results from Amgen-sponsored and collaborative studies, including two late-breaking oral presentations, will feature data in a range of tough-to-treat cancers.""}, {""date"": ""20231016090005"", ""headline"": ""Why Investors Need to Take Advantage of These 2 Medical Stocks Now"", ""summary"": ""The Zacks Earnings ESP is a great way to find potential earnings surprises. Why investors should take advantage now.""}, {""date"": ""20231016121010"", ""headline"": ""Will Amgen (AMGN) Beat Estimates Again in Its Next Earnings Report?"", ""summary"": ""Amgen (AMGN) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.""}, {""date"": ""20231016123700"", ""headline"": ""Amgen Inc. stock rises Monday, still underperforms market"", ""summary"": ""Shares of Amgen Inc. inched 0.98% higher to $286.88 Monday, on what proved to be an all-around positive trading session for the stock market, with the S&P...""}, {""date"": ""20231016152500"", ""headline"": ""Investors Shun Dividend-Paying Stocks"", ""summary"": ""One aspect of the equity market advance this year is investors' heightened focus on a handful of stocks some are referring to as Magnificent Seven. Read more here.""}, {""date"": ""20231016223700"", ""headline"": ""Amgen Unusual Options Activity For October 17"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20231016235500"", ""headline"": ""William Blair healthcare/biotech analysts hold analyst/industry conference call"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20231017041600"", ""headline"": ""Amgen price target raised to $310 from $280 at Argus"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20231017065527"", ""headline"": ""Morgan Stanley Reiterates AMGEN (AMGN) Equal-Weight Recommendation"", ""summary"": """"}, {""date"": ""20231017090006"", ""headline"": ""Investors Heavily Search Amgen Inc. (AMGN): Here is What You Need to Know"", ""summary"": ""Amgen (AMGN) has been one of the stocks most watched by Zacks.com users lately. So, it is worth exploring what lies ahead for the stock.""}, {""date"": ""20231017114011"", ""headline"": ""PBYI vs. AMGN: Which Stock Is the Better Value Option?"", ""summary"": ""PBYI vs. AMGN: Which Stock Is the Better Value Option?""}, {""date"": ""20231017163000"", ""headline"": ""Dividend Income Update September 2023"", ""summary"": ""With the start of the final quarter of 2023, it\u2019s time to take a look back at my previous month of dividend income.""}, {""date"": ""20231017205541"", ""headline"": ""Argus Research Maintains AMGEN (AMGN) Buy Recommendation"", ""summary"": """"}, {""date"": ""20231018044500"", ""headline"": ""Seagen abstract hits best case scenario, says RBC Capital"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20231018083900"", ""headline"": ""10 Health Care Stocks Whale Activity In Today's Session"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20231018112000"", ""headline"": ""5 Biotech Stocks Set to Outpace Q3 Earnings Estimates"", ""summary"": ""Let us look at some biotech stocks, AMGN, BIIB, GSK, PRTA and VRTX, which are poised to beat on third-quarter earnings.""}, {""date"": ""20231018123700"", ""headline"": ""Amgen Inc. stock outperforms competitors despite losses on the day"", ""summary"": ""Shares of Amgen Inc. slid 0.30% to $283.58 Wednesday, on what proved to be an all-around dismal trading session for the stock market, with the S&P 500 Index...""}, {""date"": ""20231018175017"", ""headline"": ""Amgen (AMGN) Stock Moves -0.3%: What You Should Know"", ""summary"": ""Amgen (AMGN) closed the most recent trading day at $283.58, moving -0.3% from the previous trading session.""}, {""date"": ""20231019020100"", ""headline"": ""Invest with Confidence: Intrinsic Value Unveiled of Amgen Inc"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20231019035700"", ""headline"": ""Amgen\u2019s Growth Potential: A Comprehensive Analysis of Stock Rally, EPS Expectations, and Emerging Catalysts"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20231019061800"", ""headline"": ""Dow drops nearly 100 points on losses in shares of Merck, Amgen"", ""summary"": ""Shares of Merck and Amgen are posting losses Thursday morning, dragging the Dow Jones Industrial Average into negative territory. The Dow was most recently...""}, {""date"": ""20231019072400"", ""headline"": ""See Which Of The Latest 13F Filers Holds Amgen"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20231019082500"", ""headline"": ""Baron Health Care Fund Q3 2023 Shareholder Letter"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20231019123800"", ""headline"": ""Amgen Inc. stock underperforms Thursday when compared to competitors"", ""summary"": ""Shares of Amgen Inc. shed 1.05% to $280.60 Thursday, on what proved to be an all-around grim trading session for the stock market, with the S&P 500 Index...""}, {""date"": ""20231019160000"", ""headline"": ""AMGEN TO WEBCAST INVESTOR CALL AT ESMO 2023"", ""summary"": ""Amgen (NASDAQ:AMGN) today announced that it will host a webcasted call for the investment community at 8:00 a.m. ET on Tuesday, Oct. 24, 2023 following the presentation of new data from Amgen's innovative oncology portfolio including AMG 193 at the AACR-NCI-EORTC International Conference on Molecular Targets and Cancer Therapeutics 2023 and data from tarlatamab, xaluritamig, and LUMAKRAS\u00ae (sotorasib) that will be presented at the European Society for Medical Oncology (ESMO) Congress 2023. David""}, {""date"": ""20231019220200"", ""headline"": ""Catalyst Watch: Tech earnings blitz, Qualcomm event and Stellantis reveals"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20231019230000"", ""headline"": ""Bond Prices Are Slumping Again. Consider These Dividend ETFs Instead."", ""summary"": ""Morningstar has identified four dividend funds that hold quality companies and have a proven record.""}, {""date"": ""20231020012200"", ""headline"": ""Amgen price target raised to $300 from $290 at Oppenheimer"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20231020020600"", ""headline"": ""Amgen reinstated with a Neutral at JPMorgan"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20231020030400"", ""headline"": ""Amgen presents data from global Phase 2 DeLLphi-301 study"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20231020043700"", ""headline"": ""SolarEdge downgraded, Crocs upgraded: Wall Street's top analyst calls"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20231020045600"", ""headline"": ""Amgen hails new tarlatamab data in small cell lung cancer"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20231020080000"", ""headline"": ""AMGEN PRESENTS NEW TARLATAMAB DATA IN SMALL CELL LUNG CANCER"", ""summary"": ""Amgen (NASDAQ:AMGN) today announced results from the global Phase 2 DeLLphi-301 study, evaluating tarlatamab, an investigational delta-like ligand 3 (DLL3) targeting BiTE\u00ae (bispecific T-cell engager) molecule, in patients with advanced stage small cell lung cancer (SCLC) who had failed two or more prior lines of treatment. The data are being presented today at 3:20 PM CEST at a Proffered Paper session as a late-breaking oral presentation (LBA92) during the European Society for Medical Oncology (""}, {""date"": ""20231020083000"", ""headline"": ""Amgen posts Phase 2 data for targeted immunotherapy in lung cancer"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20231020123700"", ""headline"": ""Amgen Inc. stock outperforms market despite losses on the day"", ""summary"": ""Shares of Amgen Inc. dropped 0.64% to $278.81 Friday, on what proved to be an all-around rough trading session for the stock market, with the S&P 500 Index...""}, {""date"": ""20231020144100"", ""headline"": ""Top Stock Reports for Apple, Amgen & Becton, Dickinson"", ""summary"": ""Today's Research Daily features new research reports on 12 major stocks, including Apple Inc. (AAPL), Amgen Inc. (AMGN) and Becton, Dickinson and Company (BDX).""}, {""date"": ""20231020214342"", ""headline"": ""Oppenheimer Maintains AMGEN (AMGN) Outperform Recommendation"", ""summary"": """"}, {""date"": ""20231020214342"", ""headline"": ""JP Morgan Reiterates AMGEN (AMGN) Neutral Recommendation"", ""summary"": """"}, {""date"": ""20231021231300"", ""headline"": ""Ambrx Biopharma 'the real winner in prostate' at ESMO, says Oppenheimer"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20231021234500"", ""headline"": ""Amgen presents data from the global Phase 3 CodeBreaK 300 trial"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20231022103000"", ""headline"": ""AMGEN PRESENTS NEW LUMAKRAS\u00ae (SOTORASIB) PLUS VECTIBIX\u00ae (PANITUMUMAB) DATA IN PATIENTS WITH KRAS G12C-MUTATED METASTATIC COLORECTAL CANCER"", ""summary"": ""Amgen (NASDAQ:AMGN) today announced data from the global Phase 3 CodeBreaK 300 trial evaluating two doses of LUMAKRAS\u00ae (sotorasib) (960 mg or 240 mg) in combination with Vectibix\u00ae (panitumumab). Both doses demonstrated a statistically significant superiority in progression-free survival (PFS) over the investigator's choice of therapy in patients with chemorefractory KRAS G12C-mutated metastatic colorectal cancer (mCRC). The results are being presented today at the Presidential Symposium 2 sessio""}]",{}
41,2023-10-22,276.6348876953125,2023-10-29,259.5294189453125,-0.06183409797841577,D5+,"[{""date"": ""20231021231300"", ""headline"": ""Ambrx Biopharma 'the real winner in prostate' at ESMO, says Oppenheimer"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20231021234500"", ""headline"": ""Amgen presents data from the global Phase 3 CodeBreaK 300 trial"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20231022103000"", ""headline"": ""AMGEN PRESENTS NEW LUMAKRAS\u00ae (SOTORASIB) PLUS VECTIBIX\u00ae (PANITUMUMAB) DATA IN PATIENTS WITH KRAS G12C-MUTATED METASTATIC COLORECTAL CANCER"", ""summary"": ""Amgen (NASDAQ:AMGN) today announced data from the global Phase 3 CodeBreaK 300 trial evaluating two doses of LUMAKRAS\u00ae (sotorasib) (960 mg or 240 mg) in combination with Vectibix\u00ae (panitumumab). Both doses demonstrated a statistically significant superiority in progression-free survival (PFS) over the investigator's choice of therapy in patients with chemorefractory KRAS G12C-mutated metastatic colorectal cancer (mCRC). The results are being presented today at the Presidential Symposium 2 sessio""}, {""date"": ""20231022233200"", ""headline"": ""Looking At Amgen's Recent Unusual Options Activity"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20231023021200"", ""headline"": ""Amgen's Lumakras shows progression-free survival improvement in trial"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20231023043200"", ""headline"": ""AbbVie (ABBV) to Report Q3 Earnings: What's in the Cards?"", ""summary"": ""AbbVie's (ABBV) Q3 performance will likely reflect its newer immunotherapy drugs trying to compensate for declining Humira sales following the loss of U.S. exclusivity.""}, {""date"": ""20231023063200"", ""headline"": ""The Zacks Analyst Blog Highlights Apple, Amgen, Becton, Dickinson, UnitedHealth and Verisk"", ""summary"": ""Apple, Amgen, Becton, Dickinson, UnitedHealth and Verisk are included in this Analyst Blog.""}, {""date"": ""20231023123700"", ""headline"": ""Amgen Inc. stock falls Monday, underperforms market"", ""summary"": ""Shares of Amgen Inc. shed 2.06% to $273.06 Monday, on what proved to be an all-around poor trading session for the stock market, with the S&P 500 Index...""}, {""date"": ""20231023142600"", ""headline"": ""Circling Bank On Tango Therapeutics"", ""summary"": ""We are circling back on clinical stage developmental concern Tango Therapeutics, Inc. for the first time since November 2022. Read more about TNGX stock here.""}, {""date"": ""20231023211000"", ""headline"": ""Video: Dow Movers: AMGN, VZ"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20231023221300"", ""headline"": ""Amgen Layoffs 2023: What to Know About the Latest AMGN Job Cuts"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20231023230600"", ""headline"": ""Amgen declares $2.13 dividend"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20231024080600"", ""headline"": ""Amgen reportedly to cut 350 Horizon employees in wake of merger"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20231024085000"", ""headline"": ""Amgen to Lay Off 350 U.S. Employees of Horizon Therapeutics"", ""summary"": ""By Joseph Walker Amgen is laying off about 350 U.S. employees of Horizon Therapeutics, the drugmaker that Amgen bought in a $27.8 billion deal that closed...""}, {""date"": ""20231024090347"", ""headline"": ""Hematology/Oncology Update ESMO 2023"", ""summary"": ""The following slide deck was published by Amgen Inc.""}, {""date"": ""20231024091500"", ""headline"": ""3 Biotech Stocks With Decent Dividend for a Steady Return"", ""summary"": ""Here we pick three medical device stocks, AbbVie (ABBV), Amgen (AMGN) and Gilead Sciences (GILD), which have a solid five-year dividend growth history.""}, {""date"": ""20231024100052"", ""headline"": ""Amgen (AMGN) Expected to Beat Earnings Estimates: What to Know Ahead of Q3 Release"", ""summary"": ""Amgen (AMGN) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.""}, {""date"": ""20231024110259"", ""headline"": ""12 Defensive Healthcare Dividend Stocks To Invest In"", ""summary"": ""In this article, we discuss 12 defensive healthcare dividend stocks to invest in. You can skip our detailed analysis of the healthcare sector and dividend stocks, and go directly to read 5 Defensive Healthcare Dividend Stocks To Invest In. The healthcare sector has undergone significant evolution over the years, especially after the pandemic. Advances in [\u2026]""}, {""date"": ""20231024111908"", ""headline"": ""Amgen Inc. (AMGN) Amgen Conference Call Following European Society for Medical Oncology Congress 2023 Transcript"", ""summary"": ""Amgen Inc. (NASDAQ:NASDAQ:AMGN) Amgen Conference Call Following European Society for Medical Oncology Congress 2023 October 24, 2023 8:00 AM ETCompany...""}, {""date"": ""20231024123800"", ""headline"": ""Amgen Inc. stock outperforms market on strong trading day"", ""summary"": ""Shares of Amgen Inc. advanced 1.12% to $276.12 Tuesday, on what proved to be an all-around favorable trading session for the stock market, with the S&P 500...""}, {""date"": ""20231024160000"", ""headline"": ""AMGEN ANNOUNCES 2023 FOURTH QUARTER DIVIDEND"", ""summary"": ""Amgen (NASDAQ:AMGN) today announced that its Board of Directors declared a $2.13 per share dividend for the fourth quarter of 2023. The dividend will be paid on December 8, 2023, to all stockholders of record as of the close of business on November 17, 2023.""}, {""date"": ""20231024175018"", ""headline"": ""Amgen (AMGN) Outperforms Broader Market: What You Need to Know"", ""summary"": ""In the latest trading session, Amgen (AMGN) closed at $276.12, marking a +1.12% move from the previous day.""}, {""date"": ""20231024214500"", ""headline"": ""These Gene-Editing Stocks Are Survivors. Take Another Look."", ""summary"": ""The market has nearly abandoned many of the biotech start-ups it funded in the excitement of the first Covid-19 vaccines in 2021.""}, {""date"": ""20231024234800"", ""headline"": ""Amgen\u2019s Promising Oncology Pipeline Progress and Favorable Clinical Trials Fuel Analyst\u2019s Buy Rating"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20231025013600"", ""headline"": ""Amgen price target raised to $310 from $300 at Oppenheimer"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20231025022100"", ""headline"": ""Analysts Offer Insights on Healthcare Companies: Amgen (AMGN), Danaher (DHR) and Sanofi (OtherSNYNF)"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20231025023300"", ""headline"": ""Amgen price target raised to $336 from $293 at TD Cowen"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20231025042809"", ""headline"": ""20 Countries with Lowest Rates of Cancer"", ""summary"": ""In this article, we will be taking a look at the 20 countries with lowest rates of cancer. If you want to skip our analysis of the oncology industry, then head straight to 5 Countries with Lowest Rates of Cancer. Cancer\u2014 a disease in which some of the body\u2019s cells grow uncontrollably and spread to [\u2026]""}, {""date"": ""20231025044900"", ""headline"": ""USA Compression and Disney have been highlighted as Zacks Bull and Bear of the Day"", ""summary"": ""USA Compression and Disney have been highlighted as Zacks Bull and Bear of the Day.""}, {""date"": ""20231025070100"", ""headline"": ""Video: Daily Dividend Report: AMGN,ROL,APH,WFC,SWK"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20231025072600"", ""headline"": ""Amgen (AMGN) to Report Q3 Earnings: Will It Beat Estimates?"", ""summary"": ""Volume growth from Amgen's (AMGN) key drugs like Prolia, Repatha and Evenity, among others, is expected to have been partially offset by biosimilar/generic competition for mature drugs.""}, {""date"": ""20231025084200"", ""headline"": ""10 Health Care Stocks With Whale Alerts In Today's Session"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20231025100219"", ""headline"": ""UniQure (QURE) Expected to Beat Earnings Estimates: Should You Buy?"", ""summary"": ""UniQure (QURE) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.""}, {""date"": ""20231025112040"", ""headline"": ""Oppenheimer Maintains AMGEN (AMGN) Outperform Recommendation"", ""summary"": """"}, {""date"": ""20231025123700"", ""headline"": ""Amgen Inc. stock underperforms Wednesday when compared to competitors"", ""summary"": ""Shares of Amgen Inc. slid 1.43% to $272.16 Wednesday, on what proved to be an all-around rough trading session for the stock market, with the S&P 500 Index...""}, {""date"": ""20231025160000"", ""headline"": ""AMGEN ANNOUNCES WEBCAST OF 2023 THIRD QUARTER FINANCIAL RESULTS"", ""summary"": ""Amgen (NASDAQ:AMGN) today announced that it will report its third quarter financial results on Tuesday, October 31, 2023, before the opening of the U.S. financial markets. The announcement will be followed by a conference call with the investment community at 5:00 a.m. PT. Participating in the call from Amgen will be Robert A. Bradway, chairman and chief executive officer, and other members of Amgen's senior management team.""}, {""date"": ""20231026014800"", ""headline"": ""ImmunoGen 'should rank high on list' of possible M&A targets, says Guggenheim"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20231026070000"", ""headline"": ""A large international study of migraine reveals new biological pathways for treatment"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20231026073000"", ""headline"": ""3 Pharma Stocks That Are Screaming Buys in October"", ""summary"": ""It hasn't been the easiest of years for Johnson & Johnson (NYSE: JNJ), Amgen (NASDAQ: AMGN) and Gilead Sciences (NASDAQ: GILD).  Continued uncertainty regarding talc lawsuits is weighing on Johnson & Johnson.  Amgen's huge pipeline hasn't been fully appreciated by the market, and Gilead's settlement of an antitrust lawsuit resulted in lowering yearly earnings per share guidance.""}, {""date"": ""20231026123700"", ""headline"": ""Amgen Inc. stock outperforms market despite losses on the day"", ""summary"": ""Shares of Amgen Inc. dropped 0.90% to $269.71 Thursday, on what proved to be an all-around rough trading session for the stock market, with the S&P 500 Index...""}, {""date"": ""20231026215600"", ""headline"": ""Amgen\u2019s Promising Oncology Pipeline: A Buy Rating Driven by T-Cell Engagers\u2019 Potential"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20231026220300"", ""headline"": ""Catalyst Watch: Apple earnings, Fed policy meeting, jobs report"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20231026224100"", ""headline"": ""Analysts Conflicted on These Healthcare Names: Amgen (AMGN), Immutep (IMMP) and Bristol-Myers Squibb (BMY)"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20231026233600"", ""headline"": ""Bears Roam Wall Street As Middle East Conflict, Earnings Outlook Raise Concerns Despite Strong Q3 US Economic Growth: This Week In Markets"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20231027074650"", ""headline"": ""UPDATE 4-AbbVie takes $2.1 bln charge on cancer drug ahead of US price negotiation"", ""summary"": ""AbbVie, girding for government price negotiations on its big-selling cancer drug Imbruvica, on Friday disclosed a $2.1 billion charge related to an expected drop in revenue once the new price for U.S. Medicare patients goes into effect.  The Illinois-based drugmaker's leukemia pill in August was selected as one of the 10 drugs subject to the first-ever price negotiations by U.S. Medicare insurance plans with a stated government goal of saving $25 billion per year on drug costs by 2031.  While new prices for the first 10 drugs have yet to be negotiated and will not go into effect until 2026, AbbVie said it had used an undisclosed placeholder price that led it to estimate \""a significant decrease in the estimated future cash flows\"" from the drug.""}, {""date"": ""20231027075653"", ""headline"": ""Xencor: Data In Early 2024 Could Bring Shareholder Value"", ""summary"": ""Xencor is expected to release data from a phase 2 study in early 2024 targeting patients with mCRPC and gynecological cancers. Read more about XNCR stock here.""}, {""date"": ""20231027123700"", ""headline"": ""Amgen Inc. stock falls Friday, underperforms market"", ""summary"": ""Shares of Amgen Inc. shed 3.02% to $261.57 Friday, on what proved to be an all-around rough trading session for the stock market, with the S&P 500 Index...""}, {""date"": ""20231027145250"", ""headline"": ""Apple Headlines Earnings Calendar With Chip Titan AMD, Amgen Also Set To Report"", ""summary"": ""Apple stock is below its 200-day line with earnings due. Advanced Micro Devices and Amgen also report next week.""}, {""date"": ""20231028114350"", ""headline"": ""Microsoft Leads These 5 Dow Jones Stocks Near Buy Points"", ""summary"": ""Microsoft, one of just two Magnificent Seven stocks to move higher last week, leads this watchlist of five Dow Jones stocks. near buy points.""}, {""date"": ""20231029033000"", ""headline"": ""Earnings week ahead: Apple, AMD, Pfizer, McDonald's, Starbucks and more"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20231029063000"", ""headline"": ""2 Dow Jones Dividend Stocks to Buy Hand Over Fist Right Now"", ""summary"": ""Dividend stocks have not performed particularly well in 2023, and for good reason.  With many financial institutions offering safer alternatives, such as money market accounts and certificates of deposit, with annualized rates above 5%, there's been little reason for investors to stomach the volatility associated with equities.  Dividend stocks have a long history of outperforming most other asset classes over holding periods of 20 years or longer.""}, {""date"": ""20231029070500"", ""headline"": ""Pharma, PBMs spar over rising drug costs amid public scrutiny"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}]",{}
42,2023-10-29,259.5294189453125,2023-11-05,267.75469970703125,0.031693057361839916,U4,"[{""date"": ""20231029033000"", ""headline"": ""Earnings week ahead: Apple, AMD, Pfizer, McDonald's, Starbucks and more"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20231029063000"", ""headline"": ""2 Dow Jones Dividend Stocks to Buy Hand Over Fist Right Now"", ""summary"": ""Dividend stocks have not performed particularly well in 2023, and for good reason.  With many financial institutions offering safer alternatives, such as money market accounts and certificates of deposit, with annualized rates above 5%, there's been little reason for investors to stomach the volatility associated with equities.  Dividend stocks have a long history of outperforming most other asset classes over holding periods of 20 years or longer.""}, {""date"": ""20231029070500"", ""headline"": ""Pharma, PBMs spar over rising drug costs amid public scrutiny"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20231029224600"", ""headline"": ""Apple, AMD, Palantir Earnings On Deck This Week As Market Seeks Positive Catalysts In Fed Decision Week"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20231029231300"", ""headline"": ""Amgen slated to release first earnings report since Horizon merger on Tuesday"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20231030050400"", ""headline"": ""Earnings Outlook For Amgen"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20231030052541"", ""headline"": ""11 Best Immunotherapy Stocks To Buy Now"", ""summary"": ""In this article, we discuss 11 of the best immunotherapy stocks to buy now. If you want to skip our detailed discussion on the cancer and oncology industry, head directly to the 5 Best Immunotherapy Stocks To Buy Now. The global oncology landscape is continually transforming, driven by persistent efforts to explore, create, and deliver [\u2026]""}, {""date"": ""20231030054635"", ""headline"": ""11 Best Pharma Stocks To Buy Now"", ""summary"": ""In this article, we discuss the 12 best pharma stocks to buy now. You can skip our detailed analysis of the pharmaceutical sector and its outlook this year, and go directly to read the 5 Best Pharma Stocks To Buy Now. Shortly following the onset of the COVID-19 pandemic, it became evident that the world [\u2026]""}, {""date"": ""20231030060300"", ""headline"": ""Notable earnings before Tuesday's open"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20231030070000"", ""headline"": ""SCHD Just Fell Off A Cliff: An Inside Look"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20231030073927"", ""headline"": ""Schwab Dividend ETF (SCHD) Just Fell Off A Cliff: An Inside Look"", ""summary"": ""SCHD ETF faced a drop in value due to selling pressure in top holdings. Look for the trend to reverse over time due to the high quality nature of the holdings.""}, {""date"": ""20231030082600"", ""headline"": ""Notable companies reporting before tomorrow's open"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20231030113700"", ""headline"": ""Drug, Biotech Stocks' Q3 Earnings Due on Oct 31: AMGN, PFE, INCY"", ""summary"": ""Let's take a look at three biotech/drug companies, AMGN, PFE and INCY, slated to release quarterly results on Oct 31.""}, {""date"": ""20231030123800"", ""headline"": ""Amgen Inc. stock rises Monday, still underperforms market"", ""summary"": ""Shares of Amgen Inc. inched 0.62% higher to $263.19 Monday, on what proved to be an all-around favorable trading session for the stock market, with the S&P...""}, {""date"": ""20231030211600"", ""headline"": ""Noteworthy Tuesday Option Activity: AMGN, CE, REGN"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20231030234000"", ""headline"": ""What You Missed On Wall Street On Tuesday"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20231031004100"", ""headline"": ""Analysts Conflicted on These Healthcare Names: Amgen (AMGN), Qiagen (QGEN) and HCA Healthcare (HCA)"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20231031020100"", ""headline"": ""Amgen reports Q3 adjusted EPS $4.96, consensus $4.39"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20231031020300"", ""headline"": ""Amgen narrows FY23 adjusted EPS view to $18.20-$18.80 from $17.80-$18.80"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20231031021100"", ""headline"": ""Amgen sees FY23 CapEx about $950M"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20231031022000"", ""headline"": ""Amgen\u2019s stock jumps premarket after earnings beat and company again raises guidance"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20231031022500"", ""headline"": ""Amgen reports Q3 total product sales up 5% y/y"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20231031024100"", ""headline"": ""Amgen Non-GAAP EPS of $4.96 beats by $0.28, revenue of $6.9B misses by $50M"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20231031024700"", ""headline"": ""U.S. Stocks Poised To Extend Gains As Fed Meeting Gets Underway; Why This Analyst Expects 'Young Bull Market' To Remain Alive"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20231031025800"", ""headline"": ""Amgen stock gains after lifting annual outlook"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20231031030000"", ""headline"": ""Amgen 3Q Profit Sinks On Discontinued Development Charge"", ""summary"": ""By Ben Glickman Amgen's third-quarter profit sank on an impairment charge related to discontinued development of one of its drug candidates. The Thousand...""}, {""date"": ""20231031030200"", ""headline"": ""Charlie Munger says there\u2019s not much \u2018low-hanging fruit left\u2019 as he discusses Apple, Costco vs. Walmart, and EVs"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20231031030800"", ""headline"": ""Amgen Lifts FY23 Guidance After 3Q Adjusted Profit Tops Estimates"", ""summary"": ""By Ben Glickman Amgen narrowed its full-year guidance for adjusted profit and raised its revenue guidance after third-quarter adjusted profit topped Wall...""}, {""date"": ""20231031031700"", ""headline"": ""Amgen: Q3 Earnings Snapshot"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20231031031900"", ""headline"": ""Amgen's stock hit by expectations its obesity pipeline is facing a longer wait"", ""summary"": ""Amgen Inc.'s stock fell 3.3% Tuesday despite an earnings beat and raised guidance. Obesity drugs were to blame.""}, {""date"": ""20231031033700"", ""headline"": ""Amgen\u2019s Stock Rated as Buy: Promising Earnings, HZNP Acquisition Impact, and Product Pipeline Strengths"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20231031035000"", ""headline"": ""Amgen in charts: Sales of Prolia, XGEVA surge on higher prices; Enbrel, Otezla fall Y/Y"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20231031035000"", ""headline"": ""5 stocks to watch on Tuesday: Sarepta Therapeutics, Pfizer, AMD and more"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20231031040400"", ""headline"": ""Amgen Boosts Revenue Guidance, but the Stock Is Falling"", ""summary"": ""The biotechnology company beat third-quarter adjusted earnings estimates but fell a bit short on sales.""}, {""date"": ""20231031041700"", ""headline"": ""Amgen (NASDAQ:AMGN) Delivers Better-than-Expected Q3 Earnings"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20231031042900"", ""headline"": ""Amgen ups annual revenue guidance despite quarterly income dip"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20231031045800"", ""headline"": ""Amgen stock erases gains despite outlook boost (update)"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20231031053100"", ""headline"": ""Analysts Offer Insights on Healthcare Companies: Amgen (AMGN), AbbVie (ABBV) and Crispr Therapeutics AG (CRSP)"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20231031054500"", ""headline"": ""Dow drops 85 points on losses for Caterpillar, Amgen shares"", ""summary"": ""Behind negative returns for shares of Caterpillar and Amgen, the Dow Jones Industrial Average is falling Tuesday morning. The Dow was most recently trading...""}, {""date"": ""20231031062600"", ""headline"": ""Amgen says study of AMG 340 in mCRPC will be discontinued"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20231031070000"", ""headline"": ""AMGEN REPORTS THIRD QUARTER FINANCIAL RESULTS"", ""summary"": ""Amgen (NASDAQ:AMGN) today announced financial results for the third quarter of 20231.""}, {""date"": ""20231031070500"", ""headline"": ""Treasury Announcement More Important Than Fed's, Japan Abandons Yield Control, Tesla Under $200"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20231031071017"", ""headline"": ""Amgen third-quarter sales rise 5%; profit up before charge"", ""summary"": ""Amgen, which earlier this month acquired Horizon Therapeutics for $27.8 billion, on Tuesday said its third-quarter product sales rose 5% as double-digit volume growth was offset by lower prices.  Amgen said it would discuss sales of Horizon's drugs on a conference call with analysts and investors, but raised its post-acquisition forecast for full-year sales to between $28 billion and $28.4 billion from a previous estimate of $26.6 billion to $27.4 billion.  Wall Street analysts, on average, have forecast 2023 earnings of $18.47 per share on revenue of $28 billion, according to LSEG data.""}, {""date"": ""20231031075841"", ""headline"": ""UPDATE 1-Amgen third-quarter sales rise 5%; profit up before charge"", ""summary"": ""Amgen, which earlier this month acquired Horizon Therapeutics for $27.8 billion, on Tuesday said its third-quarter product sales rose 5% as double-digit volume growth was offset by lower prices.  Amgen said it would discuss sales of Horizon's drugs on a conference call with analysts and investors, but raised its post-acquisition forecast for full-year sales to between $28 billion and $28.4 billion from a previous estimate of $26.6 billion to $27.4 billion.  Wall Street analysts, on average, have forecast 2023 earnings of $18.47 per share on revenue of $28 billion, according to LSEG data.""}, {""date"": ""20231031080000"", ""headline"": ""Amgen\u2019s stock hit by expectations its obesity pipeline is facing a longer wait"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20231031080400"", ""headline"": ""Amgen Boosts Revenue Guidance. But the Stock Trades Lower."", ""summary"": ""The biotechnology company beat third-quarter adjusted earnings estimates but fell a bit short on sales.""}, {""date"": ""20231031081500"", ""headline"": ""Stocks Lack Direction As Traders Remain Cautious Ahead Of Fed Meeting, Nvidia Falls On Export Controls: What's Driving Markets Tuesday?"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20231031082506"", ""headline"": ""Amgen (AMGN) Q3 Earnings Top Estimates"", ""summary"": ""Amgen (AMGN) delivered earnings and revenue surprises of 6.67% and 0.80%, respectively, for the quarter ended September 2023. Do the numbers hold clues to what lies ahead for the stock?""}, {""date"": ""20231031083254"", ""headline"": ""Amgen Inc (AMGN) Q3 2023 Earnings: Revenue Up 4% to $6.9 Billion, GAAP EPS Down 19% to $3.22"", ""summary"": ""Amgen Inc (AMGN) reports Q3 2023 financial results, highlighting growth in product sales and pipeline progress""}, {""date"": ""20231031083800"", ""headline"": ""10 Health Care Stocks Whale Activity In Today's Session"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20231031091504"", ""headline"": ""Amgen Inc. (AMGN) Q3 2023 Earnings Call Transcript"", ""summary"": ""Amgen Inc. (NASDAQ:NASDAQ:AMGN) Q3 2023 Earnings Conference Call October 31, 2023 8:00 AM ETCompany ParticipantsJustin Claeys - VP, IRRobert Bradway -...""}, {""date"": ""20231031091616"", ""headline"": ""Amgen Inc. 2023 Q3 - Results - Earnings Call Presentation"", ""summary"": ""The following slide deck was published by Amgen Inc.""}, {""date"": ""20231031093028"", ""headline"": ""Here's What Key Metrics Tell Us About Amgen (AMGN) Q3 Earnings"", ""summary"": ""Although the revenue and EPS for Amgen (AMGN) give a sense of how its business performed in the quarter ended September 2023, it might be worth considering how some key metrics compare with Wall Street estimates and the year-ago numbers.""}, {""date"": ""20231031113000"", ""headline"": ""Amgen (AMGN) Beats on Q3 Earnings Beat, Lags Sales, Ups View"", ""summary"": ""Amgen (AMGN) beats Q3 estimates for earnings but misses on sales. Following the acquisition of Horizon Therapeutics, it raises earnings and sales guidance for 2023.""}, {""date"": ""20231031121800"", ""headline"": ""NEW YORK MARKET CLOSE: Stocks up with Fed likely to extend rate pause"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20231031123500"", ""headline"": ""Never Mind Covid, Investors Want a Pfizer Obesity Pill"", ""summary"": ""It is little wonder, then, that investors were hoping Pfizer could jump to the winning camp with an obesity pill.  \u201cNot one mention [of danuglipron] in the prepared remarks from Pfizer,\u201d noted  Will Sevush,  a healthcare strategist for Jefferies.  Before today\u2019s earnings,  David Risinger,  a Leerink Partners analyst, had written that Pfizer might even release data from its mid-stage study alongside the earnings results as soon as Tuesday.""}, {""date"": ""20231031123800"", ""headline"": ""Amgen Inc. stock falls Tuesday, underperforms market"", ""summary"": ""Shares of Amgen Inc. slid 2.85% to $255.70 Tuesday, on what proved to be an all-around favorable trading session for the stock market, with the S&P 500 Index...""}, {""date"": ""20231031125601"", ""headline"": ""Amgen's obesity drug plans, outlook for 2024"", ""summary"": ""Amgen (AMGN) reported third-quarter earnings that beat expectations and raised its full-year revenue guidance. The company recently completed its acquisition of Horizon Therapeutics, which brings its drug Tepezza to Amgen. Amgen is also looking to move into the obesity drug space which has garnered much attention from Wall Street. Yahoo Finance Senior Reporter Anjalee Khemlani interviewed Amgen CFO Peter Griffith to get his take on the company's performance. When it comes to the obesity space, Griffith says, \""what I am delighted to announce is that we've completed enrollment in Maridebart Cafraglutide, or we call it 'Mari', formerly AMG 133, for the treatment of obesity, in phase 2. We've got over 570 patients in the cohort, with and without diabetes, and so that's the center of the platform that we want to build on with obesity.\"" For more expert insight and the latest market action, click here to watch this full episode of Yahoo Finance Live.""}, {""date"": ""20231031130000"", ""headline"": ""GSK Reports Earnings Wednesday. Here\u2019s What to Expect."", ""summary"": ""The company will for the first time report sales of Arexvy, its new RSV vaccine that launched this fall.""}, {""date"": ""20231031131851"", ""headline"": ""Markets Edge Higher at Midday Ahead of Wednesday's Fed Decision"", ""summary"": ""U.S. equities edged higher at midday on Tuesday, Oct. 31, 2023 ahead of Wednesday's decision by the Federal Reserve, with policymakers widely expected to keep interest rates steady.""}, {""date"": ""20231031133628"", ""headline"": ""Amgen Tumbles After Scrapping A $900 Million Prostate Cancer Drug"", ""summary"": ""Amgen handily beat earnings forecasts Tuesday, but Amgen stock tumbled after the company scrapped an experimental prostate cancer treatment.""}, {""date"": ""20231031150500"", ""headline"": ""Amgen gets FDA approval for its inflammatory diseases treatment Wezlana"", ""summary"": ""Amgen has received approval from the U.S. Food and Drug Administration for Wezlana, its treatment for multiple inflammatory diseases.""}, {""date"": ""20231031170020"", ""headline"": ""S&P 500 Gains and Losses Today: Arista Networks Results and Guidance Beat Estimates"", ""summary"": ""The S&P 500 gained 0.65% on Tuesday, Oct. 31, 2023, ahead of Wednesday's Federal Reserve decision, more key earnings news, and Friday's jobs report.""}, {""date"": ""20231031211300"", ""headline"": ""Fear & Greed Index Remains In 'Fear' Zone Ahead Of Fed's Decision"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20231031212200"", ""headline"": ""These Analysts Revise Their Forecasts On Amgen After Q3 Results"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20231101001237"", ""headline"": ""Q3 2023 Amgen Inc Earnings Call"", ""summary"": ""Q3 2023 Amgen Inc Earnings Call""}, {""date"": ""20231101013900"", ""headline"": ""Amgen cleared in U.S. to market biosimilar to J&J\u2019s Stelara"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20231101014100"", ""headline"": ""Analysts Offer Insights on Healthcare Companies: Amgen (AMGN), Biogen (BIIB) and Vertex Pharmaceuticals (VRTX)"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20231101020000"", ""headline"": ""Amgen price target lowered to $268 from $272 at UBS"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20231101020200"", ""headline"": ""Beyond Market Price: Uncovering Amgen Inc's Intrinsic Value"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20231101022700"", ""headline"": ""Hold Rating on Amgen: Balancing Expectations with Underperformance and Future Prospects"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20231101035900"", ""headline"": ""GLOBAL BROKER RATINGS: JPMorgan cuts BP to 'underweight'"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20231101043700"", ""headline"": ""Positive Prospects for Amgen: A Comprehensive Analysis of Q3 Performance and Future Catalysts"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20231101080500"", ""headline"": ""Company News for Nov 01, 2023"", ""summary"": ""Companies In The Article Are: AMGN, NVDA, RGEN, COCO""}, {""date"": ""20231101090000"", ""headline"": ""AMGEN TO PRESENT DATA AT ACR 2023 ACROSS EXPANDED RHEUMATOLOGY PIPELINE AND PORTFOLIO"", ""summary"": ""Amgen (NASDAQ:AMGN) today announced the presentation of new scientific and clinical research across its expanded rheumatology pipeline and portfolio, following the recent acquisition of Horizon Therapeutics. More than 20 abstracts will be presented during the American College of Rheumatology (ACR) Convergence 2023, taking place Nov. 10-15, in San Diego.""}, {""date"": ""20231101103148"", ""headline"": ""Amgen Inc. (NASDAQ:AMGN) Q3 2023 Earnings Call Transcript"", ""summary"": ""Amgen Inc. (NASDAQ:AMGN) Q3 2023 Earnings Call Transcript October 31, 2023 Operator: My name is Julianne, and I\u2019ll be your conference facilitator today for Amgen\u2019s Third Quarter 2023 Financial Results Conference Call. All lines have been placed on mute to prevent any background noise. There will be a question-and-answer session at the conclusion of the [\u2026]""}, {""date"": ""20231101130000"", ""headline"": ""Novo Nordisk Reports Earnings Soon. Wegovy and Ozempic Will Be in Focus."", ""summary"": ""The report comes amid what has been a surprisingly grim two weeks for the pharmaceutical stocks.""}, {""date"": ""20231101212100"", ""headline"": ""Analysts Offer Insights on Healthcare Companies: Rani Therapeutics Holdings (RANI) and Amgen (AMGN)"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20231101220300"", ""headline"": ""Amgen Wins Big With FDA, Analyst Sees Soaring Potential"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20231102000900"", ""headline"": ""What You Missed On Wall Street On Thursday"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20231102010600"", ""headline"": ""Amgen upgraded to Buy from Hold at Truist"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20231102010808"", ""headline"": ""The Amgen Inc (AMGN) Company: A Short SWOT Analysis"", ""summary"": ""Unveiling the Strengths and Challenges: A Deep Dive into Amgen Inc (AMGN) SWOT Analysis""}, {""date"": ""20231102011700"", ""headline"": ""Amgen upgraded to Buy on pipeline execution at Truist"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20231102015948"", ""headline"": ""Amazon headed for rosy period, says HSBC; Roku flying: 6 big analyst picks"", ""summary"": ""Truist upgraded Amgen (NASDAQ:AMGN) to Buy from Hold with a price target of $320.00 (from $260.00), citing the biotech's commercial execution and \""ability to grow mid-cycle assets\"" to achieve record sales, \""despite underwhelming initial launches.\""""}, {""date"": ""20231102032500"", ""headline"": ""Amgen presents new data on KRYSTEXXA"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20231102045700"", ""headline"": ""Roku upgraded, Amazon initiated: Wall Street's top analyst calls"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20231102053100"", ""headline"": ""Analysts Offer Insights on Healthcare Companies: Amgen (AMGN), IQVIA Holdings (IQV) and Argenx Se (ARGX)"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20231102054500"", ""headline"": ""Dow up 200 points on gains in Amgen, Walgreens Boots shares"", ""summary"": ""Buoyed by strong returns for shares of Amgen and Walgreens Boots, the Dow Jones Industrial Average is up Thursday morning. The Dow is trading 200 points...""}, {""date"": ""20231102070000"", ""headline"": ""What You Missed On Wall Street This Morning"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20231102080000"", ""headline"": ""AMGEN PRESENTS NEW DATA THAT SHOW BLOOD PRESSURE DECREASES FOR ADULTS TREATED WITH KRYSTEXXA\u00ae (PEGLOTICASE)"", ""summary"": ""Amgen (NASDAQ:AMGN) today announced new data for KRYSTEXXA\u00ae (pegloticase) showing a decrease in blood pressure during treatment of adults living with chronic gout refractory to oral urate-lowering treatment \u2212 uncontrolled gout \u2212 both with and without chronic kidney disease (CKD). The data will be presented at the American Society of Nephrology Kidney Week, taking place Nov. 2-5, in Philadelphia.""}, {""date"": ""20231102082100"", ""headline"": ""Analysts Offer Insights on Healthcare Companies: Amgen (AMGN), Beam Therapeutics (BEAM) and Argenx Se (ARGX)"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20231102083200"", ""headline"": ""Concerns Over Amgen\u2019s Performance and Future Prospects: An In-Depth Sell Rating Analysis"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20231102083200"", ""headline"": ""Analysts Have Conflicting Sentiments on These Healthcare Companies: Amgen (AMGN), Eli Lilly & Co (LLY) and Repligen (RGEN)"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20231102091835"", ""headline"": ""Truist Securities Upgrades AMGEN (AMGN)"", ""summary"": """"}, {""date"": ""20231102231600"", ""headline"": ""Morgan Stanley Sticks to Its Hold Rating for Amgen (AMGN)"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20231103123800"", ""headline"": ""Amgen Inc. stock outperforms market on strong trading day"", ""summary"": ""Shares of Amgen Inc. rallied 1.23% to $269.86 Friday, on what proved to be an all-around great trading session for the stock market, with the S&P 500 Index...""}]",{}
43,2023-11-05,267.75469970703125,2023-11-12,265.224609375,-0.009449284493604049,D1,"[{""date"": ""20231105220200"", ""headline"": ""The doctor lowering drug prices for 1 million patients, with help from Mark Cuban, Sam Altman \u2013 and Martin Shkreli"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20231106090006"", ""headline"": ""Amgen Inc. (AMGN) Is a Trending Stock: Facts to Know Before Betting on It"", ""summary"": ""Zacks.com users have recently been watching Amgen (AMGN) quite a bit. Thus, it is worth knowing the facts that could determine the stock's prospects.""}, {""date"": ""20231106110000"", ""headline"": ""Epidemiology and Genetics of Clonal Hematopoiesis, a Premalignant Hematopoietic Stem Cell Condition"", ""summary"": ""A comprehensive new study from deCODE genetics, a subsidiary of Amgen, published today in Nature Genetics, provides insights into the epidemiology and somatic and germline genetics of clonal hematopoiesis. Whole genome sequence data from Iceland and the UK Biobank, combined with a unique somatic mutation Barcoding strategy, was used to investigate clonal hematopoiesis at the population scale.""}, {""date"": ""20231106112812"", ""headline"": ""November Dogs Of The Dow: 3 Buyable, 4 Watchable"", ""summary"": ""Learn about the Dow Jones Industrial Average and the top-performing stocks in November. Click to see our exclusive list of dividend stocks we consider buyable now.""}, {""date"": ""20231106113800"", ""headline"": ""Amgen Inc. stock outperforms market on strong trading day"", ""summary"": ""Shares of Amgen Inc. rallied 1.10% to $272.83 Monday, on what proved to be an all-around positive trading session for the stock market, with the S&P 500...""}, {""date"": ""20231106220400"", ""headline"": ""Amgen reports data from Phase 2 study evaluating dazodalibep"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20231107055300"", ""headline"": ""See How Amgen Ranks Among Analysts' Top Dow 30 Picks"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20231107055500"", ""headline"": ""Video: Dow Analyst Moves: AMGN"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20231107082823"", ""headline"": ""High Yield Stock Watchlist - November 2023"", ""summary"": ""The majority of the 22 stocks on my high yield watchlist for November 2023 are undervalued based on dividend yield theory. Click here for the complete list.""}, {""date"": ""20231107095008"", ""headline"": ""Why This 1 Momentum Stock Could Be a Great Addition to Your Portfolio"", ""summary"": ""Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.""}, {""date"": ""20231107113800"", ""headline"": ""Amgen Inc. stock falls Tuesday, underperforms market"", ""summary"": ""Shares of Amgen Inc. slipped 0.63% to $271.11 Tuesday, on what proved to be an all-around positive trading session for the stock market, with the S&P 500...""}, {""date"": ""20231107160000"", ""headline"": ""AMGEN PRESENTS NEW DATA FROM PHASE 2 TRIAL OF DAZODALIBEP IN SJ\u00d6GREN'S SYNDROME AT ACR 2023"", ""summary"": ""Amgen (NASDAQ:AMGN) today announced new data from its Phase 2 study evaluating dazodalibep, an investigational medicine, for the treatment of Sj\u00f6gren's. These results will be featured in presentations at the American College of Rheumatology (ACR) Convergence 2023, Nov. 10-15, in San Diego. Findings from the study demonstrate that dazodalibep may improve both the systemic and symptomatic disease burden of two different patient populations.""}, {""date"": ""20231107160500"", ""headline"": ""AMGEN PRESENTS NEW RESEARCH IN EARLY PSORIATIC ARTHRITIS AT ACR 2023"", ""summary"": ""Amgen (NASDAQ:AMGN) today announced results from the global Phase 4 FOREMOST study evaluating Otezla\u00ae (apremilast) in patients with early oligoarticular psoriatic arthritis. FOREMOST is the first placebo-controlled study designed to specifically assess people with oligoarticular psoriatic arthritis with early disease duration of five or fewer years. Results will be presented at the American College of Rheumatology (ACR) Convergence 2023, Nov. 10-15 in San Diego.""}, {""date"": ""20231107222600"", ""headline"": ""Amgen initiated with a Hold at Deutsche Bank"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20231108054700"", ""headline"": ""Amgen's Rare Autoimmune Disease Candidate Shows Improvement In Disease Burden In Treating Sj\u00f6gren's Syndrome"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20231108075700"", ""headline"": ""CytomX Therapeutics price target raised to $3 from $2 at Wedbush"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20231108110100"", ""headline"": ""Ligand Reports Third Quarter 2023 Financial Results"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20231108113800"", ""headline"": ""Amgen Inc. stock rises Wednesday, outperforms market"", ""summary"": ""Shares of Amgen Inc. inched 0.79% higher to $273.26 Wednesday, on what proved to be an all-around mixed trading session for the stock market, with the S&P...""}, {""date"": ""20231108200900"", ""headline"": ""Sen. Elizabeth Warren tells FTC she remains concerned about Amgen's Horizon deal"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20231109015700"", ""headline"": ""GLOBAL BROKER RATINGS: Wells Fargo raises Adyen; HSBC likes AB InBev"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20231109034940"", ""headline"": ""Top 20 Drug Companies in the US by Revenue"", ""summary"": ""In this article, we will be taking a look at the top 20 drug companies in the US by revenue. To skip our detailed analysis, you can go directly to see the Top 5 Drug Companies in the US by Revenue. Following the Covid-19 pandemic, which drastically altered the way of living, the top pharmaceutical [\u2026]""}, {""date"": ""20231109072200"", ""headline"": ""Eli Lilly declines a day after FDA nod for weight loss therapy"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20231109075200"", ""headline"": ""Fortunes Can Be Made With Bristol-Myers Squibb"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20231109080000"", ""headline"": ""US Senator Elizabeth Warren expresses 'disappointment' in FTC's Amgen decision"", ""summary"": ""Senator Elizabeth Warren, an antitrust hawk, expressed disappointment with the U.S. Federal Trade Commission's decision to allow pharmaceutical firm Amgen to move forward with its acquisition of Horizon Therapeutics.  Warren, a Democrat, has staunchly supported the FTC and Justice Department's tougher stance on mergers under President Joe Biden.  In a rare break with the Biden administration's antitrust enforcers, she urged them to get even tougher.""}, {""date"": ""20231109080800"", ""headline"": ""Amgen, Home Depot share losses contribute to Dow's 150-point drop"", ""summary"": ""Shares of Amgen and Home Depot are trading lower Thursday afternoon, sending the Dow Jones Industrial Average into negative territory. The Dow was most...""}, {""date"": ""20231109083606"", ""headline"": ""Deutsche Bank Initiates Coverage of AMGEN (AMGN) with Hold Recommendation"", ""summary"": """"}, {""date"": ""20231109094200"", ""headline"": ""Dow's nearly 250-point fall led by losses in shares of Amgen, Home Depot"", ""summary"": ""Shares of Amgen and Home Depot are posting losses Thursday afternoon, sending the Dow Jones Industrial Average into negative territory. Shares of Amgen and...""}, {""date"": ""20231109113800"", ""headline"": ""Amgen Inc. stock underperforms Thursday when compared to competitors"", ""summary"": ""Shares of Amgen Inc. shed 3.37% to $264.06 Thursday, on what proved to be an all-around dismal trading session for the stock market, with the S&P 500 Index...""}, {""date"": ""20231110015300"", ""headline"": ""Mirati lung cancer therapy endorsed in EU"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20231110073800"", ""headline"": ""12 Dogs of the Dow Dividend Stocks to Buy"", ""summary"": ""In this article, we discuss 12 Dogs of the Dow dividend stocks to buy. You can skip our detailed analysis of the dogs of the Dow strategy and its returns over the years, and go directly to read 5 Dogs of the Dow Dividend Stocks to Buy. Many investors who prioritize dividends find dividend yields [\u2026]""}, {""date"": ""20231110090000"", ""headline"": ""AMGEN PRESENTS NEW CARDIOVASCULAR RESEARCH AT AHA 2023"", ""summary"": ""Amgen (NASDAQ:AMGN) today announced new data reinforcing the safety and efficacy of Repatha\u00ae (evolocumab) from the FOURIER Open Label Extension (OLE) [FOURIER-OLE] trial at the American Heart Association (AHA) Scientific Sessions 2023 in Philadelphia. These presentations will focus on the reduction of a known cardiovascular disease (CVD) risk factor, LDL \""bad\"" cholesterol (LDL-C). Amgen will also present new research from the Phase 2 OCEAN(a)-DOSE study of its investigational small interfering R""}, {""date"": ""20231110101500"", ""headline"": ""2 Top Biotech Stocks to Buy Right Now"", ""summary"": ""It's been a rough year for the biotech industry, which as a whole has substantially lagged the broader market.  Two worth a closer look today are Amgen (NASDAQ: AMGN) and Moderna (NASDAQ: MRNA) whose prospects really don't look as bad as their year-to-date performances suggest.  At current levels, both Amgen and Moderna are worth investing in now.""}, {""date"": ""20231110113800"", ""headline"": ""Amgen Inc. stock rises Friday, still underperforms market"", ""summary"": ""Shares of Amgen Inc. rose 1.23% to $267.31 Friday, on what proved to be an all-around positive trading session for the stock market, with the S&P 500 Index...""}, {""date"": ""20231111040000"", ""headline"": ""Why You Should Aim For $2 Million For Retirement"", ""summary"": ""Retirement goals should be set based on individual situations and factors like your pre-retirement earnings. Explore more details here.""}, {""date"": ""20231111070535"", ""headline"": ""Amgen Inc. (NASDAQ:AMGN) Looks Like A Good Stock, And It's Going Ex-Dividend Soon"", ""summary"": ""Regular readers will know that we love our dividends at Simply Wall St, which is why it's exciting to see Amgen Inc...""}, {""date"": ""20231111144055"", ""headline"": ""Dividend Champion, Contender, And Challenger Highlights: Week Of November 12"", ""summary"": ""A weekly summary of dividend activity for Dividend Champions, Contenders, and Challengers. Read more to see the November 12 weekly update.""}, {""date"": ""20231111171424"", ""headline"": ""3.2%-Yielding Amgen's Realistic Path To >11% Annual Returns"", ""summary"": ""Amgen completes acquisition of Horizon Therapeutics, boosting long-term growth potential. Read why we have a buy rating on AMGN stock.""}, {""date"": ""20231112060500"", ""headline"": ""Eli Lilly expected to add $4.1B U.S. sales from new weight loss drug"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}]",{}
44,2023-11-12,265.224609375,2023-11-19,265.3900146484375,0.0006236422548695497,U1,"[{""date"": ""20231112060500"", ""headline"": ""Eli Lilly expected to add $4.1B U.S. sales from new weight loss drug"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20231112230400"", ""headline"": ""PRIMECAP Management Adjusts Portfolio, Notably Trims Eli Lilly Stake"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20231112231955"", ""headline"": ""OUSA: Attractive Quality, Average Performance"", ""summary"": ""OUSA ETF holds 100 dividend stocks selected and weighted based on profitability, dividend quality, leverage and volatility. Read why I'm neutral on the fund.""}, {""date"": ""20231113113800"", ""headline"": ""Amgen Inc. stock underperforms Monday when compared to competitors"", ""summary"": ""Shares of Amgen Inc. slipped 0.23% to $266.69 Monday, on what proved to be an all-around mixed trading session for the stock market, with the Dow Jones...""}, {""date"": ""20231113130601"", ""headline"": ""6 intriguing stocks investors should consider: Piper Sandler"", ""summary"": ""The market has slightly rebounded, with some investors excited for a possible Santa Claus rally to close out the year. Piper Sandler's technical research team announced six stocks that are currently looking attractive for investor portfolios: Amazon (AMZN), Amgen Inc. (AMGN), Coterra Energy (CTRA), Lululemon (LULU), Assurant (AIZ), and Palo Alto Networks (PANW). Jason Glazer, Piper Sandler & Co. Managing Director and Head of Product Management, joins Yahoo Finance to break down the company's picks, how they arrived there, and give insight into the chosen stocks. \""[Lululemon] stands out because it has both high earnings growth and earnings expectations and if you go into the business they have pretty high margins with about 45% of sales coming from company-owned sales and 45% of sales coming through the e-commerce channel,\"" Glazer explains. \""They're tremendous at product innovation, they keep full-price selling, unlike a lot of the discounting you see in the retail industry, and they also have some tremendous growth opportunities in China.\"" For more expert insight and the latest market action, click here to watch this full episode of Yahoo Finance Live.""}, {""date"": ""20231113142229"", ""headline"": ""13 Dividend Giants with Lowest Short Interest"", ""summary"": ""In this article, we discuss 13 dividend giants with the lowest short interest. You can skip our detailed analysis of dividend stocks and their previous performance, and go directly to read 5 Dividend Giants with Lowest Short Interest. While the financial world is typically viewed as serious and analytical, the art of short selling adds [\u2026]""}, {""date"": ""20231113190505"", ""headline"": ""13 Cheap Blue Chip Stocks To Buy"", ""summary"": ""In this piece, we will take a look at the 13 cheap blue chip stocks to buy. To skip our overview of the blue chip sector and the latest news about the stock market, take a look at the 5 Cheap Blue Chip Stocks To Buy. Within the American stock market, the Dow Jones Industrial [\u2026]""}, {""date"": ""20231114014650"", ""headline"": ""Amgen Is Still A Hold, But Should Be On Your Watchlist"", ""summary"": ""Amgen is a resilient healthcare company that tends to perform well in challenging business environments. See why I think AMGN stock is still a hold.""}, {""date"": ""20231114042100"", ""headline"": ""Ex-Dividend Reminder: Amgen, Royalty Pharma and Phillips Edison"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20231114063100"", ""headline"": ""Eli Lilly (NYSE:LLY) Slips despite Good News on Heart Drug"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20231114113800"", ""headline"": ""Amgen Inc. stock rises Tuesday, still underperforms market"", ""summary"": ""Shares of Amgen Inc. rose 1.25% to $270.02 Tuesday, on what proved to be an all-around positive trading session for the stock market, with the S&P 500 Index...""}, {""date"": ""20231114160734"", ""headline"": ""Amgen: Buy In Stable Fundamental And Technical Price Growth"", ""summary"": ""Amgen's Q3 2023 financial performance showed increased total revenues and product sales, driven by volume growth and strong international markets. Click here to read my analysis.""}, {""date"": ""20231115000300"", ""headline"": ""Invest with Confidence: Intrinsic Value Unveiled of Amgen Inc"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20231115034500"", ""headline"": ""O'Keefe Stevens Advisory Q3 2023 Update"", ""summary"": ""At the end of Q3 2023, O'Keefe Stevens Advisory's top 5 holdings represented ~27% of assets, down from 35% at the end of Q2. Click here to read the full fund letter. ""}, {""date"": ""20231115044900"", ""headline"": ""1 in 25 carries a genotype that is associated with a shortened lifespan"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20231115050611"", ""headline"": ""Amgen Inc's Dividend Analysis"", ""summary"": ""Amgen Inc(NASDAQ:AMGN) recently announced a dividend of $2.13 per share, payable on 2023-12-08, with the ex-dividend date set for 2023-11-16.  As investors look forward to this upcoming payment, the spotlight also shines on the company's dividend history, yield, and growth rates.  Using the data from GuruFocus, let's look into Amgen Inc's dividend performance and assess its sustainability.""}, {""date"": ""20231115063900"", ""headline"": ""10 Health Care Stocks Whale Activity In Today's Session"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20231115113800"", ""headline"": ""Amgen Inc. stock outperforms market on strong trading day"", ""summary"": ""Shares of Amgen Inc. rose 1.11% to $273.03 Wednesday, on what proved to be an all-around positive trading session for the stock market, with the S&P 500...""}, {""date"": ""20231116011200"", ""headline"": ""Homology Medicines, Q32 Bio enter all-stock merger agreement"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20231116030000"", ""headline"": ""Big Pharma scrambles to feed demand for weight-loss treatments amid rising US obesity rates"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20231116062200"", ""headline"": ""Amgen Inc(AMGN) 2022 CEO Robert A. Bradway's shareholder letter: A Year of Strong Performance ..."", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20231116063200"", ""headline"": ""Homology Medicines slumps after merger deal with Q32 Bio"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20231116113800"", ""headline"": ""Amgen Inc. stock falls Thursday, underperforms market"", ""summary"": ""Shares of Amgen Inc. slipped 0.70% to $269.00 Thursday, on what proved to be an all-around mixed trading session for the stock market, with the S&P 500 Index...""}, {""date"": ""20231116143601"", ""headline"": ""Amgen : LUMAKRAS\u00ae (sotorasib) Dose Comparison Study Results"", ""summary"": ""LUMAKRAS\u00ae Dose Comparison Study Results Today, during an ESMO Plenary Virtual Session, Amgen presented data from the LUMAKRAS\u00ae 960 mg versus 240 mg dose comparison study in...""}, {""date"": ""20231117090005"", ""headline"": ""Amgen Inc. (AMGN) is Attracting Investor Attention: Here is What You Should Know"", ""summary"": ""Zacks.com users have recently been watching Amgen (AMGN) quite a bit. Thus, it is worth knowing the facts that could determine the stock's prospects.""}, {""date"": ""20231117113800"", ""headline"": ""Amgen Inc. stock falls Friday, underperforms market"", ""summary"": ""Shares of Amgen Inc. shed 1.34% to $265.39 Friday, on what proved to be an all-around favorable trading session for the stock market, with the S&P 500 Index...""}, {""date"": ""20231119053901"", ""headline"": ""18 Best-Performing Dow Stocks in 2023"", ""summary"": ""In this article, we will take a look at the 18 best-performing Dow stocks in 2023. To see more such companies, go directly to 5 Best-Performing Dow Stocks in 2023. The economy and stock markets have defied almost every prediction and estimate in 2023. When the year started there was almost a consensus among notable [\u2026]""}, {""date"": ""20231119060200"", ""headline"": ""M&A, GLP-1s to dominate healthcare themes in 2024 as COVID fades: survey"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20231119163759"", ""headline"": ""Tracking George Soros' 13F Portfolio - Q3 2023 Update"", ""summary"": ""George Soros' 13F portfolio value increased by 10% to $7.05B. Click here to read more about Soros Fund Management's holdings and trades for Q3 2023.""}]",{}
45,2023-11-19,265.3900146484375,2023-11-26,265.4599914550781,0.00026367535618598836,U1,"[{""date"": ""20231119053901"", ""headline"": ""18 Best-Performing Dow Stocks in 2023"", ""summary"": ""In this article, we will take a look at the 18 best-performing Dow stocks in 2023. To see more such companies, go directly to 5 Best-Performing Dow Stocks in 2023. The economy and stock markets have defied almost every prediction and estimate in 2023. When the year started there was almost a consensus among notable [\u2026]""}, {""date"": ""20231119060200"", ""headline"": ""M&A, GLP-1s to dominate healthcare themes in 2024 as COVID fades: survey"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20231119163759"", ""headline"": ""Tracking George Soros' 13F Portfolio - Q3 2023 Update"", ""summary"": ""George Soros' 13F portfolio value increased by 10% to $7.05B. Click here to read more about Soros Fund Management's holdings and trades for Q3 2023.""}, {""date"": ""20231119204500"", ""headline"": ""Fly Insider: Air Products, Amgen among  this week's notable insider trades"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20231119212600"", ""headline"": ""Bernard Horn's Polaris Global Value Fund 3rd-Quarter Letter"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20231119232800"", ""headline"": ""Rep. James Comer probes FTC conduct in Amgen's takeover of Horizon Therapeutics"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20231120002900"", ""headline"": ""Harpoon Therapeutics initiated with an Outperform at TD Cowen"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20231120065224"", ""headline"": ""20 Most Valuable Healthcare Companies in the World"", ""summary"": ""In this article, we will look into the 20 most valuable healthcare companies in the world. If you want to skip our detailed analysis, you can go directly to the 5 Most Valuable Healthcare Companies in the World. Healthcare Services Industry: A Market Analysis According to a report by Verified Market Research, the global healthcare [\u2026]""}, {""date"": ""20231120113800"", ""headline"": ""Amgen Inc. stock underperforms Monday when compared to competitors"", ""summary"": ""Shares of Amgen Inc. dropped 0.02% to $265.35 Monday, on what proved to be an all-around favorable trading session for the stock market, with the S&P 500...""}, {""date"": ""20231120190148"", ""headline"": ""Billionaire Steven Cohen\u2019s Top High Dividend Stock Picks"", ""summary"": ""In this article, we discuss billionaire Steve Cohen\u2019s top high-dividend stock picks. You can skip our detailed analysis of Point72 Asset Management\u2019s holding and recent developments, and go directly to read Billionaire Steven Cohen\u2019s Top 5 High Dividend Stock Picks. Steve Cohen is a prominent figure in the world of finance and investing, known for [\u2026]""}, {""date"": ""20231121030500"", ""headline"": ""Munger And Buffett Say Invest $100,000 For Financial Freedom: Consider SCHD"", ""summary"": ""Charlie Munger has emphasized the importance of investing $100,000. See why SCHD ETF is a strong investment option for reaching financial freedom.""}, {""date"": ""20231121065300"", ""headline"": ""AbbVie Vs. Amgen: How Peter Lynch Picks Dividend Stocks"", ""summary"": ""This article examines two healthcare stalwarts, AbbVie (ABBV) and Amgen (AMGN) through the lens of Lynch's approach. Check out which stock I prefer.""}, {""date"": ""20231121083210"", ""headline"": ""Bristol-Myers Squibb: A Tough But Cheap Spot"", ""summary"": ""Learn about the challenges facing Bristol-Myers Squibb as it deals with loss of exclusivity, growth concerns, and other issues. Click here for more on BMY stock.""}, {""date"": ""20231121113800"", ""headline"": ""Amgen Inc. stock falls Tuesday, underperforms market"", ""summary"": ""Shares of Amgen Inc. dropped 0.95% to $262.82 Tuesday, on what proved to be an all-around poor trading session for the stock market, with the S&P 500 Index...""}, {""date"": ""20231121225500"", ""headline"": ""Matrix Asset Advisors Q3 2023 Capital Markets Commentary And Quarterly Report"", ""summary"": ""For Q3 2023, Matrix\u00e2\u0080\u0099s LCV and MDI portfolios were down modestly, and bond returns mostly flat or down. Click here to read the full fund letter.""}, {""date"": ""20231122040000"", ""headline"": ""Merck: Keytruda Patent Expiry Nears With Replacement Yet To Be Found"", ""summary"": ""For now, Merck's prospects have somewhat dimmed, with management engaging on expensive partnerships to boost its pipelines. Learn why we rate MRK stock a hold.""}, {""date"": ""20231122051700"", ""headline"": ""P/E Ratio Insights for Amgen"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20231122113800"", ""headline"": ""Amgen Inc. stock outperforms competitors on strong trading day"", ""summary"": ""Shares of Amgen Inc. inched 0.67% higher to $264.59 Wednesday, on what proved to be an all-around great trading session for the stock market, with the S&P...""}, {""date"": ""20231122160000"", ""headline"": ""AMGEN TO PRESENT AT THE EVERCORE ISI HEALTHCONX CONFERENCE"", ""summary"": ""Amgen (NASDAQ:AMGN) will present at the Evercore ISI HealthCONx Conference at 9:10 a.m. EST on Wednesday, Nov. 29, 2023. Peter H. Griffith, executive vice president and chief financial officer at Amgen, and Paul Burton, senior vice president and chief medical officer at Amgen will present at the conference. The webcast will be broadcast over the internet simultaneously and will be available to members of the news media, investors and the general public.""}, {""date"": ""20231123213000"", ""headline"": ""Mario Gabelli's Gabelli Asset Fund 3rd-Quarter Commentary"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20231123223900"", ""headline"": ""Amgen Inc. stock outperforms market on strong trading day"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20231124005300"", ""headline"": ""Innovent marks China's first regulatory review of a KRAS G12C inhibitor"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20231124050200"", ""headline"": ""Investigating Amgen's Standing In Biotechnology Industry Compared To Competitors"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20231126065103"", ""headline"": ""15 Best Drug Stocks To Invest In"", ""summary"": ""In this article, we discuss the 15 best drug stocks to invest in. You can skip our detailed analysis of the drug and pharmaceutical sector and its outlook this year, and go directly to read the 5 Best Drug Stocks To Invest In. Healthcare expands on the defensive concept, encompassing a myriad of companies. This [\u2026]""}]",{}
46,2023-11-26,265.4599914550781,2023-12-03,272.45001220703125,0.026331729740660448,U3,"[{""date"": ""20231126065103"", ""headline"": ""15 Best Drug Stocks To Invest In"", ""summary"": ""In this article, we discuss the 15 best drug stocks to invest in. You can skip our detailed analysis of the drug and pharmaceutical sector and its outlook this year, and go directly to read the 5 Best Drug Stocks To Invest In. Healthcare expands on the defensive concept, encompassing a myriad of companies. This [\u2026]""}, {""date"": ""20231127054410"", ""headline"": ""Mastercard, Pfizer Among 18 Companies To Announce Dividend Increases In December"", ""summary"": ""2H of November saw announcements of annual dividend increases from 9 companies. 16 other companies will announce annual increases before Christmas. Read more here.""}, {""date"": ""20231127070300"", ""headline"": ""Novo falls as long-time investor cuts stake on weight loss hype"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20231127113800"", ""headline"": ""Amgen Inc. stock falls Monday, underperforms market"", ""summary"": ""Shares of Amgen Inc. dropped 0.45% to $264.27 Monday, on what proved to be an all-around poor trading session for the stock market, with the S&P 500 Index...""}, {""date"": ""20231127203500"", ""headline"": ""Amazon Web Services, Amgen to work on generative AI solutions to advance therapies"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20231127213800"", ""headline"": ""Amgen (NASDAQ:AMGN) Gains with New AWS Partnership"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20231127221500"", ""headline"": ""Amgen (NASDAQ:AMGN) Gains on New AWS Partnership"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20231128012000"", ""headline"": ""Amgen receives Orphan Drug Designation for treatment of biliary tract cancers"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20231128090000"", ""headline"": ""1 Spectacular Dividend Stock Every Investor Should Consider"", ""summary"": ""Dividend stocks are versatile investments that can serve different purposes in a portfolio.  Others use them to boost their portfolio's performance by reinvesting the dividends to compound their returns over time.  Here is a brief overview of one blue-chip dividend stock that has successfully served both roles (income generation and above-average capital appreciation) over the past 12 years and that also appears more than capable of continuing this tradition for the foreseeable future.""}, {""date"": ""20231128090005"", ""headline"": ""Is Trending Stock Amgen Inc. (AMGN) a Buy Now?"", ""summary"": ""Zacks.com users have recently been watching Amgen (AMGN) quite a bit. Thus, it is worth knowing the facts that could determine the stock's prospects.""}, {""date"": ""20231128103617"", ""headline"": ""This Stock Hasn't Split Since 1999 \u2014 $1,000 Invested Then Would Be Worth A Boatload Today"", ""summary"": ""When investing in the stock market, a history of strong returns should be high on your priority list. Combine this with a positive outlook on the future, and you may have a winner to add to your portfolio. Amgen Inc., an American multinational biopharmaceutical company, fits this mold. The company has a 10-year annualized total return of 13.69% through the end of 2022. And if that's not enough to pique your interest, consider this: It pays out billions of dollars in dividends to investors every""}, {""date"": ""20231128133441"", ""headline"": ""AWS expands big pharma partnerships in manufacturing, AI, and R&D"", ""summary"": ""Pfizer and Amazon Web Services are just another example of how artificial intelligence is working in the background in healthcare.""}, {""date"": ""20231129000400"", ""headline"": ""The Art of Valuation: Discovering Amgen Inc's Intrinsic Value"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20231129022200"", ""headline"": ""Amazon cloud conference impresses, Rosenblatt sees AI boost"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20231129025700"", ""headline"": ""Amazon cloud conference impresses, Wall Street sees AI boost"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20231129062526"", ""headline"": ""Why I Made Big Changes To My Dividend Growth Portfolio"", ""summary"": ""How to make significant changes to your portfolio, for when buying a new house and selling stocks for cash? Click here to read about my strategy.""}, {""date"": ""20231129070600"", ""headline"": ""Analyst Ratings for Amgen"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20231129074805"", ""headline"": ""Amgen Inc. (AMGN) Presents at 6th Annual Evercore ISI HealthCONx Conference (Transcript)"", ""summary"": ""Amgen Inc. (NASDAQ:NASDAQ:AMGN) 6th Annual Evercore ISI HealthCONx Conference November 29, 2023 9:10 AM ETCompany ParticipantsPeter Griffith - EVP and...""}, {""date"": ""20231129145200"", ""headline"": ""Top Stock Reports for McDonald's, Amgen & NextEra Energy"", ""summary"": ""Today's Research Daily features new research reports on 16 major stocks, including McDonald's Corporation (MCD), Amgen Inc. (AMGN) and NextEra Energy, Inc. (NEE).""}, {""date"": ""20231130060200"", ""headline"": ""Looking Into Amgen's Recent Short Interest"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20231130084400"", ""headline"": ""Amazon (AMZN) Teams Up With Amgen, Expands Customer Base"", ""summary"": ""Amazon's (AMZN) AWS gets selected by Amgen. This highlights the efficiency and reliability of AWS' innovative cloud products and services.""}, {""date"": ""20231130101600"", ""headline"": ""The Zacks Analyst Blog Highlights McDonald's, Amgen, NextEra Energy, General Mills and Take-Two Interactive Software"", ""summary"": ""McDonald's, Amgen, NextEra Energy, General Mills and Take-Two Interactive Software are included in this Analyst Blog.""}, {""date"": ""20231130113055"", ""headline"": ""Amgen (AMGN) Up 2.2% Since Last Earnings Report: Can It Continue?"", ""summary"": ""Amgen (AMGN) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.""}, {""date"": ""20231130113800"", ""headline"": ""Amgen Inc. stock underperforms Thursday when compared to competitors despite daily gains"", ""summary"": ""Shares of Amgen Inc. rallied 1.14% to $269.64 Thursday, on what proved to be an all-around positive trading session for the stock market, with the S&P 500...""}, {""date"": ""20231201011600"", ""headline"": ""Pfizer pulls back from twice-daily regime of weight-loss drug candidate"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20231201040008"", ""headline"": ""Arrowhead Pharmaceuticals: Balance Sheet Concern Needs To Be Addressed"", ""summary"": ""Arrowhead Pharmaceuticals stock drops on balance sheet concerns following fiscal Q3 results. Read why I think positive preclinical results offer hope for ARWR.""}, {""date"": ""20231201043000"", ""headline"": ""Worried About a Weight-Loss Stock Bubble? Here Are Some Alternatives."", ""summary"": ""Eli Lilly and Novo Nordisk, riding the wave of enthusiasm for obesity meds, are seeing their stock prices soar. But behind them are coming new therapies from companies for investors that are drawn to the size of the obesity market but put off by the valuations.""}, {""date"": ""20231201065400"", ""headline"": ""Pfizer hits new 52-week low after weight loss setback"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20231201084749"", ""headline"": ""\u2018From Hype to Clinical\u2018: Cowen Suggests 2 AI Healthcare Stocks to Consider"", ""summary"": ""Just over a year ago, AI technology burst into our collective consciousness with the launch of ChatGPT. Generative AI has quickly shown a high potential to change the way we communicate with the digital world \u2013 and it can bring a similar potential to other fields, from automobiles to healthcare. The magnitude of AI\u2019s potential is clear from the estimates: tech experts are predicting that AI\u2019s application to the healthcare market could exceed $100 billion before 2030. The gains will come on the h""}, {""date"": ""20231201095700"", ""headline"": ""Weight-Loss Stocks Are Getting Pricey. Time to Worry About a Bubble?"", ""summary"": ""Eli Lilly and Novo Nordisk, riding the wave of enthusiasm for obesity meds, are seeing their stock prices soar. But behind them are coming new therapies from companies for investors that are drawn to the size of the obesity market but put off by the valuations.""}, {""date"": ""20231201113800"", ""headline"": ""Amgen Inc. stock outperforms market on strong trading day"", ""summary"": ""Shares of Amgen Inc. advanced 1.04% to $272.45 Friday, on what proved to be an all-around positive trading session for the stock market, with the S&P 500...""}, {""date"": ""20231203021023"", ""headline"": ""Dividend Champion, Contender, And Challenger Highlights: Week Of December 3"", ""summary"": ""A weekly summary of dividend activity for Dividend Champions, Contenders, and Challengers. Read more to see the update for the week of December 3.""}, {""date"": ""20231203060400"", ""headline"": ""Biotechs post record gains in November amid improving outlook"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20231203161400"", ""headline"": ""Obesity Drugs Have Multi-Billion-Dollar Market Potential, Says Oppenheimer \u2014 Here Are 2 Stocks to Take Advantage"", ""summary"": ""A key to success in the stock market is a touch of foresight. Not quite precognition, but an ability to spot and put together clues and trends, to discern the \u2018next big thing\u2019 before it hits. This is true in every stock sector, but today we\u2019ll focus on biotech. The biotech firms have famously high product lead times, paired with equally high overhead expenses; it\u2019s a combination that would make them unlikely investments, except that when a drug is approved, it can turn into a blockbuster. Succes""}]",{}
47,2023-12-03,272.45001220703125,2023-12-10,269.1199951171875,-0.012222488312143343,D2,"[{""date"": ""20231203021023"", ""headline"": ""Dividend Champion, Contender, And Challenger Highlights: Week Of December 3"", ""summary"": ""A weekly summary of dividend activity for Dividend Champions, Contenders, and Challengers. Read more to see the update for the week of December 3.""}, {""date"": ""20231203060400"", ""headline"": ""Biotechs post record gains in November amid improving outlook"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20231203161400"", ""headline"": ""Obesity Drugs Have Multi-Billion-Dollar Market Potential, Says Oppenheimer \u2014 Here Are 2 Stocks to Take Advantage"", ""summary"": ""A key to success in the stock market is a touch of foresight. Not quite precognition, but an ability to spot and put together clues and trends, to discern the \u2018next big thing\u2019 before it hits. This is true in every stock sector, but today we\u2019ll focus on biotech. The biotech firms have famously high product lead times, paired with equally high overhead expenses; it\u2019s a combination that would make them unlikely investments, except that when a drug is approved, it can turn into a blockbuster. Succes""}, {""date"": ""20231203235100"", ""headline"": ""Roche ventures into weight-loss drug market with $2.7B buyout of Carmot"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20231204025109"", ""headline"": ""December Dogs Of The Dow: 3 Buyable, 5 Watchable"", ""summary"": ""Some of these Dow Industrials are too pricey and reveals only skinny dividends. Read here about 3 of the 5 lowest-priced Dogs of the Dow which are ready to buy.""}, {""date"": ""20231204055900"", ""headline"": ""Viking Therapeutics rises on Roche acquiring peer Carmot"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20231204113800"", ""headline"": ""Amgen Inc. stock rises Monday, outperforms market"", ""summary"": ""Shares of Amgen Inc. inched 0.03% higher to $272.54 Monday, on what proved to be an all-around rough trading session for the stock market, with the S&P 500...""}, {""date"": ""20231204141402"", ""headline"": ""Amgen : Understanding Patient Communities Is Vital for Clinical Trial Education"", ""summary"": ""Hispanic communities in the US face health disparities across a wide range of conditions, from cancer and heart disease to obesity and diabetes. One potential root of these disparities...""}, {""date"": ""20231204210342"", ""headline"": ""Dominate the Dow for safe returns, fat dividends with our AI-driven ProPicks"", ""summary"": ""Amid the 30 companies that compose the Dow Jones Industrial Average, 'Dominate the Dow' pinpoints the top 10 \""blue chip\"" stocks that offer the best buy proposition at the moment.""}, {""date"": ""20231205113800"", ""headline"": ""Amgen Inc. stock underperforms Tuesday when compared to competitors"", ""summary"": ""Shares of Amgen Inc. sank 0.61% to $270.87 Tuesday, on what proved to be an all-around rough trading session for the stock market, with the S&P 500 Index...""}, {""date"": ""20231206034700"", ""headline"": ""P/E Ratio Insights for Amgen"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20231206052200"", ""headline"": ""Top stocks with highest hedge fund + mutual fund positions, according to GS"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20231206054000"", ""headline"": ""Top 30 stocks with highest hedge fund + mutual fund short positions \u2013 GS"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20231206060900"", ""headline"": ""30 Stocks shunned by hedge and mutual funds - GS"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20231206113800"", ""headline"": ""Amgen Inc. stock falls Wednesday, underperforms market"", ""summary"": ""Shares of Amgen Inc. sank 0.56% to $269.35 Wednesday, on what proved to be an all-around poor trading session for the stock market, with the S&P 500 Index...""}, {""date"": ""20231206175015"", ""headline"": ""Amgen (AMGN) Registers a Bigger Fall Than the Market: Important Facts to Note"", ""summary"": ""In the latest trading session, Amgen (AMGN) closed at $269.35, marking a -0.56% move from the previous day.""}, {""date"": ""20231206180903"", ""headline"": ""Amgen: Relative Valuation Remains Unattractive"", ""summary"": ""A closer look at the leader in the global osteoporosis treatment market""}, {""date"": ""20231207060058"", ""headline"": ""Amgen (NASDAQ:AMGN) shareholders have earned a 9.8% CAGR over the last five years"", ""summary"": ""If you buy and hold a stock for many years, you'd hope to be making a profit. Furthermore, you'd generally like to see...""}, {""date"": ""20231207113800"", ""headline"": ""Amgen Inc. stock rises Thursday, still underperforms market"", ""summary"": ""Shares of Amgen Inc. inched 0.73% higher to $271.31 Thursday, on what proved to be an all-around favorable trading session for the stock market, with the S&P...""}, {""date"": ""20231207185714"", ""headline"": ""MoonLake Immunotherapeutics: Poised For Acquisition"", ""summary"": ""MoonLake, a clinical-stage biopharmaceutical company, is gaining attention with its promising nanobody-based therapies for inflammatory diseases. Read more here.""}, {""date"": ""20231207210300"", ""headline"": ""Catalyst Watch: Intel's AI event, Oracle earnings and CAVA IPO lockup expiration"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20231207233100"", ""headline"": ""Analysts Offer Insights on Healthcare Companies: Amgen (AMGN) and Edwards Lifesciences (EW)"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20231208053300"", ""headline"": ""Like Dividends? You Should Check Out This Wealth-Creating Income Investment"", ""summary"": ""The Schwab U.S. Dividend Equity ETF focuses on stocks that have historically delivered market-beating total returns.""}, {""date"": ""20231208090000"", ""headline"": ""AMGEN HIGHLIGHTS HEMATOLOGY PORTFOLIO AT ASH 2023"", ""summary"": ""Amgen (NASDAQ:AMGN) today announced the presentation of new data from its blood cancer portfolio and pipeline at the 65th American Society of Hematology (ASH) Annual Meeting and Exposition, taking place from Dec. 9-12 in San Diego.""}, {""date"": ""20231208113800"", ""headline"": ""Amgen Inc. stock underperforms Friday when compared to competitors"", ""summary"": ""Shares of Amgen Inc. shed 0.81% to $269.12 Friday, on what proved to be an all-around favorable trading session for the stock market, with the S&P 500 Index...""}, {""date"": ""20231209054414"", ""headline"": ""Better Dividend ETF For December 2023: SCHD Or JEPI?"", ""summary"": ""Discover the power of dividend investing with popular ETFs SCHD and JEPI.""}, {""date"": ""20231209193938"", ""headline"": ""15 Least Competitive Medical Specialties in America"", ""summary"": ""In this article, we will look at the 15 least competitive medical specialities in America. We have also discussed the state of the healthcare industry in the US. If you want to skip our detailed analysis, head straight to the 5 Least Competitive Medical Specialities in America. Choosing a medical speciality involves a combination of [\u2026]""}, {""date"": ""20231210040000"", ""headline"": ""BST: High Income And Decent Growth, Can We Ask More?"", ""summary"": ""For nine years of its existence, BST has offered nearly 14% of annualized total returns. Check out our analysis of BST CEF and our recommendation.""}, {""date"": ""20231210130746"", ""headline"": ""12 Dow Stocks Billionaires Like The Most"", ""summary"": ""In this piece, we will take a look at the 12 Dow stocks that billionaires like the most. If you don\u2019t want to learn more about the Dow Jones Industrial Average (DJIA), its history, and recent performance, then skip ahead to 5 Dow Stocks Billionaires Like The Most. In its current form today, the Dow [\u2026]""}, {""date"": ""20231210160000"", ""headline"": ""INSIGHT-No global carbon price? Some companies set their own"", ""summary"": ""A growing list of global companies are setting a price or charging themselves for each metric ton of their carbon emissions, looking to shape their investments and business for future pollution taxes or other new climate rules.  Their prices are all over the place, from less than $1 per metric ton of carbon emissions to $1,600, the most of any company worldwide, set by California drugmaker Amgen.""}, {""date"": ""20231210160456"", ""headline"": ""No global carbon price? Some companies set their own"", ""summary"": ""BOSTON/DUBAI/SAN FRANCISCO (Reuters) -A growing list of global companies are setting a price or charging themselves for each metric ton of their carbon emissions, looking to shape their investments and business for future pollution taxes or other new climate rules.  Their prices are all over the place, from less than $1 per metric ton of carbon emissions to $1,600, the most of any company worldwide, set by California drugmaker Amgen.  Regulators, too, have offered a range of prices, including the Biden administration's \""social cost\"" of carbon, around $200, and a suggestion from the International Monetary Fund that it should be at least $85 by 2030.""}]",{}
48,2023-12-10,269.1199951171875,2023-12-17,275.45001220703125,0.023521169755845728,U3,"[{""date"": ""20231209193938"", ""headline"": ""15 Least Competitive Medical Specialties in America"", ""summary"": ""In this article, we will look at the 15 least competitive medical specialities in America. We have also discussed the state of the healthcare industry in the US. If you want to skip our detailed analysis, head straight to the 5 Least Competitive Medical Specialities in America. Choosing a medical speciality involves a combination of [\u2026]""}, {""date"": ""20231210040000"", ""headline"": ""BST: High Income And Decent Growth, Can We Ask More?"", ""summary"": ""For nine years of its existence, BST has offered nearly 14% of annualized total returns. Check out our analysis of BST CEF and our recommendation.""}, {""date"": ""20231210130746"", ""headline"": ""12 Dow Stocks Billionaires Like The Most"", ""summary"": ""In this piece, we will take a look at the 12 Dow stocks that billionaires like the most. If you don\u2019t want to learn more about the Dow Jones Industrial Average (DJIA), its history, and recent performance, then skip ahead to 5 Dow Stocks Billionaires Like The Most. In its current form today, the Dow [\u2026]""}, {""date"": ""20231210160456"", ""headline"": ""No global carbon price? Some companies set their own"", ""summary"": ""BOSTON/DUBAI/SAN FRANCISCO (Reuters) -A growing list of global companies are setting a price or charging themselves for each metric ton of their carbon emissions, looking to shape their investments and business for future pollution taxes or other new climate rules.  Their prices are all over the place, from less than $1 per metric ton of carbon emissions to $1,600, the most of any company worldwide, set by California drugmaker Amgen.  Regulators, too, have offered a range of prices, including the Biden administration's \""social cost\"" of carbon, around $200, and a suggestion from the International Monetary Fund that it should be at least $85 by 2030.""}, {""date"": ""20231211045628"", ""headline"": ""AMGEN HIGHLIGHTS HEMATOLOGY PORTFOLIO AT ASH 2023"", ""summary"": ""THOUSAND OAKS - Amgen today announced the presentation of new data from its blood cancer portfolio and pipeline at the 65th American Society of Hematology Annual Meeting and Exposition, taking...""}, {""date"": ""20231211050500"", ""headline"": ""Insights Into Amgen's Performance Versus Peers In Biotechnology Sector"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20231211080013"", ""headline"": ""Here's Why We Think Amgen (NASDAQ:AMGN) Might Deserve Your Attention Today"", ""summary"": ""For beginners, it can seem like a good idea (and an exciting prospect) to buy a company that tells a good story to...""}, {""date"": ""20231211090007"", ""headline"": ""Here is What to Know Beyond Why Amgen Inc. (AMGN) is a Trending Stock"", ""summary"": ""Amgen (AMGN) has received quite a bit of attention from Zacks.com users lately. Therefore, it is wise to be aware of the facts that can impact the stock's prospects.""}, {""date"": ""20231211094007"", ""headline"": ""Here's Why Amgen (AMGN) is a Strong Value Stock"", ""summary"": ""The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.""}, {""date"": ""20231211101800"", ""headline"": ""Humira leads ICER\u2019s latest list of \u2018unsupported\u2019 price hikes"", ""summary"": ""AbbVie\u2019s blockbuster medicine topped a list of\u00a0treatments that, combined, elevated U.S. healthcare spending by $1.3 billion in 2022, according to the price watchdog\u2019s latest yearly report.""}, {""date"": ""20231211153911"", ""headline"": ""INSIGHT-No global carbon price? Some companies set their own"", ""summary"": ""A growing list of global companies are setting a price or charging themselves for each metric ton of their carbon emissions, looking to shape their investments and business for future pollution taxes or other new climate rules.  Their prices are all over the place, from less than $1 per metric ton of carbon emissions to $1,600, the most of any company worldwide, set by California drugmaker Amgen.""}, {""date"": ""20231211220200"", ""headline"": ""Amgen raises dividend to $2.25 from $2.13"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20231211221300"", ""headline"": ""Amgen raises quarterly dividend by 5.6% to  $2.25/share"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20231211234200"", ""headline"": ""RBC Capital gets more bullish on Amgen, upgrades shares"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20231212012100"", ""headline"": ""Pfizer to close Seagen buyout this week as regulatory reviews complete"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20231212014900"", ""headline"": ""Amgen price target lowered by $10 at Morgan Stanley, here's why"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20231212020400"", ""headline"": ""PVH To Rally Around 11%? Here Are 10 Top Analyst Forecasts For Tuesday"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20231212023000"", ""headline"": ""Amgen just upgraded at RBC Capital, here's why"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20231212042300"", ""headline"": ""Zillow upgraded, Airbnb downgraded: Wall Street's top analyst calls"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20231212055500"", ""headline"": ""Amgen upgraded at RBC on catalyst setup and growth drivers"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20231212101319"", ""headline"": ""US STOCKS-Wall St slips as investors assess November inflation data"", ""summary"": ""Wall Street's main indexes slipped on Tuesday following inflation data that was in line with estimates ahead of the U.S. Federal Reserve's policy decision later in the week, while losses in energy stocks also weighed.  Consumer Price Index (CPI) rose 3.1% on an annual basis in line with estimates from economists polled by Reuters.""}, {""date"": ""20231212110900"", ""headline"": ""Amgen raises dividend to $2.25 a share"", ""summary"": ""Amgen Inc. said late Tuesday its board has authorized a dividend of $2.25 a share, up from $2.13 a share. That\u2019s the 12th straight year that Amgen has...""}, {""date"": ""20231212112705"", ""headline"": ""Amgen Raises Dividend 5.6% To $2.25 A Share"", ""summary"": ""By Ben Glickman Amgen is raising its dividend by 5.6%, marking the company's 12th consecutive year with an increased payout to shareholders. The Thousand Oaks, Calif.-based pharmaceutical...""}, {""date"": ""20231212160000"", ""headline"": ""AMGEN ANNOUNCES 2024 FIRST QUARTER DIVIDEND INCREASE TO $2.25 PER SHARE"", ""summary"": ""Amgen (NASDAQ:AMGN) today announced that its Board of Directors declared a $2.25 per share dividend for the first quarter of 2024. This is the 12th consecutive year that Amgen has increased its dividend and comes as the Company continues to invest in innovation and deleverage its balance sheet. The dividend will be paid on March 7, 2024, to all stockholders of record as of the close of business on February 16, 2024.""}, {""date"": ""20231212172310"", ""headline"": ""RBC Capital Upgrades AMGEN (AMGN)"", ""summary"": """"}, {""date"": ""20231212175014"", ""headline"": ""Amgen (AMGN) Outpaces Stock Market Gains: What You Should Know"", ""summary"": ""Amgen (AMGN) reachead $273.99 at the closing of the latest trading day, reflecting a +0.68% change compared to its last close.""}, {""date"": ""20231212220200"", ""headline"": ""Amgen granted Priority Review by FDA for BLA for tarlatamab"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20231212224800"", ""headline"": ""Amgen gets FDA priority review for small cell lung cancer drug"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20231213010403"", ""headline"": ""Amgen : increase in quarterly dividend"", ""summary"": ""Amgen announced Tuesday evening that its Board of Directors has decided to increase its quarterly dividend to $2.25 per share for the first quarter of 2024. The dividend will be payable on March 7 to...""}, {""date"": ""20231213101500"", ""headline"": ""1 Biotech Stock That Could Be the Next Amgen"", ""summary"": ""The emergence of genomic medicine as a viable modality could transform this midcap biotech into the next Amgen.""}, {""date"": ""20231213104030"", ""headline"": ""Big Pharma: Why the drug industry faces a 3-front battle with the FTC, Medicare, and the White House"", ""summary"": ""The Biden administration is increasingly focused on finding ways to lower drug prices, putting the drug industry in a three-way battle to defend its ecosystem.""}, {""date"": ""20231213112603"", ""headline"": ""Amgen Gets FDA Priority Review For Lung Cancer Treatment"", ""summary"": ""By Ben Glickman Amgen has received priority review status from the Food and Drug Administration for its biologics license application for a small cell lung cancer treatment. The Thousand...""}, {""date"": ""20231213113800"", ""headline"": ""Amgen Inc. stock outperforms market on strong trading day"", ""summary"": ""Shares of Amgen Inc. advanced 2.78% to $281.62 Wednesday, on what proved to be an all-around positive trading session for the stock market, with the S&P 500...""}, {""date"": ""20231213160000"", ""headline"": ""FDA Grants Priority Review to Amgen's Tarlatamab Application for Advanced Small Cell Lung Cancer"", ""summary"": ""Amgen (NASDAQ:AMGN) today announced that the U.S. Food and Drug Administration (FDA) has accepted and granted Priority Review for the Company's Biologics License Application (BLA) for tarlatamab.""}, {""date"": ""20231214000500"", ""headline"": ""Invest with Confidence: Intrinsic Value Unveiled of Amgen Inc"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20231214014000"", ""headline"": ""Amgen Reaches Analyst Target Price"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20231214030300"", ""headline"": ""Amgen announces senior leadership appointments"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20231214043900"", ""headline"": ""Amgen names former Novartis exec James Bradner as chief scientific officer"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20231214043905"", ""headline"": ""Amgen Names James Bradner Chief Scientific Officer"", ""summary"": ""By Colin Kellaher Amgen has hired James Bradner as executive vice president of research and development and chief scientific officer of the biotechnology company. Amgen on Thursday said...""}, {""date"": ""20231214050000"", ""headline"": ""AMGEN TO SPONSOR THE IRISH OPEN"", ""summary"": ""Amgen (NASDAQ:AMGN) today announced it will serve as the title sponsor of the Irish Open starting in 2024, following the acquisition of Horizon Therapeutics plc in October 2023. Horizon Therapeutics, a leading Irish company, began sponsoring the tournament in 2022 as part of a multi-year commitment to the Irish community.""}, {""date"": ""20231214055100"", ""headline"": ""Market Whales and Their Recent Bets on AMGN Options"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20231214061200"", ""headline"": ""Vertex (VRTX) Soars 13.2%: Is Further Upside Left in the Stock?"", ""summary"": ""Vertex (VRTX) saw its shares surge in the last session with trading volume being higher than average. The latest trend in earnings estimate revisions could translate into further price increase in the near term.""}, {""date"": ""20231214063600"", ""headline"": ""AbbVie, Amgen among firms targeted for latest Medicare inflation penalties"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20231214072524"", ""headline"": ""Biopharmaceutical Stocks: The Rally Has Just Begun"", ""summary"": ""With the recent rise in the XBI ETF, investors may begin to wonder if they 'missed the rally'. Read more to see my analysis.""}, {""date"": ""20231214073200"", ""headline"": ""Oppenheimer, Wedbush say buy these biotech stocks for 2024"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20231214082400"", ""headline"": ""Amgen's (AMGN) Tarlatamab BLA Gets FDA Priority Tag for SCLC"", ""summary"": ""Amgen's (AMGN) BLA for tarlatamab to treat advanced small cell lung cancer gets FDA's priority review. A decision is expected on Jun 12, 2024.""}, {""date"": ""20231214090000"", ""headline"": ""AMGEN ANNOUNCES EXECUTIVE APPOINTMENTS TO ACCELERATE INNOVATION"", ""summary"": ""Amgen (NASDAQ:AMGN) today announced two changes to its senior leadership team in the areas of research and development (R&D) and technology, underscoring the advancement of the company's robust pipeline and its commitment to ongoing scientific and technological innovation. James Bradner, M.D., has joined Amgen as executive vice president of Research and Development, and chief scientific officer. Bradner is succeeding David M. Reese, M.D., who has been appointed executive vice president and chief""}, {""date"": ""20231214113800"", ""headline"": ""Amgen Inc. stock falls Thursday, underperforms market"", ""summary"": ""Shares of Amgen Inc. slid 1.88% to $276.32 Thursday, on what proved to be an all-around favorable trading session for the stock market, with the S&P 500...""}, {""date"": ""20231215012400"", ""headline"": ""Amgen finds a new top scientist in Novartis veteran Bradner"", ""summary"": ""Jay Bradner, a well-known physician-scientist who left Novartis last year amid an organizational shakeup, will now serve a Amgen\u2019s chief scientific officer and head of R&D.""}, {""date"": ""20231215013000"", ""headline"": ""Dividend Roundup: Alibaba, Amgen, AT&T, Southwest Airlines, and more"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20231215032200"", ""headline"": ""Morning Brew: Costco Rises on Strong Sales, Semiconductor Bill Approved"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20231215054000"", ""headline"": ""SCHD: Avoid Disaster To Sleep Well At Night"", ""summary"": ""The Schwab U.S. Dividend Equity ETF is surprisingly controversial among the community. Learn why I believe SCHD is a seemingly low-risk ETF.""}, {""date"": ""20231215080016"", ""headline"": ""Amgen Insiders Sold US$5.8m Of Shares Suggesting Hesitancy"", ""summary"": ""In the last year, many Amgen Inc. ( NASDAQ:AMGN ) insiders sold a substantial stake in the company which may have...""}, {""date"": ""20231215113800"", ""headline"": ""Amgen Inc. stock outperforms competitors despite losses on the day"", ""summary"": ""Shares of Amgen Inc. slipped 0.31% to $275.45 Friday, on what proved to be an all-around mixed trading session for the stock market, with the Dow Jones...""}, {""date"": ""20231216223123"", ""headline"": ""Dividend Champion, Contender, And Challenger Highlights: Week Of December 17"", ""summary"": ""Weekly summary of dividend activity for Dividend Champions, Contenders, Challengers. Read more to see the companies with upcoming ex-dividend dates.""}, {""date"": ""20231217090000"", ""headline"": ""Is Amgen Stock a Buy Now?"", ""summary"": ""Boring businesses can be successful, too.""}]",{}
49,2023-12-17,275.45001220703125,2023-12-24,284.1600036621094,0.031620951421601706,U4,"[{""date"": ""20231216223123"", ""headline"": ""Dividend Champion, Contender, And Challenger Highlights: Week Of December 17"", ""summary"": ""Weekly summary of dividend activity for Dividend Champions, Contenders, Challengers. Read more to see the companies with upcoming ex-dividend dates.""}, {""date"": ""20231217090000"", ""headline"": ""Is Amgen Stock a Buy Now?"", ""summary"": ""Boring businesses can be successful, too.""}, {""date"": ""20231217204300"", ""headline"": ""Healthcare Sector Stocks: Consistent Above-Average Growth And Income"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20231218061108"", ""headline"": ""XLV: Considering The Low-Maintenance Option To Navigate The Healthcare Sector"", ""summary"": ""XLV comprises major healthcare industry players and offers a convenient and cost-effective way to invest in the sector. Find out my analysis of XLV ETF.""}, {""date"": ""20231218113900"", ""headline"": ""Amgen Inc. stock rises Monday, still underperforms market"", ""summary"": ""Shares of Amgen Inc. inched 0.01% higher to $275.48 Monday, on what proved to be an all-around mixed trading session for the stock market, with the S&P 500...""}, {""date"": ""20231218133500"", ""headline"": ""7 Dividend Stocks to Buy as Bond Yields Fall"", ""summary"": ""Stocks that pay growing dividends are starting look more attractive as bond yields have dropped.  The rate of inflation has continued to decline, and the Federal Reserve is now more likely to cut short-term interest rates than lift them.  Fatter yields from stock dividends now beckon.""}, {""date"": ""20231218170304"", ""headline"": ""Amgen: Bet On Its Breakthrough Drug"", ""summary"": ""Amgen may be impacted by the Inflation Reduction Act and the potential benefits of FDA granting priority review. See why we believe AMGN stock is a buy.""}, {""date"": ""20231218175020"", ""headline"": ""Amgen (AMGN) Advances But Underperforms Market: Key Facts"", ""summary"": ""Amgen (AMGN) reachead $275.48 at the closing of the latest trading day, reflecting a +0.01% change compared to its last close.""}, {""date"": ""20231218204900"", ""headline"": ""Amgen Provides Exposure To Obesity Drug At A Reasonable Price, Says Bullish Analyst"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20231218222000"", ""headline"": ""What You Missed On Wall Street On Tuesday"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20231218230800"", ""headline"": ""Amgen upgraded to Outperform from Market Perform at BMO Capital"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20231219010758"", ""headline"": ""Amgen raised to Outperform on 'promising pipeline': 4 big analyst picks"", ""summary"": ""Here is your Pro Recap of the biggest analyst picks you may have missed today: upgrades at Amgen, Sunrun, American International Group, and Rockwell Automation.  BMO Capital upgraded Amgen (NASDAQ:AMGN) to Outperform from Market Perform and raised its price target to $326.00 from $286.00.  The analysts noted that the upgrade is based on several key factors:Amgen's emerging oral and injectable metabolic pipeline presents an attractive investment opportunity in the obesity metabolic market without the same premium as peers; The completion of the Horizon deal is seen as a strategic move to offset revenues lost to base business erosion; Amgen's promising pipeline, with numerous potential catalysts through 2024, is expected to foster further expansion of its multiple.""}, {""date"": ""20231219012800"", ""headline"": ""Viridian Therapeutics price target raised to $36 from $35 at Oppenheimer"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20231219013500"", ""headline"": ""Uber To Rally Over 13%? Here Are 10 Top Analyst Forecasts For Tuesday"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20231219021700"", ""headline"": ""GLOBAL BROKER RATINGS: Adobe raised to 'overweight'; SAP cut to 'hold'"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20231219022600"", ""headline"": ""4 Sizzling Stocks Highlight Tuesday\u2019s Top Wall Street Upgrades and Downgrades"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20231219030300"", ""headline"": ""Amgen upgraded by BMO on underappreciated opportunity in obesity/metabolic space"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20231219031000"", ""headline"": ""Amgen: Wonderful Stock At Decent Price"", ""summary"": ""Amgen has outperformed S&P 500 and other peers in terms of total returns over the past decade. Read why I maintain my buy rating on AMGN stock.""}, {""date"": ""20231219040100"", ""headline"": ""Amgen shares rise as analysts see \u2018value obesity play\u2019"", ""summary"": ""Shares of Amgen Inc. gained 1.1% premarket on Tuesday after BMO Capital Markets analysts upgraded the stock to outperform, from market perform, citing the...""}, {""date"": ""20231219060400"", ""headline"": ""Dow's nearly 200-point rally highlighted by gains for Walgreens Boots, Amgen stocks"", ""summary"": ""Shares of Walgreens Boots and Amgen are posting positive gains Tuesday morning, lifting the Dow Jones Industrial Average into positive territory. The Dow was...""}, {""date"": ""20231219063400"", ""headline"": ""What You Missed On Wall Street This Morning"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20231219070022"", ""headline"": ""Amgen Inc. (NASDAQ:AMGN) is largely controlled by institutional shareholders who own 78% of the company"", ""summary"": ""Key Insights Given the large stake in the stock by institutions, Amgen's stock price might be vulnerable to their...""}, {""date"": ""20231219070600"", ""headline"": ""In-Depth Examination Of 18 Analyst Recommendations For Amgen"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20231219094341"", ""headline"": ""Amgen upgraded, PepsiCo downgraded: Wall Street's top analyst calls"", ""summary"": ""Amgen upgraded, PepsiCo downgraded: Wall Street's top analyst calls""}, {""date"": ""20231219113900"", ""headline"": ""Amgen Inc. stock rises Tuesday, outperforms market"", ""summary"": ""Shares of Amgen Inc. rallied 1.07% to $278.44 Tuesday, on what proved to be an all-around great trading session for the stock market, with the S&P 500 Index...""}, {""date"": ""20231219141301"", ""headline"": ""BMO Capital Upgrades Amgen (AMGN)"", ""summary"": """"}, {""date"": ""20231219173701"", ""headline"": ""Tracking John Paulson's Paulson & Company Portfolio - Q3 2023 Update"", ""summary"": ""John Paulson's 13F portfolio surged to $1.12B with notable holdings in HZNP, BHC, and more, while making strategic adjustments. Explore more here.""}, {""date"": ""20231219175443"", ""headline"": ""US STOCKS-Wall Street ends higher as rate-cut fever lingers"", ""summary"": ""Wall Street extended its rally on Tuesday, advancing on the day as last week's dovish policy pivot from the Federal Reserve continued to reverberate and investors looked ahead to crucial inflation data.  Broad-based gains boosted all three major U.S. stock indexes and nudged the S&P 500 to within 1 percentage point of its all-time closing high reached in January 2022.""}, {""date"": ""20231219200400"", ""headline"": ""Looking Into Amgen's Recent Short Interest"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20231219214100"", ""headline"": ""Noteworthy Wednesday Option Activity: AMGN, ADSK, WSO"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20231220034400"", ""headline"": ""CRSP Stock Alert: CRISPR Therapeutics Is Losing Its Medical Chief"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20231220113800"", ""headline"": ""Amgen Inc. stock outperforms competitors despite losses on the day"", ""summary"": ""Shares of Amgen Inc. slid 1.17% to $275.18 Wednesday, on what proved to be an all-around poor trading session for the stock market, with the S&P 500 Index...""}, {""date"": ""20231220200300"", ""headline"": ""CRISPR chief medical officer resigns, stepping down Jan. 26"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20231220203400"", ""headline"": ""Spotlight on Amgen: Analyzing the Surge in Options Activity"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20231220235800"", ""headline"": ""Daiwa gets more bullish on Amgen, upgrades shares"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20231221041200"", ""headline"": ""Blue Chip Sell-Off Stocks Highlight Thursday\u2019s Top Wall Street Upgrades and Downgrades"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20231221080516"", ""headline"": ""5 Biotech Acquisition Targets To Accumulate In 2024"", ""summary"": ""Discover why the current slump in biotech valuations presents a great opportunity for acquisitions. Click here to read what investors need to know.""}, {""date"": ""20231221112317"", ""headline"": ""3 Biotech Stocks to Buy in the TradeSmith \u2018Green Zone\u2019"", ""summary"": ""Investors in search of high-risk, high-reward investments can often find them among the top biotech stocks to buy. Identifying worthwhile opportunities can be easier said than done when investing in biotech. Extensive due diligence is required. Therefore you may want to consider taking into account whether a particular biotech stock is in the \u201cGreen Zone.\u201d TradeSmith offers investors valuable tools for determining which stocks to watch. A good example is its Health Indicator feature. This compre""}, {""date"": ""20231221113800"", ""headline"": ""Amgen Inc. stock outperforms market on strong trading day"", ""summary"": ""Shares of Amgen Inc. rose 1.51% to $279.33 Thursday, on what proved to be an all-around great trading session for the stock market, with the S&P 500 Index...""}, {""date"": ""20231222021206"", ""headline"": ""The Inflation Reduction Act's First Potential Impact On Biosimilars"", ""summary"": ""On October 31, 2023, FDA approved Amgen's Wezlana as a biosimilar to and interchangeable with Janssen's Stelara . Stelara has been selected by the Center for Medicare & Medicaid Services as one of...""}, {""date"": ""20231222044800"", ""headline"": ""Walgreens Boots, Amgen share gains contribute to Dow's 100-point jump"", ""summary"": ""Shares of Walgreens Boots and Amgen are trading higher Friday morning, sending the Dow Jones Industrial Average into positive territory. The Dow is trading...""}, {""date"": ""20231222053600"", ""headline"": ""Biotech stocks set for a rebound in 2024, analysts say"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20231222063602"", ""headline"": ""For Those Investors Stuck On Yield, 2023 Was Opportunistic"", ""summary"": ""Discover the power of active stock picking and contrarian investing in today's volatile market. Click here to read what investors need to know.""}, {""date"": ""20231222090006"", ""headline"": ""Investors Heavily Search Amgen Inc. (AMGN): Here is What You Need to Know"", ""summary"": ""Recently, Zacks.com users have been paying close attention to Amgen (AMGN). This makes it worthwhile to examine what the stock has in store.""}, {""date"": ""20231222113800"", ""headline"": ""Amgen Inc. stock outperforms competitors on strong trading day"", ""summary"": ""Shares of Amgen Inc. advanced 1.73% to $284.16 Friday, on what proved to be an all-around mixed trading session for the stock market, with the S&P 500 Index...""}, {""date"": ""20231222231853"", ""headline"": ""AbbVie Vs. GSK: Dual Dominance In Pharma"", ""summary"": ""AbbVie and GSK are both solid investment choices in the biopharmaceutical industry. Explore more details here.""}, {""date"": ""20231222232425"", ""headline"": ""Bristol Myers Squibb: Aggressive M&A, A Riskier Strategy To Fix The Growth Challenge"", ""summary"": ""Bristol Myers Squibb's (BMY) 2023 outlook is tough, with stagnation and a decline in sales expected, along with increasing debt. Click here to read more.""}, {""date"": ""20231223070300"", ""headline"": ""SCHD: Dividend ETF That Delivers Consistent Dividend Growth"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}]",{}
50,2023-12-24,284.1600036621094,2023-12-31,288.0199890136719,0.013583844671371637,U2,"[{""date"": ""20231225050302"", ""headline"": ""Capital Gain/Loss On Holdings And Trading Gain/Loss With Cash Cows"", ""summary"": ""I highlight the importance of trade income, capital gains, dividend collection, and tax harvesting in my investment approach. Read more here.""}, {""date"": ""20231225050400"", ""headline"": ""Analyzing Amgen In Comparison To Competitors In Biotechnology Industry"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20231226032800"", ""headline"": ""Amgen says FDA has issued new postmarketing requirement for Lumakras"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20231226033300"", ""headline"": ""Amgen says FDA declined full approval for lung cancer drug Lumakras"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20231226040328"", ""headline"": ""US FDA turns down Amgen lung cancer drug Lumakras for full approval"", ""summary"": ""The U.S. Food and Drug Administrationon Tuesday declined to grant traditional approval to Amgen'sLumakras for treating lung cancer patients with aspecific gene mutation, but did not withdraw the...""}, {""date"": ""20231226042600"", ""headline"": ""Amgen\u2019s NDA for Lumakras cancer treatment resulted in complete response letter"", ""summary"": ""Amgen Inc. said Tuesday that the regulatory review of its supplemental new drug application seeking full approval of Lumakras resulted in a \u201ccomplete...""}, {""date"": ""20231226042900"", ""headline"": ""Video: Dow Movers: AMGN, INTC"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20231226044900"", ""headline"": ""Full Approval For Amgen's Flagship Cancer Drug Lumakras Pushed For Around Four Years"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20231226090000"", ""headline"": ""AMGEN PROVIDES REGULATORY UPDATE ON STATUS OF LUMAKRAS\u00ae (SOTORASIB)"", ""summary"": ""Amgen (NASDAQ:AMGN) announced today that the U.S. Food and Drug Administration (FDA) has completed its review of the company's supplemental New Drug Application seeking full approval of LUMAKRAS\u00ae (sotorasib). This review, which resulted in a Complete Response Letter, was based on the CodeBreaK 200 trial results for the treatment of adults with previously treated locally advanced or metastatic KRAS G12C-mutated non-small cell lung cancer (NSCLC). The FDA also issued a new postmarketing requiremen""}, {""date"": ""20231226090959"", ""headline"": ""UPDATE 2-US FDA turns down full approval of Amgen lung cancer drug Lumakras"", ""summary"": ""The U.S. health regulator on Tuesday declined to grant traditional approval to Amgen's Lumakras for treating lung cancer patients with a specific gene mutation, although it kept the drug's existing accelerated approval status.  The U.S. Food and Drug Administration (FDA) now requires data from an additional confirmatory study to support the drug's full approval, which will be completed no later than February 2028, the company said.  Lumakras was approved by the FDA in 2021 under an accelerated pathway, with confirmatory data as a condition for gaining traditional approval.""}, {""date"": ""20231226113800"", ""headline"": ""Amgen Inc. stock underperforms Tuesday when compared to competitors"", ""summary"": ""Shares of Amgen Inc. dropped 0.09% to $283.90 Tuesday, on what proved to be an all-around favorable trading session for the stock market, with the S&P 500...""}, {""date"": ""20231226114729"", ""headline"": ""Midday Movers: Intel's Israel Deal, Bristol-Myers Squibb Buys RayzeBio"", ""summary"": ""U.S. equities continued their pre-Christmas rally into the last week of 2023, with the Dow, S&P 500, and Nasdaq all up.""}, {""date"": ""20231226130553"", ""headline"": ""FDA Wants Another Amgen Study on Lumakras"", ""summary"": ""Amgen will need to run another confirmatory study to win full FDA approval of its lung-cancer drug Lumakras.  Amgen says the FDA, which granted conditional approval to the drug in 2021, has turned away its application seeking full approval and called on the company to complete the additional study by February 2028.  An FDA advisory panel in October raised issues with Amgen's previous confirmatory study, citing problems with how the study was conducted, its small size and relatively minor extension of the time that patients lived without their cancers getting worse.""}, {""date"": ""20231226220000"", ""headline"": ""Healthcare Stocks Had a Terrible 2023. Things Are Looking Up."", ""summary"": ""Things could hardly have gone worse for healthcare investors this year.""}, {""date"": ""20231226223300"", ""headline"": ""Amgen complete response letter has minimal impact, says Barclays"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20231227025100"", ""headline"": ""Amgen bid for Lumakras full approval rejected by US FDA"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20231227043800"", ""headline"": ""LegoChem signs antibody deal with Amgen worth up to $1.25B"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20231227110900"", ""headline"": ""FDA Rejects Amgen's (AMGN) NDA Seeking Full Nod for Lumakras"", ""summary"": ""Per the FDA, Amgen (AMGN) will need to complete an additional confirmatory study on Lumakras in certain lung cancer patients before February 2028 to secure full approval.""}, {""date"": ""20231227113800"", ""headline"": ""Amgen Inc. stock outperforms competitors on strong trading day"", ""summary"": ""Shares of Amgen Inc. inched 0.93% higher to $286.53 Wednesday, on what proved to be an all-around positive trading session for the stock market, with the S&P...""}, {""date"": ""20231227140020"", ""headline"": ""TScan: Two 2024 TCR-T Data Readouts Could Bring Significant Value"", ""summary"": ""TScan's results from T-Plex targeting patients with solid tumors in the Phase 1 study are expected to be released in 2024. Read my analysis of TCRX stock.""}, {""date"": ""20231227180019"", ""headline"": ""Amgen (AMGN) Surpasses Market Returns: Some Facts Worth Knowing"", ""summary"": ""In the latest trading session, Amgen (AMGN) closed at $286.53, marking a +0.93% move from the previous day.""}, {""date"": ""20231227211000"", ""headline"": ""Pharma and biotech deal values spike 35% in 2023: report"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20231227220000"", ""headline"": ""Buy AstraZeneca Stock. It Looks Much Better Going Into 2024."", ""summary"": ""The Big Pharma mainstay is set to deliver double-digit earnings growth, driven by a diverse portfolio of blockbusters and promising newcomers.""}, {""date"": ""20231228064700"", ""headline"": ""Amgen's Options: A Look at What the Big Money is Thinking"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20231228083900"", ""headline"": ""Biotech Stock Roundup: BMY's KRTX and RYZB Acquisition, CYTK Surges on Study Data"", ""summary"": ""Bristol Myers (BMY) and Cytokinetics (CYTK) are in the news on acquisition announcements and study updates, respectively.""}, {""date"": ""20231228110700"", ""headline"": ""Coherus (CHRS) Stock Rallies on FDA Nod for Udenyca Onbody"", ""summary"": ""The FDA approves Coherus' (CHRS) Udenyca Onbody, an on-body injector presentation of Udenyca (pegfilgrastim-cbqv). Shares of the company rise on the news.""}, {""date"": ""20231228113800"", ""headline"": ""Amgen Inc. stock outperforms market on strong trading day"", ""summary"": ""Shares of Amgen Inc. inched 0.67% higher to $288.46 Thursday, on what proved to be an all-around great trading session for the stock market, with the S&P 500...""}, {""date"": ""20231229000200"", ""headline"": ""Amgen Inc: An Exploration into Its Intrinsic Value"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20231229060053"", ""headline"": ""Is Amgen Inc. (NASDAQ:AMGN) Trading At A 40% Discount?"", ""summary"": ""Key Insights Using the 2 Stage Free Cash Flow to Equity, Amgen fair value estimate is US$479 Amgen's US$288 share price...""}, {""date"": ""20231229062328"", ""headline"": ""Viridian Therapeutics: Disconnect Between Fundamentals And Share Price In 2023"", ""summary"": ""Shares of Viridian Therapeutics performed poorly this year, even if we consider the underperformance of biotech stocks. Read more about VRDN stock here.""}, {""date"": ""20231229092400"", ""headline"": ""Can Amgen's Price Strength Continue Into 2024?"", ""summary"": ""Biotechnology firm Amgen  has moved higher on the charts the past seven months and made a new 52-week high on Thursday.  Can this price strength continue or are we looking at a \""last gasp\"" as we head into the new year?  Prices are trading above the 50-day moving average line but the slope of the line is neutral or flat.""}, {""date"": ""20231229113800"", ""headline"": ""Amgen Inc. stock falls Friday, still outperforms market"", ""summary"": ""Shares of Amgen Inc. sank 0.15% to $288.02 Friday, on what proved to be an all-around rough trading session for the stock market, with the S&P 500 Index...""}, {""date"": ""20231229172154"", ""headline"": ""Neurological and obesity drugs will be prevalent in 2024"", ""summary"": ""The rollout of GLP-1 weight loss drugs was prevalent in several pharmaceutical companies' 2023 narratives, among other core biotech products. Jefferies Managing Director Michael Yee joins Yahoo Finance Live to discuss the outlook for pharma and biotech companies in 2024, predicting an increase in M&A activity and continuance of investments into certain drug treatments. \""Obesity is one area, I would definitely say you can't just say it is going to be obesity,\"" Yee says. \""Neurology, Alzheimer's, but more broadly... schizophrenia, depression, Parkinson's, other important areas \u2014 neurology is perhaps one of the biggest epidemics across our country.\"" For more expert insight and the latest market action, click\u00a0here\u00a0to watch this full episode of Yahoo Finance Live.""}, {""date"": ""20231229175020"", ""headline"": ""Amgen (AMGN) Stock Moves -0.15%: What You Should Know"", ""summary"": ""The latest trading day saw Amgen (AMGN) settling at $288.02, representing a -0.15% change from its previous close.""}, {""date"": ""20231231052603"", ""headline"": ""Chevron, Kimberly-Clark Among 14 Companies To Announce Dividend Increases In January"", ""summary"": ""Investors celebrate double-digit increases for Mastercard and Broadcom.""}, {""date"": ""20231231060600"", ""headline"": ""Morgan Stanley positive on healthcare services despite election year"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}]",{}
51,2023-12-31,288.0199890136719,2024-01-07,303.0,0.05201031719231497,U5+,"[{""date"": ""20231231052603"", ""headline"": ""Chevron, Kimberly-Clark Among 14 Companies To Announce Dividend Increases In January"", ""summary"": ""Investors celebrate double-digit increases for Mastercard and Broadcom.""}, {""date"": ""20231231060600"", ""headline"": ""Morgan Stanley positive on healthcare services despite election year"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20231231234400"", ""headline"": ""Dow Dogs Gain Some Respect In Q4 2023"", ""summary"": ""In the fourth quarter, the Dow Dogs generated mid-teens growth that resulted in the 2023 total return equaling 14.5% for the year and almost matching the Dow's return of 16.0%.""}, {""date"": ""20240101013312"", ""headline"": ""IGA: Trading At A Discount For A Very Good Reason"", ""summary"": ""Voya Global Advantage and Premium Opportunity Fund offers high level income through its equities and dividend-paying stock portfolios. Read my analysis of IGA.""}, {""date"": ""20240101223400"", ""headline"": ""Stock market today: Asian markets track Wall Street's decline, eroding last year's gains"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20240101223800"", ""headline"": ""Did Santa Claus Leave Town A Day Early?"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20240102050000"", ""headline"": ""Anticompetitive Behavior At United Therapeutics"", ""summary"": ""United Therapeutics calls itself a Public Benefit company; in reality, it is a cynical monopolist about to lose its monopoly. Click here to read more.""}, {""date"": ""20240102070500"", ""headline"": ""FDA ends busy year with three drug rejections"", ""summary"": ""Amgen had its\u00a0bid for full approval of the cancer drug Lumakras turned back by the agency, which also issued complete response letters to Zealand Pharma and Merck & Co. in December.""}, {""date"": ""20240102072500"", ""headline"": ""Dogs Of The Dow: Top 10 Highest Yielding Dow Jones Stocks, How To Get Dividends Of 3% to 7.4% In 2024"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20240102074000"", ""headline"": ""Amgen, Merck share gains lead Dow's 100-point jump"", ""summary"": ""Behind strong returns for shares of Amgen and Merck, the Dow Jones Industrial Average is climbing Tuesday afternoon. The Dow was most recently trading 100...""}, {""date"": ""20240102220400"", ""headline"": ""Revenge of the Boring Stocks! Dividends Are Sexy Again."", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20240103090006"", ""headline"": ""Amgen Inc. (AMGN) Is a Trending Stock: Facts to Know Before Betting on It"", ""summary"": ""Amgen (AMGN) has been one of the stocks most watched by Zacks.com users lately. So, it is worth exploring what lies ahead for the stock.""}, {""date"": ""20240103113800"", ""headline"": ""Amgen Inc. stock outperforms competitors on strong trading day"", ""summary"": ""Shares of Amgen Inc. rose 1.11% to $300.69 Wednesday, on what proved to be an all-around dismal trading session for the stock market, with the S&P 500 Index...""}, {""date"": ""20240103135900"", ""headline"": ""Pharma Stocks Are on a Health Kick"", ""summary"": ""Stocks are down Wednesday, but big pharma shares are bucking the trend. + Shares of Eli Lilly, one of last year's darling stocks, were up nearly 4%, + Amgen, which is a Dow Jones Industrial Average component, and Merck also advanced.""}, {""date"": ""20240103160000"", ""headline"": ""AMGEN TO PRESENT AT THE 42ND ANNUAL J.P. MORGAN HEALTHCARE CONFERENCE"", ""summary"": ""Amgen (NASDAQ:AMGN) will present at the 2024 J.P. Morgan Healthcare Conference at 9:00 a.m. PT on Monday, January 8, 2024. Robert A. Bradway, chairman and chief executive officer at Amgen will present at the conference. The webcast will be broadcast over the internet simultaneously and will be available to members of the news media, investors and the general public.""}, {""date"": ""20240104000200"", ""headline"": ""The Art of Valuation: Discovering Amgen Inc's Intrinsic Value"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20240104001305"", ""headline"": ""How The Supreme Court's Decision In Amgen v. Sanofi Impacts Pharmaceutical Patents"", ""summary"": ""On May 18, 2023, the Supreme Court of the United States handed down its decision in Amgen Inc. v. Sanofi 1 , a fairly notorious case among pharmaceutical companies and patent nerds. Amgen/Sanofi is...""}, {""date"": ""20240104010000"", ""headline"": ""Generate:Biomedicines Fortifies Leadership in Generative AI with Advancing Clinical Pipeline and Expanded Amgen Collaboration, Overviewed at the 42nd Annual J.P. Morgan Healthcare Conference"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20240104060700"", ""headline"": ""QQQ ETF Update, 1/5/2024"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20240104063900"", ""headline"": ""10 Health Care Stocks Whale Activity In Today's Session"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20240104070926"", ""headline"": ""January Dogs Of The Dow: 2 Buyable, 6 Watchable"", ""summary"": ""Discover criteria for stocks to be added to the Dow, find the highest-yield stocks in December, and see stocks with most potential. Click here for our list!""}, {""date"": ""20240104074900"", ""headline"": ""Johnson & Johnson: Rock Solid 3% Yield With Over 10% Annual Return Potential (Rating Upgrade)"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20240104082938"", ""headline"": ""Johnson & Johnson: Rock Solid 3% Yield With Over 10% Return Potential (Rating Upgrade)"", ""summary"": ""Johnson & Johnson offers a safe and attractive investment opportunity with solid growth, a strong balance sheet, and a +3% dividend yield. Learn more on JNJ stock here.""}, {""date"": ""20240104083005"", ""headline"": ""Here's How Much a $1000 Investment in Amgen Made 10 Years Ago Would Be Worth Today"", ""summary"": ""Holding on to popular or trending stocks for the long-term can make your portfolio a winner.""}, {""date"": ""20240104113800"", ""headline"": ""Amgen Inc. stock rises Thursday, outperforms market"", ""summary"": ""Shares of Amgen Inc. inched 0.82% higher to $303.17 Thursday, on what proved to be an all-around mixed trading session for the stock market, with the Dow...""}, {""date"": ""20240104180018"", ""headline"": ""Why the Market Dipped But Amgen (AMGN) Gained Today"", ""summary"": ""Amgen (AMGN) reachead $303.17 at the closing of the latest trading day, reflecting a +0.82% change compared to its last close.""}, {""date"": ""20240104205100"", ""headline"": ""Looking At Amgen's Recent Unusual Options Activity"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20240104230100"", ""headline"": ""Dogs of the Dow 2024: Cheap Dividends, But Are They Values?"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20240105015116"", ""headline"": ""Generate : Biomedicines Fortifies Leadership in Generative AI with Advancing Clinical Pipeline and Expanded Amgen Collaboration, Overviewed at the 42nd Annual J.P. Morgan Healthcare Conference"", ""summary"": ""Cambridge - Generate:Biomedicines today announced key advancements across its clinical pipeline and generative AI platform, including its first patient dosed in GB-0895, progress in the phase 1 study...""}, {""date"": ""20240105025100"", ""headline"": ""Analysts Conflicted on These Healthcare Names: Innate Pharma SA (OtherIPHYF), Amgen (AMGN) and Regeneron (REGN)"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20240105031200"", ""headline"": ""Florida to become first state to win FDA nod for mass drug imports from Canada: NYT"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20240105042300"", ""headline"": ""Florida wins FDA nod for mass drug imports from Canada (update)"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20240105113800"", ""headline"": ""Amgen Inc. stock falls Friday, underperforms market"", ""summary"": ""Shares of Amgen Inc. slid 0.06% to $303.00 Friday, on what proved to be an all-around great trading session for the stock market, with the S&P 500 Index...""}, {""date"": ""20240105130709"", ""headline"": ""How I Beat The Market Again In 2023"", ""summary"": ""I express frustration with the constant negativity surrounding the idea that beating the market is impossible for the average investor. Click here to read more.""}, {""date"": ""20240105175019"", ""headline"": ""Amgen (AMGN) Stock Sinks As Market Gains: What You Should Know"", ""summary"": ""In the closing of the recent trading day, Amgen (AMGN) stood at $303, denoting a -0.06% change from the preceding trading day.""}, {""date"": ""20240106031200"", ""headline"": ""7 Rock-Solid Healthcare Dividend Stocks to Buy in January"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20240106042248"", ""headline"": ""Johnson & Johnson's Bullish Outlook: Surprising Strength You Shouldn't Overlook"", ""summary"": ""Johnson & Johnson is a Dividend King focused on the creation and manufacturing of medical devices, vaccines, and medicines. Read more about JNJ stock here.""}, {""date"": ""20240106174529"", ""headline"": ""These Dow Stocks Will Boost Their Dividends Soon"", ""summary"": ""In this article, we discuss 10 Dow stocks that will boost their dividends soon. You can skip our detailed analysis of dividend stocks and their performance over the years, and go directly to read These 5 Dow Stocks Will Boost Their Dividends Soon. The Dow Jones Industrial Average, known as the Dow, is a famous [\u2026]""}, {""date"": ""20240106230100"", ""headline"": ""A Rough Start To 2024 What Might Be In Store For The Rest Of 2024?"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}]",{}
52,2024-01-07,303.0,2024-01-14,306.510009765625,0.011584190645627102,U2,"[{""date"": ""20240106230100"", ""headline"": ""A Rough Start To 2024 What Might Be In Store For The Rest Of 2024?"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20240108001200"", ""headline"": ""5 Biotech Stocks That Should Be On Investors' Radar As JPMorgan Healthcare Conference Gets Underway Monday"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20240108050300"", ""headline"": ""Investigating Amgen's Standing In Biotechnology Industry Compared To Competitors"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20240108053000"", ""headline"": ""Investors Hope the Dogs of the Dow Can Find Their Bite"", ""summary"": ""Big tech stocks are off to a sluggish start in January, offering a chance for value-oriented shares to shine.""}, {""date"": ""20240108063900"", ""headline"": ""10 Health Care Stocks With Whale Alerts In Today's Session"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20240108065600"", ""headline"": ""QQQ ETF Update, 1/9/2024"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20240108070100"", ""headline"": ""Nvidia dives deeper into AI drug development with Amgen, Recursion partnerships"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20240108080000"", ""headline"": ""Nvidia dives deeper into AI drug development with Amgen, Recursion partnerships\u00a0"", ""summary"": ""Nvidia is doubling down on artificial-intelligence-powered drug discovery and development, announcing expanded partnerships with Amgen and Recursion...""}, {""date"": ""20240108080901"", ""headline"": ""Dow Jones Futures Fall As Boeing Dives On Groundings; Coinbase Rallies On Price Target Hike"", ""summary"": ""Dow Jones futures dropped 170 points Monday, as Boeing dived after its 737 Max 9 jets were grounded. Coinbase rallied on a price-target hike.""}, {""date"": ""20240108093501"", ""headline"": ""Dow Jones Falls As Boeing Dives On Groundings; Coinbase Rallies On Price Target Hike"", ""summary"": ""The Dow Jones dropped 150 points Monday, as Boeing dived after its 737 Max 9 jets were grounded. Coinbase rallied on a price-target hike.""}, {""date"": ""20240108094800"", ""headline"": ""Nvidia\u2019s stock breaks new ground after healthcare partnerships and ahead of CES"", ""summary"": ""Shares of Nvidia Corp. kept rallying Monday, enough to enter record territory for the first time in nearly two months, after the semiconductor and...""}, {""date"": ""20240108103208"", ""headline"": ""Amgen Inc. (AMGN) Presents at J.P. Morgan 42nd Annual Healthcare Conference 2024 (Transcript)"", ""summary"": ""Amgen Inc. (NASDAQ:NASDAQ:AMGN) J.P.""}, {""date"": ""20240108103435"", ""headline"": ""How To Build A Dividend Growth Portfolio As A 'Young Investor' With $100,000"", ""summary"": ""Number of years left before retirement is an important factor to consider when planning investments. Click here to read what young investors should focus on.""}, {""date"": ""20240108113800"", ""headline"": ""Amgen Inc. stock rises Monday, outperforms market"", ""summary"": ""Shares of Amgen Inc. rallied 2.60% to $310.88 Monday, on what proved to be an all-around positive trading session for the stock market, with the S&P 500...""}, {""date"": ""20240108133130"", ""headline"": ""Dow Jones Leader Amgen Extends Gains Past Buy Point; Ozempic Maker Novo Nordisk Breaks Out"", ""summary"": ""Dow Jones biotech leader Amgen extended its breakout gains, while Ozempic maker Novo Nordisk is in buy range past its latest buy point.""}, {""date"": ""20240108140400"", ""headline"": ""Top Stock Reports for Apple, UnitedHealth & Exxon Mobil"", ""summary"": ""Today's Research Daily features new research reports on 16 major stocks, including Apple Inc. (AAPL), UnitedHealth Group Incorporated (UNH) and Exxon Mobil Corporation (XOM).""}, {""date"": ""20240108191244"", ""headline"": ""Dow Jones Futures: Magnificent Seven Stocks Rally; Nvidia Breaks Out Past Buy Point"", ""summary"": ""Dow Jones futures: The Magnificent Seven stocks rallied sharply Monday, with Nvidia stock breaking out past a new buy point to record highs.""}, {""date"": ""20240108214044"", ""headline"": ""Dow Jones Futures Fall: Magnificent Seven Stocks Rally; Nvidia Breaks Out Past Buy Point"", ""summary"": ""Dow Jones futures: The Magnificent Seven stocks rallied sharply Monday, with Nvidia stock breaking out past a new buy point to record highs.""}, {""date"": ""20240108230600"", ""headline"": ""Amgen Hold Rating Justified by Promising Pipeline and Measured Growth Expectations"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20240109003600"", ""headline"": ""Buy Rating for Amgen Backed by Strong Pipeline and Strategic Acquisitions"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20240109012100"", ""headline"": ""Noteworthy Tuesday Option Activity: AMGN, PINS, JOE"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20240109032600"", ""headline"": ""BMO Capital Sticks to Their Buy Rating for Amgen (AMGN)"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20240109042300"", ""headline"": ""Looking At Amgen's Recent Unusual Options Activity"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20240109071300"", ""headline"": ""Xeris Biopharma: Speculative Buy, Size Your Position Accordingly"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20240109113800"", ""headline"": ""Amgen Inc. stock falls Tuesday, underperforms market"", ""summary"": ""Shares of Amgen Inc. slipped 1.16% to $307.26 Tuesday, on what proved to be an all-around dismal trading session for the stock market, with the S&P 500 Index...""}, {""date"": ""20240109203500"", ""headline"": ""How Is The Market Feeling About Amgen?"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20240110000900"", ""headline"": ""Is AI More Valuable In Advertising Than Healthcare? Jim Cramer Questions Wall Street's Preference"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20240110022400"", ""headline"": ""Amgen in pact with Xeris Biopharma for Tepezza injectable"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20240110024100"", ""headline"": ""Analysts Offer Insights on Healthcare Companies: Amgen (AMGN) and Sarepta Therapeutics (SRPT)"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20240110033914"", ""headline"": ""Xeris Biopharma Reaches License Agreement With Amgen On Thyroid Eye Disease Treatment"", ""summary"": ""By Ben Glickman Xeris Biopharma has entered an exclusive worldwide license agreement with Amgen related to a subcutaneous formulation of a Thyroid Eye Disease treatment. The Chicago-based...""}, {""date"": ""20240110045806"", ""headline"": ""Xeris Biopharma Shares Climb 12% on Amgen License Agreement"", ""summary"": ""By Ben Glickman Shares of Xeris Biopharma rose Wednesday after the company reached a license agreement with Amgen involving its XeriJect technology. The stock was up 12% to $2.67 in...""}, {""date"": ""20240110070800"", ""headline"": ""What You Missed On Wall Street This Morning"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20240110075500"", ""headline"": ""Commit To Purchase Amgen At $185, Earn 1.1% Using Options"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20240110113800"", ""headline"": ""Amgen Inc. stock falls Wednesday, underperforms market"", ""summary"": ""Shares of Amgen Inc. slipped 0.88% to $304.57 Wednesday, on what proved to be an all-around positive trading session for the stock market, with the S&P 500...""}, {""date"": ""20240110125232"", ""headline"": ""SCHD Vs. SPHD: Only One Is A Worthy Passive Income Snowball"", ""summary"": ""Investors can look at two popular dividend ETFs to see which one makes for a better passive income snowball. Learn more about the SCHD and SPHD ETFs here.""}, {""date"": ""20240110150218"", ""headline"": ""JPM's annual healthcare conference: Here's what's next for GLP-1s and the weight loss market"", ""summary"": ""Several big pharma companies are rushing into the GLP-1 obesity space, which currently has two market leaders. How they plan to take some of that market share will be the story of the drug class for 2024.""}, {""date"": ""20240110165314"", ""headline"": ""Dogs of the Dow: January\u2019s Top 3 Picks to Buy for Big Gains"", ""summary"": ""\u201cThe Dogs of the Dow\u201d system involves purchasing the index\u2019s 10 stocks with the highest dividend yields at the end of each year. Using the technique has a few major advantages. Of course, stocks with high dividend yields pay investors to wait for a rebound to provide either significant income or the ability to buy more shares of stock at no extra cost. Moreover, for the most part, the members of the Dow are profitable leaders in their sectors, so they pose little risk. The members with the highe""}, {""date"": ""20240110214400"", ""headline"": ""Amgen may be evaluating Cytokinetics bid; CYTK wants $130-$145 a share - report"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20240110232600"", ""headline"": ""Amgen may be evaluating Cytokinetics bid; CYTK wants $130-$145 a share - report (update)"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20240111000200"", ""headline"": ""Beyond Market Price: Uncovering Amgen Inc's Intrinsic Value"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20240111040300"", ""headline"": ""AbbVie's Strategic Move: ImmunoGen Acquisition Triggers Golden Cross, Yet Valuation Caution Remains"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20240111055000"", ""headline"": ""Large Drugmakers Show Enthusiasm To Embrace $100B Obesity Market, Despite Novo And Lilly's Dominance"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20240111060000"", ""headline"": ""Drugmakers plot way into obesity market with deals and development"", ""summary"": ""Pharmaceutical executives from Amgen to Pfizer are plotting to break into the lucrative obesity market by developing or cutting deals to acquire better drugs that will compete with Novo Nordisk's Wegovy and Zepbound from Eli Lilly.  Amgen has an experimental dual mechanism obesity drug in mid-stage trials it hopes will have fewer side effects with less frequent dosing than Wegovy or Zepbound, Chief Scientific Officer Jay Bradner told Reuters at the annual JPMorgan health conference in San Francisco this week.""}, {""date"": ""20240111083000"", ""headline"": ""Xeris (XERS) Up on Licensing Deal With Amgen to Develop Tepezza"", ""summary"": ""Xeris (XERS) gains 16% after signing a licensing deal with Amgen, which allows the latter to utilize the XeriJect technology to develop a subcutaneous formulation of teprotumumab in Thyroid Eye Disease.""}, {""date"": ""20240111113800"", ""headline"": ""Amgen Inc. stock underperforms Thursday when compared to competitors"", ""summary"": ""Shares of Amgen Inc. slumped 0.48% to $303.10 Thursday, on what proved to be an all-around mixed trading session for the stock market, with the Dow Jones...""}, {""date"": ""20240111131048"", ""headline"": ""UPDATE 1-Weight loss drug windfall attracts pharma companies"", ""summary"": ""Pharmaceutical executives from Amgen to Pfizer are plotting to break into the lucrative obesity market by developing or cutting deals to acquire better drugs that will compete with Novo Nordisk's Wegovy and Zepbound from Eli Lilly.  Shares Eli Lilly and Novo Nordisk are up around 75% and 60%, respectively, over the last year, far outpacing the broader pharmaceutical sector.  Amgen has an experimental dual mechanism obesity drug in mid-stage trials it hopes will have fewer side effects with less frequent dosing than Wegovy or Zepbound, Chief Scientific Officer Jay Bradner told Reuters at the annual JPMorgan health conference in San Francisco this week.""}, {""date"": ""20240111175022"", ""headline"": ""Amgen (AMGN) Suffers a Larger Drop Than the General Market: Key Insights"", ""summary"": ""Amgen (AMGN) reachead $303.10 at the closing of the latest trading day, reflecting a -0.48% change compared to its last close.""}, {""date"": ""20240112015207"", ""headline"": ""Wall Street Breakfast Podcast: EV Names Fall As Hertz Hits The Gas Pedal"", ""summary"": ""EV shocker: Tesla, Rivian and Fisker fall after Hertz hits the gas pedal. CVS paring down pharmacy footprint inside Target: WSJ. Amgen may be evaluating Cytokinetics bid.""}, {""date"": ""20240112024100"", ""headline"": ""Q3 2020 Amgen Inc Earnings Call"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20240112024100"", ""headline"": ""Q2 2020 Amgen Inc Earnings Call"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20240112024100"", ""headline"": ""Q1 2020 Amgen Inc Earnings Call"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20240112024100"", ""headline"": ""Q4 2019 Amgen Inc Earnings Call"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20240112024100"", ""headline"": ""Q3 2019 Amgen Inc Earnings Call"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20240112024100"", ""headline"": ""Q2 2019 Amgen Inc Earnings Call"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20240112024100"", ""headline"": ""Q1 2019 Amgen Inc Earnings Call"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20240112024100"", ""headline"": ""Q4 2018 Amgen Inc Earnings Call"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20240112024100"", ""headline"": ""Q4 2020 Amgen Inc Earnings Call"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20240112024200"", ""headline"": ""Q2 2023 Amgen Inc Earnings Call"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20240112024200"", ""headline"": ""Q1 2023 Amgen Inc Earnings Call"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20240112024200"", ""headline"": ""Q4 2022 Amgen Inc Earnings Call"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20240112024200"", ""headline"": ""Q3 2022 Amgen Inc Earnings Call"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20240112024200"", ""headline"": ""Q2 2022 Amgen Inc Earnings Call"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20240112024200"", ""headline"": ""Q1 2022 Amgen Inc Earnings Call"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20240112024200"", ""headline"": ""Q3 2021 Amgen Inc Earnings Call"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20240112024200"", ""headline"": ""Q2 2021 Amgen Inc Earnings Call"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20240112024200"", ""headline"": ""Q1 2021 Amgen Inc Earnings Call"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20240112024200"", ""headline"": ""Q3 2023 Amgen Inc Earnings Call"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20240112071952"", ""headline"": ""2024 Dividend Growth Portfolio Review And Look Ahead"", ""summary"": ""My dividend growth portfolio has consistently grown income in excess of 10% annually. Read more to see a review of the portfolio's positions.""}, {""date"": ""20240112074700"", ""headline"": ""FDA Finds No Link Between Obesity Drugs and Suicidal Thoughts"", ""summary"": ""The GLP-1 segment is an important class of drugs for multiple cardiometabolic diseases and is gaining significant popularity.""}, {""date"": ""20240112102319"", ""headline"": ""Dow Jones Falls On Cool Inflation Data; Tesla Stock Slides Despite Cathie Wood Buys"", ""summary"": ""The Dow Jones fell Friday after key inflation data. Tesla stock dived on China price cuts despite Cathie Wood's new purchases.""}, {""date"": ""20240112113800"", ""headline"": ""Amgen Inc. stock outperforms competitors on strong trading day"", ""summary"": ""Shares of Amgen Inc. rose 1.13% to $306.51 Friday, on what proved to be an all-around mixed trading session for the stock market, with the S&P 500 Index...""}, {""date"": ""20240114034513"", ""headline"": ""Vectoring In On Verve Therapeutics"", ""summary"": ""Verve's lead candidate, VERVE-101, has shown promising results in reducing LDL-C levels in preclinical studies. Find out my recommendation on VERV stock.""}, {""date"": ""20240114060600"", ""headline"": ""Optimistic Outlook for Amgen: Robust Financial Health and Strategic R&D Expansion Fuel Buy Rating"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}]",{}
53,2024-01-14,306.510009765625,2024-01-21,304.0799865722656,-0.007928038615174438,D1,"[{""date"": ""20240114034513"", ""headline"": ""Vectoring In On Verve Therapeutics"", ""summary"": ""Verve's lead candidate, VERVE-101, has shown promising results in reducing LDL-C levels in preclinical studies. Find out my recommendation on VERV stock.""}, {""date"": ""20240114060600"", ""headline"": ""Optimistic Outlook for Amgen: Robust Financial Health and Strategic R&D Expansion Fuel Buy Rating"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20240115021307"", ""headline"": ""USPTO Says Wands Is Still The Test Post-Amgen"", ""summary"": ""The United States Patent and Trademark Office issued a notice in the Federal Register on January 10, 2024, providing guidelines to assist USPTO personnel in assessing enablement under 35 U.S.C. 112,...""}, {""date"": ""20240115044600"", ""headline"": ""QQQ ETF Update, 1/16/2024"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20240115055000"", ""headline"": ""The Zacks Analyst Blog Highlights Eli Lilly, Novo Nordisk, Amgen and AstraZeneca"", ""summary"": ""Eli Lilly, Novo Nordisk, Amgen and AstraZeneca are included in this Analyst Blog.""}, {""date"": ""20240115063000"", ""headline"": ""5 Biotech Stocks That Could Be Big Winners in 2024 and Beyond"", ""summary"": ""These five biotech companies could have a lot of room to run.""}, {""date"": ""20240115064100"", ""headline"": ""10 Health Care Stocks With Whale Alerts In Today's Session"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20240115090006"", ""headline"": ""Amgen Inc. (AMGN) is Attracting Investor Attention: Here is What You Should Know"", ""summary"": ""Amgen (AMGN) has received quite a bit of attention from Zacks.com users lately. Therefore, it is wise to be aware of the facts that can impact the stock's prospects.""}, {""date"": ""20240115095006"", ""headline"": ""Are You a Momentum Investor? This 1 Stock Could Be the Perfect Pick"", ""summary"": ""Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.""}, {""date"": ""20240115232800"", ""headline"": ""Stocks Struggle As U.S. Dollar Sees Safety Bid"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20240116021207"", ""headline"": ""Enabling Practitioners : USPTO Issues Guidelines For Assessing Enablement Post-Amgen"", ""summary"": ""What You Need to Know ...""}, {""date"": ""20240116044300"", ""headline"": ""Cathie Wood's Ark Invest Liquidates $15.8M Worth Of ProShares Bitcoin Strategy ETF Units"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20240116055009"", ""headline"": ""Top And Bottom S&P 500 Stocks To Consider In 2024"", ""summary"": ""Investors keep a close eye on the S&P 500 as it retreats at the start of the year. Check out the top and bottom S&P 500 stocks to consider in 2024.""}, {""date"": ""20240116061210"", ""headline"": ""A Look Ahead : Key Intellectual Property Legal Topics In 2024"", ""summary"": ""What should in-house counsel be on the lookout for in 2024? As we begin a new year, our attorneys look ahead at intellectual property topics they expect will be trending in 2024. They cover areas...""}, {""date"": ""20240116113700"", ""headline"": ""Amgen Inc. stock outperforms competitors despite losses on the day"", ""summary"": ""Shares of Amgen Inc. sank 0.99% to $303.48 Tuesday, on what proved to be an all-around poor trading session for the stock market, with the S&P 500 Index...""}, {""date"": ""20240116203200"", ""headline"": ""Amgen Options Trading: A Deep Dive into Market Sentiment"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20240116220000"", ""headline"": ""10 Stocks That Show Why Healthcare Stocks Are Hot in 2024"", ""summary"": ""The sector has seen one of the best starts to the year in decades, Goldman says.""}, {""date"": ""20240116223900"", ""headline"": ""Amgen Inc. stock outperforms competitors on strong trading day"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20240117003000"", ""headline"": ""Dividend Income Update December 2023"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20240117180017"", ""headline"": ""Amgen (AMGN) Ascends While Market Falls: Some Facts to Note"", ""summary"": ""Amgen (AMGN) closed the most recent trading day at $304.08, moving +0.2% from the previous trading session.""}, {""date"": ""20240117210600"", ""headline"": ""AMGN Dividend Yield Pushes Past 3%"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20240117223900"", ""headline"": ""Amgen Inc. stock rises Thursday, still underperforms market"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20240118000100"", ""headline"": ""The Art of Valuation: Discovering Amgen Inc's Intrinsic Value"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20240118041234"", ""headline"": ""Tourmaline Bio: Time For A Pause"", ""summary"": ""Tourmaline Bio's main asset, TOUR006, shows potential as a therapy for thyroid eye disease and atherosclerotic cardiovascular disease. Find out where the TRML stock will go in 2024.""}, {""date"": ""20240118071500"", ""headline"": ""QQQ ETF Update, 1/18/2024"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20240119014300"", ""headline"": ""Amgen price target raised by $36 at Piper Sandler, here's why"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20240119030000"", ""headline"": ""IYH: Healthcare Dashboard For January"", ""summary"": ""The healthcare sector is overvalued currenty, but with promising value scores. Click for my review of iShares U.S. Healthcare ETF (IYH).""}, {""date"": ""20240119035600"", ""headline"": ""FDA adds boxed warning to Amgen's Prolia"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20240119040400"", ""headline"": ""See Which Of The Latest 13F Filers Holds Amgen"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20240119053000"", ""headline"": ""Trump and Biden Both Hate Pharma\u2014Investors Shouldn\u2019t"", ""summary"": ""The drug sector just had one of its worst years ever relative to the S&P 500 and now faces political attacks, but investors should focus on the value.""}, {""date"": ""20240119055400"", ""headline"": ""FDA issues boxed warning for Amgen's osteoporosis drug"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}]",{}
